Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Cellular Response To Starvation R-HSA-9711097,-0.825595909469776,-2.9230091152182056,0.0,0.0,0.0,88/140,6.58%,RPS29;RPL38;RPL6;RPL27A;RPL21;ATP6V0C;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;ATP6V1G2;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;ATP6V0E2;RPL34;ATP6V1F;ATP6V1D;RPS17;RPL7A;RPS6;ATP6V0B;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;LAMTOR3;RPSA;LAMTOR2;FAU;RPL36A;IMPACT;RPL35;RPL22L1;ATP6V1G1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;ATP6V1A;RPL11;RPL22;EIF2S2;CEBPB;RPS16;RPL31;RPS5;RRAGA;UBA52;RPL7;RPL32;ATP6V1E1;CEBPG;LAMTOR1
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.7324523415270181,-2.914195188142175,0.0,0.0,0.0,95/196,6.78%,UBB;RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;PSMB3;PFN1;ELOB;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;PSMC6;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;PSMC1;PSMD2;RPL11;PSMA4;RPL22;UBC;PFN2;PSMB6;RPS16;GSPT2;RPL31;RPS5;CAP1;PSMA3;UBA52;PSMA7;NCK1;RPL7;RPL32;PSMA2;PPP3CB;ELOC;PSMC5;SEM1;PSMC3;PSMC2;UPF2
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.7508126203283625,-2.9046514937679744,0.0,0.0,0.0,80/171,8.04%,RPS29;RPL38;RPL6;RPL27A;LAS1L;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;SNU13;RPS16;RPL31;RPS5;UTP3;UBA52;RPL7;RPL32;RPP21;GNL3;UTP11;NOP58;RPS14;RPP38
gsea,Influenza Infection R-HSA-168255,-0.7907633038863153,-2.902708074802763,0.0,0.0,0.0,82/145,6.45%,RPS29;RPL38;HSP90AA1;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;CANX;RPL30;RPS15A;RAN;RPS12;RPL29;RPL36AL;RPL14;RPL9;PABPN1;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;POLR2G;CALR;CLTA;POLR2K;RPL11;TPR;RPL22;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32;GNL3;POLR2E
gsea,rRNA Processing R-HSA-72312,-0.721915606211479,-2.8995435077919143,0.0,0.0,0.0,79/191,5.85%,RPS29;RPL38;RPL6;RPL27A;LAS1L;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;NOP10;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;SNU13;RPS16;THUMPD1;TRMT112;RPL31;RPS5;UTP3;UBA52;RPL7;RPL32;RPP21;GNL3
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.7388435655748343,-2.890423836079648,0.0,0.0,0.0,79/181,5.85%,RPS29;RPL38;RPL6;RPL27A;LAS1L;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;NOP10;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;SNU13;RPS16;THUMPD1;TRMT112;RPL31;RPS5;UTP3;UBA52;RPL7;RPL32;RPP21;GNL3
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.8184777895182,-2.856976686684069,0.0,0.0,0.0,77/127,6.45%,RPS29;RPL38;HSP90AA1;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;POLR2G;POLR2K;RPL11;TPR;RPL22;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32;GNL3;POLR2E
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7820493795567847,-2.843868288498731,0.0,0.0,0.0,90/157,6.78%,UBB;RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;PSMB3;ELOB;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;PSMC6;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;PSMC1;PSMD2;RPL11;PSMA4;RPL22;UBC;PSMB6;RPS16;GSPT2;RPL31;RPS5;PSMA3;UBA52;PSMA7;RPL7;RPL32;PSMA2;ELOC;PSMC5;SEM1;PSMC3;PSMC2;UPF2
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.8723646497660296,-2.8289696473574693,0.0,0.0,0.0,78/108,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;EIF5;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;EIF3A;RPL11;RPL22;EIF5B;EIF2S2;EIF4A2;RPS16;RPL31;RPS5;EIF2B4;UBA52;EIF3C;RPL7;RPL32
gsea,Translation R-HSA-72766,-0.684037742238351,-2.8065540420658697,0.0,0.0,0.0,150/255,17.87%,RPS29;EEF1A1;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;EIF5;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;EEF1G;RPS12;RPL29;RPL36AL;RPL14;RPL9;MRPL53;RPSA;FAU;RPL36A;RPL35;EEF1B2;RPL22L1;RPS4X;RPL23A;RPS13;SPCS2;RPS11;RPS9;RPS2;RPL35A;EIF3A;RPL11;MRPL52;RPL22;MRPL46;EIF5B;EIF2S2;EIF4A2;MRPL38;RPS16;GSPT2;SSR3;TRMT112;RPL31;MARS2;MRPS17;MRPL23;RPS5;MRPL47;MRPS26;EIF2B4;MRPL41;MRPS5;UBA52;EIF3C;RPL7;RPL32;SEC61B;RPN2;AURKAIP1;SEC61G;SRP14;MRPL36;EIF2B1;MRPL57;RPS14;MRPL17;SSR4;MRPS14;EEF2;MRPL20;SSR1;SPCS1;MRPL11;MRPS31;MRPS10;AIMP1;OXA1L;MRPS16;SPCS3;MRPL35;MRPS15;MRPL18;MRPL50;EIF4H;SRPRB;SRP19;MRPL34;EEF1D;EIF4A1;MRPS2;MRPS9;MRPS33;MRPS22;MRPL43;EIF3K;EIF1AX;SSR2;PABPC1;MRPL4;YARS2;MTIF2;MRPL12;MRPL51;MARS1;SEC11C;MRPL15;MRPL55;MRPL42;CHCHD1;MRPS34
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.8589394210378264,-2.7965491918418364,0.0,0.0,0.0,73/106,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;PPP2R1A;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;GSPT2;RPL31;RPS5;UBA52;RPL7;RPL32
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.8756661650579323,-2.788202135651533,0.0,0.0,0.0,72/97,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;RPL31;RPS5;SEPHS2;UBA52;RPL7;RPL32
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.8864889719143619,-2.7788346918432065,0.0,0.0,0.0,77/101,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;EIF5;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;EIF3A;RPL11;RPL22;EIF5B;EIF2S2;EIF4A2;RPS16;RPL31;RPS5;UBA52;EIF3C;RPL7;RPL32
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.736835630108679,-2.7728090629761994,0.0,0.0,0.0,64/96,16.02%,COX7C;COX8A;COX6C;COX4I1;NDUFC1;NDUFB3;UQCRQ;NDUFA1;NDUFB1;UQCR10;COX19;UQCRFS1;NDUFS5;ATP5PB;COX6A1;COX5B;CYCS;NDUFB10;NDUFAF4;NDUFC2;NDUFA3;COX7B;NDUFAF7;NDUFA13;UQCR11;COX6B1;NDUFA5;UQCRB;NDUFB9;NDUFS8;NDUFB8;NDUFA7;NDUFB11;TMEM186;COX14;COX7A2L;NDUFB2;NDUFB6;COX5A;NDUFAB1;NDUFA6;NDUFS6;COX20;NDUFS2;NDUFS7;NDUFA2;NDUFV1;UQCRC2;NDUFB7;NDUFA12;NDUFB5;NDUFAF1;TMEM126B;SCO2;TIMMDC1;SURF1;NDUFA11;NDUFA10;CCNI;UQCRH;NDUFA8;NDUFS1;UQCRC1;NDUFV3
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.605669772197516,-2.7680641050182797,0.0,0.0,0.0,111/318,12.40%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;SERINC1;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;CKB;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;PSMB3;OAZ1;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;PSMC6;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;PSMC1;PSMD2;RPL11;PSMA4;RPL22;GLUL;PSMB6;RPS16;RPL31;RPS5;SEPHS2;PSMA3;NDUFAB1;UBA52;PSMA7;RPL7;RPL32;ALDH6A1;PSMA2;TDO2;PSMC5;SEM1;PSMC3;PSMC2;PHGDH;RPS14;PSPH;PSTK;PRODH;PCBD1;OAT;NAT8L;CHGA;CHDH;AIMP1;TXN2;PSMB5;PSMB7;GSTZ1;PDHX;SLC7A5;HNMT;ADO
gsea,Respiratory Electron Transport R-HSA-611105,-0.7517053220759743,-2.761604661863596,0.0,0.0,0.0,63/89,16.02%,COX7C;COX8A;COX6C;COX4I1;NDUFC1;NDUFB3;UQCRQ;NDUFA1;NDUFB1;UQCR10;COX19;UQCRFS1;NDUFS5;COX6A1;COX5B;CYCS;NDUFB10;NDUFAF4;NDUFC2;NDUFA3;COX7B;NDUFAF7;NDUFA13;UQCR11;COX6B1;NDUFA5;UQCRB;NDUFB9;NDUFS8;NDUFB8;NDUFA7;NDUFB11;TMEM186;COX14;COX7A2L;NDUFB2;NDUFB6;COX5A;NDUFAB1;NDUFA6;NDUFS6;COX20;NDUFS2;NDUFS7;NDUFA2;NDUFV1;UQCRC2;NDUFB7;NDUFA12;NDUFB5;NDUFAF1;TMEM126B;SCO2;TIMMDC1;SURF1;NDUFA11;NDUFA10;CCNI;UQCRH;NDUFA8;NDUFS1;UQCRC1;NDUFV3
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6730358951182764,-2.7424298002715726,0.0,0.0,0.0,72/142,13.39%,COX7C;COX8A;IDH3B;COX6C;COX4I1;NDUFC1;NDUFB3;UQCRQ;NDUFA1;NDUFB1;UQCR10;MDH2;COX19;UQCRFS1;NDUFS5;ATP5PB;COX6A1;BSG;COX5B;CYCS;NDUFB10;NDUFAF4;NDUFC2;LDHB;NDUFA3;COX7B;NDUFAF7;NDUFA13;UQCR11;COX6B1;NDUFA5;UQCRB;NDUFB9;NDUFS8;NDUFB8;NDUFA7;NDUFB11;TMEM186;COX14;GLO1;COX7A2L;NDUFB2;NDUFB6;COX5A;NDUFAB1;NDUFA6;HAGH;MPC2;NDUFS6;COX20;NDUFS2;NDUFS7;NDUFA2;NDUFV1;UQCRC2;PLPP6;NDUFB7;NDUFA12;SUCLG1;VDAC1;NDUFB5;NDUFAF1;TMEM126B;GSTZ1;SCO2;TIMMDC1;PDHX;SURF1;NDUFA11;NDUFA10;CCNI;UQCRH
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.8806965889264237,-2.7402148175005214,0.0,0.0,0.0,75/100,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;EIF3A;RPL11;RPL22;EIF2S2;EIF4A2;RPS16;RPL31;RPS5;UBA52;EIF3C;RPL7;RPL32
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.9052545445144308,-2.7385939272739335,0.0,0.0,0.0,73/91,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;EIF3A;RPL11;RPL22;RPS16;RPL31;RPS5;UBA52;EIF3C;RPL7;RPL32
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.8981885107509391,-2.7350583840860443,0.0,0.0,0.0,75/89,6.16%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;IMPACT;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;EIF2S2;CEBPB;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32;CEBPG
gsea,Complex I Biogenesis R-HSA-6799198,-0.7814431776999085,-2.708635402329602,0.0,0.0,0.0,39/50,16.93%,NDUFC1;NDUFB3;NDUFA1;NDUFB1;NDUFS5;NDUFB10;NDUFAF4;NDUFC2;NDUFA3;NDUFAF7;NDUFA13;NDUFA5;NDUFB9;NDUFS8;NDUFB8;NDUFA7;NDUFB11;TMEM186;NDUFB2;NDUFB6;NDUFAB1;NDUFA6;NDUFS6;NDUFS2;NDUFS7;NDUFA2;NDUFV1;NDUFB7;NDUFA12;NDUFB5;NDUFAF1;TMEM126B;TIMMDC1;NDUFA11;NDUFA10;NDUFA8;NDUFS1;NDUFV3;NDUFA9
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.9225035758491481,-2.704298903464611,0.0,0.0,0.0,73/84,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;GSPT2;TRMT112;RPL31;RPS5;UBA52;RPL7;RPL32
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.9102031798881408,-2.702995274466366,0.0,0.0,0.0,72/86,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;GSPT2;RPL31;RPS5;UBA52;RPL7;RPL32
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.911703988198059,-2.67187896175688,0.0,0.0,0.0,72/83,5.48%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;RPL31;RPS5;SEPHS2;UBA52;RPL7;RPL32
gsea,Viral mRNA Translation R-HSA-192823,-0.9029293609415386,-2.6586555923982953,0.0,0.0,0.0,72/84,5.85%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32;GNL3
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.9134247213224798,-2.6575806596014218,0.0,0.0,0.0,74/84,5.48%,RPS29;EEF1A1;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;EEF1G;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;EEF1B2;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.8546412163859803,-2.653202522958086,0.0,0.0,0.0,77/100,6.23%,RPS29;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;SPCS2;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;SSR3;RPL31;RPS5;UBA52;RPL7;RPL32;SEC61B;RPN2;SEC61G;SRP14
gsea,Peptide Chain Elongation R-HSA-156902,-0.9199611250786712,-2.6361563447361362,0.0,0.0,0.0,72/80,5.48%,RPS29;EEF1A1;RPL38;RPL6;RPL27A;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;RPL23;RPL5;RPL28;RPL15;RPL39;RPLP2;RPS10;RPL36;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;RPL12;RPL26;RPL3;RPS20;RPS15;RPL34;RPS17;RPL7A;RPS6;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;RPS13;RPS11;RPS9;RPS2;RPL35A;RPL11;RPL22;RPS16;RPL31;RPS5;UBA52;RPL7;RPL32
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.6225844665063685,-2.6154070288573488,0.0,0.0,0.0,61/82,28.82%,MRPL53;MRPL52;MRPL46;MRPL38;MRPS17;MRPL23;MRPL47;MRPS26;MRPL41;MRPS5;AURKAIP1;MRPL36;MRPL57;MRPL17;MRPS14;MRPL20;MRPL11;MRPS31;MRPS10;OXA1L;MRPS16;MRPL35;MRPS15;MRPL18;MRPL50;MRPL34;MRPS2;MRPS9;MRPS33;MRPS22;MRPL43;MRPL4;MRPL12;MRPL51;MRPL15;MRPL55;MRPL42;CHCHD1;MRPS34;MRPS18C;MRPL10;MRPL24;MRPL14;MRPS7;MRPL48;MRPS18B;MRPL33;MRPL40;MRRF;MRPS24;MRPS18A;MRPS21;MRPL3;MRPS30;MRPL54;MRPL39;MRPS36;MRPL58;MRPL19;GADD45GIP1;MRPL49
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.8239251174432163,-2.6105773300971093,0.0,0.0,0.0,32/52,5.07%,RPS29;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;RPS10;RPS25;RPS24;RPS3;RPS20;EIF5;RPS15;RPS17;RPS6;RPS15A;RPS12;RPSA;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;EIF3A;EIF2S2;EIF4A2;RPS16;RPS5;EIF3C
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.5839818961135265,-2.6017111100227117,0.0,0.0,0.0,42/162,6.02%,RPS29;HSP90AA1;HSP90AB1;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;YWHAE;YWHAH;RPS10;YWHAB;RPS25;RPS24;RPS3;YWHAG;YWHAZ;RPS20;GJA1;RPS15;RPS17;RPS6;SNRPG;RPS15A;RPS12;RPSA;SNRPF;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;TPR;UBE2N;CNBP;RPS16;RPS5;SNRPD2;AKT1
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.6222274411550519,-2.5978002561513756,0.0,0.0,0.0,61/82,28.82%,MRPL53;MRPL52;MRPL46;MRPL38;MRPS17;MRPL23;MRPL47;MRPS26;MRPL41;MRPS5;AURKAIP1;MRPL36;MRPL57;MRPL17;MRPS14;MRPL20;MRPL11;MRPS31;MRPS10;OXA1L;MRPS16;MRPL35;MRPS15;MRPL18;MRPL50;MRPL34;MRPS2;MRPS9;MRPS33;MRPS22;MRPL43;MRPL4;MRPL12;MRPL51;MRPL15;MRPL55;MRPL42;CHCHD1;MRPS34;MRPS18C;MRPL10;MRPL24;MRPL14;MRPS7;MRPL48;MRPS18B;MRPL33;MRPL40;MRPS24;MRPS18A;MRPS21;MRPL3;MRPS30;MRPL54;MRPL39;TSFM;MRPS36;MRPL58;MRPL19;GADD45GIP1;MRPL49
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.8596755070399461,-2.5965619714913046,0.0,0.0,0.0,30/45,5.07%,RPS29;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;RPS10;RPS25;RPS24;RPS3;RPS20;RPS15;RPS17;RPS6;RPS15A;RPS12;RPSA;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;EIF3A;EIF2S2;RPS16;RPS5;EIF3C
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.6428774926440208,-2.583956375634797,0.0,0.0,0.0,34/77,12.66%,COX7C;COX8A;COX6C;YWHAE;COX4I1;YWHAH;YWHAB;YWHAG;COX19;YWHAZ;PRDX5;COX6A1;COX5B;CYCS;COX7B;LAMTOR3;LAMTOR2;COX6B1;PRDX2;COX14;COX7A2L;COX5A;RRAGA;DDIT4;COX20;AKT1;LAMTOR1;MLST8;UBL4A;TXN2;RRM2B;SCO2;SURF1;AKT3
gsea,Axon Guidance R-HSA-422475,-0.5215091080077984,-2.576636242457602,0.0,0.0,0.0,124/484,7.98%,UBB;RPS29;RPL38;HSP90AA1;RPL6;HSP90AB1;RPL27A;ACTG1;RPL21;RPS21;RPS28;RPL37;RPLP1;RPS27;RPS23;RPL19;RPS8;RPS27A;RPS7;HSPA8;RPL23;RPL5;RPL28;PRNP;RPL15;RPL39;RPLP2;RPS10;RPL36;MYL6;RPL37A;RPL4;RPL18;RPL18A;RPL8;RPS25;RPL41;RPL27;RPL10A;RPS24;RPL13A;RPS3;EPHA7;RPL12;RPL26;RPL3;SEMA5A;RPS20;RPS15;RPL34;HRAS;CDK5R1;RPS17;RPL7A;RPS6;PSMB3;AP2M1;PFN1;ELOB;RHOB;RPL30;RPS15A;RPS12;RPL29;RPL36AL;RPL14;RPL9;PSMC6;RPSA;FAU;RPL36A;RPL35;RPL22L1;RPS4X;RPL23A;ACTR2;RPS13;RPS11;RPS9;RPS2;RPL35A;COL4A2;PSMC1;PSMD2;CLTA;RPL11;ARPC3;PSMA4;RPL22;UBC;ARPC2;PFN2;PSMB6;ARPC5;CLTB;RPS16;GSPT2;RPL31;RPS5;CAP1;GSK3B;PSMA3;MYL12B;UBA52;PSMA7;NCK1;EFNB3;RPL7;RPL32;DOK6;PSMA2;PPP3CB;ELOC;PSMC5;SEM1;PSMC3;PSMC2;RNMT;UPF2;TIAM1;YES1;PKN2;CSNK2B;RPS14
gsea,Mitochondrial Translation R-HSA-5368287,-0.6035748477470727,-2.563874770374068,0.0,0.0,0.0,63/88,28.82%,MRPL53;MRPL52;MRPL46;MRPL38;MRPS17;MRPL23;MRPL47;MRPS26;MRPL41;MRPS5;AURKAIP1;MRPL36;MRPL57;MRPL17;MRPS14;MRPL20;MRPL11;MRPS31;MRPS10;OXA1L;MRPS16;MRPL35;MRPS15;MRPL18;MRPL50;MRPL34;MRPS2;MRPS9;MRPS33;MRPS22;MRPL43;MRPL4;MTIF2;MRPL12;MRPL51;MRPL15;MRPL55;MRPL42;CHCHD1;MRPS34;MRPS18C;MRPL10;MRPL24;MRPL14;MRPS7;MRPL48;MRPS18B;MRPL33;MRPL40;MRRF;MRPS24;MRPS18A;MRPS21;MRPL3;MRPS30;MRPL54;MRPL39;TSFM;MRPS36;MRPL58;MRPL19;GADD45GIP1;MRPL49
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.6147685863005734,-2.5607897937336905,0.0,0.0,0.0,61/82,28.82%,MRPL53;MRPL52;MRPL46;MRPL38;MRPS17;MRPL23;MRPL47;MRPS26;MRPL41;MRPS5;AURKAIP1;MRPL36;MRPL57;MRPL17;MRPS14;MRPL20;MRPL11;MRPS31;MRPS10;OXA1L;MRPS16;MRPL35;MRPS15;MRPL18;MRPL50;MRPL34;MRPS2;MRPS9;MRPS33;MRPS22;MRPL43;MRPL4;MTIF2;MRPL12;MRPL51;MRPL15;MRPL55;MRPL42;CHCHD1;MRPS34;MRPS18C;MRPL10;MRPL24;MRPL14;MRPS7;MRPL48;MRPS18B;MRPL33;MRPL40;MRPS24;MRPS18A;MRPS21;MRPL3;MRPS30;MRPL54;MRPL39;MRPS36;MRPL58;MRPL19;GADD45GIP1;MRPL49
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.8075267244779756,-2.5603170710767995,0.0,0.0,0.0,31/53,5.07%,RPS29;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;RPS10;RPS25;RPS24;RPS3;RPS20;RPS15;RPS17;RPS6;RPS15A;RPS12;RPSA;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;EIF3A;EIF2S2;EIF4A2;RPS16;RPS5;EIF3C
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.8109901256861884,-2.5579849153079253,0.0,0.0,0.0,31/52,5.07%,RPS29;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;RPS10;RPS25;RPS24;RPS3;RPS20;RPS15;RPS17;RPS6;RPS15A;RPS12;RPSA;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;EIF3A;EIF2S2;EIF4A2;RPS16;RPS5;EIF3C
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.6153406615769833,-2.5338628733132618,0.0,0.0,0.0,41/79,22.29%,CALM1;UBB;PPIA;RPS27A;PPP3CA;PPP3R1;HRAS;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PPP3CB;PSMC5;FKBP1A;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;IKBKG;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;NFATC1;PSMD8;PSMB11
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.5615340532854656,-2.50299701806338,0.0,4.649260186472827e-05,0.001,53/106,24.84%,UBB;RPS27A;HMGB1;PSMB3;PSMC6;PELI2;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;IL1RAP;PSMC5;SEM1;PSMC3;PSMC2;SQSTM1;S100B;LRRC14;PELI1;TRAF6;MAP2K6;PSMB5;USP14;PSMB7;IKBKG;RBX1;CUL1;PSMB4;NKIRAS2;UBE2V1;PSMD7;PSMA1;IRAK1;PSMB8;PSMB2;PSMD14;IRAK2;PSMD6;IL1R2;PSMD8;PSMB11;MAP2K1;PSMB1;PSME2;NKIRAS1
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.8484402920721941,-2.4978422979047656,0.0,4.5385635153663314e-05,0.001,30/44,5.76%,RPS29;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;RPS10;RPS25;RPS24;RPS3;RPS20;RPS15;RPS17;RPS6;SNRPG;RPS15A;RPS12;RPSA;SNRPF;FAU;RPS4X;RPS13;RPS11;RPS9;RPS2;RPS16;RPS5;SNRPD2
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.5261525413669992,-2.490860142763878,0.0,4.433015526636881e-05,0.001,84/242,19.27%,UBB;RPS29;HSP90AA1;DDX5;HSP90AB1;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;YWHAE;YWHAH;RPS10;YWHAB;RPS25;RPS24;RPS3;YWHAG;YWHAZ;RPS20;GJA1;RPS15;RPS17;RPS6;SNRPG;CANX;RPS15A;RPS12;RPSA;SNRPF;FAU;RPS4X;CHMP2A;RPS13;RPS11;RPS9;RPS2;SDC4;TPR;ISCU;UBC;UBE2N;CNBP;RPS16;RPS5;GSK3B;UBA52;SNRPD2;RPN2;AKT1;CTSL;DAD1;RPS14;SAR1B;ISG15;TYK2;FURIN;TRAF6;AGRN;ZDHHC8;AKT3;IKBKG;ST6GALNAC2;MAP1LC3B;CAV1;FUT8;RB1;SNRPD3;B2M;ZCRB1;UBE2I;UBE2V1;SDC3;PARP6;MASP1;NUP54;IRAK1;SEC24A;NUP37;RPS19;DDOST;SNRPB
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.5937533256509503,-2.4737212259984793,0.0,4.33226517375877e-05,0.001,43/83,22.29%,UBB;RPS27A;PSMB3;PSMC6;PPP2R1A;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;TLE5;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CTBP2;TLE4;PPP2CA;PSMB5;PSMB7;FRAT1;RBX1;CTBP1;CUL1;PSMB4;HDAC1;CTNNB1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;AXIN2;PSMD8;TLE1;PSMB11
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.6326799489047558,-2.46245040973827,0.0,8.471985228683818e-05,0.001,35/62,24.34%,UBB;RPS27A;PSMB3;ELOB;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;HIF1A;PSMA2;ELOC;PSMC5;SEM1;PSMC3;PSMC2;UBE2D3;PSMB5;PSMB7;RBX1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.5407227411008477,-2.4544241489193865,0.0,8.287811636755909e-05,0.001,81/168,24.60%,UBB;COX7C;COX8A;COX6C;RPS27A;COX4I1;COX19;PRDX5;COX6A1;COX5B;CYCS;PSMB3;COX7B;PSMC6;COX6B1;PRDX2;MAFG;SKP1;PSMC1;PSMD2;PSMA4;COX14;UBC;PSMB6;COX7A2L;SRXN1;COX5A;GSK3B;PSMA3;UBA52;PSMA7;GPX1;COX20;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;PHGDH;SQSTM1;CSNK2B;ATF4;CYBA;UBL4A;SOD1;GSTP1;TXN2;PSMB5;PPARA;ATOX1;PSMB7;SCO2;SURF1;AKT3;SKP2;STAP2;P4HB;MAP1LC3B;RBX1;PRDX1;CUL1;PSMB4;CHD9;TBL1XR1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;HMOX1;PSMD8;PSMB11;SLC7A11;TKT;PSMB1;TXNRD1;PSME2;SOD3;SCO1
gsea,Iron Uptake And Transport R-HSA-917937,-0.6636109493217077,-2.4469310643330737,0.0,8.111475218952593e-05,0.001,21/51,10.78%,FTH1;UBB;ATP6V0C;RPS27A;ATP6V1G2;SLC22A17;ATP6V0E2;ATP6V1F;ATP6V1D;ATP6V0B;ATP6V1G1;ATP6V1A;SKP1;NEDD8;UBC;UBA52;ATP6V1E1;FBXL5;ATP6V1H;TFRC;IREB2
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.6394442001397337,-2.4462352913492604,0.0,7.94248615189108e-05,0.001,33/58,22.05%,SLC25A4;COX19;DNAJC19;COX17;TOMM6;CHCHD10;CHCHD2;TOMM20;NDUFB8;TIMM23;COQ2;HSPD1;TOMM5;TOMM7;HSPA9;COA6;TOMM22;CHCHD4;BCS1L;VDAC1;TIMM13;TIMM9;TIMM8B;CCNI;PMPCA;PAM16;MTX1;TIMM10;TIMM21;MTX2;TIMM17A;PMPCB;TIMM10B
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.6001621228612383,-2.446055150393159,0.0,7.780394597770853e-05,0.001,41/75,24.34%,UBB;RPS27A;H2AZ1;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;TCF12;PSMA7;H2AJ;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;CBFB;PSMB5;PSMB7;YAP1;CCNH;H2AZ2;PSMB4;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;MNAT1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.6110633582081766,-2.4453035357743165,0.0,7.624786705815436e-05,0.001,38/69,24.34%,UBB;RPS27A;PSMB3;ELOB;PSMC6;HIGD1A;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;HIF1A;PSMA2;ELOC;PSMC5;SEM1;PSMC3;PSMC2;UBE2D3;PSMB5;PSMB7;RBX1;CITED2;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;VEGFA;PSMD8;PSMB11;PSMB1;PSME2
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.641769678680087,-2.4426717873548367,0.0,7.47528108413278e-05,0.001,33/54,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.655140123832207,-2.4426092634185026,0.0,7.331525678668688e-05,0.001,32/53,20.32%,UBB;RPS27A;YWHAZ;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;FBXW7;PSMB5;PSMB7;RBX1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.609506508398694,-2.4380664369455247,0.0,7.193195005486261e-05,0.001,38/68,24.34%,UBB;RPS27A;ORC4;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ORC6;MCM6;PSMB5;PSMB7;SKP2;RBX1;ORC5;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6502546202502674,-2.4354738098746544,0.0,7.059987690569848e-05,0.001,33/51,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CDK4;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5805964353973188,-2.4321324691406545,0.0,6.931624278014034e-05,0.001,41/85,20.32%,UBB;RPS27A;HSPA8;YWHAB;YWHAZ;SET;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;ZFP36L1;SEM1;PSMC3;PSMC2;XPO1;PSMB5;PSMB7;ANP32A;EXOSC9;ELAVL1;PABPC1;PSMB4;DCP2;TNFSF13;HNRNPD;PSMD7;PSMA1;DCP1A;PSMB8;PSMB2;PSMD14;PSMD6
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.6280713156107263,-2.425410097624445,0.0,6.807845273049497e-05,0.001,36/58,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PRKACB;GLI2;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.6509586866147946,-2.4247049099847544,0.0,6.688409391066172e-05,0.001,13/47,8.76%,CALM1;VAMP2;YWHAE;YWHAH;YWHAB;YWHAG;YWHAZ;RALA;RAB14;AKT1;KIFAP3;RAB11A;EXOC3
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6300387802791013,-2.423208291902529,0.0,6.573091987771928e-05,0.001,36/58,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;GLI3;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PRKACB;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Protein Localization R-HSA-9609507,-0.5339005382675197,-2.421494537978903,0.0,6.461683648996133e-05,0.001,72/149,26.08%,UBB;SLC25A4;RPS27A;VAMP2;PRNP;COX19;DNAJC19;COX17;TOMM6;CHCHD10;CHCHD2;TOMM20;AGPS;SYCP2;NDUFB8;UBC;TIMM23;COQ2;HSPD1;TOMM5;TOMM7;NUDT19;UBA52;ZFAND6;HSPA9;COA6;TOMM22;SEC61B;SEC61G;ABCD3;CHCHD4;BCS1L;UBE2D3;VDAC1;TIMM13;UBL4A;LONP2;TIMM9;SERP1;TIMM8B;ACOX1;PEX19;CCNI;PMPCA;PAM16;PXMP4;BAG6;MTX1;PEX10;AMACR;VAPA;TIMM10;MPV17;PEX26;FIS1;TIMM21;MTX2;TIMM17A;ACBD5;PMPCB;CROT;HMOX1;TIMM10B;PIPOX;PECR;ATAD1;ECI2;DDO;CS;ABCD2;SLC25A13;ECH1
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5560409831294252,-2.4187156913139165,0.0,6.353988921512863e-05,0.001,50/106,25.81%,CALM1;UBB;PPIA;RPS27A;PPP3CA;PPP3R1;HRAS;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;NCK1;PSMA2;FBXW11;PPP3CB;AHCYL1;PSMC5;FKBP1A;SEM1;PSMC3;PSMC2;ORAI2;PSMB5;PSMB7;IKBKG;SOS1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;NFATC1;PSMD8;PSMB11;PSMB1;PSME2;BTK;MALT1;PSME3
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.6535133910560403,-2.417697276042189,0.0,6.249825168701178e-05,0.001,34/52,24.34%,UBB;RPS27A;PSMB3;ELOB;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;ELOC;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;CUL5;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.588739652550354,-2.413969865617888,0.0,9.2235323054219e-05,0.001,45/79,24.34%,UBB;RPS27A;YWHAZ;PSMB3;MAML2;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;ACTA2;MAML3;FBXW7;PSMB5;SNW1;PSMB7;PSENEN;HEY1;RBX1;CUL1;PSMB4;PSMD7;PSMA1;HES5;APH1B;PSMB8;PSMB2;PSMD14;PSMD6;KAT2B;PSMD8;APH1A;PSMB1;PSME2
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.6396290742834598,-2.41351604656253,0.0,9.077127030732663e-05,0.001,32/53,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.6268174053453157,-2.4084150548567167,0.0,8.935296920877466e-05,0.001,36/58,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CDK4;CDKN1B;PSMB5;PSMB7;SKP2;CUL1;PSMB4;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;PSMD14;PSMD6;CCNE2;PSMD8;PSMB1;PSME2
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.5998861866407039,-2.4083930063162393,0.0,8.797830814402427e-05,0.001,39/65,27.36%,UBB;RPS27A;HRAS;PSMB3;PSMC6;RASAL2;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;NF1;PSMB1;PSME2;PSME3;CUL3;SPRED3;RASA2
gsea,Protein Folding R-HSA-391251,-0.56921466412909,-2.4022898826827155,0.0,8.664530347517543e-05,0.001,39/84,21.72%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;GNG3;GNB2;CCT5;PFDN5;CCT7;TBCA;TUBA1B;TCP1;TUBB2B;CCT8;GNG7;CSNK2B;CCT6A;FBXW7;FBXL5;FBXW2;AP3M1;LONP2;CCT2;PFDN4;PFDN6;GNAQ;TUBB4A;TBCC;GNG10;ARL2;XRN2;CCT3;CCT4;PFDN2;GAPDHS;GNG11;TBCB;CCNE2;VBP1
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.6377952211126021,-2.391368518614814,0.0,8.535208999047131e-05,0.001,33/53,24.34%,UBB;RPS27A;HSPA8;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PABPC1;PSMB4;HNRNPD;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6450359182552442,-2.389991575138885,0.0,8.40969121964938e-05,0.001,30/51,20.32%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.549733886299931,-2.389954935320675,0.0,8.28781163675591e-05,0.001,41/95,22.29%,CALM1;UBB;RPS27A;PPP3CA;PPP3R1;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PPP3CB;AHCYL1;PSMC5;SEM1;PSMC3;PSMC2;TRAF6;PSMB5;PSMB7;IKBKG;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;NFATC1;PSMD8;PSMB11
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.6304038105194115,-2.389900368687795,0.0,8.169414327659397e-05,0.001,32/56,24.34%,UBB;HSP90AA1;HSP90AB1;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.6102367145480687,-2.382777045780342,0.0,0.00010739136205373853,0.002,33/60,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.5366572605876436,-2.38067047226415,0.0,0.00010589981535854772,0.002,53/119,22.29%,UBB;SLC25A4;PPIA;SLC25A5;RPS27A;NPM1;PSMB3;AP2M1;ELOB;RAN;PSMC6;PSIP1;SKP1;PSMC1;PSMD2;PSMA4;TPR;RANBP1;UBC;PSMB6;BANF1;PSMA3;UBA52;PSMA7;PSMA2;AP1S1;ELOC;PSMC5;SEM1;PSMC3;PSMC2;PKN2;ATP6V1H;XPO1;PSMB5;PSMB7;KPNA1;RBX1;B2M;AP2S1;PSMB4;NUP54;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;CUL5;PSMD14;PSMD6;AP2B1;PSMD8;PSMB11
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.6450599474235345,-2.380367179580971,0.0,0.00010444913295637584,0.002,31/49,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PKN2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,HIV Infection R-HSA-162906,-0.49763558902528093,-2.3736095431545134,0.0,0.00015455648728004263,0.002,92/211,24.43%,UBB;SLC25A4;PPIA;SLC25A5;RPS27A;NPM1;PSMB3;AP2M1;ELOB;RAN;PSMC6;CHMP2A;PSIP1;POLR2G;SKP1;PSMC1;PSMD2;POLR2K;PSMA4;TPR;RANBP1;UBC;PSMB6;TAF11;BANF1;PSMA3;UBA52;TCEA1;PSMA7;ERCC3;GTF2H5;PSMA2;AP1S1;ELOC;PSMC5;SEM1;PSMC3;POLR2E;PSMC2;RNMT;PKN2;VPS4A;CHMP5;ATP6V1H;XRCC6;XPO1;FURIN;NMT1;PSMB5;PSMB7;CCNK;GTF2F1;TAF7L;KPNA1;GTF2B;CCNH;TAF10;RBX1;VPS28;B2M;GTF2A1;AP2S1;CCNT2;PSMB4;XRCC4;NUP54;TAF13;POLR2F;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;CUL5;PSMD14;PSMD6;MNAT1;FEN1;POLR2L;AP2B1;NCBP2;CHMP4C;PSMD8;PSMB11;NELFB;VPS37D;POLR2D;PSMB1;GTF2F2;POLR2H;PSME2;NUP43
gsea,SARS-CoV Infections R-HSA-9679506,-0.4937762310442141,-2.3729474457119215,0.0,0.00015249573411630873,0.002,105/316,19.47%,ATP1B1;UBB;RPS29;HSP90AA1;DDX5;ATP1A2;HSP90AB1;RPS21;RPS28;RPS27;RPS23;RPS8;RPS27A;RPS7;YWHAE;YWHAH;RPS10;YWHAB;RPS25;RPS24;RPS3;YWHAG;YWHAZ;RPS20;GJA1;RPS15;RPS17;RPS6;SNRPG;AP2M1;CANX;RPS15A;RPS12;RPSA;SNRPF;FAU;RPS4X;CHMP2A;RPS13;RPS11;RPS9;RPS2;ATP1B2;SDC4;TPR;ISCU;UBC;UBE2N;CNBP;RPS16;RPS5;GSK3B;S1PR1;UBA52;NCK1;PTGES3;SNRPD2;RPN2;AKT1;CHD3;FKBP1A;CTSL;DAD1;RPS14;IFNGR2;SAR1B;FXYD1;ISG15;TYK2;FURIN;TRAF6;SIGMAR1;AGRN;ZDHHC8;AKT3;IKBKG;SOS1;ST6GALNAC2;MAP1LC3B;SAP18;CAV1;ITGA4;RBX1;FUT8;RB1;SNRPD3;B2M;ZCRB1;AP2S1;UBE2I;ROCK2;HDAC1;UBE2V1;SDC3;PARP6;MASP1;NUP54;IRAK1;SEC24A;NUP37;RPS19;FXYD2;DDOST;SNRPB;ATP1B3
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6420184881653946,-2.3728352952085134,0.0,0.00015048921129898887,0.002,31/50,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,mRNA Splicing - Major Pathway R-HSA-72163,-0.5129370342288823,-2.3686581158309914,0.0,0.00017329060695035083,0.002,86/180,24.61%,DDX5;HSPA8;HNRNPA2B1;SNRNP70;SRSF2;SNRPG;HNRNPA0;PABPN1;BCAS2;SNRPF;PCBP1;POLR2G;HNRNPA1;POLR2K;SRSF10;SNU13;HNRNPA3;LSM4;CWC15;PCBP2;SNRNP27;SNRPN;LSM7;PRPF19;SF3B5;HNRNPH1;SNRPD2;POLR2E;PRPF40A;SRSF9;SF3B6;SRSF7;PUF60;CPSF6;SYF2;WBP4;WBP11;TRA2B;HNRNPU;CDC40;SNRPB2;FIP1L1;U2SURP;PQBP1;U2AF1;DNAJC8;LSM8;HNRNPK;CSTF2T;SNW1;HNRNPH2;PRPF3;PCF11;CWC27;GTF2F1;SNRNP200;ELAVL1;SRSF1;SART1;SRSF11;U2AF1L4;MAGOHB;PRPF31;PHF5A;SNRPD3;SLU7;BUD31;PAPOLA;HNRNPD;POLR2F;RNPS1;SNRPB;ALYREF;POLR2L;NCBP2;U2AF2;XAB2;CWC22;SMNDC1;PRPF8;PRPF38A;POLR2D;DDX23;GTF2F2;POLR2H;CPSF2
gsea,Mitophagy R-HSA-5205647,-0.7528155921256499,-2.3661257794659285,0.0,0.00017106893250226944,0.002,16/27,14.32%,UBB;RPS27A;TOMM6;TOMM20;UBC;TOMM5;TOMM7;UBA52;TOMM22;SQSTM1;CSNK2B;VDAC1;MAP1LC3A;ATG12;MAP1LC3B;FUNDC1
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.5656665379697131,-2.3648536942103973,0.0,0.00021716164668461688,0.002,42/89,21.98%,UBB;RPS27A;ORC4;H2AZ1;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ORC6;ANAPC4;MCM6;PSMB5;PSMB7;CDC26;KPNA1;ORC5;H2AZ2;ANAPC16;PSMB4;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;UBE2E1;PSMD8
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.5654716413237065,-2.3617402721703153,0.0,0.0002144471261010592,0.002,41/81,21.98%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;CDK4;CDKN1B;PSMB5;PSMB7;AKT3;SKP2;CCNH;RB1;CUL1;PSMB4;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;E2F4;PSMD14;PSMD6;TFDP2;MNAT1;CCNE2;PSMD8
gsea,G1/S Transition R-HSA-69206,-0.5183932005540585,-2.359424957120601,0.0,0.00023533292301899497,0.002,52/123,21.98%,UBB;RPS27A;ORC4;PSMB3;PSMC6;PPP2R1A;SKP1;PSMC1;PSMD2;PSMA4;UBC;PCNA;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;ORC6;CDK4;MCM6;PPP2CA;CDKN1B;PSMB5;PSMB7;AKT3;SKP2;POLE3;CCNH;RPA3;RB1;ORC5;CUL1;PSMB4;HDAC1;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;E2F4;PSMD14;PSMD6;TFDP2;MNAT1;POLE4;CCNE2;PSMD8
gsea,mRNA Splicing R-HSA-72172,-0.5108859942916791,-2.358246648014469,0.0,0.0002324630093236414,0.002,89/188,24.61%,DDX5;HSPA8;HNRNPA2B1;SNRNP70;SRSF2;RNPC3;SNRPG;HNRNPA0;PABPN1;BCAS2;SNRPF;PCBP1;POLR2G;HNRNPA1;POLR2K;SRSF10;SNU13;HNRNPA3;LSM4;CWC15;PCBP2;SNRNP27;SNRPN;LSM7;PRPF19;SF3B5;HNRNPH1;SNRPD2;POLR2E;PRPF40A;SRSF9;SF3B6;SRSF7;PUF60;CPSF6;SYF2;WBP4;WBP11;TRA2B;HNRNPU;CDC40;SNRPB2;FIP1L1;U2SURP;PQBP1;U2AF1;DNAJC8;LSM8;HNRNPK;CSTF2T;SNW1;HNRNPH2;PRPF3;PCF11;CWC27;GTF2F1;SNRNP200;ELAVL1;SRSF1;SART1;SRSF11;U2AF1L4;MAGOHB;PRPF31;PHF5A;SNRPD3;ZCRB1;SLU7;BUD31;PAPOLA;HNRNPD;POLR2F;RNPS1;SNRPB;ALYREF;POLR2L;NCBP2;U2AF2;XAB2;CWC22;SMNDC1;PRPF8;PRPF38A;PDCD7;POLR2D;DDX23;GTF2F2;POLR2H;CPSF2
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.5683715145942239,-2.3562699306730712,0.0,0.00025262847519268015,0.002,40/76,25.81%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;TRAF6;PSMB5;PSMB7;IKBKG;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;MALT1;PSME3
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5827864889016728,-2.355627194997631,0.0,0.00024962099334514826,0.002,36/66,25.81%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;IKBKG;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;MALT1;PSME3
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.5813519052161373,-2.3552851618734167,0.0,0.0002466842757763818,0.002,44/77,24.34%,UBB;RPS27A;PSMB3;PSMC6;MAFG;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;SRXN1;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PHGDH;SQSTM1;ATF4;UBL4A;PSMB5;PSMB7;RBX1;PRDX1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;HMOX1;PSMD8;SLC7A11;TKT;PSMB1;TXNRD1;PSME2
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.5240048834558895,-2.3537499113123475,0.0,0.0002438158539650285,0.002,42/110,20.63%,CALM1;UBB;RPS27A;PPP3CA;PPP3R1;HRAS;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PPP3CB;AHCYL1;PSMC5;SEM1;PSMC3;PSMC2;PKN2;TRAF6;PSMB5;PSMB7;IKBKG;PRKACB;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;NFATC1
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.6354379060704515,-2.35316000792385,0.0,0.00024101337288497072,0.002,30/49,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.6115371982142237,-2.3524779373881874,0.0,0.0002382745845567324,0.002,33/58,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Regulation Of Apoptosis R-HSA-169911,-0.6251568125973812,-2.3486673638504647,0.0,0.00025701528221849784,0.002,31/52,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PKN2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Amyloid Fiber Formation R-HSA-977225,-0.6225593202605205,-2.342740445180589,0.0,0.0002753395199322241,0.002,16/48,12.12%,UBB;CST3;APOE;RPS27A;ITM2B;H2AZ1;CALB1;SORL1;SNCA;UBC;UBA52;APOA1;H2BC4;MFGE8;FURIN;PSENEN
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6108033288319745,-2.3330117103808554,0.0,0.0002932610271467476,0.002,34/55,26.46%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;DERL2;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;SYVN1;PSMB1;PSME2;PSME3;SEL1L
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.536332899604075,-2.3295144803517838,0.0,0.00029007340728645685,0.002,45/105,21.98%,UBB;RPS27A;ORC4;H2AZ1;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ORC6;ANAPC4;MCM6;PSMB5;PSMB7;CDC26;KPNA1;POLE3;RPA3;ORC5;H2AZ2;ANAPC16;PSMB4;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;POLE4;UBE2E1;PSMD8
gsea,Downstream TCR Signaling R-HSA-202424,-0.5561478143602684,-2.3294160981414644,0.0,0.00028695433839090353,0.002,39/80,25.81%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;TRAF6;PSMB5;PSMB7;IKBKG;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;MALT1;PSME3
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.5594475276729303,-2.329408003057712,0.0,0.00028390163266334075,0.002,35/78,21.72%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;GNG3;GNB2;CCT5;PFDN5;CCT7;TUBA1B;TCP1;TUBB2B;CCT8;GNG7;CSNK2B;CCT6A;FBXW7;FBXL5;FBXW2;AP3M1;LONP2;CCT2;PFDN4;PFDN6;GNAQ;TUBB4A;GNG10;XRN2;CCT3;CCT4;PFDN2;GAPDHS;GNG11;CCNE2;VBP1
gsea,G2/M Checkpoints R-HSA-69481,-0.5137677036861493,-2.329281678551741,0.0,0.00028091319442477927,0.002,51/126,25.81%,UBB;RPS27A;YWHAE;YWHAH;ORC4;YWHAB;YWHAG;YWHAZ;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ORC6;MCM6;BABAM2;PSMB5;PSMB7;RAD17;BRCC3;RPA3;ORC5;PSMB4;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;PSMD8;PSMB11;PSMB1;PSME2;RFC5;TOPBP1;RMI2;PSME3
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.5889118425708304,-2.328876503412513,0.0,0.0002779870153161878,0.002,37/62,26.46%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;DISP2;P4HB;NOTUM;DERL2;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;SYVN1;PSMB1;PSME2;PSME3;SEL1L
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.6046694780337918,-2.323455264845508,0.0,0.00029477268192585455,0.002,34/58,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PRKACB;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.7097460270592891,-2.320772473512291,0.0,0.00031121578391083413,0.002,8/25,1.19%,DYNLL1;DYNLL2;YWHAE;YWHAH;YWHAB;PPP3R1;YWHAG;YWHAZ
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.5534753493674247,-2.3203152416045563,0.0,0.00030807219013395703,0.002,41/88,22.29%,UBB;RPS27A;ORC4;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ORC6;ANAPC4;MCM6;PSMB5;PSMB7;CDC26;SKP2;RBX1;ORC5;CUL1;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;CCNE2;UBE2E1;PSMD8;PSMB11
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6031696657459433,-2.3158282097003045,0.0,0.00030499146823261745,0.002,34/56,26.46%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;DERL2;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;SYVN1;PSMB1;PSME2;PSME3;SEL1L
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.558227538812948,-2.311923198643007,0.0,0.0003019717507253638,0.002,39/78,24.82%,UBB;RPS27A;HMGB1;PSMB3;PSMC6;CALR;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;SEC61B;PSMA2;SEC61G;PSMC5;SEM1;PSMC3;PSMC2;NDUFA2;VAMP3;PSMB5;PSMB7;IKBKG;B2M;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;BTK
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.5479864883496571,-2.311627903784636,0.0,0.0002990112433653112,0.002,41/83,21.98%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;CDK4;CDKN1B;PSMB5;PSMB7;AKT3;SKP2;CCNH;RB1;CUL1;PSMB4;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;E2F4;PSMD14;PSMD6;TFDP2;MNAT1;CCNE2;PSMD8
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.5309903493570963,-2.3104399627403356,0.0,0.00029610822158506546,0.002,37/84,22.29%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;BIRC2;TNFRSF1A;PSMB5;PSMB7;TNFRSF12A;CUL1;PSMB4;EDARADD;TNFSF13;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;CD27;PSMD6;PSMD8;PSMB11
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.5408398623403405,-2.3099178228971713,0.0,0.00029326102714674753,0.002,50/98,24.34%,UBB;RPS27A;PSMB3;PSMC6;MAFG;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;SRXN1;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;PHGDH;SQSTM1;CSNK2B;ATF4;UBL4A;PSMB5;PSMB7;AKT3;SKP2;MAP1LC3B;RBX1;PRDX1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;HMOX1;PSMD8;PSMB11;SLC7A11;TKT;PSMB1;TXNRD1;PSME2
gsea,DNA Replication R-HSA-69306,-0.5122290006531605,-2.3069658619348066,0.0,0.00030862231904491054,0.002,63/133,27.19%,UBB;RPS27A;ORC4;H2AZ1;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PCNA;PSMB6;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;POLD4;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ORC6;ANAPC4;MCM6;PSMB5;PSMB7;CDC26;SKP2;KPNA1;POLE3;RBX1;RPA3;ORC5;H2AZ2;CUL1;ANAPC16;PSMB4;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;FEN1;POLE4;CCNE2;UBE2E1;GINS4;PSMD8;PSMB11;GINS2;PSMB1;PSME2;RFC5;PSME3;GINS1;MCM7;ANAPC10
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.7899411230681272,-2.3034245214851032,0.0,0.0003416767627605974,0.002,14/21,14.28%,UBB;RPS27A;TOMM6;TOMM20;UBC;TOMM5;TOMM7;UBA52;TOMM22;SQSTM1;VDAC1;MAP1LC3A;ATG12;MAP1LC3B
gsea,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.7657160464879638,-2.297934183427267,0.0,0.0003741133664068322,0.003,10/17,13.21%,UBB;RPS27A;UBC;UBE2N;UBA52;TLR3;BIRC2;UBE2D3;TRAF6;IKBKG
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5911761360037685,-2.2972412864072838,0.0,0.0003706493537549171,0.003,35/60,26.46%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;DERL2;RNF5;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;ERLIN2;PSMB1;PSME2;PSME3;SEL1L
gsea,Neddylation R-HSA-8951664,-0.47273019452542786,-2.2952152415282403,0.0,0.0003672489009681747,0.003,95/224,26.78%,UBB;RPS27A;COMMD3;PSMB3;ELOB;KLHL9;PSMC6;FBXL16;SKP1;DCAF6;PSMC1;PSMD2;PSMA4;NEDD8;UBC;KBTBD7;PSMB6;PSMA3;UBA52;PSMA7;COPS8;HIF1A;PSMA2;FBXW11;ELOC;DDA1;PSMC5;SEM1;PSMC3;KCTD6;PSMC2;SQSTM1;FBXL14;FBXO9;UBE2D3;DCAF17;FBXW7;FBXL5;COPS5;FBXW2;COPS7A;DCUN1D5;PSMB5;PSMB7;COPS6;LMO7;FBXL4;ASB13;BTBD1;SKP2;RNF7;WSB2;COMMD1;RBX1;FBXO15;KLHL25;CUL1;LRRC41;PSMB4;COMMD5;NAE1;PSMD7;PSMA1;PSMB8;PSMB2;CUL5;PSMD14;COMMD6;ASB14;PSMD6;COMMD8;KLHL22;PSMD8;ANKRD9;PSMB11;CCDC22;ASB11;FBXO44;TULP4;CCDC8;PSMB1;WSB1;FBXO27;PSME2;NUB1;PUM2;SPSB3;NEURL2;COMMD4;PSME3;SENP8;KLHL5;CUL3;EPAS1;FBXL8
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.6131625503031419,-2.2930131937301925,0.0,0.0003639102745957368,0.003,30/51,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.6517054575402839,-2.2920304237953277,0.0,0.00036063180365343285,0.003,15/36,11.69%,HSP90AA1;HSP90AB1;DYNLL1;DYNLL2;HSPA8;DNAJA1;CAPZA2;HSPA2;FKBP5;PTGES3;DNAJA2;NR3C2;DCTN1;DCTN3;DCTN4
gsea,Degradation Of AXIN R-HSA-4641257,-0.6044538336578478,-2.2916560610036125,0.0,0.00035741187683509864,0.003,34/54,26.14%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;TNKS;AXIN2;PSMD8;PSMB11;PSMB1;PSME2;PSME3;RNF146
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.5676197239492574,-2.2898406545985175,0.0,0.0003542489398719562,0.003,36/70,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;SKP2;RB1;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.5403118796783773,-2.2895553482363984,0.0,0.0003511414930309741,0.003,41/89,24.82%,UBB;RPS27A;HMGB1;PSMB3;PSMC6;CALR;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;SEC61B;PSMA2;SEC61G;PSMC5;SEM1;PSMC3;PSMC2;NDUFA2;CTSL;VAMP3;CYBA;PSMB5;PSMB7;IKBKG;B2M;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;BTK
gsea,G2/M Transition R-HSA-69275,-0.4866570854739494,-2.2866706488984163,0.0,0.0003480880887437482,0.003,73/173,26.23%,UBB;HSP90AA1;HSP90AB1;TUBA1A;DYNLL1;RPS27A;YWHAE;YWHAG;TUBA4A;PSMB3;PSMC6;PPP2R1A;NME7;TUBB4B;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;CETN2;SEM1;PSMC3;PSMC2;PHLDA1;DCTN1;PPP2CA;PLK4;XPO1;PSMB5;PSMB7;TUBB4A;DCTN3;CEP78;BORA;SSNA1;HAUS3;MZT1;CCNH;RBX1;CUL1;PSMB4;CEP135;PSMD7;PSMA1;ODF2;PSMB8;PSMB2;AKAP9;PSMD14;TUBG2;PSMD6;MNAT1;PCM1;ACTR1A;PSMD8;PSMB11;PRKAR2B;PSMB1;CENPF;PPME1;PSME2;CEP43;SDCCAG8;PSME3;HMMR;DYNC1I2
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.5090940468712097,-2.2843617454609353,0.0,0.00034508732935802626,0.003,56/125,25.81%,CALM1;UBB;RPS27A;PPP3CA;PPP3R1;JUN;HRAS;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PPP3CB;AHCYL1;PSMC5;SEM1;PSMC3;PSMC2;PKN2;MAPK3;TRAF6;PSMB5;PSMB7;IKBKG;SOS1;MAP2K7;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;MAPK1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;VAV3;NFATC1;PSMD8;PSMB11;PSMB1;PSME2;BTK;MAPK9;MALT1;PSME3
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.5518364835913524,-2.2838722694467597,0.0,0.0003421378650045388,0.003,37/77,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;BUB3;CUL1;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.5421557596867455,-2.2820613510161656,0.0,0.000339238391572297,0.003,39/83,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;SKP2;RB1;BUB3;CUL1;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.48456061674892525,-2.281317570516594,0.0,0.00033638764878597514,0.003,73/175,26.23%,UBB;HSP90AA1;HSP90AB1;TUBA1A;DYNLL1;RPS27A;YWHAE;YWHAG;TUBA4A;PSMB3;PSMC6;PPP2R1A;NME7;TUBB4B;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;FBXW11;PSMC5;CETN2;SEM1;PSMC3;PSMC2;PHLDA1;DCTN1;PPP2CA;PLK4;XPO1;PSMB5;PSMB7;TUBB4A;DCTN3;CEP78;BORA;SSNA1;HAUS3;MZT1;CCNH;RBX1;CUL1;PSMB4;CEP135;PSMD7;PSMA1;ODF2;PSMB8;PSMB2;AKAP9;PSMD14;TUBG2;PSMD6;MNAT1;PCM1;ACTR1A;PSMD8;PSMB11;PRKAR2B;PSMB1;CENPF;PPME1;PSME2;CEP43;SDCCAG8;PSME3;HMMR;DYNC1I2
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.7839672458630192,-2.2792661667447005,0.0,0.0003335844183794254,0.003,8/18,4.99%,UBB;EEF1A1;HSP90AA1;HSP90AB1;RPS27A;HSPA8;UBC;UBA52
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.6746159874237594,-2.275706712887382,0.0,0.0003465812139007017,0.003,8/28,5.99%,FTH1;HSP90AA1;APOE;HSP90B1;COL4A2;CALR;HSPH1;APOA1
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.5974625369868978,-2.2737958471944895,0.002044989775051125,0.0003437403842785648,0.003,19/54,10.16%,HSP90AA1;HSP90AB1;ACTG1;WIPF3;ACTR2;BAIAP2;ARPC3;ARPC2;ARPC5;ELMO2;NCK1;NCKAP1;CYFIP1;WASF1;ABI1;WASL;ABI2;MAPK3;ACTR3
gsea,Synthesis Of DNA R-HSA-69239,-0.5109690953751557,-2.2669670121255314,0.0,0.00038743834887273565,0.003,56/117,27.19%,UBB;RPS27A;ORC4;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PCNA;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;POLD4;PSMC5;SEM1;PSMC3;PSMC2;ORC6;ANAPC4;MCM6;PSMB5;PSMB7;CDC26;SKP2;POLE3;RBX1;RPA3;ORC5;CUL1;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;FEN1;POLE4;CCNE2;UBE2E1;GINS4;PSMD8;PSMB11;GINS2;PSMB1;PSME2;RFC5;PSME3;GINS1;MCM7;ANAPC10
gsea,ESR-mediated Signaling R-HSA-8939211,-0.4806016014616974,-2.266052351398894,0.0,0.00038431384605924583,0.003,54/154,21.83%,CALM1;HSP90AA1;DDX5;HSP90AB1;H2AZ1;JUN;HRAS;PPID;FKBP5;JUND;GNG3;POLR2G;POLR2K;GNB2;PTGES3;H2AJ;AKT1;GNG7;POLR2E;KCTD6;TGFA;H2BC4;CBFB;USF1;CDKN1B;XPO1;GPAM;MAPK3;IGF1R;SMC1A;GNG10;AKT3;GTF2F1;KANK1;S1PR3;ZDHHC21;CXCL12;CAV1;POU2F1;NR5A2;H2AZ2;GTF2A1;HDAC1;H2AX;POLR2F;CCND1;MAPK1;AGO3;GNG11;UHMK1;H2BC21;POLR2L;KDM1A;KAT2B
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.599132533039339,-2.262584102974019,0.0,0.00041173848211403357,0.003,27/46,25.81%,PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;PSMB6;PSMA3;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;PSME3
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.5718875532733106,-2.2623234751828316,0.0,0.00040847071638296984,0.003,34/65,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.5729602861217141,-2.2621449098226347,0.0,0.0004052544115295606,0.003,32/62,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CDKN1B;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;CCNE2;PSMD8;PSMB11;PSMB1;PSME2
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.551206843723034,-2.261015168541808,0.0,0.0004020883614394859,0.003,35/71,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;CCNE2;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.566586004353872,-2.257213245321637,0.0,0.00041374811581944233,0.004,38/67,26.14%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;CSNK2B;PSMB5;PREX2;PSMB7;AKT3;STUB1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;TNKS;PSMD8;PSMB11;PSMB1;PSME2;PSME3;RNF146
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.573010946164235,-2.2552548921805506,0.0,0.00041056543800544663,0.004,33/62,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB1;PSME2
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.618190207751989,-2.2544907083265096,0.0,0.000407431350692428,0.004,14/39,9.93%,YWHAE;YWHAH;MYL6;YWHAB;H2AZ1;YWHAG;YWHAZ;RHOB;MYL12B;H2AJ;H2BC4;KDM4C;PKN2;MYL9
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.5576540426473258,-2.2538592143879477,0.0,0.00041878563346334793,0.004,35/69,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;BUB3;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Selective Autophagy R-HSA-9663891,-0.5868324464394703,-2.252027700011417,0.0,0.0004156368693019694,0.004,21/58,14.32%,UBB;HSP90AA1;DYNLL1;RPS27A;DYNLL2;HSPA8;TOMM6;TOMM20;UBC;UBE2N;TOMM5;TOMM7;UBA52;TOMM22;SQSTM1;CSNK2B;VDAC1;MAP1LC3A;ATG12;MAP1LC3B;FUNDC1
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.5949497677269572,-2.244627933572812,0.0,0.0004125351016206114,0.004,18/52,13.80%,COX7C;COX8A;COX6C;COX4I1;COX19;COX6A1;COX5B;CYCS;COX7B;COX6B1;COX14;COX7A2L;COX5A;COX20;PPARA;SCO2;SURF1;STAP2
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.552120788264158,-2.244137652048859,0.0,0.0004094792860530513,0.004,35/70,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;BUB3;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Stabilization Of P53 R-HSA-69541,-0.5900163650672015,-2.240222620433154,0.0,0.00042048456098246897,0.004,30/54,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.5290716529717534,-2.238156331003494,0.0,0.00043132917496401196,0.005,41/81,25.81%,UBB;RPS27A;JUN;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;SEPTIN7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PKN2;CDC42EP3;XPO1;PSMB5;PSMB7;PRKACB;PSMB4;PSMD7;PSMA1;ETV4;AGO3;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;FOXO1;PSME2;TNRC6C;PSME3
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.4835726372758505,-2.2335634199034695,0.0,0.00042820360123238874,0.005,52/139,21.22%,UBB;RPS27A;ORC4;PSMB3;PSMC6;PPP2R1A;SKP1;PSMC1;PSMD2;PSMA4;UBC;PCNA;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;ORC6;CDK4;MCM6;PPP2CA;CDKN1B;PSMB5;CDKN2D;PSMB7;AKT3;SKP2;POLE3;CCNH;RPA3;RB1;ORC5;CUL1;PSMB4;HDAC1;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;E2F4;PSMD14;PSMD6;TFDP2;MNAT1;POLE4;CCNE2
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6981519050921063,-2.2314298443649023,0.0,0.00042512299978467367,0.005,10/20,13.21%,UBB;RPS27A;UBC;UBE2N;UBA52;NDUFA2;BIRC2;UBE2D3;TRAF6;IKBKG
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.5453234381935296,-2.2309478840244594,0.0,0.0004220864069290688,0.005,35/72,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;BUB3;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.7254750447120364,-2.2298336961720207,0.0,0.00041909288631255057,0.005,19/25,17.40%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;CCT5;PFDN5;CCT7;TUBA1B;TCP1;TUBB2B;CCT8;CCT6A;CCT2;PFDN4;PFDN6;TUBB4A;CCT3;CCT4;PFDN2
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.5411006040013749,-2.228654819750023,0.0,0.00041614152795823683,0.005,35/73,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PSMB5;PSMB7;CDC26;BUB3;ANAPC16;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;PSMB11;PSMB1;PSME2
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.5266293506548434,-2.2237999370393204,0.0,0.00041323144734314426,0.005,23/84,12.53%,UBB;HSP90AA1;TUBA1A;DYNLL1;RPS27A;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;SKP1;UBC;UBA52;FBXW11;CETN2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;BORA;SSNA1;HAUS3
gsea,HSF1 Activation R-HSA-3371511,-0.6856758638238396,-2.2233038054744694,0.0,0.00041036178451437245,0.005,8/26,5.53%,UBB;EEF1A1;HSP90AA1;HSP90AB1;YWHAE;HSBP1;HSPH1;PTGES3
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.6336254878446326,-2.220867476826532,0.0,0.0004338240711929473,0.006,12/33,10.84%,UBB;HSP90AA1;HSP90AB1;HSPA8;HSPA2;CAMK2B;HSBP1;CRYAB;HSPH1;PTGES3;MLST8;MRPL18
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.4437937088859448,-2.2205880201664776,0.0,0.0004308526734450504,0.006,119/318,25.80%,UBB;COX7C;COX8A;COX6C;RPS27A;YWHAE;COX4I1;YWHAH;YWHAB;YWHAG;COX19;YWHAZ;JUN;PRDX5;NPM1;CDK5R1;COX6A1;COX5B;CYCS;ELOB;COX7B;LAMTOR3;PPP2R1A;LAMTOR2;COX6B1;POLR2G;PRDX2;POLR2K;CNOT4;COX14;UBC;PCNA;TAF11;COX7A2L;CNOT6L;COX5A;RRAGA;UBA52;TCEA1;PRELID3A;DDIT4;ERCC3;GTF2H5;COX20;AKT1;ELOC;CHD3;POLR2E;LAMTOR1;PDZD2;BNIP3L;CSNK2B;RABGGTB;MLST8;CNOT8;PPP2CA;UBL4A;TRIAP1;CDKN1B;TXN2;MAP2K6;RRM2B;ING3;KMT5A;SCO2;SURF1;CCNK;CDK13;AKT3;GTF2F1;BRD7;TAF7L;RAD17;CCNH;TAF10;MLH1;PRELID1;LAMTOR5;PRDX1;PLK2;RGCC;RPA3;GADD45A;MSH2;CCNG1;NOC2L;CCNT2;CDK5;CNOT2;BBC3;HDAC1;TAF13;POLR2F;AGO3;E2F4;PIP4K2A;TFDP2;MNAT1;POLR2L;CCNE2;PIP4P1;NELFB;APAF1;HDAC2;STEAP3;POLR2D;USP2;TXNRD1;GTF2F2;POLR2H;SCO1;LAMTOR4;RBL1;KAT6A;TNRC6C;RFC5;TOPBP1;RMI2;BCL6
gsea,p75NTR Signals Via NF-kB R-HSA-193639,-0.7611132070425785,-2.2194635475698665,0.0,0.00042792170287739696,0.006,7/15,10.73%,UBB;RPS27A;UBC;UBA52;SQSTM1;TRAF6;PRKCI
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.4837501864392264,-2.218858281141471,0.0,0.0004250303400201173,0.006,70/131,32.75%,UBB;RPS27A;HMGB1;PSMB3;PSMC6;PELI2;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;IL1RAPL1;FBXW11;IL1RAP;PSMC5;SEM1;PSMC3;PSMC2;SQSTM1;S100B;LRRC14;PELI1;TRAF6;MAP2K6;PSMB5;USP14;PSMB7;IKBKG;RBX1;CUL1;PSMB4;NKIRAS2;UBE2V1;PSMD7;PSMA1;IRAK1;PSMB8;PSMB2;PSMD14;IRAK2;PSMD6;IL1R2;PSMD8;PSMB11;MAP2K1;PSMB1;PSME2;NKIRAS1;PTPN12;PSME3;GSDMD;IRAK4;SMAD3;TIFA;NFKB2;TANK;PTPN20;IL18;PSME1;PTPN4;PSMD4;PTPN11;TAB3;PSMF1
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.6613930369793504,-2.218286269852204,0.001968503937007874,0.0004221777874025326,0.006,16/33,10.16%,ACTG1;WIPF3;ACTR2;BAIAP2;ARPC3;ARPC2;ARPC5;NCK1;NCKAP1;CYFIP1;WASF1;ABI1;WASL;ABI2;MAPK3;ACTR3
gsea,M Phase R-HSA-68886,-0.4445087830647223,-2.2164445602145704,0.0,0.00041936326881984905,0.006,122/330,24.50%,UBB;HSP90AA1;TUBA1A;TUBB2A;DYNLL1;RPS27;RPS27A;DYNLL2;YWHAE;H2AZ1;YWHAG;TUBA4A;SET;PSMB3;RAN;PSMC6;PPP2R1A;CHMP2A;NME7;TUBB4B;ITGB3BP;PSMC1;PSMD2;PSMA4;TPR;UBC;PSMB6;BANF1;RAB2A;TUBA1B;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;PSMC5;CETN2;TUBB2B;SEM1;PSMC3;PSMC2;H2BC4;CSNK2B;ARPP19;VPS4A;ANAPC4;DCTN1;PPP2CA;NCAPD2;PLK4;XPO1;MAPK3;PDS5B;PSMB5;NUDC;PSMB7;TUBB4A;DCTN3;CEP78;RAB1B;KMT5A;SMC1A;NEK7;NUF2;PDS5A;SSNA1;HAUS3;TAOK1;CENPP;CDC26;MZT1;KIF23;AHCTF1;RB1;BUB3;H2AZ2;RAB33B;ZWINT;ANAPC16;PSMB4;BLZF1;CEP135;CENPE;UBE2I;GORASP2;H2AX;USO1;NUP54;RCC2;PSMD7;PSMA1;NUP37;ODF2;MAPK1;PSMB8;PSMB2;AKAP9;PSMD14;TUBG2;PSMD6;H2BC21;VRK1;PCM1;ENSA;UBE2E1;ACTR1A;CHMP4C;PSMD8;SUMO1;NDEL1;PSMB11;PRKAR2B;MIS12;TUBB6;PSMB1;CNEP1R1;CENPF;KIF2A;SPAST;PSME2;NUP43;CEP43
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.5995481557481938,-2.2149504012106935,0.0,0.00041658602862898914,0.006,20/40,20.82%,H2AZ1;POLR2K;CBX3;H2AJ;ERCC3;GTF2H5;POLR2E;H2BC4;TAF1D;POLR1H;UBTF;CCNH;H2AZ2;POLR1D;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.5564046553477772,-2.2122611392006877,0.0,0.0004263860986804685,0.006,32/64,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CDKN1B;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;CCNE2;PSMD8;PSMB11;PSMB1;PSME2
gsea,Autophagy R-HSA-9612973,-0.49653643308463175,-2.21193200335289,0.0,0.00042359926143419095,0.006,37/122,14.97%,UBB;EEF1A1;HSP90AA1;HSP90AB1;DYNLL1;RPS27A;DYNLL2;HSPA8;GABARAP;TOMM6;LAMTOR3;LAMTOR2;GABARAPL1;TOMM20;CHMP2A;GABARAPL2;UBC;UBE2N;TOMM5;TOMM7;RRAGA;UBA52;TOMM22;LAMTOR1;SQSTM1;CSNK2B;MLST8;VDAC1;ATG9A;MAP1LC3A;GFAP;ATG12;MAP1LC3B;FUNDC1;ATG101;LAMTOR5;VPS28
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5428801657302489,-2.2097691652185913,0.0,0.00042084861687942344,0.006,41/69,26.10%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CBFB;FBXW7;PSMB5;PSMB7;SKP2;RBX1;STUB1;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;WWP1;PSME3;DLX6
gsea,S Phase R-HSA-69242,-0.47312923519977906,-2.2092529941931027,0.0,0.0004181334645124594,0.006,64/156,22.62%,UBB;RPS27A;ORC4;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PCNA;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;AKT1;POLD4;PSMC5;SEM1;PSMC3;PSMC2;ORC6;CDK4;ANAPC4;MCM6;CDKN1B;PDS5B;PSMB5;PSMB7;SMC1A;PDS5A;AKT3;CDC26;SKP2;ESCO1;POLE3;CCNH;RBX1;RPA3;RB1;ORC5;CUL1;ANAPC16;PSMB4;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;E2F4;PSMD14;PSMD6;TFDP2;MNAT1;FEN1;POLE4;CCNE2;UBE2E1;GINS4;PSMD8;PSMB11;GINS2
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.4650829171468274,-2.2055851805472377,0.0,0.0004521107501845692,0.008,124/236,31.96%,DDX5;HSPA8;HNRNPA2B1;SNRNP70;SRSF2;RNPC3;SNRPG;HNRNPA0;PABPN1;BCAS2;SNRPF;PCBP1;POLR2G;HNRNPA1;POLR2K;TPR;SRSF10;SNU13;HNRNPA3;LSM4;CWC15;PCBP2;SNRNP27;SNRPN;LSM7;PRPF19;SF3B5;HNRNPH1;SNRPD2;FYTTD1;POLR2E;PRPF40A;SRSF9;SF3B6;SRSF7;PUF60;CPSF6;SYF2;WBP4;WBP11;TRA2B;HNRNPU;CDC40;SNRPB2;FIP1L1;U2SURP;PQBP1;U2AF1;DNAJC8;LSM8;THOC2;HNRNPK;CSTF2T;METTL14;SNW1;HNRNPH2;PRPF3;PCF11;CWC27;GTF2F1;SNRNP200;ELAVL1;SRSF1;SART1;SRSF11;U2AF1L4;MAGOHB;PRPF31;PHF5A;SNRPD3;ZCRB1;ZC3H11A;SLU7;BUD31;SARNP;PAPOLA;NUP54;HNRNPD;POLR2F;NUP37;THOC1;RNPS1;SNRPB;ALYREF;POLR2L;NCBP2;U2AF2;XAB2;CWC22;SMNDC1;PRPF8;PRPF38A;PDCD7;POLR2D;DDX23;GTF2F2;POLR2H;NUP43;CPSF2;SNRNP25;SF3B3;EIF4E;LSM2;SF1;SEC13;LSM3;SF3B1;NUP153;MAGOH;CHERP;SRSF3;GLE1;RBM8A;PLRG1;TFIP11;DDX42;PPIL4;PPIL3;THOC3;RBM42;NUDT21;NXT1;SRSF6;SEH1L
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.5597407814321619,-2.2024034686974305,0.0,0.000485655204192066,0.011,34/62,24.34%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PARD6A;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;FZD2;FZD1;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;FZD9;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2
gsea,ABC Transporter Disorders R-HSA-5619084,-0.5348081440810172,-2.1892932983450786,0.0,0.0005187750448576959,0.012,37/75,26.75%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;APOA1;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;DERL2;RNF5;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;ERLIN2;PSMB1;PSME2;PSME3;SEL1L;LMBRD1
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.5742890441751352,-2.18680099166185,0.0,0.0005155123087265154,0.012,28/49,25.65%,SRSF2;RNPC3;SNRPG;SNRPF;POLR2G;POLR2K;SF3B5;SNRPD2;POLR2E;SF3B6;SRSF7;GTF2F1;SNRNP200;SRSF1;SNRPD3;ZCRB1;POLR2F;SNRPB;POLR2L;NCBP2;PRPF8;PDCD7;POLR2D;DDX23;GTF2F2;POLR2H;SNRNP25;SF3B3
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.7671920251951013,-2.186440738912885,0.0,0.0005122903567969747,0.012,7/15,6.02%,YWHAE;YWHAH;YWHAB;PPP3R1;YWHAG;YWHAZ;AKT1
gsea,TCR Signaling R-HSA-202403,-0.5035232923654567,-2.1805981368188965,0.0,0.0005801468145729137,0.015,42/101,25.81%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;NCK1;PSMA2;FBXW11;PSMC5;SEM1;PSMC3;PSMC2;PKN2;TRAF6;PSMB5;PSMB7;IKBKG;ENAH;CUL1;PSMB4;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;MALT1;PSME3
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.4883795242023042,-2.178448543921396,0.0,0.0006236322460003367,0.016,47/107,20.32%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;GLI3;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;CBFB;YES1;CDK4;FBXW7;MAPK3;PSMB5;PSMB7;YAP1;AKT3;SOX9;SKP2;HEY1;RBX1;RB1;STUB1;GLI2;CUL1;PSMB4;PSMD7;PSMA1;CCND1;MAPK1;PSMB8;PSMB2;PSMD14;PSMD6
gsea,Apoptosis R-HSA-109581,-0.4776331837183052,-2.177361475409375,0.0,0.0006198062813009481,0.016,64/155,24.34%,UBB;DYNLL1;RPS27A;DYNLL2;YWHAE;YWHAH;MAGED1;YWHAB;HMGB1;PPP3R1;YWHAG;YWHAZ;CYCS;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;GSDME;UBA52;PSMA7;C1QBP;PSMA2;AKT1;PSMC5;DNM1L;SEM1;PSMC3;PSMC2;NDUFA2;BIRC2;PKN2;MAPK3;NMT1;PSMB5;PSMB7;DFFB;AKT3;KPNA1;UACA;FADD;PSMB4;BBC3;APPL1;CTNNB1;PSMD7;PSMA1;MAPK1;PSMB8;PSMB2;PSMD14;PSMD6;TFDP2;BAD;BAK1;PSMD8;PSMB11;APAF1;PSMB1;DIABLO;PSME2
gsea,Degradation Of DVL R-HSA-4641258,-0.5739776040673099,-2.177194064290612,0.0,0.0006276501251738317,0.017,33/55,26.54%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;PSME3;CUL3
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7619599352150213,-2.1739286900796566,0.0,0.0006353988921512865,0.017,15/19,16.22%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;CCT5;CCT7;TUBA1B;TCP1;TUBB2B;CCT8;CCT6A;CCT2;TUBB4A;CCT3;CCT4
gsea,Macroautophagy R-HSA-1632852,-0.49548150012994463,-2.1706745357649093,0.0,0.0006545374129992167,0.018,33/109,14.81%,UBB;HSP90AA1;DYNLL1;RPS27A;DYNLL2;HSPA8;GABARAP;TOMM6;LAMTOR3;LAMTOR2;GABARAPL1;TOMM20;CHMP2A;GABARAPL2;UBC;UBE2N;TOMM5;TOMM7;RRAGA;UBA52;TOMM22;LAMTOR1;SQSTM1;CSNK2B;MLST8;VDAC1;ATG9A;MAP1LC3A;ATG12;MAP1LC3B;FUNDC1;ATG101;LAMTOR5
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.6877299647862254,-2.1698756792494187,0.0,0.0006506180272926347,0.018,7/21,6.50%,UBB;HSP90AA1;RPS27A;HRAS;UBC;UBA52;TGFA
gsea,Programmed Cell Death R-HSA-5357801,-0.463279755220338,-2.16793898681119,0.0,0.000669438118516534,0.018,67/180,22.29%,UBB;HSP90AA1;DYNLL1;RPS27A;DYNLL2;YWHAE;YWHAH;MAGED1;YWHAB;HMGB1;PPP3R1;YWHAG;YWHAZ;CYCS;PSMB3;PSMC6;CHMP2A;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;GSDME;UBA52;PSMA7;C1QBP;GNL3;PSMA2;AKT1;PSMC5;DNM1L;SEM1;PSMC3;PSMC2;NDUFA2;BIRC2;PKN2;PELI1;MAPK3;NMT1;PSMB5;PSMB7;DFFB;AKT3;KPNA1;STUB1;UACA;FADD;PSMB4;BBC3;APPL1;CTNNB1;SDCBP;PSMD7;PSMA1;MAPK1;PSMB8;PSMB2;PSMD14;PSMD6;TFDP2;BAD;BAK1;CHMP4C;PSMD8;PSMB11
gsea,Attenuation Phase R-HSA-3371568,-0.6899784955470203,-2.1675427599040673,0.0,0.0006767562164924944,0.018,8/23,5.53%,UBB;HSP90AA1;HSP90AB1;HSPA8;HSPA2;HSBP1;HSPH1;PTGES3
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.7210291052828546,-2.167518889331278,0.0,0.0006839882191981496,0.019,18/23,17.40%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;CCT5;PFDN5;CCT7;TCP1;TUBB2B;CCT8;CCT6A;CCT2;PFDN4;PFDN6;TUBB4A;CCT3;CCT4;PFDN2
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.5711109092491026,-2.166305529199418,0.0,0.0006799882880917275,0.019,19/43,21.22%,UBB;RPS27A;PPP2R1A;SKP1;UBC;UBA52;CDK4;PPP2CA;CDKN1B;CDKN2D;SKP2;CCNH;RB1;CUL1;CCND1;E2F4;TFDP2;MNAT1;CCNE2
gsea,UCH Proteinases R-HSA-5689603,-0.5069906670898348,-2.164915855951166,0.0,0.0006760348678121245,0.019,39/87,26.07%,UBB;RPS27A;MBD5;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;NEDD8;UBC;PSMB6;PSMA3;H2AC25;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;UCHL1;PSMB5;RUVBL1;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;FOXK1;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;PSME3;SENP8;TGFB1
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.49779468844604746,-2.1595334418107286,0.0,0.0007051825855089421,0.021,24/91,12.23%,UBB;EEF1A1;HSP90AA1;HSP90AB1;YWHAE;HSPA8;HSPA2;CAMK2B;HSBP1;HSPA5;CRYAB;TPR;BAG4;GSK3B;HSPA9;HSPH1;PTGES3;HSPA4;MLST8;CCAR2;MAPK3;MRPL18;HSPA4L;BAG1
gsea,Hedgehog Off State R-HSA-5610787,-0.49693845957231614,-2.1582414551140223,0.0,0.0007120849653419589,0.021,42/96,24.34%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;GLI3;PSMA4;UBC;PSMB6;PRKAR1A;GSK3B;PSMA3;UBA52;PSMA7;GNAS;ADCY9;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;RBX1;PRKACB;GLI2;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;KIF3A;PSMD8;PSMB11;PRKAR2B;PSMB1;PSME2
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.4996067948067735,-2.1538058191577747,0.0,0.0007624786705815436,0.021,44/95,26.46%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;EIF2S2;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;ABCB7;APOA1;PSMC5;SEM1;PSMC3;PSMC2;ABCD3;ABCB10;PSMB5;PSMB7;PEX19;DERL2;RNF5;PSMB4;PSMD7;PSMA1;ABCC4;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;ERLIN2;PSMB1;ABCA2;PSME2;ABCD2;PSME3;SEL1L
gsea,Signaling By FGFR3 R-HSA-5654741,-0.5935905156968693,-2.151944972799859,0.0,0.0007581464054077848,0.021,12/36,14.03%,UBB;RPS27A;HRAS;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;FGFR3;SOS1;FGF1
gsea,Aggrephagy R-HSA-9646399,-0.6772017568129899,-2.1499449495633347,0.0,0.0007538630923828821,0.021,8/23,4.99%,UBB;HSP90AA1;DYNLL1;RPS27A;DYNLL2;UBC;UBE2N;UBA52
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.46519393369200696,-2.1476378738607766,0.0,0.0007496279064706187,0.021,54/136,22.29%,CALM1;UBB;RPS27A;PPP3CA;PPP3R1;PSMB3;AP2M1;PFN1;PSMC6;GNG3;PSMC1;PSMD2;CLTA;PSMA4;GNB2;UBC;PSMB6;CLTB;PLCB1;PARD6A;PSMA3;UBA52;PSMA7;PSMA2;PPP3CB;PSMC5;GNG7;SEM1;PSMC3;PSMC2;FZD2;FZD1;PSMB5;PSMB7;GNG10;AP2S1;PSMB4;CTNNB1;PSMD7;PSMA1;RHOA;AGO3;PSMB8;PSMB2;GNG11;FZD9;PSMD14;PSMD6;NFATC1;AP2B1;AXIN2;PSMD8;PLCB2;PSMB11
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.4908062571346339,-2.146923747430997,0.0,0.0007560891845152179,0.021,32/91,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.5374867449642653,-2.1448307597934666,0.0,0.000794248615189108,0.024,27/57,24.32%,H2AZ1;POLR2K;CBX3;H2AJ;ERCC3;GTF2H5;CHD3;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;MAPK3;UBTF;CCNH;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L;KAT2B;HDAC2;POLR2H
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.49646011132261764,-2.1444440838133962,0.0,0.0007898605012930356,0.024,31/87,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.7084951972524524,-2.1431267630825266,0.0,0.0007855206084287881,0.024,6/18,4.99%,UBB;HSP90AA1;RPS27A;HRAS;UBC;UBA52
gsea,Scavenging By Class A Receptors R-HSA-3000480,-0.7572512578803278,-2.1409787123127915,0.0,0.0008124772719311532,0.026,6/15,5.99%,FTH1;APOE;HSP90B1;COL4A2;CALR;APOA1
gsea,Signaling By NOTCH R-HSA-157118,-0.44831257957780357,-2.1407153133743773,0.0,0.0008184213991296461,0.027,71/175,24.70%,UBB;RPS27A;H2AZ1;YWHAZ;JUN;PSMB3;MAML2;PSMC6;SKP1;PSMC1;PSMD2;TMED2;PSMA4;RAB6A;UBC;PSMB6;PSMA3;UBA52;PSMA7;H2AJ;HIF1A;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ACTA2;HDAC11;TLE4;MAML3;FBXW7;FURIN;PSMB5;SNW1;PRKCI;CNTN1;PSMB7;PSENEN;HEY1;RBX1;H2AZ2;FABP7;CUL1;PSMB4;WWC1;HDAC1;H2AX;TBL1XR1;PSMD7;PSMA1;HES5;APH1B;CCND1;AGO3;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;TFDP2;KAT2B;PSMD8;TLE1;HDAC2;APH1A;PSMB1;ATP2A1;PSME2;SIRT6
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.5332452152109668,-2.1357313335436827,0.0,0.0008346050313122302,0.028,27/58,24.32%,H2AZ1;POLR2K;CBX3;H2AJ;ERCC3;GTF2H5;CHD3;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;MAPK3;UBTF;CCNH;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L;KAT2B;HDAC2;POLR2H
gsea,RHO GTPase Effectors R-HSA-195258,-0.4436158389584161,-2.1340733962494154,0.0,0.0008403662767162176,0.029,66/229,19.12%,CALM1;ACTG1;DYNLL1;RPS27;DYNLL2;YWHAE;YWHAH;WIPF3;MYL6;YWHAB;DIAPH2;H2AZ1;YWHAG;YWHAZ;PFN1;RHOB;KTN1;PPP2R1A;ACTR2;IQGAP2;ITGB3BP;BAIAP2;ARPC3;ARPC2;PFN2;LIN7B;ARPC5;MYL12B;NCK1;NCKAP1;H2AJ;CYFIP1;WASF1;H2BC4;PDZD2;KDM4C;PKN2;CTNNA1;ABI1;WASL;CYBA;PPP2CA;CDKN1B;XPO1;MYL9;ABI2;MAPK3;ACTR3;NUDC;NUF2;TAOK1;CENPP;AHCTF1;ARPC1B;BUB3;H2AZ2;ZWINT;CENPE;ROCK2;CTNNB1;H2AX;RCC2;KIF14;NUP37;RHOA;MAPK1
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.5582985454320631,-2.1308317906511394,0.0,0.0008970337300959338,0.031,15/51,9.33%,ATP6V0C;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1D;ATP6V0B;LAMTOR3;LAMTOR2;ATP6V1G1;ATP6V1A;RRAGA;ATP6V1E1;LAMTOR1;MLST8;ATP6V1H
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6753378550851198,-2.1286153069147398,0.0,0.0009226803061558574,0.032,13/23,19.12%,UBB;RPS27A;UBC;UBA52;RAB5A;ATP6V1H;MAPK3;KPNA1;CORO1A;B2M;PGK1;ENO1;MAPK1
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.6996728775155916,-2.127578258812478,0.0,0.0009581411865773367,0.033,10/18,20.42%,ORC4;H2AZ1;H2AJ;H2BC4;ORC6;KPNA1;ORC5;H2AZ2;H2AX;H2BC21
gsea,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.7550786677510762,-2.1248518110649885,0.0,0.0010233266368331244,0.036,10/16,12.78%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;TBCA;TUBA1B;TUBB2B;TUBB4A;TBCC;ARL2
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.40724642851242726,-2.12475624962065,0.0,0.0010179689057502285,0.036,157/461,24.50%,UBB;HSP90AA1;HSP90AB1;TUBA1A;TUBB2A;DYNLL1;RPS27;RPS27A;DYNLL2;YWHAE;ORC4;H2AZ1;YWHAG;TUBA4A;SET;PSMB3;RAN;PSMC6;PPP2R1A;CHMP2A;NME7;TUBB4B;ITGB3BP;SKP1;PSMC1;PSMD2;PSMA4;TPR;UBC;PCNA;PSMB6;BANF1;RAB2A;GSK3B;TUBA1B;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;FBXW11;AKT1;POLD4;PSMC5;CETN2;TUBB2B;SEM1;PSMC3;PSMC2;H2BC4;ORC6;CDK4;PHLDA1;CSNK2B;ARPP19;VPS4A;ANAPC4;DCTN1;MCM6;PPP2CA;NCAPD2;CDKN1B;PLK4;XPO1;MAPK3;PDS5B;PSMB5;CDKN2D;NUDC;PSMB7;TUBB4A;DCTN3;CEP78;RAB1B;KMT5A;SMC1A;NEK7;NUF2;PDS5A;BORA;SSNA1;HAUS3;AKT3;TAOK1;CENPP;CDC26;SKP2;MZT1;ESCO1;POLE3;CCNH;RBX1;KIF23;AHCTF1;RPA3;RB1;ORC5;BUB3;H2AZ2;RAB33B;ZWINT;CUL1;ANAPC16;PSMB4;BLZF1;CEP135;CENPE;UBE2I;GORASP2;HDAC1;H2AX;USO1;NUP54;RCC2;PSMD7;PSMA1;NUP37;ODF2;CCND1;MAPK1;PSMB8;PSMB2;E2F4;AKAP9;PSMD14;TUBG2;PSMD6;H2BC21;TFDP2;MNAT1;VRK1;PCM1;FEN1;POLE4;ENSA;CCNE2;UBE2E1;ACTR1A;CHMP4C;GINS4;PSMD8;SUMO1;NDEL1;PSMB11;GINS2;PRKAR2B;MIS12;TUBB6;PSMB1;CNEP1R1;CENPF;PPME1;KIF2A;SPAST;PSME2;NUP43;CEP43
gsea,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.7369768515248245,-2.124431705903382,0.0,0.0010126669843661127,0.036,8/16,13.21%,UBB;RPS27A;UBC;UBA52;LRRC14;TRAF6;USP14;IKBKG
gsea,RAF Activation R-HSA-5673000,-0.6110548334649826,-2.12378400353768,0.0,0.0010172966718898834,0.037,7/30,9.36%,CALM1;YWHAB;HRAS;CAMK2B;PPP2R1A;BRAF;PPP2CA
gsea,PTEN Regulation R-HSA-6807070,-0.4749176371203137,-2.12378305282747,0.0,0.0010120528746121005,0.037,62/133,26.14%,UBB;RPS27A;JUN;PSMB3;CBX6;PSMC6;LAMTOR3;LAMTOR2;PSMC1;PSMD2;PSMA4;UBC;PSMB6;CNOT6L;RRAGA;PSMA3;UBA52;PSMA7;PSMA2;AKT1;SCMH1;CHD3;PSMC5;SEM1;PSMC3;PSMC2;LAMTOR1;CSNK2B;MLST8;MAPK3;PSMB5;PREX2;PSMB7;MECOM;AKT3;LAMTOR5;STUB1;PSMB4;PHC3;VAPA;MAF1;HDAC1;PSMD7;PSMA1;MAPK1;AGO3;PSMB8;PSMB2;PSMD14;PSMD6;TNKS;KDM1A;EZH2;PSMD8;PSMB11;HDAC2;PSMB1;PSME2;LAMTOR4;TNRC6C;PSME3;RNF146
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.5013572719425192,-2.118696248519821,0.0,0.001045964330156733,0.038,25/87,10.97%,UBB;RPS27A;VAMP2;NECAP1;AP2M1;SH3GL1;CLTA;NEDD8;UBC;CLTB;UBQLN2;UBA52;COPS8;TGFA;STAM2;REPS2;M6PR;VAMP3;TOR1A;COPS5;SNAP91;COPS7A;PICALM;TFRC;COPS6
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.4432058760851466,-2.118094968999782,0.0,0.0010503532706990653,0.038,77/208,24.43%,UBB;TUBA1A;TUBB2A;DYNLL1;RPS27;RPS27A;DYNLL2;TUBA4A;PSMB3;RAN;PSMC6;PPP2R1A;CHMP2A;TUBB4B;ITGB3BP;PSMC1;PSMD2;PSMA4;UBC;PSMB6;BANF1;TUBA1B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;TUBB2B;SEM1;PSMC3;PSMC2;VPS4A;ANAPC4;PPP2CA;XPO1;PDS5B;PSMB5;NUDC;PSMB7;TUBB4A;SMC1A;NUF2;PDS5A;TAOK1;CENPP;CDC26;AHCTF1;BUB3;ZWINT;ANAPC16;PSMB4;CENPE;UBE2I;NUP54;RCC2;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;PSMD14;PSMD6;VRK1;UBE2E1;CHMP4C;PSMD8;SUMO1;NDEL1;PSMB11;MIS12;TUBB6;PSMB1;CENPF;KIF2A;SPAST;PSME2;NUP43
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.5521408673636395,-2.1175592869960425,0.0,0.0010450215282082071,0.038,32/53,26.07%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CBFB;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB1;PSME2;PSME3;TGFB1
gsea,Mitotic Anaphase R-HSA-68882,-0.44374241923837204,-2.1151787833647693,0.0,0.0010493708976437913,0.039,77/207,24.43%,UBB;TUBA1A;TUBB2A;DYNLL1;RPS27;RPS27A;DYNLL2;TUBA4A;PSMB3;RAN;PSMC6;PPP2R1A;CHMP2A;TUBB4B;ITGB3BP;PSMC1;PSMD2;PSMA4;UBC;PSMB6;BANF1;TUBA1B;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;TUBB2B;SEM1;PSMC3;PSMC2;VPS4A;ANAPC4;PPP2CA;XPO1;PDS5B;PSMB5;NUDC;PSMB7;TUBB4A;SMC1A;NUF2;PDS5A;TAOK1;CENPP;CDC26;AHCTF1;BUB3;ZWINT;ANAPC16;PSMB4;CENPE;UBE2I;NUP54;RCC2;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;PSMD14;PSMD6;VRK1;UBE2E1;CHMP4C;PSMD8;SUMO1;NDEL1;PSMB11;MIS12;TUBB6;PSMB1;CENPF;KIF2A;SPAST;PSME2;NUP43
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.48206062429172003,-2.1099397509017543,0.0,0.0010865321055786997,0.042,32/92,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.48206062429172003,-2.1099397509017543,0.0,0.0010865321055786997,0.042,32/92,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6191585311761464,-2.106616224422605,0.0,0.001119060735430624,0.043,9/29,5.99%,UBB;APOE;RPS27A;AP2M1;CLTA;UBC;NCEH1;UBA52;APOA1
gsea,Glutathione Conjugation R-HSA-156590,-0.6016536027531038,-2.1060790898661312,0.0,0.001113520830799779,0.043,14/28,21.61%,PRNP;ESD;GSTM5;AKR1A1;MGST3;GSTO1;GSTM1;CHAC2;HPGDS;GSTP1;GSTZ1;GGCT;CNDP2;GSTM4
gsea,PCP/CE Pathway R-HSA-4086400,-0.5014763085476666,-2.10592292813435,0.0,0.0011080355065101251,0.043,39/85,22.29%,UBB;RPS27A;PSMB3;AP2M1;PFN1;PSMC6;PSMC1;PSMD2;CLTA;PSMA4;UBC;PSMB6;CLTB;PARD6A;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;FZD2;FZD1;PSMB5;PSMB7;AP2S1;PSMB4;PSMD7;PSMA1;RHOA;PSMB8;PSMB2;FZD9;PSMD14;PSMD6;AP2B1;PSMD8;PSMB11
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.5486658417348,-2.1047763288384003,0.002066115702479339,0.001149324466685415,0.045,30/50,28.46%,PSMB3;OAZ1;PSMC6;PSMC1;PSMD2;PSMA4;PSMB6;PSMA3;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;PSME3;AZIN1;OAZ3
gsea,HIV Life Cycle R-HSA-162587,-0.457784398766123,-2.101865739016673,0.0,0.0011716135669911523,0.045,53/137,24.43%,UBB;PPIA;RPS27A;ELOB;RAN;CHMP2A;PSIP1;POLR2G;POLR2K;TPR;RANBP1;UBC;TAF11;BANF1;UBA52;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;RNMT;VPS4A;CHMP5;XRCC6;XPO1;FURIN;NMT1;CCNK;GTF2F1;TAF7L;KPNA1;GTF2B;CCNH;TAF10;VPS28;GTF2A1;CCNT2;XRCC4;NUP54;TAF13;POLR2F;NUP37;MNAT1;FEN1;POLR2L;NCBP2;CHMP4C;NELFB;VPS37D;POLR2D;GTF2F2;POLR2H;NUP43
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5056052282382775,-2.1016805283288837,0.0,0.0011659261224911954,0.045,21/65,20.02%,CALM1;HSP90AA1;HRAS;GNG3;GNB2;AKT1;GNG7;TGFA;CDKN1B;XPO1;MAPK3;IGF1R;GNG10;AKT3;S1PR3;ZDHHC21;CAV1;CCND1;MAPK1;GNG11;UHMK1
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.44970070509427834,-2.0961504412097796,0.0,0.0012247543863205955,0.047,59/157,24.43%,UBB;DYNLL1;RPS27;RPS27A;DYNLL2;PSMB3;PSMC6;PPP2R1A;ITGB3BP;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;ANAPC4;PPP2CA;XPO1;PDS5B;PSMB5;NUDC;PSMB7;SMC1A;NUF2;PDS5A;TAOK1;CENPP;CDC26;AHCTF1;BUB3;ZWINT;ANAPC16;PSMB4;CENPE;RCC2;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;PSMD14;PSMD6;UBE2E1;PSMD8;NDEL1;PSMB11;MIS12;PSMB1;CENPF;KIF2A;PSME2;NUP43
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.48833224616963017,-2.0918330000099807,0.0,0.0012738525866686848,0.047,54/88,33.34%,UBB;RPS27A;PSMB3;MAML2;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;BRD2;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;CBFB;MAML3;PSMB5;SNW1;PSMB7;YAP1;ITGA4;PSMB4;CTNNB1;PSMD7;PSMA1;CCND1;PSMB8;PSMB2;PSMD14;PSMD6;KAT2B;PSMD8;PSMB1;PSME2;PSME3;TGFB1;TCF7L2;SMAD4;SMAD3;CCN2;NOTCH1;TEAD4;PSME1;WWTR1;PSMD4;MAMLD1;PSMF1;MYC;CXXC1
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.42184931114716717,-2.0911697158920184,0.0,0.0013042398312579037,0.049,86/235,28.15%,UBB;DYNLL1;RPS27;RPS27A;DYNLL2;YWHAE;YWHAH;ORC4;YWHAB;YWHAG;YWHAZ;PSMB3;PSMC6;PPP2R1A;ITGB3BP;PSMC1;PSMD2;PSMA4;UBC;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;ORC6;ANAPC4;MCM6;PPP2CA;CDKN1B;XPO1;BABAM2;PSMB5;NUDC;PSMB7;NUF2;TAOK1;CENPP;CDC26;RAD17;BRCC3;AHCTF1;RPA3;ORC5;BUB3;ZWINT;ANAPC16;PSMB4;CENPE;H2AX;RCC2;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;CCNE2;UBE2E1;PSMD8;NDEL1;PSMB11;MIS12;PSMB1;CENPF;KIF2A;PSME2;NUP43;RFC5;TOPBP1;RMI2;PSME3;DYNC1I2;MCM7;ANAPC10;MDM4;SPC25;ANAPC7;SEC13
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.5179361063387363,-2.0907276391947427,0.0,0.0013071062924255035,0.049,17/59,16.91%,UBB;HSP90AA1;HSP90AB1;RPS27A;HMGB1;UBC;PCBP2;UBA52;PDZD2;S100B;UBE2D3;ISG15;TRAF6;IKBKG;ATG12;FADD;NKIRAS2
gsea,Signaling By FGFR2 R-HSA-5654738,-0.5250539312587209,-2.089672803769529,0.0,0.00132801379828776,0.049,28/64,24.61%,UBB;RPS27A;FGFR2;HRAS;PPP2R1A;POLR2G;HNRNPA1;POLR2K;UBC;UBA52;HNRNPH1;POLR2E;BRAF;PPP2CA;MAPK3;GTF2F1;TIA1;SOS1;FGF1;POLR2F;MAPK1;FGFBP3;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H;FGF10
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.4770913260240318,-2.086052304487923,0.0,0.0013577155572855317,0.051,33/93,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;MEF2A;SKP1;UBC;UBE2N;UBA52;TLR3;FBXW11;BIRC2;S100B;UBE2D3;LRRC14;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;FADD;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.5651749544738626,-2.08571620669951,0.0,0.0013692398661851665,0.052,13/44,7.99%,UBB;RPS27A;UBC;PCNA;UBE2N;SELENOS;RRAGA;UBA52;UBE2A;H2BC4;WAC;UBE2D3;TMEM129
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.4858272008571716,-2.084860922221908,0.0,0.0013806564712633093,0.053,20/82,15.04%,CST3;APOE;SPARCL1;PPP3CA;SCG2;TMEM132A;VGF;HSP90B1;KTN1;CHGB;GOLM1;APOA1;FAM20A;MFGE8;DNAJC3;RCN1;APLP2;EVA1A;P4HB;NOTUM
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.6899263811723202,-2.080984576498751,0.0,0.0014540290927368975,0.058,4/18,6.02%,CALM1;HSP90AA1;COQ2;AKT1
gsea,Platelet Degranulation R-HSA-114608,-0.47150266307496674,-2.0800030375195253,0.0,0.0014737724304064558,0.058,26/97,13.81%,CALM1;TMSB4X;PPIA;TUBA4A;PFN1;MANF;CLU;HSPA5;CAP1;APOA1;TGFB3;OLA1;TIMP3;SERPING1;VTI1B;RAB27B;VCL;SELENOP;PCYOX1L;SOD1;CYRIB;CD9;ENDOD1;FAM3C;SOS1;APLP2
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.5741263070392596,-2.0795739984296033,0.0,0.0014669808523861496,0.058,15/35,20.42%,H2AZ1;NPM1;ITGB3BP;HJURP;H2AJ;H2BC4;MIS18A;RUVBL1;CENPP;RSF1;H2AZ2;H2AX;MIS18BP1;CENPW;H2BC21
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.7381564967486047,-2.079003878552105,0.0,0.0014777396253243223,0.059,8/16,10.10%,UBB;RPS27A;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5500041823266849,-2.077391110811157,0.0,0.0015145124278674498,0.061,23/48,24.04%,DYNLL1;DYNLL2;YWHAE;YWHAH;YWHAB;PPP3R1;YWHAG;YWHAZ;CYCS;GSDME;C1QBP;AKT1;MAPK3;NMT1;AKT3;UACA;BBC3;MAPK1;TFDP2;BAD;BAK1;APAF1;DIABLO
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.5240625587144909,-2.0712713911273752,0.0,0.001628931705333298,0.066,21/55,21.36%,UBB;RPS27A;H2AZ1;JUN;UBC;CEBPB;UBA52;H2AJ;H2BC4;CDK4;ANAPC4;CDKN1B;MAPK3;CDKN2D;CDC26;H2AZ2;ANAPC16;H2AX;MAPK1;H2BC21;UBE2E1
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.5758519667763478,-2.0686338093084604,0.0,0.0016474369466184936,0.066,14/34,16.22%,GNG3;GNB2;CCT5;CCT7;TCP1;CCT8;GNG7;CSNK2B;CCT6A;CCT2;GNAQ;GNG10;CCT3;CCT4
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.4795382213620174,-2.068616824304201,0.0,0.0016400160594715635,0.066,39/93,25.78%,HSP90AA1;DDX5;HSP90AB1;H2AZ1;JUN;JUND;POLR2G;POLR2K;PTGES3;H2AJ;POLR2E;KCTD6;TGFA;H2BC4;CBFB;USF1;GPAM;SMC1A;GTF2F1;KANK1;CXCL12;POU2F1;NR5A2;H2AZ2;GTF2A1;HDAC1;H2AX;POLR2F;CCND1;AGO3;H2BC21;POLR2L;KDM1A;KAT2B;POLR2D;GTF2F2;POLR2H;TNRC6C;PGR
gsea,Hedgehog On State R-HSA-5632684,-0.48516504357255946,-2.068145549794273,0.0,0.0016412096945252958,0.066,39/83,26.54%,UBB;RPS27A;PSMB3;PSMC6;PSMC1;PSMD2;GLI3;PSMA4;UBC;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;EFCAB7;RBX1;GLI2;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;KIF3A;PSMD8;PSMB11;SPOPL;PSMB1;PSME2;GAS8;PSME3;CUL3
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.6196263911088301,-2.067536315425519,0.0,0.0016423926721231914,0.066,11/29,9.33%,ATP6V0C;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1D;ATP6V0B;ATP6V1G1;ATP6V1A;ATP6V1E1;CYBA;ATP6V1H
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.46735735717450483,-2.063450753141527,0.0,0.0017452289571088667,0.068,32/96,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6434478618486533,-2.061450595101368,0.0020408163265306124,0.0017796791979281606,0.07,9/23,10.10%,HSP90AA1;HSP90AB1;ACTG1;CCT7;TXNL1;TRA2B;CCT6A;CCT2;PHIP
gsea,MAP Kinase Activation R-HSA-450294,-0.5155113530001997,-2.057733709451821,0.0,0.0019061966764538595,0.076,24/60,19.83%,UBB;RPS27A;JUN;PPP2R1A;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;PPP2CA;MAPK3;TRAF6;MAP2K6;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.5757433033124926,-2.0574486100029334,0.0020161290322580645,0.0019061966764538593,0.076,12/39,12.44%,UBB;RPS27A;YWHAB;HRAS;PPP2R1A;PEBP1;UBC;UBA52;BRAF;PPP2CA;MAPK3;DUSP6
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.6391244045508054,-2.0543527228544827,0.0,0.0019478166912235944,0.076,11/26,10.27%,ATP6V0C;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1D;ATP6V0B;ATP6V1G1;ATP6V1A;ATP6V1E1;ATP6V1H;TFRC
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.41913810535622914,-2.0540550372552793,0.0,0.001939347923000883,0.076,69/205,25.23%,CALM1;HSP90AA1;DDX5;HSP90AB1;APOE;H2AZ1;JUN;HRAS;PPID;FKBP5;JUND;GNG3;POLR2G;POLR2K;GNB2;PLTP;PTGES3;H2AJ;AKT1;GNG7;POLR2E;KCTD6;TGFA;H2BC4;CBFB;USF1;CDKN1B;XPO1;GPAM;MAPK3;IGF1R;SMC1A;GNG10;PDHX;ARL4C;AKT3;GTF2F1;KANK1;RXRB;S1PR3;ZDHHC21;APOD;CXCL12;CAV1;POU2F1;NR5A2;H2AZ2;GTF2A1;HDAC1;H2AX;TBL1XR1;POLR2F;CCND1;MAPK1;AGO3;GNG11;UHMK1;H2BC21;POLR2L;KDM1A;RDH14;KAT2B;PDK3;POLR2D;GTF2F2;POLR2H;RXRG;PTK2;TNRC6C
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6243916029222897,-2.0536695923474504,0.0,0.0019309524774467667,0.076,10/26,14.03%,UBB;RPS27A;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;FGFR3;FGF1
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6280583907005646,-2.0527898958975705,0.0,0.0019472785013774341,0.077,9/23,13.72%,UBB;RPS27A;ELOB;UBC;UBA52;ELOC;UBE2D3;TYK2;RNF7
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.6107780992437879,-2.051356053922421,0.0,0.0019798265909949956,0.078,11/27,17.98%,UBB;HSP90AA1;RPS27A;UBC;UBA52;GNL3;BIRC2;PELI1;STUB1;FADD;SDCBP
gsea,Signaling By FGFR4 R-HSA-5654743,-0.5785355536452264,-2.050562070817621,0.0,0.0019795119332405462,0.078,11/35,14.03%,UBB;RPS27A;HRAS;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;SOS1;FGF1
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.5368416962118843,-2.0495069157061634,0.0,0.0019710884782054797,0.078,24/50,25.14%,UBB;RPS27A;POLR2G;POLR2K;UBC;UBA52;TCEA1;COPS8;PRPF19;ERCC3;GTF2H5;POLR2E;COPS5;COPS7A;COPS6;CCNH;RBX1;POLR2F;MNAT1;POLR2L;XAB2;POLR2D;POLR2H;HMGN1
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.44929858081021307,-2.0479068710004893,0.0,0.001986967722066311,0.08,47/125,24.43%,UBB;PPIA;RPS27A;ELOB;RAN;CHMP2A;POLR2G;POLR2K;TPR;RANBP1;UBC;TAF11;UBA52;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;RNMT;VPS4A;CHMP5;XPO1;FURIN;NMT1;CCNK;GTF2F1;TAF7L;GTF2B;CCNH;TAF10;VPS28;GTF2A1;CCNT2;NUP54;TAF13;POLR2F;NUP37;MNAT1;POLR2L;NCBP2;CHMP4C;NELFB;VPS37D;POLR2D;GTF2F2;POLR2H;NUP43
gsea,Signaling By WNT R-HSA-195721,-0.4125448481970795,-2.0462878823884005,0.0,0.0020268420357230908,0.082,90/253,22.29%,CALM1;UBB;RPS27A;PPP3CA;PPP3R1;H2AZ1;YWHAZ;PSMB3;AP2M1;PFN1;PSMC6;PPP2R1A;GNG3;SKP1;PSMC1;PSMD2;CLTA;PSMA4;GNB2;UBC;PSMB6;CLTB;PLCB1;PARD6A;GSK3B;PSMA3;UBA52;VPS29;PSMA7;TLE5;H2AJ;PSMA2;AKT1;PPP3CB;PSMC5;GNG7;SEM1;PSMC3;PSMC2;SNX3;H2BC4;FZD2;CTBP2;CSNK2B;TLE4;VPS35;FZD1;PPP2CA;XPO1;PSMB5;ZNRF3;RUVBL1;PSMB7;PYGO2;GNG10;FRAT1;PIP5K1B;SOX9;ASH2L;CAV1;RBX1;CTBP1;H2AZ2;AP2S1;CUL1;PSMB4;HDAC1;CTNNB1;H2AX;PSMD7;PSMA1;TMED5;RHOA;AGO3;PSMB8;PSMB2;GNG11;FZD9;PSMD14;PSMD6;H2BC21;NFATC1;TNKS;AP2B1;AXIN2;PYGO1;PSMD8;TLE1;PLCB2;PSMB11
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.680077325242305,-2.045768800530446,0.0,0.002018325892715851,0.082,12/20,19.12%,UBB;RPS27A;UBC;UBA52;RAB5A;ATP6V1H;MAPK3;KPNA1;CORO1A;PGK1;ENO1;MAPK1
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.5386076624777215,-2.044899702323714,0.002008032128514056,0.002025832451126696,0.082,16/46,12.68%,RAB3A;VAMP2;HSPA8;SLC1A3;LIN7C;PPFIA2;ARL6IP5;CPLX1;LIN7B;SNAP25;SLC32A1;RIMS1;SLC17A7;SYN2;GAD1;SLC1A2
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.6156219873813598,-2.0404681627078194,0.0,0.0021047588302511365,0.086,10/24,20.56%,CALM1;HSP90AA1;AKT1;PKN2;MLST8;CTNNA1;AKT3;CAV1;CTNNB1;VAV3
gsea,Insulin Receptor Recycling R-HSA-77387,-0.6727595037847596,-2.036656254540054,0.0,0.0021434825697883644,0.086,10/21,9.33%,ATP6V0C;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1D;ATP6V0B;ATP6V1G1;ATP6V1A;ATP6V1E1;ATP6V1H
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6705610252913449,-2.0345144575955443,0.0,0.0021661325868793852,0.088,9/21,11.22%,TUBA1A;TUBB2A;TUBA4A;CHMP2A;TUBB4B;TUBA1B;TUBB2B;VPS4A;TUBB4A
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.664761642859712,-2.034431354725032,0.0,0.002157218461007454,0.088,8/19,8.15%,UBB;RPS27A;SH3GL1;UBC;UBA52;RNMT;STAM2;CBLL1
gsea,Regulated Necrosis R-HSA-5218859,-0.5343731918311967,-2.0328848551626484,0.0,0.0021561896832019063,0.088,12/46,9.30%,UBB;HSP90AA1;RPS27A;HMGB1;CYCS;CHMP2A;UBC;GSDME;UBA52;GNL3;BIRC2;PELI1
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5558641644061176,-2.031879937739246,0.0,0.0021707300927780683,0.089,15/42,17.36%,UBB;RPS27A;SUMO2;UBC;UBE2N;PIAS1;UBA52;ERCC3;GTF2H5;CETN2;CCNH;RAD23B;RBX1;RPA3;UBE2I
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.46330517840336966,-2.031557106933352,0.0,0.002161905986709865,0.089,33/96,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;BIRC2;S100B;UBE2D3;LRRC14;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;FADD;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Metabolism Of Polyamines R-HSA-351202,-0.5147432380093179,-2.026110963948532,0.002183406113537118,0.0022997838444665996,0.097,34/57,32.75%,PSMB3;OAZ1;PSMC6;PSMC1;PSMD2;PSMA4;PSMB6;PSMA3;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;PSMD8;PSMB11;PSMB1;PSME2;PSME3;AZIN1;OAZ3;PSME1;PAOX;PSMD4;PSMF1
gsea,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7343135933953642,-2.024956600090181,0.0,0.00232894190711903,0.1,8/15,12.12%,UBB;RPS27A;ITGB3BP;UBC;UBA52;SQSTM1;TRAF6;PSENEN
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.50411831601612,-2.0237228123871134,0.002079002079002079,0.002334899543447498,0.1,25/79,15.60%,HSP90AA1;HSP90AB1;ACTG1;WIPF3;ACTR2;BAIAP2;ARPC3;ARPC2;ARPC5;ELMO2;NCK1;NCKAP1;CYFIP1;AHCYL1;WASF1;YES1;ABI1;WASL;ABI2;MAPK3;ACTR3;PRKCE;PLD3;ARPC1B;DOCK1
gsea,Protein Methylation R-HSA-8876725,-0.6828148705932099,-2.0224550275521285,0.0,0.002371308665508601,0.103,5/17,8.35%,CALM1;EEF1A1;HSPA8;RPS2;EEF2
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.5990589302376835,-2.0210553123008044,0.0,0.0023922388569042456,0.106,9/29,10.10%,UBB;RPS27A;FGFR2;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3
gsea,Transcription Of HIV Genome R-HSA-167172,-0.48845177496313125,-2.0201534319230396,0.0,0.0023978743906185452,0.107,27/64,24.32%,ELOB;POLR2G;POLR2K;TAF11;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;RNMT;CCNK;GTF2F1;TAF7L;GTF2B;CCNH;TAF10;GTF2A1;CCNT2;TAF13;POLR2F;MNAT1;POLR2L;NCBP2;NELFB;POLR2D;GTF2F2;POLR2H
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.5417128887883974,-2.0192459384410086,0.0020833333333333333,0.0023959310004439812,0.108,18/54,10.16%,ACTG1;WIPF3;ACTR2;BAIAP2;ARPC3;ARPC2;ARPC5;ELMO2;NCK1;NCKAP1;CYFIP1;WASF1;YES1;ABI1;WASL;ABI2;MAPK3;ACTR3
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.4614782669030742,-2.0161715116358105,0.0,0.0024390311805019852,0.111,32/99,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;S100B;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.6745317086100917,-2.010857450217168,0.0,0.00252664500643688,0.112,5/17,4.99%,UBB;RPS27A;UBC;PCNA;UBA52
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.7062246943127063,-2.010149919557155,0.0,0.00253911354168268,0.113,7/15,7.26%,UBB;RPS27A;SH3GL1;UBC;UBA52;RNMT;STAM2
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.6965727407625395,-2.00719691877411,0.0,0.0025885705839781975,0.119,5/16,4.99%,UBB;RPS27A;UBC;PCNA;UBA52
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.5395552460971041,-1.9986418114600466,0.0,0.002800188140992297,0.129,10/35,15.03%,SLC25A4;SLC25A5;SLCO1C1;SLC35A1;SLC27A1;ARL2BP;ARL2;SLC35A3;APOD;PDZD11
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.4467165900289995,-1.9931941958287227,0.0,0.002914493760137947,0.134,26/101,13.81%,CALM1;TMSB4X;PPIA;TUBA4A;PFN1;MANF;CLU;HSPA5;CAP1;APOA1;TGFB3;OLA1;TIMP3;SERPING1;VTI1B;RAB27B;VCL;SELENOP;PCYOX1L;SOD1;CYRIB;CD9;ENDOD1;FAM3C;SOS1;APLP2
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.39298300695517013,-1.9911658057466273,0.0,0.0029692678998608194,0.137,148/390,28.35%,CALM1;UBB;HSP90AA1;RPS27A;YWHAB;FGFR2;HRAS;NPM1;RPS6;CAMK2B;PSMB3;MAML2;EEF1G;PSMC6;PPP2R1A;QKI;PEBP1;POLR2G;SKP1;PSMC1;PSMD2;POLR2K;PSMA4;TPR;UBC;PSMB6;CEBPB;PRKAR1A;BAG4;GSK3B;PSMA3;UBA52;RPS6KB2;PSMA7;PSMA2;AKT1;PSMC5;FKBP1A;SEM1;PSMC3;POLR2E;BRAF;TGFA;PSMC2;RNMT;CTBP2;SQSTM1;ERBIN;CPSF6;YES1;VCL;PDGFRA;HDAC11;DCTN1;MLST8;FIP1L1;MAML3;FBXW7;PPP2CA;CDKN1B;MAPK3;PSMB5;SNW1;PSMB7;FGFR3;LMO7;IRS2;PSENEN;NRG2;DUSP6;AKT3;GTF2F1;KDM7A;SOS1;KANK1;HEY1;GCC2;FGF1;RBX1;DERL2;CTBP1;AGTRAP;CUL1;PSMB4;HDAC1;CTNNB1;DUSP7;RAP1A;GOLGB1;TBL1XR1;POLR2F;PSMD7;PSMA1;HES5;APH1B;MAPK1;ZFYVE9;PSMB8;PSMB2;AKAP9;PSMD14;PSMD6;PPFIBP1;TNKS;POLR2L;NCBP2;BAD;PPM1B;KAT2B;PSMD8;PSMB11;MAP2K1;ERLIN2;SYVN1;FAM114A2;NF1;AGGF1;HDAC2;APH1A;POLR2D;PSMB1;FOXO1;FAM131B;GTF2F2;POLR2H;PSME2;CEP43;FGF10;RNF213;SND1;ATIC;PTPN12;CNKSR2;PSME3;TGFB1;FGFR1;SEL1L;CDC37;SPRED3;TCF7L2;MAPKAP1;BCL2L1;RRBP1;AGK;SMAD4;MYH9;SMAD3;MIB1
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.42440151019326616,-1.990967461887745,0.0,0.0029578913944973678,0.137,61/168,22.29%,UBB;RPS27A;H2AZ1;PSMB3;CBX6;PSMC6;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;UBA52;TCF12;PSMA7;H2AJ;PSMA2;SCMH1;PSMC5;SEM1;PSMC3;KCTD6;PSMC2;H2BC4;CBFB;CTSL;CSNK2B;MYL9;GPAM;ELOF1;PSMB5;PSMB7;CLDN5;YAP1;SMARCC2;PRMT6;ASH2L;CCNH;DPY30;H2AZ2;PSMB4;PHC3;HDAC1;H2AX;PSMD7;PSMA1;CCND1;AGO3;ACTL6B;SMARCE1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;MNAT1;KAT2B;KMT2C;PSMD8;ELF2;PSMB11
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.42166150011786985,-1.990887684833384,0.0,0.002953877292520103,0.137,60/165,22.29%,UBB;RPS27A;H2AZ1;YWHAZ;PSMB3;PSMC6;PPP2R1A;PSMC1;PSMD2;PSMA4;UBC;PSMB6;GSK3B;PSMA3;UBA52;PSMA7;H2AJ;PSMA2;AKT1;PSMC5;SEM1;PSMC3;PSMC2;H2BC4;FZD2;CSNK2B;TLE4;FZD1;PPP2CA;XPO1;PSMB5;ZNRF3;RUVBL1;PSMB7;PYGO2;FRAT1;PIP5K1B;SOX9;ASH2L;CAV1;RBX1;CTBP1;H2AZ2;PSMB4;HDAC1;CTNNB1;H2AX;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;TNKS;AXIN2;PYGO1;PSMD8;TLE1;PSMB11
gsea,Signaling By FGFR R-HSA-190236,-0.4759224395539689,-1.984601610683514,0.0,0.00309485163819695,0.148,29/76,24.61%,UBB;RPS27A;FGFR2;HRAS;PPP2R1A;POLR2G;HNRNPA1;POLR2K;UBC;UBA52;HNRNPH1;POLR2E;BRAF;PPP2CA;MAPK3;FGFR3;GTF2F1;TIA1;SOS1;FGF1;POLR2F;MAPK1;FGFBP3;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H;FGF10
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.46636887775616803,-1.984482492754716,0.0,0.003090349157281257,0.148,30/89,21.23%,UBB;RPS27A;YWHAE;BEX3;MAGED1;ARHGEF4;ITGB3BP;UBC;UBA52;FGD4;ARHGEF9;SQSTM1;TIAM1;PRDM4;TRAF6;PRKCI;OMG;PSENEN;SOS1;RTN4;ARHGEF12;PRPF38B;HDAC1;IRAK1;APH1B;RHOA;ARHGEF26;SMPD2;VAV3;BAD
gsea,Interleukin-17 Signaling R-HSA-448424,-0.49161921484505755,-1.9844412270779515,0.0,0.003085880657353606,0.149,24/65,19.83%,UBB;RPS27A;JUN;PPP2R1A;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;PPP2CA;MAPK3;TRAF6;MAP2K6;VRK3;DUSP6;IKBKG;MAP2K7;CUL1;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5466531722409618,-1.9835013728585855,0.0,0.003124442672683769,0.153,15/39,19.83%,UBB;RPS27A;HMGB1;UBC;UBE2N;UBA52;S100B;LRRC14;TRAF6;USP14;IKBKG;NKIRAS2;UBE2V1;IRAK1;IRAK2
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.451882592866232,-1.9829734195454154,0.0,0.0031198799535967657,0.153,20/91,15.04%,CST3;APOE;SPARCL1;PPP3CA;SCG2;TMEM132A;VGF;HSP90B1;KTN1;CHGB;GOLM1;APOA1;FAM20A;MFGE8;DNAJC3;RCN1;APLP2;EVA1A;P4HB;NOTUM
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.6750775394557118,-1.9817361825177424,0.0,0.0031366893071498206,0.156,5/17,4.99%,UBB;RPS27A;UBC;PCNA;UBA52
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.5305408338890931,-1.9805573532438352,0.0,0.0031462874510985632,0.157,20/41,24.32%,ELOB;POLR2G;POLR2K;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;CCNK;GTF2F1;CCNH;CCNT2;POLR2F;MNAT1;POLR2L;NCBP2;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.6048009415289668,-1.9804267947321663,0.002061855670103093,0.003141694522303583,0.157,9/26,14.03%,UBB;RPS27A;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;FGF1
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.492336243371097,-1.980363498538864,0.0,0.0031301015535865956,0.157,23/55,24.32%,JUN;ELOB;POLR2G;POLR2K;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;CCNK;CDK13;GTF2F1;CCNH;MLH1;MSH2;CCNT2;POLR2F;MNAT1;POLR2L;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.5561967142374732,-1.9794463283382306,0.0021141649048625794,0.0031536342073685175,0.16,8/32,10.04%,UBB;RPS27A;UBC;PCBP2;UBA52;PDZD2;UBE2D3;ISG15
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.4487853829541871,-1.9791379009078058,0.0,0.003142082433715153,0.16,33/124,10.97%,UBB;RPS27A;VAMP2;HSPA8;NECAP1;AP2M1;SH3GL1;ACTR2;CLTA;ARPC3;NEDD8;UBC;ARPC2;ARPC5;CLTB;UBQLN2;UBA52;COPS8;RAB5A;TGFA;STAM2;REPS2;M6PR;VAMP3;TOR1A;COPS5;SNAP91;WASL;COPS7A;PICALM;ACTR3;TFRC;COPS6
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.5879721660671005,-1.9783372820656226,0.0,0.0031653995904617005,0.161,17/26,25.77%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;POLR3E;POU2F1;POLR1D;POLR3D;SNAPC5;POLR2F;SNAPC1;POLR3F;POLR2L;BRF2;POLR2H;SNAPC3
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.5935433774997098,-1.976485501142337,0.0020161290322580645,0.0032024104164424835,0.162,9/28,10.59%,CALM1;HSP90AA1;HSP90AB1;VAMP2;SNAP25;EEF2;FURIN;CD9;MAP2K6
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.5010877681811298,-1.9718551772683577,0.0,0.0033565637128861437,0.172,21/52,22.31%,UBB;APOE;RPS27A;AP2M1;CLTA;UBC;PLTP;NCEH1;UBA52;APOA1;SAR1B;FURIN;ZDHHC8;P4HB;PRKACB;AP2S1;LCAT;MBTPS1;NPC2;AP2B1;VLDLR
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.5593928949350154,-1.971189669630406,0.001937984496124031,0.0033513277308051606,0.172,12/36,14.68%,UBB;RPS27A;UBC;UBA52;COPS8;CETN2;COPS5;COPS7A;RUVBL1;COPS6;RAD23B;RBX1
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.5213334070571257,-1.9703238590705212,0.0,0.0033666998853915287,0.174,16/43,22.03%,UBB;RPS27A;EYA1;UBC;UBE2N;UBA52;BAZ1B;H2BC4;BABAM2;EYA4;BRCC3;UBXN1;UBE2I;H2AX;H2BC21;SUMO1
gsea,Long-term Potentiation R-HSA-9620244,-0.6331610270494958,-1.9698747422232563,0.0,0.0033546328607127057,0.174,5/23,1.70%,NRGN;CALM1;NEFL;GRIA2;CAMK2B
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.3857718068104584,-1.9696079000502498,0.0,0.0033698834101595007,0.174,129/340,28.15%,UBE3A;UBB;RPS27A;HMGB1;PSMB3;ELOB;CANX;KLHL9;PSMC6;FBXL16;HSPA5;PJA2;PJA1;SKP1;CALR;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;SEC61B;UBE2A;PSMA2;FBXW11;HACE1;ELOC;SEC61G;PSMC5;SEM1;PSMC3;KCTD6;PSMC2;NDUFA2;FBXL14;CTSL;TRIM32;FBXO9;UBE2D3;VAMP3;ANAPC4;RNF138;SAR1B;FBXW7;FBXL5;FBXW2;CYBA;ANAPC13;PSMB5;DZIP3;PSMB7;UBE2Q1;LMO7;RNF114;FBXL4;ASB13;CDC26;ZNRF2;BTBD1;SKP2;IKBKG;RNF7;CBLB;RNF182;UBE2E3;RBX1;TPP2;DET1;B2M;STUB1;FBXO15;RNF19A;KLHL25;CUL1;LRRC41;PSMB4;HECTD2;UBE2V1;PSMD7;PSMA1;SEC24A;PSMB8;PSMB2;CUL5;PSMD14;UFL1;ASB14;PSMD6;RLIM;RNF25;KLHL22;UBE2E1;UBR1;ATG14;PSMD8;PSMB11;ASB11;UBE2B;FBXO44;UBE2R2;UBE2Q2;UBE2G2;PSMB1;WSB1;FBXO27;PSME2;RNF14;RNF213;BTK;SOCS1;WWP1;PSME3;UBE2K;KLHL5;CUL3;FBXL8;ANAPC10;FBXW4;DCAF1;RNF6;NEDD4;ANAPC7;FBXL22;SEC23A;SEC13
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.5736539752485139,-1.9693414494241668,0.002109704641350211,0.0033714581786390323,0.175,10/30,9.66%,PPIA;HNRNPA2B1;RALA;HNRNPDL;HSPA9;TCP1;GSTO1;AURKAIP1;PKN2;SOD1
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.3946528355694692,-1.9693060168221783,0.0,0.0033595026531828653,0.175,91/243,27.48%,UBB;RPS27A;JUN;FGFR2;PSMB3;CBX6;PSMC6;LAMTOR3;PPP2R1A;LAMTOR2;PSMC1;PSMD2;PSMA4;UBC;PSMB6;CNOT6L;GSK3B;RRAGA;PSMA3;UBA52;RPS6KB2;PSMA7;PSMA2;AKT1;IL1RAP;SCMH1;CHD3;PSMC5;SEM1;PSMC3;TGFA;PSMC2;LAMTOR1;RNMT;CSNK2B;PDGFRA;MLST8;IER3;PPP2CA;CDKN1B;MAPK3;TRAF6;PSMB5;PREX2;PSMB7;FGFR3;IRS2;PHLPP1;NRG2;MECOM;AKT3;PIP5K1B;SOS1;FGF1;LAMTOR5;STUB1;PSMB4;PHC3;VAPA;MAF1;HDAC1;PSMD7;PSMA1;IRAK1;MAPK1;AGO3;PSMB8;PSMB2;PSMD14;PIP4K2A;PSMD6;TNKS;BAD;KDM1A;EZH2;PSMD8;PSMB11;HDAC2;PSMB1;FOXO1;PSME2;FGF10;LAMTOR4;TNRC6C;PSME3;RNF146;FGFR1;IRAK4;RRAGD;CBX4;MAPKAP1
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.39222622081143,-1.9685231392703073,0.0,0.00336783865097855,0.176,111/285,28.05%,UBE3A;UBB;RPS27A;PSMB3;ELOB;KLHL9;PSMC6;FBXL16;PJA2;PJA1;SKP1;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;UBE2N;PSMA3;UBA52;PSMA7;UBE2A;PSMA2;FBXW11;HACE1;ELOC;PSMC5;SEM1;PSMC3;KCTD6;PSMC2;FBXL14;TRIM32;FBXO9;UBE2D3;ANAPC4;RNF138;FBXW7;FBXL5;FBXW2;ANAPC13;PSMB5;DZIP3;PSMB7;UBE2Q1;LMO7;RNF114;FBXL4;ASB13;CDC26;ZNRF2;BTBD1;SKP2;RNF7;CBLB;RNF182;UBE2E3;RBX1;TPP2;DET1;STUB1;FBXO15;RNF19A;KLHL25;CUL1;LRRC41;PSMB4;HECTD2;UBE2V1;PSMD7;PSMA1;PSMB8;PSMB2;CUL5;PSMD14;UFL1;ASB14;PSMD6;RLIM;RNF25;KLHL22;UBE2E1;UBR1;PSMD8;PSMB11;ASB11;UBE2B;FBXO44;UBE2R2;UBE2Q2;UBE2G2;PSMB1;WSB1;FBXO27;PSME2;RNF14;RNF213;SOCS1;WWP1;PSME3;UBE2K;KLHL5;CUL3;FBXL8;ANAPC10;FBXW4;DCAF1;RNF6;NEDD4;ANAPC7;FBXL22
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.5993735662312474,-1.9680865594828625,0.0020964360587002098,0.003369403984436047,0.177,10/25,17.98%,UBB;HSP90AA1;RPS27A;UBC;UBA52;BIRC2;PELI1;STUB1;FADD;SDCBP
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.5209022275828465,-1.9675022682505516,0.0,0.003370958333097351,0.177,16/44,22.03%,UBB;RPS27A;EYA1;UBC;UBE2N;UBA52;BAZ1B;H2BC4;BABAM2;EYA4;BRCC3;UBXN1;UBE2I;H2AX;H2BC21;SUMO1
gsea,VLDLR Internalisation And Degradation R-HSA-8866427,-0.689023528461708,-1.9666057550702045,0.0,0.0033791668355318415,0.177,6/16,4.99%,UBB;RPS27A;AP2M1;CLTA;UBC;UBA52
gsea,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.6895842657940732,-1.9656680081754783,0.0022471910112359553,0.0034138853369243332,0.18,8/15,19.28%,CALM1;HSP90AA1;AKT1;WASL;ZDHHC21;CAV1;CYGB;DDAH1
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.3898965072897057,-1.965115720964032,0.0,0.0034086503068532555,0.18,105/279,27.88%,CALM1;UBB;RPS27A;JUN;FGFR2;CAMK2B;PSMB3;CBX6;PSMC6;LAMTOR3;PPP2R1A;LAMTOR2;PSMC1;PSMD2;PSMA4;UBC;PSMB6;CNOT6L;PRKAR1A;GSK3B;RRAGA;PSMA3;UBA52;RPS6KB2;PSMA7;ADCY9;PSMA2;AKT1;AHCYL1;IL1RAP;SCMH1;CHD3;PSMC5;CAMKK1;SEM1;PSMC3;TGFA;PSMC2;LAMTOR1;RNMT;CSNK2B;PDGFRA;MLST8;IER3;PPP2CA;CDKN1B;MAPK3;TRAF6;PSMB5;PREX2;PSMB7;FGFR3;IRS2;PHLPP1;NRG2;MECOM;AKT3;PIP5K1B;SOS1;FGF1;PRKCE;LAMTOR5;PRKACB;STUB1;PSMB4;PHC3;VAPA;MAF1;HDAC1;PSMD7;PSMA1;IRAK1;MAPK1;AGO3;PSMB8;PSMB2;PSMD14;PIP4K2A;PSMD6;TNKS;PDE1B;BAD;KDM1A;EZH2;PSMD8;PSMB11;PRKAR2B;HDAC2;PSMB1;FOXO1;PSME2;FGF10;LAMTOR4;TNRC6C;PRKX;PSME3;RNF146;FGFR1;IRAK4;RRAGD;ITPR2;CBX4;MAPKAP1;PRKCD;NEDD4
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.587682963866125,-1.9646806564124073,0.0,0.003396855669113279,0.18,14/26,24.32%,POLR2G;POLR2K;ERCC3;GTF2H5;POLR2E;RNMT;GTF2F1;CCNH;POLR2F;MNAT1;POLR2L;POLR2D;GTF2F2;POLR2H
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.5200191291886718,-1.9644927795583056,0.0,0.003391715465690315,0.18,21/46,23.69%,UBB;RPS27A;MAML2;SKP1;UBC;UBA52;HIF1A;HDAC11;TLE4;MAML3;FBXW7;SNW1;HEY1;RBX1;CUL1;HDAC1;TBL1XR1;HES5;KAT2B;TLE1;HDAC2
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.4726461438584802,-1.9601818919118792,0.0,0.0034521156305538964,0.189,25/76,22.67%,HSP90AA1;TUBA1A;DYNLL1;YWHAE;YWHAG;TUBA4A;PPP2R1A;NME7;TUBB4B;CETN2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;SSNA1;HAUS3;MZT1;CEP135;ODF2;AKAP9;TUBG2;PCM1;ACTR1A;PRKAR2B
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.5718025796536794,-1.959358523808814,0.0,0.0034664055999897234,0.192,9/28,13.72%,UBB;RPS27A;ELOB;UBC;UBA52;ELOC;UBE2D3;TYK2;RNF7
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.6719617147953538,-1.958192693710633,0.0,0.0034871038176766847,0.193,6/16,6.01%,UBB;RPS27A;SKP1;UBC;UBA52;FBXW11
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.3774117564321079,-1.9574782263337756,0.0,0.003514144893326502,0.197,166/451,28.17%,CALM1;UBB;HSP90AA1;ATP6V0C;APOE;RPS27A;YWHAB;ATP6V1G2;FGFR2;ATP6V0E2;HRAS;ATP6V1F;CDK5R1;ATP6V1D;AP2M1;ATP6V0B;JUND;PTK2B;STMN1;VGF;SH3GL1;PPP2R1A;ATP6V1G1;RALA;POLR2G;MEF2A;ATP6V1A;COL4A2;BAIAP2;HNRNPA1;CLTA;POLR2K;UBC;F3;ELMO2;UBA52;TCF12;NCK1;GABRG2;NCKAP1;HNRNPH1;ID3;ATP6V1E1;HIF1A;AKT1;CYFIP1;AHCYL1;BCL11B;POLR2E;BRAF;TGFA;WASF1;PDE3B;RNMT;NTRK3;ID2;ERBIN;STAM2;TIAM1;YES1;PKN2;GABRB3;S100B;PDGFRA;MLST8;CTNNA1;ABI1;CYBA;ATP6V1H;PPP2CA;GABRB2;ABI2;MAPK3;FURIN;LAMA5;FGFR3;IGF1R;VRK3;LAMA2;IRS2;COL6A1;PSENEN;YAP1;NRG2;DUSP6;GFAP;AKT3;GTF2F1;TIA1;SOS1;PGF;FGF1;CXCL12;CAV1;PRKCE;PTN;CDK5R2;AAMP;PRKACB;DOCK1;STUB1;EGR4;AP2S1;CDK5;ATP6V1B2;ROCK2;HDAC1;CTNNB1;DUSP7;RAP1A;POLR2F;APH1B;RHOA;MAPK1;GABRA1;ARF6;LAMA1;CUL5;PTPRZ1;STAM;FGFBP3;VAV3;FLT1;POLR2L;AP2B1;COL4A1;NCBP2;MYCN;VEGFA;MAP2K1;VEGFC;NELFB;BRK1;ID1;HDAC2;APH1A;POLR2D;ATP6V0A2;GTF2F2;POLR2H;PTPN3;FGF10;SOCS1;NAB2;PTK2;PTPN12;ITGB1;WWP1;PGR;PXDN;COL4A5;DUSP3;FGFR1;CDC37;HGFAC;SH3KBP1;ITPR2;MAPKAP1;THBS4;SPHK1;PRKCD;NEDD4;MXD4;TIAL1;LAMB1;ASCL1
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.6305872636934499,-1.9569507478696544,0.002044989775051125,0.0035216175887028923,0.198,6/20,12.12%,UBB;RPS27A;UBC;UBA52;CNTN1;PSENEN
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.5086195265751436,-1.9564931887718857,0.0,0.0035354796465309752,0.2,16/48,17.94%,UBB;DDX5;RPS27A;CANX;CHMP2A;UBC;GSK3B;UBA52;CTSL;ST6GALNAC2;MAP1LC3B;CAV1;RB1;ZCRB1;UBE2I;PARP6
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.46640616602033347,-1.9560896536900236,0.002066115702479339,0.0035364120159127157,0.201,37/84,27.12%,ATP1B1;HSP90AA1;ATP1A2;HSP90AB1;AP2M1;ATP1B2;S1PR1;NCK1;PTGES3;CHD3;FKBP1A;IFNGR2;FXYD1;TYK2;FURIN;SIGMAR1;SOS1;SAP18;ITGA4;RBX1;AP2S1;ROCK2;HDAC1;FXYD2;ATP1B3;AP2B1;KDM1A;VEGFA;BRMS1L;HDAC2;COMT;BTK;ITGB1;ARID4B;CUL3;PHF21A;SH3KBP1
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5545801074423466,-1.9558476610853448,0.0,0.003537338127781826,0.202,14/30,25.32%,UBB;RPS27A;USP1;UBC;PCNA;UBA52;POLD4;POLE3;RBX1;RPA3;POLE4;UBE2B;RAD18;RFC5
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.5637681149219758,-1.9529426429768926,0.0040650406504065045,0.003608385681849112,0.207,7/28,11.36%,UBB;RPS27A;LCT;UBC;UBA52;PPP1R3C;IDS
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.4797634220925792,-1.952892278143455,0.0,0.003596357729576281,0.207,18/64,14.03%,ATP6V0C;ATP6V1G2;FGFR2;ATP6V0E2;HRAS;ATP6V1F;ATP6V1D;ATP6V0B;ATP6V1G1;ATP6V1A;ATP6V1E1;PDE3B;ATP6V1H;MAPK3;FGFR3;IRS2;SOS1;FGF1
gsea,HIV Transcription Initiation R-HSA-167161,-0.5070485224080832,-1.9522582014840673,0.0,0.003584409697252108,0.207,19/45,24.32%,POLR2G;POLR2K;TAF11;ERCC3;GTF2H5;POLR2E;GTF2F1;TAF7L;GTF2B;CCNH;TAF10;GTF2A1;TAF13;POLR2F;MNAT1;POLR2L;POLR2D;GTF2F2;POLR2H
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.5977119094368457,-1.9518225049287767,0.0,0.0035977884290685417,0.209,10/23,16.22%,CCT5;BBIP1;TCP1;CCT8;BBS5;CCT2;TTC8;ARL6;CCT3;CCT4
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.49496578399985414,-1.9501042893766052,0.0,0.0036614074775450367,0.215,24/53,24.32%,H2AZ1;POLR2K;CBX3;GSK3B;BAZ1B;H2AJ;CHD3;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;POLR2L;KAT2B;MYBBP1A;HDAC2;POLR2H
gsea,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.6809466927504709,-1.9495923279864484,0.00398406374501992,0.0036619041416087296,0.216,6/16,6.41%,UBB;RPS27A;UBC;PARD6A;UBA52;FKBP1A
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.415930548226369,-1.9483164342321335,0.0,0.0036998964998710975,0.219,63/147,32.75%,UBB;RPS27A;SLC1A3;BSG;PSMB3;PSMC6;PSMC1;PSMD2;PSMA4;TPR;UBC;PSMB6;SLC35A1;SLC4A4;PSMA3;UBA52;SLC24A5;PSMA7;PSMA2;APOA1;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;SLC35A3;DERL2;RNF5;PSMB4;MAP4K5;NUP54;PSMD7;PSMA1;NUP37;PSMB8;PSMB2;PSMD14;PSMD6;SLC24A1;PSMD8;SLC9A9;PSMB11;ERLIN2;PSMB1;PSME2;NUP43;PSME3;SLC2A9;SEL1L;LMBRD1;SEC13;SLC11A2;NUP153;SLC17A8;ERLEC1;DERL1;PSME1;SLC16A1;SLC5A5;SEH1L;PSMD4;PSMF1
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.6350741648916004,-1.948072141946133,0.0,0.003694034735742283,0.22,12/19,24.32%,FGFR2;POLR2G;POLR2K;POLR2E;GTF2F1;FGF1;POLR2F;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.5551674379948222,-1.9451774240139823,0.0,0.0038061842432124296,0.224,14/30,20.82%,POLR2K;ERCC3;GTF2H5;POLR2E;TAF1D;TTF1;POLR1H;UBTF;CCNH;POLR1D;POLR2F;POLR1F;MNAT1;POLR2L
gsea,DARPP-32 Events R-HSA-180024,-0.5973312668041806,-1.9442773242410036,0.0020876826722338203,0.003824771253404172,0.228,11/23,17.17%,CALM1;PPP3CA;PPP3R1;PPP2R1A;PRKAR1A;PPP1CA;PPP3CB;PPP2CA;PPP1R1B;PRKACB;CDK5
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.477360937633862,-1.9428085624895624,0.0,0.0038740825657379405,0.23,16/67,12.53%,HSP90AA1;TUBA1A;DYNLL1;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;CETN2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;SSNA1;HAUS3
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.6326256743459844,-1.941845522314168,0.006036217303822937,0.0039046286759619373,0.232,10/22,12.68%,RAB3A;VAMP2;SLC1A3;PPFIA2;ARL6IP5;CPLX1;SNAP25;RIMS1;SLC17A7;SLC1A2
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.4904694355168136,-1.9410038443355098,0.0,0.00394110759794158,0.234,25/54,25.51%,H2AZ1;POLR2K;H2AJ;ERCC3;GTF2H5;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;UBTF;CCNH;SAP18;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L;HDAC2;POLR2H;ARID4B
gsea,mRNA Capping R-HSA-72086,-0.56954013699506,-1.9401146711168429,0.0020408163265306124,0.0039590238664810925,0.236,15/28,24.32%,POLR2G;POLR2K;ERCC3;GTF2H5;POLR2E;RNMT;GTF2F1;CCNH;POLR2F;MNAT1;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.48953086031090615,-1.938481093642543,0.0019455252918287938,0.003995095909756332,0.238,35/59,39.05%,RPS7;RPS6;NOP10;RPS9;RPS2;SNU13;THUMPD1;TRMT112;UTP3;UTP11;NOP58;RPS14;DKC1;PDCD11;TSR3;NHP2;RRP9;MPHOSPH10;NOP14;FCF1;WDR46;UTP20;DCAF13;NOP56;UTP15;UTP25;NOC4L;SPPL2A;HEATR1;DIMT1;BMS1;WDR43;GAR1;NOP2;UTP18
gsea,Centrosome Maturation R-HSA-380287,-0.4697318326521838,-1.936953434244196,0.0,0.004055220955003751,0.239,25/76,22.67%,HSP90AA1;TUBA1A;DYNLL1;YWHAE;YWHAG;TUBA4A;PPP2R1A;NME7;TUBB4B;CETN2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;SSNA1;HAUS3;MZT1;CEP135;ODF2;AKAP9;TUBG2;PCM1;ACTR1A;PRKAR2B
gsea,Protein Ubiquitination R-HSA-8852135,-0.48618365829094107,-1.932991516963162,0.0,0.00415732418007556,0.245,32/63,31.49%,UBB;RPS27A;UBC;PCNA;UBE2N;SELENOS;RRAGA;UBA52;UBE2A;H2BC4;WAC;UBE2D3;TMEM129;OTULIN;UBE2E3;RTF1;PEX10;RNF20;UBE2E1;UBE2B;UBE2R2;RAD18;UBE2Q2;UBE2G2;UBE2K;PEX2;UBE2H;UBE2V2;CTR9;CDC73;DERL1;RNF181
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,-0.4745628404657175,-1.9328697576945615,0.0,0.004144168090898105,0.245,29/66,21.33%,SRSF2;SNRPG;PABPN1;SNRPF;FYTTD1;SRSF9;SRSF7;CPSF6;CDC40;FIP1L1;U2AF1;THOC2;CSTF2T;PCF11;SRSF1;SRSF11;U2AF1L4;MAGOHB;SNRPD3;ZC3H11A;SLU7;SARNP;PAPOLA;THOC1;RNPS1;SNRPB;ALYREF;NCBP2;U2AF2
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.5222734534560114,-1.932377162208726,0.0,0.004143121482891827,0.245,19/39,24.32%,H2AZ1;POLR2K;GSK3B;BAZ1B;H2AJ;POLR2E;H2BC4;TAF1D;POLR1H;H2AZ2;POLR1D;H2AX;POLR2F;POLR1F;H2BC21;POLR2L;KAT2B;MYBBP1A;POLR2H
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.4381068199803359,-1.9320549078028968,0.0,0.004130092798983362,0.245,21/95,12.58%,HSP90AA1;TUBA1A;DYNLL1;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;AHI1;CETN2;RAB11A;TMEM216;TTBK2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;SSNA1;HAUS3;B9D1
gsea,Mitotic Prometaphase R-HSA-68877,-0.4042685329062804,-1.9309358929486515,0.0,0.0041470234904670165,0.246,53/170,24.50%,HSP90AA1;TUBA1A;DYNLL1;RPS27;DYNLL2;YWHAE;YWHAG;TUBA4A;PPP2R1A;NME7;TUBB4B;ITGB3BP;CETN2;CSNK2B;DCTN1;PPP2CA;NCAPD2;PLK4;XPO1;PDS5B;NUDC;TUBB4A;DCTN3;CEP78;SMC1A;NEK7;NUF2;PDS5A;SSNA1;HAUS3;TAOK1;CENPP;MZT1;AHCTF1;BUB3;RAB33B;ZWINT;CEP135;CENPE;RCC2;NUP37;ODF2;AKAP9;TUBG2;PCM1;ACTR1A;NDEL1;PRKAR2B;MIS12;CENPF;KIF2A;NUP43;CEP43
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.47038430205468656,-1.929006296437375,0.0,0.004229373875882,0.254,26/63,25.32%,UBB;RPS27A;POLR2G;POLR2K;UBC;PCNA;UBA52;TCEA1;PRPF19;ERCC3;GTF2H5;POLD4;POLR2E;POLE3;CCNH;RBX1;RPA3;POLR2F;MNAT1;POLE4;POLR2L;XAB2;POLR2D;POLR2H;HMGN1;RFC5
gsea,Signaling By Interleukins R-HSA-449147,-0.3840511851704648,-1.9280857098484763,0.0,0.004251828100750664,0.256,117/355,26.21%,UBB;HSP90AA1;PPIA;RPS27A;VAMP2;HSPA8;HNRNPA2B1;HMGB1;YWHAZ;JUN;NDN;PSMB3;CEBPD;CANX;PTK2B;HSP90B1;PSMC6;PPP2R1A;PELI2;RALA;MEF2A;SKP1;PSMC1;PSMD2;PSMA4;HNRNPDL;UBC;PSMB6;UBE2N;SNAP25;PSMA3;S1PR1;UBA52;PSMA7;HSPA9;TCP1;HIF1A;GSTO1;PSMA2;IL1RAPL1;FBXW11;AKT1;AURKAIP1;IL1RAP;PSMC5;SEM1;PSMC3;PSMC2;SQSTM1;YES1;PKN2;S100B;TNFRSF1A;LRRC14;PELI1;PPP2CA;SOD1;MAPK3;TYK2;TRAF6;MAP2K6;PSMB5;USP14;PSMB7;LAMA5;VRK3;IRS2;DUSP6;IKBKG;SOS1;P4HB;MAP2K7;RBX1;POU2F1;MCL1;CUL1;PSMB4;NKIRAS2;RHOU;UBE2V1;DUSP7;PSMD7;PSMA1;IRAK1;CCND1;MAPK1;PSMB8;PSMB2;PSMD14;PTPRZ1;IRAK2;PSMD6;IL1R2;IL12RB2;IL16;HMOX1;VEGFA;PSMD8;PSMB11;RPLP0;INPPL1;MAP2K1;IL5RA;PSMB1;FOXO1;PSME2;NKIRAS1;SOCS1;MAPK9;PTPN12;ITGB1;BCL6;PSME3;CRLF1;TGFB1;DUSP3;PDCD4
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.5752643580911002,-1.9271945449071983,0.0022026431718061676,0.004262303127474468,0.257,14/28,24.32%,H2AZ1;POLR2G;POLR2K;H2AJ;POLR2E;H2BC4;TERF1;H2AZ2;H2AX;POLR2F;H2BC21;POLR2L;POLR2D;POLR2H
gsea,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.6408903955025791,-1.9259636590083824,0.0064794816414686825,0.004284516368747683,0.258,5/18,10.77%,UBB;RPS27A;UBC;UBA52;ZNRF3
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.5433839198721425,-1.9256038445146748,0.0,0.004294825845096659,0.26,22/35,33.93%,UBB;RPS27A;CANX;CALR;PSMC1;UBC;UBA52;RAD23B;DERL2;UBXN1;RNF5;ENGASE;RNF139;NGLY1;SYVN1;SEL1L;MARCHF6;AMFR;DERL1;EDEM1;TRIM13;MLEC
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.46667523799472377,-1.9254999762659961,0.002066115702479339,0.0042816109963425145,0.26,16/61,11.29%,PRNP;BPNT2;ESD;TRMT112;MAT2B;GSTM5;SULT4A1;AKR1A1;MGST3;GSTO1;GSTM1;CHAC2;HPGDS;GSTP1;TPMT;GSTZ1
gsea,Death Receptor Signaling R-HSA-73887,-0.42853895451059015,-1.9201851187810928,0.0,0.004473130237690805,0.269,39/126,21.23%,UBB;RPS27A;YWHAE;BEX3;MAGED1;NSMAF;ARHGEF4;ITGB3BP;RACK1;UBC;BAG4;UBA52;SHARPIN;FGD4;ARHGEF9;SQSTM1;TIAM1;BIRC2;TNFRSF1A;PRDM4;TRAF6;PRKCI;OMG;PSENEN;OTULIN;IKBKG;SOS1;RTN4;ARHGEF12;FADD;PRPF38B;HDAC1;IRAK1;APH1B;RHOA;ARHGEF26;SMPD2;VAV3;BAD
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.5497577139543969,-1.9167785755016022,0.0,0.004558549850112899,0.275,10/33,13.21%,UBB;RPS27A;RACK1;UBC;UBA52;SHARPIN;BIRC2;TNFRSF1A;OTULIN;IKBKG
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.5216496750814786,-1.9166701036257958,0.0020920502092050207,0.004544651832277189,0.275,11/37,10.19%,PPIA;HNRNPA2B1;RALA;HNRNPDL;HSPA9;TCP1;GSTO1;AURKAIP1;PKN2;SOD1;TYK2
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.4529127256524594,-1.9137298788738335,0.0,0.0046467165182856995,0.28,22/81,15.22%,UBB;RPS27A;SUMO2;UBC;PCNA;UBE2N;PIAS1;UBA52;COPS8;ERCC3;GTF2H5;POLD4;CETN2;COPS5;COPS7A;RUVBL1;COPS6;POLE3;CCNH;RAD23B;RBX1;RPA3
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.48596414616252936,-1.9131246875177013,0.0,0.004661517326964439,0.283,22/56,20.82%,UBB;RPS27A;POLR2K;UBC;POLR3H;UBA52;TLR3;DHX36;POLR2E;TRIM32;POLR3K;POLR3A;XRCC6;POLR3E;IKBKG;POLR1D;POLR3D;NKIRAS2;CTNNB1;POLR2F;POLR3F;POLR2L
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.4706898985521123,-1.9122178994902599,0.0,0.004699264314158154,0.286,22/68,21.23%,UBB;RPS27A;YWHAE;BEX3;MAGED1;ARHGEF4;ITGB3BP;UBC;UBA52;FGD4;ARHGEF9;SQSTM1;TIAM1;TRAF6;PSENEN;SOS1;ARHGEF12;PRPF38B;APH1B;ARHGEF26;VAV3;BAD
gsea,Cilium Assembly R-HSA-5617833,-0.4010161881359366,-1.9122007817099056,0.0,0.004685109903573341,0.286,39/180,12.58%,HSP90AA1;TUBA1A;DYNLL1;DYNLL2;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;CCT5;NUDT19;AHI1;BBIP1;TCP1;KIFAP3;CETN2;IFT20;CCT8;RAB11A;TMEM216;BBS5;DYNLT2B;TTBK2;IFT43;DCTN1;ARF4;DYNLRB1;EXOC3;PLK4;CCT2;TTC8;TTC30B;TUBB4A;DCTN3;CEP78;ARL6;SSNA1;HAUS3;B9D1
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.6190659050828418,-1.9121243309070926,0.0,0.0046710405044635105,0.286,4/19,1.70%,CALM1;NEFL;HRAS;CAMK2B
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.46341620670301215,-1.9118094146213245,0.0,0.004657055353252543,0.286,31/84,20.99%,ACTG1;MYL6;EPHA7;HRAS;AP2M1;ACTR2;CLTA;ARPC3;ARPC2;ARPC5;CLTB;MYL12B;EFNB3;TIAM1;YES1;PKN2;WASL;MYL9;ACTR3;PSENEN;EPHA4;ARPC1B;EFNA3;AP2S1;ROCK2;SDCBP;APH1B;RHOA;EPHA6;VAV3;AP2B1
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.45518713941947664,-1.9115986086805414,0.0,0.004643153695481639,0.286,24/73,20.63%,UBB;YWHAE;HSPA8;HSPA2;HSBP1;HSPA5;TPR;BAG4;GSK3B;HSPA9;HSPH1;HSPA4;CCAR2;MAPK3;MRPL18;HSPA4L;BAG1;RPA3;HSPA12B;NUP54;NUP37;MAPK1;DNAJB6;HSPA13
gsea,Signaling By Hedgehog R-HSA-5358351,-0.4130211051444585,-1.9030353185368438,0.0,0.005026459093268212,0.312,53/131,26.54%,UBB;RPS27A;PSMB3;PSMC6;SKP1;PSMC1;PSMD2;GLI3;PSMA4;UBC;PSMB6;PRKAR1A;GSK3B;PSMA3;UBA52;PSMA7;GNAS;ADCY9;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;PSMB5;PSMB7;EFCAB7;DISP2;P4HB;RBX1;NOTUM;DERL2;PRKACB;GLI2;CUL1;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;KIF3A;PSMD8;PSMB11;PRKAR2B;SYVN1;SPOPL;PSMB1;PSME2;GAS8;PSME3;SEL1L;CUL3
gsea,Signaling By ERBB2 R-HSA-1227986,-0.4872403593685439,-1.902602254263929,0.0,0.005034169264225326,0.315,16/46,19.49%,UBB;HSP90AA1;RPS27A;HRAS;UBC;UBA52;AKT1;ERBIN;YES1;NRG2;AKT3;SOS1;PRKCE;STUB1;RHOA;CUL5
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.5505956855373915,-1.9021156330675781,0.0,0.005030554542594209,0.316,15/29,24.32%,ELOB;POLR2G;POLR2K;TCEA1;ELOC;POLR2E;CCNK;GTF2F1;CCNT2;POLR2F;POLR2L;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.4493838724147423,-1.9001046917972315,0.0,0.005116929131483811,0.32,30/75,25.32%,UBB;RPS27A;POLR2G;POLR2K;UBC;PCNA;UBA52;TCEA1;COPS8;PRPF19;ERCC3;GTF2H5;POLD4;POLR2E;COPS5;COPS7A;COPS6;POLE3;CCNH;RBX1;RPA3;POLR2F;MNAT1;POLE4;POLR2L;XAB2;POLR2D;POLR2H;HMGN1;RFC5
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.5874462744146082,-1.9000187657282788,0.0,0.005101879339920623,0.32,10/22,20.42%,H2AZ1;SET;H2AJ;H2BC4;KMT5A;RB1;H2AZ2;RAB33B;H2AX;H2BC21
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.5653537712425808,-1.8992142334581064,0.0,0.005142818012720089,0.324,9/28,14.03%,UBB;RPS27A;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;FGF1
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.4632575410486811,-1.8971457112466088,0.0,0.00520023830155395,0.328,26/70,26.23%,HSP90AA1;TUBA1A;DYNLL1;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;CETN2;DCTN1;PLK4;TUBB4A;DCTN3;CEP78;SSNA1;HAUS3;CEP135;ODF2;AKAP9;PCM1;ACTR1A;PRKAR2B;CEP43;SDCCAG8;HMMR;DYNC1I2
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.6233469295515256,-1.8970906380673063,0.0,0.005196192106368392,0.329,6/19,7.78%,UBB;RPS27A;UBC;PCNA;UBA52;SPRTN
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.42575499034445863,-1.896055148634577,0.0,0.005192169435573448,0.33,38/105,25.32%,UBB;RPS27A;SUMO2;POLR2G;POLR2K;UBC;PCNA;UBE2N;PIAS1;UBA52;TCEA1;COPS8;PRPF19;ERCC3;GTF2H5;POLD4;CETN2;POLR2E;COPS5;COPS7A;RUVBL1;COPS6;POLE3;CCNH;RAD23B;RBX1;RPA3;UBE2I;POLR2F;MNAT1;POLE4;POLR2L;XAB2;SUMO1;POLR2D;POLR2H;HMGN1;RFC5
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.5145689674771786,-1.8936833654331304,0.0020161290322580645,0.0052876238242502704,0.335,18/39,24.32%,ELOB;POLR2G;POLR2K;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;GTF2F1;CCNH;POLR2F;MNAT1;POLR2L;NCBP2;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.5185799976858865,-1.8917678846442199,0.0,0.005354980258708529,0.341,5/34,4.99%,UBB;RPS27A;USP1;UBC;UBA52
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.49406682807117464,-1.8902625493704475,0.0,0.005378001574202675,0.342,28/49,32.67%,IDH3B;MDH2;BSG;LDHB;GLO1;HAGH;MPC2;PLPP6;SUCLG1;VDAC1;GSTZ1;PDHX;FAHD1;PDP2;PDK3;IDH3A;NNT;CS;PDHB;SDHB;LDLR;SDHA;SLC16A1;MPC1;ADHFE1;IDH3G;SDHD;SLC16A3
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5439311058011914,-1.8866567713112812,0.0019801980198019802,0.005494009386446036,0.347,9/27,12.66%,UBB;HSP90AA1;RPS27A;UBC;UBA52;AKT1;ERBIN;NRG2;AKT3
gsea,EGFR Downregulation R-HSA-182971,-0.546666012172779,-1.8844290268505353,0.003968253968253968,0.005603890515878681,0.356,7/28,7.26%,UBB;RPS27A;SH3GL1;UBC;UBA52;TGFA;STAM2
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.45920719195621,-1.8825166305532803,0.0,0.005680466095832501,0.361,26/62,25.32%,UBB;RPS27A;POLR2G;POLR2K;UBC;PCNA;UBA52;TCEA1;PRPF19;ERCC3;GTF2H5;POLD4;POLR2E;POLE3;CCNH;RBX1;RPA3;POLR2F;MNAT1;POLE4;POLR2L;XAB2;POLR2D;POLR2H;HMGN1;RFC5
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.5497371604176964,-1.8823753559893524,0.004032258064516129,0.005675143951265764,0.361,13/31,18.93%,ACTG1;HRAS;ACTR2;ARPC3;ARPC2;ARPC5;TIAM1;YES1;WASL;ACTR3;ARPC1B;ROCK2;RHOA
gsea,Ion Channel Transport R-HSA-983712,-0.4079277342442917,-1.8818775014275215,0.0,0.005691513372025585,0.362,27/144,9.40%,CALM1;ATP1B1;UBB;ATP1A2;ATP6V0C;RPS27A;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1D;CAMK2B;ATP6V0B;ATP6V1G1;ATP6V1A;ATP1B2;UBC;ATP13A4;UBA52;CLCN2;ATP6V1E1;ATP2B1;ATP13A5;OSTM1;CLCN4;FXYD1;ATP6V1H;TRPM3
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5593357384587048,-1.879709617686463,0.002105263157894737,0.005750989972870709,0.367,11/27,14.83%,PRDX5;CYCS;PRDX2;GPX1;CYBA;SOD1;GSTP1;TXN2;ATOX1;P4HB;PRDX1
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.6238665937481966,-1.8788165965562067,0.0,0.005772437393103212,0.369,12/17,24.32%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;POLR3E;POLR1D;POLR3D;POLR2F;POLR3F;POLR2L;POLR2H
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.5131186645889008,-1.8782954442328608,0.002008032128514056,0.005799133550901883,0.373,16/37,21.22%,CCT5;CCT7;TCP1;CCT8;CCT6A;FBXW7;FBXL5;FBXW2;AP3M1;LONP2;CCT2;XRN2;CCT3;CCT4;GAPDHS;CCNE2
gsea,Leishmania Infection R-HSA-9658195,-0.39253113444422294,-1.8746477077630612,0.0,0.0059220604611178885,0.379,38/188,10.28%,CALM1;HSP90AB1;ACTG1;WIPF3;GLP2R;JUN;ACTR2;GNG3;BAIAP2;ARPC3;GNB2;ARPC2;ARPC5;PTGER4;PRKAR1A;ELMO2;CALCRL;NCK1;GNAS;ADCY9;NCKAP1;CYFIP1;AHCYL1;RAMP1;GNG7;WASF1;YES1;HTR4;ABI1;WASL;CYBA;PTRH2;CHGA;ABI2;MAPK3;ACTR3;FURIN;TXN2
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.49804973482617726,-1.8717960812242866,0.0,0.006070996137613552,0.39,11/41,15.22%,UBB;RPS27A;UBC;PCNA;UBA52;ERCC3;GTF2H5;POLD4;POLE3;RBX1;RPA3
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.5170455738164936,-1.8681425468613737,0.0038240917782026767,0.006240398058111517,0.399,19/34,27.27%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;GTF3A;POLR3E;POU2F1;POLR1D;POLR3D;SNAPC5;POLR2F;SNAPC1;POLR3F;POLR2L;BRF2;POLR2H;SNAPC3;GTF3C6
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.4547322773709656,-1.8681076150967506,0.003976143141153081,0.006223015333715664,0.399,22/57,27.04%,UBB;RPS27A;AGPS;SYCP2;UBC;NUDT19;UBA52;ZFAND6;UBE2D3;LONP2;ACOX1;PEX10;AMACR;MPV17;PEX26;CROT;PIPOX;PECR;ECI2;DDO;ECH1;PEX2
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.5876419409482928,-1.8643818622682644,0.0019305019305019305,0.006391053856888355,0.402,14/21,24.32%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;NFIA;POLR3E;SSB;POLR1D;POLR3D;POLR2F;POLR3F;POLR2L;POLR2H
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.46818386565063713,-1.8609586790745827,0.0,0.006584563034731198,0.415,21/55,23.87%,UBB;RPS27A;MAML2;SKP1;UBC;UBA52;HDAC11;MAML3;FBXW7;SNW1;PSENEN;HEY1;RBX1;CUL1;HDAC1;TBL1XR1;HES5;APH1B;KAT2B;HDAC2;APH1A
gsea,Opioid Signaling R-HSA-111885,-0.4399715625213529,-1.8593972553875022,0.002053388090349076,0.006619031000835638,0.419,19/83,11.66%,CALM1;PPP3CA;PPP3R1;CAMK2B;PPP2R1A;GNG3;GNB2;PRKAR1A;PLCB1;PPP1CA;ADCY9;PPP3CB;AHCYL1;CAMKK1;GNG7;PPP2CA;GNAQ;PPP1R1B;GNG10
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,0.5831224602258135,1.8586737711361057,0.005813953488372093,0.15247801615490378,0.403,11/25,8.92%,SPTBN4;SCN8A;ANK3;L1CAM;SPTAN1;ANK2;KCNQ2;NFASC;SPTBN5;SCN5A;KCNQ3
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.5223019404961434,-1.8583927280034462,0.0020161290322580645,0.006669062752331684,0.421,15/31,24.32%,POLR2G;POLR2K;ERCC3;GTF2H5;POLR2E;GTF2F1;CCNH;POLR2F;MNAT1;POLR2L;NCBP2;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Signaling By ERBB4 R-HSA-1236394,-0.46886805494909267,-1.8576992061261612,0.002066115702479339,0.006703109191925659,0.423,17/56,14.33%,UBB;APOE;RPS27A;HRAS;STMN1;UBC;UBA52;GABRG2;GABRB3;S100B;GABRB2;PSENEN;YAP1;NRG2;GFAP;SOS1;CXCL12
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.4061227651232711,-1.8555891302202419,0.0,0.006825750838699162,0.426,40/140,19.83%,UBB;RPS27A;HMGB1;JUN;HSP90B1;PPP2R1A;PELI2;MEF2A;SKP1;UBC;CTSB;UBE2N;GSDME;UBA52;TLR3;FBXW11;NDUFA2;CTSL;BIRC2;S100B;UBE2D3;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;FADD;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.5395034889718253,-1.8535298111922305,0.0,0.0069060568114148015,0.429,8/28,12.12%,UBB;RPS27A;MAML2;UBC;UBA52;MAML3;CNTN1;PSENEN
gsea,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.6392623294329787,-1.851128509850024,0.0038314176245210726,0.007027477120550604,0.433,3/15,7.65%,HSP90AA1;HSP90AB1;PKN2
gsea,FGFR2 Alternative Splicing R-HSA-6803529,-0.5588810047115509,-1.849431709193425,0.0038461538461538464,0.007158597301247916,0.44,18/25,35.32%,POLR2G;HNRNPA1;POLR2K;HNRNPH1;POLR2E;GTF2F1;TIA1;POLR2F;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H;TIAL1;HNRNPM;POLR2J;HNRNPF;POLR2C
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.43597980763484584,-1.845903421706285,0.0,0.0073406652499754315,0.447,29/74,24.32%,ELOB;POLR2G;POLR2K;TAF11;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;CCNK;GTF2F1;TAF7L;GTF2B;CCNH;TAF10;MLLT3;RTF1;GTF2A1;CCNT2;TAF13;POLR2F;MNAT1;POLR2L;NCBP2;IWS1;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.4611351651776519,-1.84583118725989,0.0,0.0073208256141646865,0.447,25/57,25.51%,H2AZ1;POLR2K;H2AJ;ERCC3;GTF2H5;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;UBTF;CCNH;SAP18;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L;HDAC2;POLR2H;ARID4B
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.567339616654397,-1.8446138645847552,0.0020242914979757085,0.0073833008734883986,0.449,8/27,8.56%,UBB;PPIA;RPS27A;CHMP2A;UBC;UBA52;VPS4A;CHMP5
gsea,Neutrophil Degranulation R-HSA-6798695,-0.364592188214879,-1.8437516032511847,0.0,0.007445440244321123,0.451,89/356,20.32%,FTH1;EEF1A1;CST3;HSP90AA1;HSP90AB1;PPIA;ATP6V0C;DYNLL1;RAB3A;ACTR1B;HSPA8;HMGB1;NME2;PRDX5;ATP6V1D;COMMD3;ITM2C;ALDOC;NDUFC2;PDAP1;PGRMC1;LAMTOR3;LAMTOR2;ARL8A;ACTR2;IQGAP2;ATP6AP2;TUBB4B;PSMD2;RAB6A;CTSB;ARPC5;SNAP25;DEGS1;CAP1;PKM;RAB14;PSMA2;ERP44;CYFIP1;CREG1;SRP14;CCT8;PSMC3;PSMC2;SYNGR1;NDUFA2;LAMTOR1;VCL;CSNK2B;EEF2;TMEM30A;RAP2B;DNAJC3;CYBA;XRCC6;CCT2;GSTP1;GM2A;PSMB7;PRDX4;APRT;CDK13;TMBIM1;EGFL7;RAB5B;B2M;CD47;TXNDC5;RAB9B;PDXK;PFKL;KCNAB2;VAPA;CAB39;DNAJC5;SDCBP;RAP1A;PSMD7;PA2G4;CD63;RHOA;DDOST;MAPK1;SCAMP1;PSMD14;NPC2;PRCP;PSMD6
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.53315717919364,-1.8429000317363402,0.0,0.00749191508761758,0.453,6/29,4.99%,UBB;RPS27A;CANX;UBC;GSK3B;UBA52
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.5015936365923526,-1.8421526565144561,0.003795066413662239,0.007502463924438718,0.454,21/38,27.27%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;NFIA;GTF3A;POLR3E;POU2F1;SSB;POLR1D;POLR3D;SNAPC5;POLR2F;SNAPC1;POLR3F;POLR2L;BRF2;POLR2H;SNAPC3;GTF3C6
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.6030970326938428,-1.8320096063915823,0.003875968992248062,0.008112773054987624,0.482,8/18,19.12%,NPM1;RPS6;SKP1;CEBPB;MAPK3;RBX1;CUL1;MAPK1
gsea,Signaling By FGFR1 R-HSA-5654736,-0.48801482880149893,-1.8301964844560774,0.0020920502092050207,0.008248356363272417,0.489,11/44,14.03%,UBB;RPS27A;HRAS;PPP2R1A;UBC;UBA52;BRAF;PPP2CA;MAPK3;SOS1;FGF1
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.3926014887832121,-1.8300851759022188,0.0,0.008236589883138823,0.49,54/158,24.34%,UBB;RPS27A;PSMB3;VDAC2;PSMC6;TOMM20;OTUB1;PSMC1;PSMD2;PSMA4;UBC;PSMB6;PSMA3;MAT2B;H2AC25;UBA52;PSMA7;HIF1A;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;SNX3;H2BC4;STAM2;BIRC2;VDAC1;PTRH2;TRAF6;PSMB5;USP14;RUVBL1;PSMB7;SKP2;USP19;IKBKG;TAF10;PSMB4;PSMD7;PSMA1;PSMB8;PSMB2;PSMD14;PSMD6;H2BC21;TNKS;AXIN2;PSMD8;PSMB11;FKBP8;PSMB1;USP2;PSME2
gsea,Metalloprotease DUBs R-HSA-5689901,-0.5572920514737093,-1.829758111035575,0.0,0.008229928507864281,0.49,10/24,21.83%,UBB;RPS27A;UBC;H2AC25;UBA52;BABAM2;BRCC3;PSMD14;STAM;KAT2B
gsea,Ion Homeostasis R-HSA-5578775,-0.49182485966175643,-1.8295228038733822,0.0,0.00821827274228392,0.491,9/45,8.92%,CALM1;ATP1B1;ATP1A2;CAMK2B;ATP1B2;ATP2B1;AHCYL1;ORAI2;FXYD1
gsea,Cargo Concentration In ER R-HSA-5694530,-0.5377795615919945,-1.8271356051984473,0.0020964360587002098,0.00839729799048358,0.5,9/27,9.39%,CNIH2;TMED2;PREB;CNIH1;LMAN1;MCFD2;TGFA;SAR1B;LMAN2
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.565859267473338,-1.8241119966626655,0.001996007984031936,0.00859039289625007,0.511,6/26,4.99%,UBB;RPS27A;CANX;CALR;UBC;UBA52
gsea,mRNA 3-End Processing R-HSA-72187,-0.45481074023700496,-1.8143150674529749,0.002004008016032064,0.009321401548732485,0.541,25/58,21.33%,SRSF2;PABPN1;FYTTD1;SRSF9;SRSF7;CPSF6;CDC40;FIP1L1;U2AF1;THOC2;CSTF2T;PCF11;SRSF1;SRSF11;U2AF1L4;MAGOHB;ZC3H11A;SLU7;SARNP;PAPOLA;THOC1;RNPS1;ALYREF;NCBP2;U2AF2
gsea,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.6212378178525558,-1.8128902713402344,0.0019801980198019802,0.009411535026564615,0.546,6/15,10.30%,UBB;RPS27A;UBC;UBA52;NDUFA2;TRAF6
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.4387464894751666,-1.8120113453225377,0.0,0.009446594466905453,0.552,17/67,14.33%,UBB;RPS27A;EIF4G2;TPR;UBC;EIF4A2;UBE2N;UBA52;GNL3;PDZD2;ISG15;MAPK3;KPNA3;EIF4A1;ARIH1;KPNA1;KPNA4
gsea,Signaling By VEGF R-HSA-194138,-0.4276627482054655,-1.8103381429467296,0.006263048016701462,0.009555739183262203,0.556,38/94,27.72%,CALM1;HSP90AA1;HRAS;PTK2B;BAIAP2;ELMO2;NCK1;NCKAP1;AKT1;CYFIP1;AHCYL1;WASF1;PKN2;MLST8;CTNNA1;ABI1;CYBA;ABI2;AKT3;PGF;CAV1;AAMP;PRKACB;DOCK1;ROCK2;CTNNB1;RHOA;VAV3;FLT1;VEGFA;VEGFC;BRK1;PTK2;PXDN;ITPR2;MAPKAP1;SPHK1;PRKCD
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.446410645187625,-1.8092575851093744,0.0,0.00959518171593225,0.559,24/61,19.52%,CNIH2;TMED2;NSF;PREB;CNIH1;LMAN1;MCFD2;TGFA;NAPG;TRAPPC4;SAR1B;LMAN2;TRAPPC2L;RAB1B;YKT6;TRAPPC5;TRAPPC6B;TRAPPC2;PPP6C;USO1;BET1;SEC24A;SEC23IP;SCFD1
gsea,Processing Of SMDT1 R-HSA-8949664,-0.6188429375254304,-1.8081641285079786,0.008032128514056224,0.009644271556838906,0.562,9/15,25.16%,SMDT1;MICU3;STOML2;YME1L1;PMPCA;PHB2;AFG3L2;PMPCB;MAIP1
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.5299505541375851,-1.8073636289840096,0.002109704641350211,0.009663631089135932,0.564,18/28,36.24%,FGFR2;POLR2G;POLR2K;POLR2E;GTF2F1;FGF1;POLR2F;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H;FGF10;FGF9;FGF7;POLR2J;POLR2C;FGF23
gsea,Meiotic Synapsis R-HSA-1221632,-0.4830632205527901,-1.8071506354070164,0.0020876826722338203,0.009658389843934592,0.564,12/36,20.42%,H2AZ1;HSPA2;SYCP2;H2AJ;H2BC4;SYCP3;SMC1A;TERF1;H2AZ2;UBE2I;H2AX;H2BC21
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.4566581773826597,-1.8038170923048147,0.0,0.00996109955541786,0.581,23/53,24.32%,ELOB;POLR2G;POLR2K;TCEA1;ERCC3;GTF2H5;ELOC;POLR2E;CCNK;GTF2F1;CCNH;MLLT3;RTF1;CCNT2;POLR2F;MNAT1;POLR2L;NCBP2;IWS1;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.4393184000866687,-1.8029716414529366,0.002109704641350211,0.010042877630421868,0.583,23/69,20.44%,UBB;RPS27A;H2AZ1;JUN;CBX6;UBC;UBA52;H2AJ;SCMH1;H2BC4;CDK4;MAPK3;TXN2;MAP2K6;CDKN2D;MAP2K7;H2AZ2;PHC3;H2AX;MAPK1;AGO3;H2BC21;TFDP2
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.4575231097920984,-1.8022154643553643,0.0,0.010065885510866042,0.586,16/48,19.05%,UBB;RPS27A;HRAS;UBC;ELMO2;UBA52;HIF1A;AKT1;CDK4;CDKN1B;NRG2;GPNMB;STAP2;DOCK1;RHOA;CCND1
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.398827470170285,-1.8009813487391204,0.0,0.01012757928864035,0.589,35/123,19.83%,UBB;RPS27A;HMGB1;JUN;PPP2R1A;PELI2;MEF2A;SKP1;UBC;UBE2N;UBA52;FBXW11;NDUFA2;BIRC2;S100B;UBE2D3;LRRC14;PELI1;PPP2CA;MAPK3;TRAF6;MAP2K6;USP14;VRK3;DUSP6;IKBKG;MAP2K7;FADD;CUL1;NKIRAS2;UBE2V1;DUSP7;IRAK1;MAPK1;IRAK2
gsea,TNF Signaling R-HSA-75893,-0.48957515923629885,-1.8004017965565902,0.0,0.010130903148462897,0.591,12/42,13.21%,UBB;RPS27A;NSMAF;RACK1;UBC;BAG4;UBA52;SHARPIN;BIRC2;TNFRSF1A;OTULIN;IKBKG
gsea,Chromosome Maintenance R-HSA-73886,-0.4009873573723794,-1.8000477737839722,0.0,0.010124558549873916,0.592,29/95,20.82%,H2AZ1;NPM1;NOP10;POLR2G;ITGB3BP;POLR2K;PCNA;HJURP;H2AJ;POLD4;POLR2E;H2BC4;MIS18A;RUVBL1;DKC1;CENPP;TERF1;RSF1;PPP6C;RPA3;H2AZ2;NHP2;H2AX;POLR2F;MIS18BP1;CENPW;H2BC21;FEN1;POLR2L
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.5305688063114553,-1.7998082474448305,0.0,0.010127873250653839,0.593,13/27,24.32%,ELOB;POLR2G;POLR2K;TCEA1;ELOC;POLR2E;GTF2F1;POLR2F;POLR2L;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.37153017991585174,-1.7989475379241164,0.0,0.010164781773432795,0.595,93/265,23.47%,UBB;DYNLL1;RPS27A;DYNLL2;ARF5;CAPZA2;CNIH2;CANX;TMED7;CALR;PSMC1;TMED2;DPM2;UBC;NSF;PREB;SLC35A1;CNIH1;B4GALT6;UBA52;DOLK;LMAN1;DPM1;DPM3;RPN2;MCFD2;PMM1;TGFA;NAGK;ALG5;ALG2;B4GALT4;DAD1;NAPG;DCTN1;TRAPPC4;ARF4;SAR1B;ALG11;LMAN2;TRAPPC2L;CHGA;MANEA;DCTN3;RAB1B;NUS1;YKT6;DCTN4;TRAPPC5;FUOM;TRAPPC6B;COPG2;MAN1A2;EGFL7;ST6GALNAC2;TRAPPC2;RAD23B;FUT8;PPP6C;CAPZB;DERL2;COPE;UBXN1;RNF5;MPDU1;COG5;BET1L;NANP;RFT1;KDELR1;ALG13;GOLGB1;USO1;BET1;ST8SIA3;SEC24A;ARF3;DDOST;SEC23IP;SCFD1;ENGASE;GNPNAT1;GMDS;RNF139;FUCA1;ACTR1A;TMED9;NGLY1;GFPT1;SYVN1;DCTN6;COPA;CD55
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.3666282159076648,-1.7984955209814502,0.0,0.010187136509591355,0.596,89/240,29.57%,CALM1;UBB;RPS27A;NEFL;YWHAB;FGFR2;HRAS;CAMK2B;PSMB3;PSMC6;LAMTOR3;PPP2R1A;LAMTOR2;PEBP1;RASAL2;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;BRAF;TGFA;PSMC2;RNMT;ABHD17A;VCL;PDGFRA;PPP2CA;GFRA4;TEK;MAPK3;TYK2;PSMB5;PSMB7;FGFR3;IRS2;NRG2;DUSP6;ARL2;SOS1;FGF1;RBX1;ABHD17B;PSMB4;DUSP7;RAP1A;PSMD7;PSMA1;MAPK1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;IL17RD;PSMD8;PSMB11;MAP2K1;IL5RA;NF1;PSMB1;PSME2;PTPN3;FGF10;PTK2;CNKSR2;PSME3;RAPGEF2;FGFR1;CUL3;GOLGA7;SPRED3;RASA2;CSF2RA;BCL2L1;IL6ST;PAQR3;GRIN2B;PDGFA;FGF9;DUSP12
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.4589909939122644,-1.7972097434674632,0.004291845493562232,0.010266708415286575,0.599,12/47,10.19%,PPIA;HNRNPA2B1;CANX;RALA;HNRNPDL;HSPA9;TCP1;GSTO1;AURKAIP1;PKN2;SOD1;TYK2
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.5492365753751535,-1.796623642123804,0.010245901639344262,0.010274400086086303,0.599,8/24,8.47%,YWHAB;RPS6;LAMTOR3;LAMTOR2;RRAGA;FKBP1A;LAMTOR1;MLST8
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.5674126878744084,-1.7954431978166105,0.008438818565400843,0.010320082255813786,0.599,13/21,25.16%,VDAC2;SMDT1;MICU3;STOML2;VDAC1;SLC8B1;YME1L1;PMPCA;PHB2;AFG3L2;PMPCB;LETM1;MAIP1
gsea,Glycogen Metabolism R-HSA-8982491,-0.5729875200342018,-1.7928225442843824,0.006085192697768763,0.010526757765491461,0.611,7/22,12.97%,CALM1;UBB;RPS27A;UBC;UBA52;PPP1R3C;PHKG1
gsea,Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.6185748173216261,-1.7925097117150441,0.004347826086956522,0.010510096811614082,0.611,8/15,21.38%,H2AZ1;H2AJ;H2BC4;KDM4C;H2AZ2;H2AX;H2BC21;KDM1A
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.4834353049546404,-1.791370882475781,0.002066115702479339,0.010578447892597901,0.615,15/37,24.61%,FGFR2;HRAS;POLR2G;POLR2K;POLR2E;GTF2F1;SOS1;FGF1;POLR2F;POLR2L;NCBP2;POLR2D;GTF2F2;POLR2H;FGF10
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.5283301052762917,-1.7906319490513605,0.003952569169960474,0.010599394852775534,0.616,15/30,27.31%,UBB;RPS27A;UBC;UBA52;ETS2;CDK4;MAPK3;CDKN2D;RB1;MAPK1;AGO3;TFDP2;ID1;TNRC6C;MDM4
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.4178168872335173,-1.7882145910423637,0.002188183807439825,0.010779870859945962,0.622,18/88,12.70%,CALM1;SLC1A3;AHCYL2;SLC15A2;SLC4A10;SLC6A15;SLC4A4;SLC24A5;SLC32A1;SLC7A6;SLC7A10;SLC4A7;SLC25A22;SLC17A7;SLC8B1;SLC7A5;SLC1A2;SLC16A10
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.365635340549291,-1.7881738075626434,0.0,0.010758068220674483,0.622,48/251,12.58%,CALM1;HSP90AA1;TUBA1A;DYNLL1;DYNLL2;YWHAE;YWHAG;TUBA4A;ATP5PB;CYCS;PPP2R1A;TUBB4B;CCT5;MICOS10;MICOS13;NUDT19;AHI1;BBIP1;HSPA9;TCP1;KIFAP3;CETN2;IFT20;CCT8;RAB11A;TMEM216;BBS5;DYNLT2B;TTBK2;IFT43;DCTN1;ARF4;DYNLRB1;EXOC3;PLK4;CCT2;SIRT3;PPARA;TTC8;TTC30B;TUBB4A;DCTN3;CEP78;SSBP1;ARL6;SSNA1;HAUS3;B9D1
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.5042557689851999,-1.7875194151489873,0.006072874493927126,0.010801781166571869,0.624,12/35,17.86%,HSP90AA1;HSP90AB1;ACTG1;CCT7;TXNL1;TRA2B;CCT6A;CCT2;PHIP;RNF20;ROCK2;RBM15
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.3653549623707689,-1.786894634369955,0.0,0.010817316591807843,0.625,82/237,27.81%,CALM1;UBB;RPS27A;NEFL;YWHAB;FGFR2;HRAS;CAMK2B;PSMB3;PSMC6;LAMTOR3;PPP2R1A;LAMTOR2;PEBP1;RASAL2;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;PSMA3;UBA52;PSMA7;PSMA2;PSMC5;SEM1;PSMC3;BRAF;TGFA;PSMC2;RNMT;ABHD17A;VCL;PDGFRA;PPP2CA;GFRA4;TEK;MAPK3;PSMB5;PSMB7;FGFR3;IRS2;NRG2;DUSP6;ARL2;SOS1;FGF1;RBX1;ABHD17B;PSMB4;DUSP7;RAP1A;PSMD7;PSMA1;MAPK1;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;IL17RD;PSMD8;PSMB11;MAP2K1;IL5RA;NF1;PSMB1;PSME2;PTPN3;FGF10;PTK2;CNKSR2;PSME3;RAPGEF2;FGFR1;CUL3;GOLGA7;SPRED3;RASA2;CSF2RA;BCL2L1
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.4290150690228104,-1.7865364293840764,0.0,0.010818828453922269,0.628,23/71,21.64%,UBB;RPS27A;EIF4G2;TPR;UBC;EIF4A2;UBE2N;UBA52;ABCE1;GNL3;PDZD2;ISG15;MAPK3;KPNA3;EIF4A1;ARIH1;KPNA1;KPNA4;NUP54;NUP37;PDE12;UBE2E1;PPM1B
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.5757050921575607,-1.7851242896382093,0.007874015748031496,0.01094555755822654,0.631,7/21,7.26%,UBB;RPS27A;SH3GL1;UBC;UBA52;RNMT;STAM2
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.4695185057043031,-1.7820012343558709,0.0,0.011224352274458888,0.64,19/45,24.32%,POLR2K;ERCC3;GTF2H5;CHD3;POLR2E;TAF1D;TTF1;POLR1H;UBTF;CCNH;POLR1D;HDAC1;POLR2F;POLR1F;MNAT1;POLR2L;KAT2B;HDAC2;POLR2H
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.4290642474396089,-1.7788161100322164,0.0064516129032258064,0.011538720801778809,0.649,34/86,27.72%,CALM1;HSP90AA1;HRAS;PTK2B;BAIAP2;ELMO2;NCK1;NCKAP1;AKT1;CYFIP1;AHCYL1;WASF1;PKN2;MLST8;CTNNA1;ABI1;CYBA;ABI2;AKT3;CAV1;PRKACB;DOCK1;ROCK2;CTNNB1;RHOA;VAV3;VEGFA;BRK1;PTK2;PXDN;ITPR2;MAPKAP1;SPHK1;PRKCD
gsea,Assembly Of HIV Virion R-HSA-175474,-0.6176402629981657,-1.7753500702257097,0.011976047904191617,0.011883801019148335,0.658,6/17,10.26%,UBB;PPIA;RPS27A;UBC;UBA52;FURIN
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.5281994466928122,-1.772340746343575,0.0064794816414686825,0.012167506014280176,0.665,6/25,6.19%,UBB;RPS27A;UBC;PCNA;UBA52;POLD4
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.40053144076821046,-1.7708761466277219,0.0,0.012280305511770053,0.671,30/108,19.12%,YWHAB;HRAS;CDK5R1;AP2M1;JUND;VGF;PPP2R1A;RALA;MEF2A;CLTA;F3;TCF12;ID3;BCL11B;BRAF;ID2;PPP2CA;MAPK3;VRK3;IRS2;DUSP6;SOS1;CDK5R2;EGR4;AP2S1;CDK5;DUSP7;RAP1A;RHOA;MAPK1
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.6199321284274943,-1.7689166680947668,0.008281573498964804,0.012456561015196084,0.674,6/16,8.60%,RAB3A;VAMP2;PPFIA2;CPLX1;SNAP25;RIMS1
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.5054658754354544,-1.7686693591791878,0.005825242718446602,0.012445001746513354,0.674,18/33,27.56%,DYNLL1;DYNLL2;CAPZA2;RAB6A;DCTN1;AGPAT3;DCTN3;DCTN4;CAPZB;RAB6B;BICD1;ACTR1A;DCTN6;RAB18;RAB3GAP1;DYNC1I2;DCTN5;GALNT1
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.606199386684104,-1.7675162162179874,0.005870841487279843,0.012556331329385804,0.677,6/17,8.60%,RAB3A;VAMP2;PPFIA2;CPLX1;SNAP25;RIMS1
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.5350861982830445,-1.76743153551943,0.002053388090349076,0.012526435302411074,0.677,11/25,23.69%,H2AZ1;CBX3;H2AJ;CHD3;H2BC4;TTF1;H2AZ2;HDAC1;H2AX;H2BC21;HDAC2
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5412361823678739,-1.7668181297440821,0.0041928721174004195,0.012551014696271016,0.677,4/24,4.99%,UBB;RPS27A;UBC;UBA52
gsea,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.6227958652047663,-1.764047420880085,0.010570824524312896,0.012887154307874078,0.685,5/16,6.53%,UBB;RPS27A;UBC;UBA52;NDUFA2
gsea,Transmission Across Chemical Synapses R-HSA-112315,-0.3755273579262856,-1.7638336605100504,0.0,0.012874713722526422,0.685,49/219,14.04%,NRGN;CALM1;RAB3A;VAMP2;HSPA8;NEFL;SLC1A3;GRIA2;HRAS;CAMK2B;AP2M1;TSPAN7;LIN7C;PPFIA2;GNG3;ARL6IP5;CPLX1;GNB2;NSF;GLUL;LIN7B;SNAP25;PRKAR1A;PLCB1;GLRB;ADCY9;SLC32A1;GABRG2;CAMKK1;GNG7;PPM1F;ARHGEF9;GABRB3;KCNJ3;RIMS1;GABRB2;MAPK3;SLC17A7;GNG10;CACNB3;SYN2;KCNJ10;GAD1;SLC1A2;GABRA3;KCNJ4;PPM1E;GNAL;CAMK1
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.5653127500493875,-1.7615940307869669,0.014314928425357873,0.01306913617559285,0.69,7/19,20.44%,ORC4;PPP2R1A;ORC6;PPP2CA;RB1;ORC5;TFDP2
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.499024298434218,-1.760416788309677,0.002044989775051125,0.013132573808604471,0.692,8/35,10.10%,CALM1;YWHAB;HRAS;CAMK2B;PEBP1;BRAF;VCL;MAPK3
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.5203108768976217,-1.760380764969017,0.008928571428571428,0.013106220810641675,0.692,6/25,11.66%,GLP2R;GNG3;GNB2;GNAS;GNG7;GNG10
gsea,Gluconeogenesis R-HSA-70263,-0.5326578016482586,-1.7588939170651652,0.012,0.013218380231802992,0.696,14/24,28.09%,MDH2;ALDOC;MDH1;TPI1;ENO2;SLC25A11;PGK1;ENO1;PGAM2;GAPDHS;G6PC3;GOT2;SLC25A13;GNPDA1
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.3544019848875428,-1.753572354571145,0.0,0.013802110982080631,0.718,100/273,29.67%,CALM1;UBB;RPS27A;NEFL;YWHAB;JUN;FGFR2;HRAS;CAMK2B;PSMB3;PSMC6;LAMTOR3;PPP2R1A;LAMTOR2;PEBP1;RASAL2;PSMC1;PSMD2;PSMA4;UBC;KBTBD7;PSMB6;PSMA3;UBA52;PSMA7;SEPTIN7;PSMA2;PSMC5;SEM1;PSMC3;BRAF;TGFA;PSMC2;RNMT;ABHD17A;VCL;PKN2;CDC42EP3;PDGFRA;PPP2CA;GFRA4;XPO1;TEK;MAPK3;TYK2;PSMB5;PSMB7;FGFR3;IRS2;NRG2;DUSP6;ARL2;SOS1;FGF1;RBX1;PRKACB;ABHD17B;PSMB4;DUSP7;RAP1A;PSMD7;PSMA1;ETV4;MAPK1;AGO3;PSMB8;PSMB2;PSMD14;RASGRP1;PSMD6;IL17RD;PSMD8;PSMB11;MAP2K1;IL5RA;NF1;PSMB1;FOXO1;PSME2;PTPN3;FGF10;PTK2;TNRC6C;CNKSR2;PSME3;RAPGEF2;FGFR1;CUL3;GOLGA7;SPRED3;RASA2;CSF2RA;BCL2L1;IL6ST;PAQR3;GRIN2B;PDGFA;FGF9;DUSP12;CDC42
gsea,Semaphorin Interactions R-HSA-373755,-0.4358180431467341,-1.750708226788588,0.0,0.014107632745317025,0.726,12/62,9.93%,HSP90AA1;HSP90AB1;MYL6;SEMA5A;CDK5R1;RHOB;GSK3B;MYL12B;RNMT;PKN2;SEMA6D;MYL9
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.42744098454940305,-1.745260243401449,0.006185567010309278,0.01471317853290781,0.732,18/62,25.68%,UBB;RPS27A;SUMO2;UBC;UBE2N;UBA52;H2BC4;BABAM2;RAD17;BRCC3;RPA3;UBE2I;H2AX;H2BC21;SIRT6;RFC5;TOPBP1;RMI2
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.5269608306017501,-1.7446737431232915,0.00851063829787234,0.014736536719128213,0.732,4/26,1.70%,CALM1;NEFL;HRAS;CAMK2B
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.4772609824180387,-1.7445029718741245,0.006535947712418301,0.014724486827144742,0.732,9/32,15.22%,UBB;RPS27A;UBC;PCNA;UBA52;POLD4;ISG15;POLE3;RPA3
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.5210420442295267,-1.7435927905098194,0.006172839506172839,0.01484896394845004,0.734,6/28,4.99%,UBB;RPS27A;HSPA8;CHMP2A;UBC;UBA52
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.5563306045564227,-1.7425637015706874,0.009881422924901186,0.014955298809505508,0.738,9/23,12.37%,RAB3A;VAMP2;LIN7C;PPFIA2;CPLX1;LIN7B;SNAP25;RIMS1;SYN2
gsea,Biological Oxidations R-HSA-211859,-0.38205146165696496,-1.7420888717124026,0.0,0.014951593241518546,0.739,36/114,24.18%,HSP90AB1;PRNP;CYP7B1;VDAC2;BPNT2;ESD;TRMT112;MAT2B;GSTM5;SULT4A1;AKR1A1;PTGES3;MGST3;GSTO1;AURKAIP1;GSTM1;PTGS1;CHAC2;HPGDS;GSTP1;TPMT;GSTZ1;PTGIS;MAOB;FDX1;GGCT;CNDP2;ACY1;ABHD14B;GSTM4;CMBL;FDX2;NNMT;FDXR;COMT;AS3MT
gsea,Basigin Interactions R-HSA-210991,-0.5420012665231161,-1.7368567680792344,0.013539651837524178,0.01564305437695392,0.756,6/22,5.49%,ATP1B1;PPIA;BSG;ATP1B2;SLC7A6;SLC7A10
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.508949299677443,-1.7355966156260771,0.004140786749482402,0.01574248010371162,0.761,14/26,29.80%,HSPA5;EIF2S2;CEBPB;CEBPG;ATF4;NFYA;EXOSC9;DCP2;ATF6;HERPUD1;ASNS;EXOSC7;DDIT3;NFYB
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5324986743220643,-1.7346985357409972,0.008385744234800839,0.015819691595684426,0.762,11/24,24.32%,HSP90AA1;POLR2G;POLR2K;MOV10L1;POLR2E;MYBL1;HENMT1;POLR2F;POLR2L;POLR2D;POLR2H
gsea,DNA Repair R-HSA-73894,-0.33852101443121735,-1.7338365374201958,0.0,0.01595299906444528,0.765,78/279,25.68%,UBB;RPS27A;SUMO2;EYA1;H2AZ1;ASCC3;POLR2G;USP1;POLR2K;UBC;PCNA;UBE2N;PIAS1;UBA52;BAZ1B;TCEA1;COPS8;PRPF19;H2AJ;ERCC3;GTF2H5;POLD4;CETN2;SEM1;POLR2E;H2BC4;SPRTN;COPS5;COPS7A;XRCC6;ISG15;TDP2;BABAM2;SPIDR;RUVBL1;COPS6;EYA4;PNKP;TERF1;FANCE;POLE3;RAD17;BRCC3;CCNH;RAD23B;MLH1;RBX1;RPA3;UBXN1;H2AZ2;RAD51C;MSH2;FTO;UBE2I;XRCC4;H2AX;POLR2F;H2BC21;MNAT1;FEN1;POLE4;POLR2L;FANCA;XAB2;MPG;SUMO1;TDG;UBE2B;PARG;RAD18;POLR2D;POLR2H;SIRT6;RAD51;HMGN1;RFC5;TOPBP1;RMI2
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.49824535581095597,-1.7308556959574781,0.0076481835564053535,0.016271987992637946,0.775,12/26,26.29%,NME2;DTYMK;NME4;TXN2;RRM2B;GUK1;DUT;AK1;GLRX;AK6;TXNRD1;DCTPP1
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.43498499686516007,-1.730238323637149,0.002074688796680498,0.016304249123773144,0.777,18/56,19.12%,CDK5R1;JUND;VGF;PPP2R1A;MEF2A;F3;TCF12;ID3;ID2;PPP2CA;MAPK3;VRK3;DUSP6;CDK5R2;EGR4;CDK5;DUSP7;MAPK1
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.4124868210817097,-1.7277718193200102,0.006276150627615063,0.01666843926356146,0.781,33/83,29.22%,RAB3A;YWHAE;SBF1;RAB6A;RAB14;AKT1;RAB5A;RAB27B;TRAPPC4;TRAPPC2L;RIN1;DENND1A;RAB1B;TRAPPC5;TRAPPC6B;AKT3;TRAPPC2;RAB5B;DENND5B;DENND2A;RAB6B;RAB9B;HPS4;GDI1;RIC1;RAB18;RAB3GAP1;GDI2;DENND2D;RAB35;DENND1B;TRAPPC13;SBF2
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.5535261073917785,-1.7276777244861388,0.012711864406779662,0.01664372177093347,0.781,5/19,11.66%,GNG3;GNB2;P2RY12;GNG7;GNG10
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.4861850184590112,-1.7276195383702428,0.00390625,0.016610529146846804,0.781,7/32,8.01%,VAMP2;HSPA8;CHMP2A;CLTA;CLTB;AP1S1;M6PR
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.41502225083045596,-1.7274294232671408,0.004338394793926247,0.016603187231314962,0.781,22/75,26.07%,HSP90AA1;HSPA8;NDN;CEBPD;HSP90B1;S1PR1;HIF1A;AKT1;TYK2;LAMA5;SOS1;POU2F1;MCL1;RHOU;CCND1;HMOX1;VEGFA;FOXO1;SOCS1;ITGB1;BCL6;TGFB1
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.4538935754700934,-1.723273296968388,0.008583690987124463,0.017087386350812847,0.787,10/39,15.22%,UBB;RPS27A;UBC;PCNA;UBA52;POLD4;SPRTN;ISG15;POLE3;RPA3
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.5667472902974237,-1.7222953588950505,0.02044989775051125,0.017215471997414383,0.79,4/21,1.70%,CALM1;NEFL;GRIA2;CAMK2B
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.529770077482101,-1.7215474013594865,0.016260162601626018,0.017308946606728347,0.79,5/21,5.32%,YWHAE;JUN;CDK5R1;PRDX2;C1QBP
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.5292117643448402,-1.7197629190329933,0.00998003992015968,0.017495404239791432,0.793,11/21,24.32%,POLR2G;POLR2K;POLR2E;GTF2F1;POLR2F;POLR2L;NCBP2;NELFB;POLR2D;GTF2F2;POLR2H
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.42523011679381695,-1.7166374433460097,0.002070393374741201,0.017867416847294176,0.798,23/63,24.43%,TUBA1A;TUBB2A;TUBA4A;RAN;PPP2R1A;CHMP2A;TUBB4B;BANF1;TUBA1B;TUBB2B;VPS4A;PPP2CA;TUBB4A;AHCTF1;UBE2I;NUP54;NUP37;VRK1;CHMP4C;SUMO1;TUBB6;SPAST;NUP43
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.5685897480608365,-1.7165260381289635,0.010570824524312896,0.017844705915716613,0.798,5/20,9.93%,CALM1;MYL6;MYL12B;PKN2;MYL9
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.4435124710972356,-1.711831979825471,0.005964214711729622,0.01840829312548915,0.808,20/56,25.39%,CALM1;YWHAB;HRAS;CAMK2B;QKI;PEBP1;BRAF;VCL;MAPK3;KDM7A;AGTRAP;RAP1A;MAPK1;AKAP9;MAP2K1;FAM114A2;AGGF1;FAM131B;SND1;CNKSR2
gsea,Pyruvate Metabolism R-HSA-70268,-0.5156636492105143,-1.7110573531500808,0.018367346938775512,0.018456023450169154,0.808,9/26,11.84%,BSG;LDHB;GLO1;HAGH;MPC2;PLPP6;VDAC1;GSTZ1;PDHX
gsea,DNA Damage Bypass R-HSA-73893,-0.43162148479441403,-1.7108197112814723,0.0,0.018457358127073054,0.81,12/48,15.22%,UBB;RPS27A;USP1;UBC;PCNA;UBA52;POLD4;SPRTN;ISG15;POLE3;RBX1;RPA3
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.4011498278064389,-1.7093767204199717,0.0021008403361344537,0.018605317450838658,0.813,39/80,34.89%,HSP90B1;HSPA5;CALR;PREB;EIF2S2;CEBPB;DNAJB9;CEBPG;ATF4;DCTN1;SSR1;DNAJC3;NFYA;EXTL2;SERP1;SRPRB;EXOSC9;DNAJB11;CREB3L1;DCP2;ATF6;TSPYL2;HDGF;MBTPS1;GFPT1;SYVN1;GOSR2;HERPUD1;FKBP14;ASNS;EXOSC7;DDIT3;NFYB;EDEM1;KDELR3;MYDGF;CXXC1;EXOSC8;TLN1
gsea,Regulation Of Insulin Secretion R-HSA-422356,-0.40575451602229134,-1.7090887808278932,0.0,0.018593778107163964,0.814,26/72,22.67%,VAMP2;MARCKS;GNG3;GNB2;ACSL3;SNAP25;PRKAR1A;PLCB1;GNAS;AHCYL1;GNG7;KCNG2;KCNS3;GNAQ;GNG10;CACNB3;PRKACB;SYT5;RAP1A;AKAP5;ACSL4;GNG11;CACNA1E;PLCB2;CACNA2D2;PRKAR2B
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.46370245456447307,-1.7089556330491837,0.005940594059405941,0.01858228926389922,0.814,14/37,17.89%,UBB;RPS27A;YWHAZ;UBC;UBA52;AKT1;TLE4;XPO1;PYGO2;SOX9;ASH2L;CTBP1;HDAC1;CTNNB1
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.5065524546824149,-1.708516299926834,0.014285714285714285,0.018599984600594536,0.815,13/28,26.44%,UBB;RPS27A;UBC;UBA52;UBE2A;OTULIN;UBE2E3;UBE2E1;UBE2B;UBE2R2;UBE2Q2;UBE2G2;UBE2K
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.5987924419459307,-1.707356230419953,0.030927835051546393,0.018742190851495137,0.816,10/18,18.99%,RAB3A;VAMP2;HSPA8;CPLX1;SNAP25;SLC32A1;RIMS1;GAD1;DNAJC5;GAD2
gsea,Signaling By NTRKs R-HSA-166520,-0.3798581710371399,-1.7068014522510773,0.0,0.01878846898052565,0.817,33/124,19.12%,YWHAB;HRAS;CDK5R1;AP2M1;JUND;VGF;PPP2R1A;RALA;MEF2A;CLTA;F3;TCF12;ID3;BCL11B;BRAF;NTRK3;ID2;TIAM1;PPP2CA;MAPK3;FURIN;VRK3;IRS2;DUSP6;SOS1;CDK5R2;EGR4;AP2S1;CDK5;DUSP7;RAP1A;RHOA;MAPK1
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.5505305791234558,-1.7047144098664166,0.011857707509881422,0.01898753826090265,0.818,14/21,35.50%,UBB;RPS27A;UBC;UBA52;DERL2;RNF5;RNF139;SYVN1;SEL1L;MARCHF6;AMFR;EDEM1;TRIM13;RNF103
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.4386961214873156,-1.7021570963879744,0.007952286282306162,0.01926001317248185,0.821,22/53,28.28%,NPM1;RPS6;EEF1G;SKP1;TPR;CEBPB;PRKAR1A;SQSTM1;VCL;DCTN1;MAPK3;LMO7;GCC2;RBX1;CUL1;MAPK1;PPFIBP1;PPM1B;RNF213;ATIC;RRBP1;MYH9
gsea,Signaling By EGFR R-HSA-177929,-0.4405274046614831,-1.7004516781707162,0.007827788649706457,0.019506608753862606,0.826,8/46,7.26%,UBB;RPS27A;HRAS;SH3GL1;UBC;UBA52;TGFA;STAM2
gsea,Meiotic Recombination R-HSA-912446,-0.4634183831217782,-1.6992788804737944,0.008695652173913044,0.019637112313468638,0.828,11/33,20.42%,H2AZ1;H2AJ;H2BC4;CDK4;PSMC3IP;MLH1;RPA3;H2AZ2;RAD51C;H2AX;H2BC21
gsea,Meiosis R-HSA-1500620,-0.41212437856861955,-1.6992759353913958,0.004662004662004662,0.019594881964407413,0.828,16/59,18.00%,H2AZ1;HSPA2;SYCP2;H2AJ;H2BC4;SYCP3;CDK4;PSMC3IP;SMC1A;TERF1;MLH1;RPA3;H2AZ2;RAD51C;UBE2I;H2AX
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.4961231819816865,-1.6974222434459934,0.005607476635514018,0.019863714722875406,0.832,14/27,27.27%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;GTF3A;POLR3E;POLR1D;POLR3D;POLR2F;POLR3F;POLR2L;POLR2H;GTF3C6
gsea,Deubiquitination R-HSA-5688426,-0.34698725200233793,-1.6964845245421878,0.0,0.019947715541391884,0.837,107/230,36.34%,UBB;RPS27A;MBD5;PSMB3;VDAC2;PSMC6;TOMM20;OTUB1;PSMC1;PSMD2;PSMA4;NEDD8;UBC;PSMB6;PSMA3;MAT2B;H2AC25;UBA52;PSMA7;HIF1A;PSMA2;PSMC5;SEM1;PSMC3;PSMC2;SNX3;H2BC4;UCHL1;STAM2;BIRC2;VDAC1;PTRH2;TRAF6;BABAM2;PSMB5;USP14;RUVBL1;PSMB7;SKP2;USP19;IKBKG;BRCC3;RAD23B;TAF10;PSMB4;PSMD7;PSMA1;RHOA;PSMB8;PSMB2;FOXK1;PSMD14;STAM;PSMD6;H2BC21;TNKS;AXIN2;KAT2B;PSMD8;PSMB11;FKBP8;PSMB1;USP2;PSME2;STAMBP;PSME3;SENP8;TGFB1;RNF146;ZRANB1;OTUB2;USP33;UCHL5;MDM4;MAVS;SMAD4;SMAD3;ACTL6A;TANK;TADA2B;VCPIP1;INO80C;RAD23A;SUDS3;PSME1;INO80B;ATXN3;USP32;CCNA2;RNF128;PSMD4;PSMF1;RNF123;MYC;USP8;JOSD1;MCRS1;ASXL2;RHOT1;H2BC18;SMAD2;BECN1;USP5;TFPT;BABAM1;CCP110;KEAP1
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.5937668304878264,-1.6960132262807937,0.023529411764705882,0.01995396905544328,0.839,4/15,4.99%,UBB;RPS27A;UBC;UBA52
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.4866916496976159,-1.6933910167351476,0.012711864406779662,0.02033005495868274,0.844,16/30,32.82%,GNG3;GNB2;PLCB1;AKT1;GNG7;GNG10;AKT3;RHOA;GNG11;PLCB2;BTK;PLCB3;CDC42;GNG2;ARHGEF6;PIK3CG
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.4844083805797035,-1.6932971578562512,0.011834319526627219,0.020294910997819385,0.844,19/33,33.22%,UBB;RPS27A;UBC;UBA52;MAPK3;FURIN;CCNK;CCNT2;HDAC1;MAPK1;E2F4;TFDP2;RBL1;TGIF2;SMAD4;SMAD3;CDK9;WWTR1;MYC
gsea,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.5762873584642171,-1.6918975715593183,0.016736401673640166,0.02045822547659078,0.846,5/16,11.66%,GNG3;GNB2;GNAS;GNG7;GNG10
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.5060292474086833,-1.6865942799494225,0.024896265560165973,0.02127913196660039,0.848,18/29,31.55%,UBB;RPS27A;CHMP2A;UBC;UBA52;STAM2;VPS4A;CHMP5;VPS36;VPS28;STAM;CHMP4C;VPS37D;TSG101;VTA1;CHMP2B;CHMP4B;SNF8
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.5239697149177099,-1.6862600971313781,0.00823045267489712,0.021270414499626786,0.849,8/24,16.77%,UBB;RPS27A;UBC;UBA52;ANAPC4;CDC26;BUB3;ANAPC16
gsea,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.5419757548908187,-1.6833178913026483,0.016913319238900635,0.021724207692412966,0.85,9/18,29.86%,GNG3;GNB2;PLCB1;GNG7;GNG10;GNG11;PLCB2;PLCB3;GNG2
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.4382083243218921,-1.6826310164105824,0.008403361344537815,0.021766759522285753,0.852,9/48,8.92%,CALM1;ATP1B1;ATP1A2;CAMK2B;ATP1B2;ATP13A4;ATP2B1;ATP13A5;FXYD1
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.41231601060585565,-1.6810482557596718,0.0058823529411764705,0.021973321772483876,0.857,11/57,15.22%,YWHAE;YWHAH;YWHAB;YWHAG;YWHAZ;UBE2N;H2BC4;BABAM2;RAD17;BRCC3;RPA3
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,-0.4131183015933581,-1.680404094640517,0.002074688796680498,0.022027161594577932,0.857,28/57,32.60%,H2AZ1;JUN;MAML2;TMED2;RAB6A;H2AJ;H2BC4;MAML3;FURIN;SNW1;PRKCI;H2AZ2;H2AX;CCND1;AGO3;H2BC21;TFDP2;KAT2B;ATP2A1;SIRT6;TNRC6C;SEL1L;LFNG;NOTCH1;ST3GAL6;AGO2;POGLUT1;MAMLD1
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.41830716303817733,-1.678548967846687,0.004140786749482402,0.022304096258172455,0.858,26/58,29.80%,YWHAB;YWHAG;YWHAZ;BTG1;AKT1;NPY;NFYA;CDKN1B;SIRT3;TXN2;AKT3;CAV1;CITED2;GADD45A;BBC3;HDAC1;KAT2B;HDAC2;FOXO1;FOXG1;BCL6;SMAD4;SMAD3;CCNG2;DDIT3;NFYB
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.4023055014621416,-1.6776511578349942,0.005905511811023622,0.022432631868831744,0.859,25/71,23.87%,UBB;RPS27A;MAML2;SKP1;UBC;UBA52;HIF1A;HDAC11;TLE4;MAML3;FBXW7;SNW1;CNTN1;PSENEN;HEY1;RBX1;CUL1;HDAC1;TBL1XR1;HES5;APH1B;KAT2B;TLE1;HDAC2;APH1A
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.4701142093189322,-1.677170912756409,0.010660980810234541,0.022441494622168247,0.861,9/34,12.66%,UBB;RPS27A;PPP2R1A;UBC;UBA52;AKT1;MLST8;PPP2CA;AKT3
gsea,FLT3 Signaling R-HSA-9607240,-0.4687920983533673,-1.676742172810475,0.008438818565400843,0.022466172471552866,0.861,9/36,13.44%,UBB;RPS27A;HRAS;UBC;UBA52;AKT1;CDKN1B;AKT3;SOS1
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.4277903535953327,-1.6763377206370054,0.006185567010309278,0.02252634080722237,0.861,14/55,19.11%,UBB;RPS27A;CANX;UBC;GSK3B;UBA52;RPN2;DAD1;ZDHHC8;ST6GALNAC2;FUT8;UBE2I;PARP6;DDOST
gsea,Smooth Muscle Contraction R-HSA-445355,-0.46551650807838874,-1.675883190422877,0.002150537634408602,0.022586259998644796,0.861,8/37,9.93%,CALM1;MYL6;TPM1;MYL12B;VCL;PKN2;ACTA2;MYL9
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.5345498177952462,-1.675188363600221,0.011857707509881422,0.022689254241840255,0.863,7/21,16.77%,UBB;RPS27A;UBC;UBA52;ANAPC4;CDC26;ANAPC16
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.5721975734488731,-1.6750406915537563,0.020202020202020204,0.022662123786459695,0.863,7/18,12.37%,RAB3A;VAMP2;PPFIA2;CPLX1;SNAP25;RIMS1;SYN2
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.3560457879332161,-1.6733806810355056,0.002053388090349076,0.02291358227128281,0.865,35/128,25.68%,UBB;RPS27A;SUMO2;EYA1;UBC;PCNA;UBE2N;UBA52;BAZ1B;POLD4;SEM1;H2BC4;XRCC6;TDP2;BABAM2;SPIDR;EYA4;POLE3;RAD17;BRCC3;RPA3;UBXN1;RAD51C;UBE2I;XRCC4;H2AX;H2BC21;FEN1;POLE4;SUMO1;SIRT6;RAD51;RFC5;TOPBP1;RMI2
gsea,Glucose Metabolism R-HSA-70326,-0.3995071811959396,-1.6698905349768802,0.00819672131147541,0.0234693126735469,0.871,30/74,28.89%,MDH2;ALDOC;MDH1;TPI1;PPP2R1A;TPR;ENO2;SLC25A11;PKM;PGM2L1;PPP2CA;PGP;PRKACB;PFKL;PGK1;BPGM;MAP4K5;NUP54;ENO1;NUP37;PGAM2;GAPDHS;G6PC3;NUP43;GOT2;SLC25A13;GNPDA1;SEC13;NUP153;PFKFB4
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.5182103410007256,-1.6698155699051829,0.010482180293501049,0.023432938241898977,0.871,12/22,29.80%,CEBPB;CEBPG;ATF4;NFYA;EXOSC9;DCP2;ATF6;HERPUD1;ASNS;EXOSC7;DDIT3;NFYB
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.44244582272373034,-1.6696413996035175,0.006276150627615063,0.023412305191782983,0.871,17/41,25.23%,H2AZ1;JUN;MAML2;H2AJ;H2BC4;MAML3;SNW1;PRKCI;H2AZ2;H2AX;CCND1;AGO3;H2BC21;TFDP2;KAT2B;SIRT6;TNRC6C
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.45810334647311746,-1.66835625203599,0.008403361344537815,0.023609607406935657,0.872,14/35,22.67%,AQP4;GNG3;GNB2;PRKAR1A;GNAS;ADCY9;GNG7;RAB11A;RAB11FIP2;GNG10;PRKACB;GNG11;MYO5B;PRKAR2B
gsea,G-protein Activation R-HSA-202040,-0.5034309344391663,-1.666971751661728,0.019762845849802372,0.023771165478466357,0.873,5/22,11.66%,GNG3;GNB2;GNG7;GNAQ;GNG10
gsea,RAS Processing R-HSA-9648002,-0.5542245639826886,-1.6643408646210085,0.017167381974248927,0.024207148037568522,0.877,5/17,16.23%,CALM1;HRAS;ABHD17A;ARL2;ABHD17B
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.41972482280392176,-1.6635142848167828,0.006666666666666667,0.024254709434878417,0.878,16/49,21.96%,YWHAE;H2AZ1;JUN;CDK5R1;PRDX2;GSDME;C1QBP;H2AJ;H2BC4;PRDX1;H2AZ2;FADD;CDK5;H2AX;H2BC21;EZH2
gsea,Signal Amplification R-HSA-392518,-0.47698308186229954,-1.6630798180677064,0.004,0.024290502182747052,0.878,9/29,19.60%,GNG3;GNB2;P2RY12;GNG7;GNAQ;P2RY1;GNG10;AAMP;GNG11
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.38293866888524086,-1.658930600010839,0.0020408163265306124,0.024980803717487243,0.885,43/111,28.65%,UBB;RPS27A;NEDD8;UBC;PPP1CA;PARD6A;UBA52;TGFB3;PPP1R15A;FKBP1A;UBE2D3;INHBA;FST;XPO1;MAPK3;FURIN;SNW1;BMPR1B;CCNK;BMPR1A;SRFBP1;STUB1;TRIM33;CCNT2;ACVR2A;HDAC1;GREM2;RHOA;MAPK1;ZFYVE9;E2F4;TFDP2;RBL1;BMPR2;ITGB1;FSTL1;TGFB1;TGIF2;UCHL5;ITGB8;SMAD4;SMAD3;SKI
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.3720584967794545,-1.658689992503084,0.0020964360587002098,0.024991929409232755,0.886,26/94,25.68%,UBB;RPS27A;SUMO2;UBC;PCNA;UBE2N;UBA52;POLD4;SEM1;H2BC4;BABAM2;SPIDR;POLE3;RAD17;BRCC3;RPA3;RAD51C;UBE2I;H2AX;H2BC21;POLE4;SIRT6;RAD51;RFC5;TOPBP1;RMI2
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.4201512727688006,-1.657934757199992,0.004291845493562232,0.02507971844533559,0.887,28/53,37.79%,H2AZ1;RAN;POLR2G;POLR2K;TPR;H2AJ;POLR2E;H2BC4;H2AZ2;H2AX;NUP54;POLR2F;NUP37;H2BC21;POLR2L;POLR2D;POLR2H;NUP43;SEC13;NUP153;AGO2;SEH1L;POLR2J;POLR2C;NUP93;IPO8;RANBP2;NDC1
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.401525452983569,-1.6574288217653537,0.00411522633744856,0.025105911648314983,0.888,35/70,35.32%,POLR2G;POLR2K;TAF11;POLR2E;PHAX;PCF11;CCNK;GTF2F1;GTF2B;INTS5;POU2F1;GTF2A1;CCNT2;SNAPC5;TAF13;POLR2F;INTS6;SNAPC1;POLR2L;NCBP2;TAF8;POLR2D;GTF2F2;POLR2H;INTS13;SNAPC3;SSU72;ICE1;TAF9;CDK9;ZC3H8;POLR2J;TBP;RPRD2;POLR2C
gsea,tRNA Processing R-HSA-72306,-0.36909120817495,-1.6572735283095013,0.002044989775051125,0.0250823394340602,0.888,39/96,32.80%,POP5;RAN;NSUN6;TPR;TRMT112;RPP21;TSEN15;POP7;LAGE3;DDX1;RPP38;TRMT10A;CDKAL1;RPP25;RTCB;TRNT1;TRMT44;TRMT12;TRMT6;TRMT61A;RTRAF;TRMT9B;TRMT13;NUP54;NUP37;METTL1;NUP43;THG1L;RPP30;RPP14;PUS3;SEC13;NUP153;TRMT10C;THADA;QTRT2;FAM98B;SEH1L;TRDMT1
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.4950355262353083,-1.656798009079802,0.00992063492063492,0.025108422622250232,0.889,14/28,28.65%,UBB;RPS27A;UBC;UBA52;UBE2D3;MAPK3;SNW1;TRIM33;HDAC1;MAPK1;TGIF2;SMAD4;SMAD3;SKI
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.4380685735816222,-1.6564271727904594,0.00646551724137931,0.025149620821077863,0.891,13/45,18.88%,UBB;RPS27A;MAML2;UBC;UBA52;MAML3;SNW1;PSENEN;HEY1;FABP7;WWC1;HES5;APH1B
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.472927633649026,-1.6554777513763024,0.012121212121212121,0.0252855849970244,0.891,7/33,10.10%,CALM1;YWHAB;HRAS;CAMK2B;BRAF;VCL;MAPK3
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.4988074090919949,-1.6537040560228722,0.014028056112224449,0.025534698222556867,0.893,5/26,4.99%,UBB;RPS27A;HRAS;UBC;UBA52
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.4452608309099438,-1.647471017664936,0.006396588486140725,0.026675407061565612,0.905,14/37,22.67%,AQP4;GNG3;GNB2;PRKAR1A;GNAS;ADCY9;GNG7;RAB11A;RAB11FIP2;GNG10;PRKACB;GNG11;MYO5B;PRKAR2B
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5188334745073073,-1.6470692325008611,0.011881188118811881,0.026698077411006233,0.905,12/21,32.45%,IDH3B;MDH2;SUCLG1;FAHD1;IDH3A;NNT;CS;SDHB;LDLR;SDHA;IDH3G;SDHD
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.3401810386691055,-1.646933661926375,0.0,0.026671684721923564,0.905,82/214,33.14%,CALM1;TMSB4X;PPIA;TUBA4A;DGKH;YWHAZ;PFN1;RHOB;MANF;CLU;HSPA5;GNG3;GNB2;CAP1;P2RY12;APOA1;AKT1;TGFB3;OLA1;GNG7;TIMP3;SERPING1;VTI1B;RAB27B;VCL;SELENOP;PCYOX1L;SOD1;MAPK3;CYRIB;CD9;ENDOD1;GNAQ;P2RY1;GNG10;FAM3C;SOS1;APLP2;DGKI;PRKCE;AAMP;CDC37L1;F2RL2;RAP1A;CD63;RHOA;MAPK1;ABCC4;GNG11;RASGRP1;VAV3;RARRES2;VEGFA;CLEC3B;VEGFC;TMX3;TRPC6;ITIH3;GNA13;PTK2;TGFB1;NHLRC2;LHFPL2;SCCPDH;ITPR2;PRKCD;IGF1;DGKE;PDGFA;CDC42;GNG2;VEGFB;BCAR1;PIK3R3;ADRA2A;TAGLN2;CHID1;ACTN1;PTPN11;ABHD6;PIK3CG;APOOL
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.4395427525468616,-1.6468640418701639,0.01002004008016032,0.026626597362221362,0.905,11/44,10.26%,UBB;RPS27A;NEDD8;UBC;PPP1CA;UBA52;TGFB3;PPP1R15A;FKBP1A;XPO1;FURIN
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.36697448254069537,-1.6468414683127701,0.006024096385542169,0.02657793515614702,0.905,41/125,19.52%,DYNLL1;DYNLL2;ARF5;CAPZA2;CNIH2;TMED7;TMED2;NSF;PREB;CNIH1;LMAN1;MCFD2;TGFA;NAPG;DCTN1;TRAPPC4;ARF4;SAR1B;LMAN2;TRAPPC2L;DCTN3;RAB1B;YKT6;DCTN4;TRAPPC5;TRAPPC6B;COPG2;TRAPPC2;PPP6C;CAPZB;COPE;COG5;BET1L;KDELR1;GOLGB1;USO1;BET1;SEC24A;ARF3;SEC23IP;SCFD1
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.40719646680768795,-1.6457339900983663,0.002,0.026780378061535458,0.907,13/66,11.27%,FTH1;VAMP2;HSPA8;NECAP1;CHMP2A;TBC1D8B;CLTA;CLTB;AP1S1;M6PR;PICALM;TFRC;BLOC1S4
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.4961792164951516,-1.6441342539236823,0.020242914979757085,0.027041829321850334,0.909,9/26,15.92%,UBB;RPS27A;UBC;PPP1CA;UBA52;PPP1R15A;XPO1;SRFBP1;STUB1
gsea,Glycolysis R-HSA-70171,-0.4082541406781016,-1.6403906311045413,0.0137524557956778,0.027768548061687923,0.915,19/60,19.53%,ALDOC;TPI1;PPP2R1A;TPR;ENO2;PKM;PGM2L1;PPP2CA;PGP;PRKACB;PFKL;PGK1;BPGM;MAP4K5;NUP54;ENO1;NUP37;PGAM2;GAPDHS
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.45472310308779895,-1.6397807138392018,0.016632016632016633,0.027837172948917004,0.915,14/34,25.26%,TMEM59;TUBA1B;LAMTOR1;PKN2;VAMP3;SLC4A7;TFRC;RALGAPA1;CAV1;UACA;ROCK2;DBT;ARHGDIG;WDR11
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.36530451984888895,-1.6392275925989293,0.002109704641350211,0.02786094089678565,0.917,31/106,26.23%,ACTG1;DYNLL1;RPS27;DYNLL2;DIAPH2;PFN1;RHOB;PPP2R1A;ITGB3BP;PFN2;PPP2CA;XPO1;NUDC;NUF2;TAOK1;CENPP;AHCTF1;BUB3;ZWINT;CENPE;RCC2;NUP37;RHOA;NDEL1;MIS12;CENPF;KIF2A;NUP43;ITGB1;FMNL2;DYNC1I2
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.37130608357569583,-1.6364792775119381,0.004132231404958678,0.028388979685319633,0.919,42/114,29.22%,RAB3A;YWHAE;GABARAP;GABARAPL2;SBF1;RAB6A;RAB14;AKT1;RAB5A;RAB11A;RAB27B;TRAPPC4;TRAPPC2L;RIN1;DENND1A;RAB1B;TRAPPC5;TRAPPC6B;AKT3;TRAPPC2;MAP1LC3B;RAB5B;DENND5B;RABGAP1;RAB33B;DENND2A;RAB6B;RAB9B;HPS4;ARF6;GDI1;TBC1D16;RIC1;RAB18;RAB3GAP1;GDI2;DENND2D;RAB35;DENND1B;TBC1D10B;TRAPPC13;SBF2
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.45273647190738875,-1.635407067178552,0.014675052410901468,0.02855963797187957,0.921,9/35,12.66%,UBB;RPS27A;PPP2R1A;UBC;UBA52;AKT1;MLST8;PPP2CA;AKT3
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.4374886230574825,-1.635127679756889,0.01020408163265306,0.028567090889569175,0.921,13/39,19.21%,H2AZ1;RPS2;H2AC25;H2AJ;CDK4;PRMT7;SMARCC2;PRMT6;H2AZ2;H2AX;CCND1;ACTL6B;SMARCE1
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.523113874568939,-1.6339209433656687,0.030991735537190084,0.02871462227509218,0.921,4/19,3.00%,YWHAE;JUN;CDK5R1;PRDX2
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.3551084306731896,-1.6322074897052172,0.0041928721174004195,0.028964621699552752,0.922,48/151,19.52%,DYNLL1;DYNLL2;ARF5;CAPZA2;CNIH2;TMED7;TMED2;NSF;PREB;CNIH1;B4GALT6;LMAN1;MCFD2;TGFA;B4GALT4;NAPG;DCTN1;TRAPPC4;ARF4;SAR1B;LMAN2;TRAPPC2L;CHGA;MANEA;DCTN3;RAB1B;YKT6;DCTN4;TRAPPC5;TRAPPC6B;COPG2;MAN1A2;TRAPPC2;FUT8;PPP6C;CAPZB;COPE;COG5;BET1L;KDELR1;GOLGB1;USO1;BET1;ST8SIA3;SEC24A;ARF3;SEC23IP;SCFD1
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.45908938376944425,-1.6321527899721175,0.00411522633744856,0.0289271773097314,0.922,7/34,13.21%,UBB;RPS27A;OTUB1;UBC;UBA52;TRAF6;IKBKG
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.5056860840074553,-1.6279567987255354,0.020242914979757085,0.02983930951218157,0.924,7/21,19.60%,GNG3;GNB2;GNG7;GNAQ;GNG10;AAMP;GNG11
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.5150342228754312,-1.6263885665946773,0.024793388429752067,0.030144250321119673,0.925,9/21,20.02%,AKT1;TGFA;CDKN1B;XPO1;MAPK3;AKT3;CCND1;MAPK1;UHMK1
gsea,Gene Silencing By RNA R-HSA-211000,-0.380497622354994,-1.6244632352822612,0.004338394793926247,0.03047723651663584,0.928,26/80,25.23%,HSP90AA1;H2AZ1;RAN;POLR2G;POLR2K;TPR;TSNAX;H2AJ;MOV10L1;POLR2E;H2BC4;MYBL1;TSN;HENMT1;H2AZ2;H2AX;NUP54;POLR2F;NUP37;AGO3;H2BC21;POLR2L;POLR2D;POLR2H;NUP43;TNRC6C
gsea,Ca2+ Pathway R-HSA-4086398,-0.40038095947988583,-1.6244459925250816,0.006276150627615063,0.03042260737736207,0.928,21/57,27.28%,CALM1;PPP3CA;PPP3R1;GNG3;GNB2;PLCB1;PPP3CB;GNG7;FZD2;GNG10;CTNNB1;AGO3;GNG11;FZD9;NFATC1;AXIN2;PLCB2;TNRC6C;PLCB3;ITPR2;TCF7L2
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.3700636938021175,-1.6243094707829497,0.005928853754940711,0.03039001342575485,0.928,39/102,27.56%,DYNLL1;DYNLL2;ARF5;CAPZA2;TMED7;TMED2;RAB6A;NSF;KIF26B;KIF22;KIFAP3;NAPG;DCTN1;ARF4;AGPAT3;DCTN3;RAB1B;DCTN4;COPG2;KIF23;CAPZB;COPE;RAB6B;CENPE;KDELR1;ARF3;BICD1;KIF3A;ACTR1A;TMED9;DCTN6;COPA;KIF2A;RAB18;RAB3GAP1;DYNC1I2;KIF15;DCTN5;GALNT1
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.5393348986537707,-1.624081570573603,0.017660044150110375,0.03037569789564379,0.928,7/18,20.42%,H2AZ1;H2AJ;H2BC4;TAF1D;H2AZ2;H2AX;H2BC21
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.4820025092494807,-1.6236821450368621,0.020637898686679174,0.030441163654396232,0.928,13/26,27.27%,POLR2K;POLR3H;POLR2E;POLR3K;POLR3A;POLR3E;POLR1D;POLR3D;POLR2F;POLR3F;POLR2L;POLR2H;GTF3C6
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.4624746921192498,-1.62086144171453,0.019955654101995565,0.031020005118156162,0.928,11/33,20.60%,PTGDS;GPX4;PTGES3;GPX1;PTGR2;PTGS1;HPGDS;PTGIS;PTGR1;PRXL2B;CBR1
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.4038128797076265,-1.6202038487749462,0.002079002079002079,0.03112010483150051,0.93,20/56,24.61%,FGFR2;HRAS;POLR2G;POLR2K;BAG4;POLR2E;CPSF6;FGFR3;GTF2F1;SOS1;FGF1;POLR2F;POLR2L;NCBP2;ERLIN2;POLR2D;GTF2F2;POLR2H;CEP43;FGF10
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.5525578215188721,1.6201261788523715,0.027559055118110236,0.6712770680568286,0.939,8/19,11.74%,GUCY1A2;KCNMA1;PDE2A;PDE9A;PDE11A;PDE5A;PDE1A;KCNMB4
gsea,Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.513120691766908,-1.6179723597036142,0.02526315789473684,0.03160178611058666,0.933,9/19,29.86%,GNG3;GNB2;PLCB1;GNG7;GNG10;GNG11;PLCB2;PLCB3;GNG2
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.49088290186003847,-1.6153331669900113,0.021956087824351298,0.03218235445454553,0.935,6/23,11.66%,GNG3;GNB2;GNG7;GNAQ;P2RY1;GNG10
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.3861353609312727,-1.6095616105928738,0.005940594059405941,0.033460751829051644,0.939,34/82,28.15%,DYNLL1;ACTR1B;DYNLL2;CAPZA2;AP2M1;CANX;CLTA;CTSB;KIF22;AP1S1;KIFAP3;CTSF;CTSL;IFI30;DCTN1;SAR1B;DCTN3;DCTN4;KIF23;CAPZB;AP2S1;CENPE;SEC24A;CTSO;KIF3A;AP2B1;ACTR1A;DCTN6;KIF2A;DYNC1I2;KIF15;DCTN5;SEC23A;SEC13
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.38139495267497536,-1.6079504177222455,0.0064516129032258064,0.03379199408954201,0.94,18/88,14.67%,ATP1B1;PPIA;HRAS;BSG;TSPAN7;ATP1B2;SDC4;ANGPT2;SLC7A6;SLC7A10;GRB14;YES1;SELENOP;TEK;SLC7A5;SOS1;CAV1;ITGA4
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5439181562056087,-1.6079152646741406,0.021526418786692758,0.03373217082985516,0.94,4/17,4.99%,UBB;RPS27A;UBC;UBA52
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.4934392907505402,-1.6021722725185183,0.02813852813852814,0.035089725336219915,0.944,8/23,19.60%,GNG3;GNB2;AKT1;GNG7;GNG10;AKT3;RHOA;GNG11
gsea,Telomere Maintenance R-HSA-157579,-0.3804386694716528,-1.6018871924709173,0.011086474501108648,0.03508114481563495,0.944,24/70,25.32%,H2AZ1;NOP10;POLR2G;POLR2K;PCNA;H2AJ;POLD4;POLR2E;H2BC4;RUVBL1;DKC1;TERF1;PPP6C;RPA3;H2AZ2;NHP2;H2AX;POLR2F;H2BC21;FEN1;POLR2L;POLR2D;POLR2H;RFC5
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.4056276756532155,-1.6016636078872115,0.00597609561752988,0.035104603345664266,0.944,22/54,30.23%,RAB3A;RAB6A;RAB2A;RAB14;RAB5A;RAB11A;RAB2B;RAB27B;RABGGTB;RAB1B;RAB5B;RAB33B;RAB6B;RAB9B;RAB36;RAB3C;RAB24;RAB18;RAB44;RAB35;RABGGTA;RAB40B
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.3972217972025618,-1.599772235780963,0.009861932938856016,0.03554329110117782,0.944,25/71,27.92%,CALM1;YWHAB;HRAS;CAMK2B;QKI;PEBP1;BRAF;VCL;MAPK3;DUSP6;KDM7A;AGTRAP;DUSP7;RAP1A;MAPK1;AKAP9;MAP2K1;FAM114A2;NF1;AGGF1;FAM131B;SND1;CNKSR2;SPRED3;AGK
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.42185877975784436,1.5974139514726269,0.027932960893854747,0.5361390782538955,0.963,10/45,8.68%,CDH23;PCDH15;SPTAN1;TWF2;KCNMA1;RIPOR2;MYO7A;CLIC5;EPB41L3;CHRNA9
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3852626699378569,-1.5970836496774894,0.006396588486140725,0.03620356438662738,0.948,17/61,25.68%,UBB;RPS27A;UBC;PCNA;UBA52;POLD4;SEM1;SPIDR;POLE3;RAD17;RPA3;RAD51C;POLE4;RAD51;RFC5;TOPBP1;RMI2
gsea,Plasma Lipoprotein Remodeling R-HSA-8963899,-0.5099235438996361,-1.5934344525139668,0.038461538461538464,0.03721857852133658,0.953,9/20,25.62%,APOE;PLTP;APOA1;FURIN;P4HB;LCAT;MBTPS1;TRNP1;LPL
gsea,Homology Directed Repair R-HSA-5693538,-0.3555135573631885,-1.5927480947844566,0.002109704641350211,0.037340274895423936,0.954,27/99,25.68%,UBB;RPS27A;SUMO2;UBC;PCNA;UBE2N;UBA52;POLD4;SEM1;H2BC4;BABAM2;SPIDR;POLE3;RAD17;BRCC3;RPA3;RAD51C;UBE2I;H2AX;H2BC21;FEN1;POLE4;SIRT6;RAD51;RFC5;TOPBP1;RMI2
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.4468538434692055,-1.59242344880128,0.016293279022403257,0.03732762955702807,0.954,5/33,3.91%,SLC25A4;SLC25A5;PSIP1;TPR;BANF1
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.40855647504880516,-1.5914773703344596,0.012526096033402923,0.03753308289873725,0.956,14/49,16.22%,CCT5;NUDT19;BBIP1;TCP1;CCT8;RAB11A;BBS5;ARF4;EXOC3;CCT2;TTC8;ARL6;CCT3;CCT4
gsea,MTOR Signaling R-HSA-165159,-0.4312985782226715,-1.5902192664892627,0.026262626262626262,0.03779043687297568,0.956,13/40,19.85%,YWHAB;RPS6;LAMTOR3;LAMTOR2;RRAGA;AKT1;FKBP1A;LAMTOR1;MLST8;CAB39L;LAMTOR5;CAB39;EIF4B
gsea,Cristae Formation R-HSA-8949613,-0.5625142552770882,-1.5901258563488756,0.034,0.03774549742419297,0.956,12/15,35.86%,ATP5PB;MICOS10;MICOS13;HSPA9;MTX1;MTX2;CHCHD3;APOOL;SAMM50;IMMT;TMEM11;DMAC2L
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.36342685058620366,-1.5899979976509386,0.006160164271047228,0.03770422049939927,0.956,32/92,24.32%,H2AZ1;POLR2K;CBX3;GSK3B;BAZ1B;H2AJ;ERCC3;GTF2H5;CHD3;POLR2E;H2BC4;TAF1D;TTF1;POLR1H;UBTF;CCNH;SAP18;H2AZ2;POLR1D;HDAC1;H2AX;POLR2F;POLR1F;H2BC21;MNAT1;POLR2L;KAT2B;EZH2;TDG;MYBBP1A;HDAC2;POLR2H
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.4006703167695684,-1.5895326657568163,0.004149377593360996,0.03774688363703137,0.957,11/51,10.08%,POP5;RAN;TPR;RPP21;TSEN15;POP7;DDX1;RPP38;RPP25;RTCB;TRNT1
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.4870710085363042,-1.5894527699341394,0.034334763948497854,0.03768833099789486,0.957,5/28,6.17%,CALM1;PPP3CA;PPP3R1;PPP3CB;AHCYL1
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.3814959075592389,-1.5892092223482277,0.00998003992015968,0.03769608281520159,0.957,35/87,28.65%,UBB;RPS27A;NEDD8;UBC;PPP1CA;PARD6A;UBA52;TGFB3;PPP1R15A;FKBP1A;UBE2D3;XPO1;MAPK3;FURIN;SNW1;CCNK;SRFBP1;STUB1;TRIM33;CCNT2;HDAC1;RHOA;MAPK1;ZFYVE9;E2F4;TFDP2;RBL1;ITGB1;TGFB1;TGIF2;UCHL5;ITGB8;SMAD4;SMAD3;SKI
gsea,Reproduction R-HSA-1474165,-0.3671165472528447,-1.5887542445349911,0.009070294784580499,0.037735055518580224,0.957,20/73,20.42%,H2AZ1;HSPA2;SYCP2;H2AJ;H2BC4;SYCP3;CDK4;PSMC3IP;CD9;SMC1A;TERF1;MLH1;RPA3;ADAM2;H2AZ2;RAD51C;UBE2I;H2AX;ADAM21;H2BC21
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.46518068858248957,-1.585510119423243,0.014522821576763486,0.038557160046453064,0.957,8/32,10.10%,YWHAB;HRAS;LAMTOR3;LAMTOR2;PEBP1;BRAF;VCL;MAPK3
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.4428183900126628,-1.5852494596283497,0.021321961620469083,0.03855983331352943,0.958,10/35,17.17%,CDK5R1;JUND;VGF;F3;TCF12;ID3;ID2;CDK5R2;EGR4;CDK5
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.4237367413182356,-1.583979589676186,0.019801980198019802,0.03878005195032037,0.959,15/44,20.99%,EPHA7;AP2M1;CLTA;CLTB;EFNB3;TIAM1;YES1;PSENEN;EPHA4;EFNA3;AP2S1;APH1B;EPHA6;VAV3;AP2B1
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.5107601394580559,-1.58303467235229,0.03624733475479744,0.03899947413634532,0.959,8/18,21.69%,H2AZ1;H2AJ;H2BC4;TERF1;H2AZ2;H2AX;H2BC21;MPG
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.5001818807781299,-1.5809375963646741,0.03006012024048096,0.03950368960716021,0.96,8/20,17.15%,VAMP2;PRNP;SEC61B;SEC61G;UBL4A;SERP1;BAG6;VAPA
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.46957740006717874,-1.580738034127553,0.017582417582417582,0.0395046381487789,0.96,9/25,22.11%,H2AZ1;H2AJ;H2BC4;TERF1;H2AZ2;H2AX;H2BC21;MPG;TDG
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.5366882632727566,-1.5802896999183607,0.027139874739039668,0.03958100832672627,0.96,5/16,17.89%,PPP2R1A;GSK3B;PPP2CA;FRAT1;CTNNB1
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.39973282436212315,-1.5797539071943998,0.01782178217821782,0.03969132684652039,0.962,11/70,6.83%,NRGN;CALM1;NEFL;GRIA2;HRAS;CAMK2B;LIN7C;LIN7B;PRKAR1A;CAMKK1;PPM1F
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.3396480596831862,-1.5760391132892466,0.004008016032064128,0.040675777466910576,0.965,63/161,28.60%,DYNLL1;DYNLL2;ARF5;CAPZA2;TMED7;TMED2;RAB6A;NSF;KIF26B;KIF22;SCOC;KIFAP3;NAA38;NAPG;M6PR;VAMP3;DCTN1;ARF4;STX16;AGPAT3;RHOBTB3;DCTN3;RAB1B;YKT6;DCTN4;COPG2;MAN1A2;GCC2;KIF23;CAPZB;COPE;RAB33B;RAB6B;RAB9B;COG5;CENPE;BET1L;KDELR1;RAB36;ARF3;BICD1;TMF1;KIF3A;NAA30;PLIN3;ACTR1A;RIC1;TMED9;VPS53;DCTN6;COPA;KIF2A;GOSR2;COG2;RAB18;RAB3GAP1;DYNC1I2;KIF15;DCTN5;SYS1;GALNT1;AKR1B10;ARCN1
gsea,Intraflagellar Transport R-HSA-5620924,-0.42842219427186956,-1.5755033641181342,0.018518518518518517,0.04072577264201868,0.965,8/38,10.79%,DYNLL1;DYNLL2;KIFAP3;IFT20;DYNLT2B;IFT43;DYNLRB1;TTC30B
gsea,Integration Of Energy Metabolism R-HSA-163685,-0.36175885478018394,-1.575463847928238,0.004073319755600814,0.04066325981592465,0.965,31/96,23.33%,VAMP2;PPP2R1A;MARCKS;GNG3;GNB2;ACSL3;SNAP25;PRKAR1A;PLCB1;GNAS;ADCY9;AHCYL1;GNG7;KCNG2;PPP2CA;KCNS3;GNAQ;GNG10;CACNB3;PRKACB;SYT5;RAP1A;AKAP5;ACSL4;GNG11;CACNA1E;PLCB2;CACNA2D2;TKT;PRKAR2B;ACLY
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4972161968724165,-1.5744359580405032,0.032454361054766734,0.040896583240282794,0.965,9/20,27.04%,ABCD3;PEX19;PXMP4;PEX26;FIS1;ACBD5;ATAD1;ABCD2;PEX2
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.41507640720386607,-1.5725712601662665,0.022857142857142857,0.041346152110271435,0.968,25/47,35.56%,UBB;RPS27A;UBC;UBA52;UBE2D3;MAPK3;FURIN;SNW1;CCNK;TRIM33;CCNT2;HDAC1;MAPK1;E2F4;TFDP2;RBL1;TGIF2;SMAD4;SMAD3;SKI;CDK9;WWTR1;MYC;SMAD2;SKIL
gsea,Neuronal System R-HSA-112316,-0.3242559119577204,-1.5725318025613497,0.01059322033898305,0.04127609890346181,0.968,92/346,20.99%,NRGN;CALM1;RAB3A;VAMP2;KCNA1;HSPA8;NEFL;SLC1A3;GRIA2;LRRTM1;HRAS;CAMK2B;AP2M1;GRM1;TSPAN7;LIN7C;PPFIA2;GNG3;ARL6IP5;KCNA2;CPLX1;GNB2;NSF;GLUL;LIN7B;SNAP25;PRKAR1A;PLCB1;GLRB;KCNA3;ADCY9;SLC32A1;GABRG2;SHARPIN;IL1RAPL1;IL1RAP;CAMKK1;GNG7;PPM1F;NTRK3;ARHGEF9;LRRTM2;SLITRK4;GABRB3;KCNJ3;KCNF1;KCNG2;RIMS1;SLITRK2;KCNS3;GABRB2;LRRTM4;MAPK3;SLC17A7;GNG10;CACNB3;SYN2;KCNJ10;GAD1;SLC1A2;GABRA3;KCNJ4;RTN3;PPM1E;GNAL;CAMK1;PRKACB;AP2S1;KCNK1;KCNAB2;NLGN3;KCND2;DNAJC5;APBA3;SYT7;PDLIM5;AKAP5;GRIA3;KCNN3;GABRA5;HOMER3;GAD2;KCNV1;MAPK1;GABRA1;GNG11;SLITRK6;LRFN4;PPFIBP1;SIPA1L1;GRIN2C;AP2B1
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.38344465567112596,-1.572122598959862,0.023529411764705882,0.04134486514726961,0.968,33/75,26.77%,DYNLL1;DYNLL2;ARF5;CAPZA2;TMED7;TMED2;NSF;NAPG;DCTN1;ARF4;DCTN3;RAB1B;YKT6;DCTN4;COPG2;CAPZB;COPE;COG5;BET1L;KDELR1;GOLGB1;USO1;BET1;ARF3;ACTR1A;TMED9;DCTN6;COPA;CD55;GOSR2;COG2;DYNC1I2;DCTN5
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.4409222743975462,-1.5700316206730602,0.024844720496894408,0.04190596268713873,0.969,9/30,19.60%,GNG3;GNB2;GNG7;MAPK3;GNAQ;GNG10;F2RL2;MAPK1;GNG11
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.3868710399229637,-1.568150089451513,0.01293103448275862,0.042407824293121905,0.969,23/59,31.94%,NRN1;PIGK;THY1;DPM2;LY6H;SPRN;DPM1;DPM3;PIGW;PIGP;MDGA2;LYPD1;PIGG;PIGL;PIGF;PIGC;LSAMP;PIGH;LY6E;PIGO;ART3;NEGR1;NRN1L
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.3429446989376786,-1.5616694753576195,0.014861995753715499,0.04421233243746862,0.97,33/162,14.04%,NRGN;CALM1;NEFL;GRIA2;HRAS;CAMK2B;AP2M1;TSPAN7;LIN7C;GNG3;GNB2;NSF;LIN7B;PRKAR1A;PLCB1;GLRB;ADCY9;GABRG2;CAMKK1;GNG7;PPM1F;ARHGEF9;GABRB3;KCNJ3;GABRB2;MAPK3;GNG10;KCNJ10;GABRA3;KCNJ4;PPM1E;GNAL;CAMK1
gsea,Cellular Senescence R-HSA-2559583,-0.34455168766563904,-1.5599417305615388,0.004338394793926247,0.04468487455454777,0.971,34/126,21.96%,UBB;RPS27A;H2AZ1;JUN;CBX6;UBC;CEBPB;UBA52;H2AJ;SCMH1;H2BC4;ETS2;CDK4;ANAPC4;CDKN1B;MAPK3;TXN2;MAP2K6;CDKN2D;CDC26;TERF1;MAP2K7;RB1;H2AZ2;ANAPC16;PHC3;H2AX;MAPK1;AGO3;H2BC21;TFDP2;CCNE2;UBE2E1;EZH2
gsea,Post NMDA Receptor Activation Events R-HSA-438064,-0.40490906857310005,-1.5591387611378547,0.019417475728155338,0.04486764866036298,0.971,8/57,6.32%,NRGN;CALM1;NEFL;GRIA2;HRAS;CAMK2B;PRKAR1A;CAMKK1
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.3774487737653276,-1.558543729674308,0.016701461377870562,0.044982897359615547,0.971,45/69,41.47%,SRSF2;TPR;FYTTD1;SRSF9;SRSF7;CDC40;U2AF1;THOC2;SRSF1;SRSF11;U2AF1L4;MAGOHB;ZC3H11A;SLU7;SARNP;NUP54;NUP37;THOC1;RNPS1;ALYREF;NCBP2;U2AF2;NUP43;SEC13;NUP153;MAGOH;SRSF3;GLE1;RBM8A;THOC3;NXT1;SRSF6;SEH1L;DHX38;NUP93;THOC7;RANBP2;NDC1;NUP98;DDX39B;CHTOP;EIF4A3;NUP35;THOC6;NUP88
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.39733057161257074,-1.5577581922982124,0.021653543307086614,0.04514114090894761,0.971,10/52,11.27%,FTH1;VAMP2;HSPA8;NECAP1;TBC1D8B;CLTA;AP1S1;PICALM;TFRC;BLOC1S4
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,-0.3197418390032843,-1.5496628888602413,0.0023584905660377358,0.04753161397947796,0.974,34/194,15.03%,CALM1;SLC25A4;SLC25A5;SLC1A3;AHCYL2;BSG;SLCO1C1;SLC15A2;SLC4A10;SLC6A15;SLC35A1;SLC4A4;SLC24A5;SLC32A1;SLC7A6;SLC7A10;SLC27A1;SLC4A7;SLC25A22;ARL2BP;SLC17A7;SLC2A13;SLC39A7;SLC8B1;SLC39A3;SLC39A10;SLC7A5;SLC1A2;SLC16A10;ARL2;SLC35A3;SLC39A6;APOD;PDZD11
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.3959026090263441,-1.5483176008653048,0.024439918533604887,0.04786117204911287,0.975,24/55,30.23%,JUN;CBX6;LAMTOR3;LAMTOR2;RRAGA;SCMH1;CHD3;LAMTOR1;MLST8;MAPK3;MECOM;LAMTOR5;PHC3;MAF1;HDAC1;MAPK1;KDM1A;EZH2;HDAC2;LAMTOR4;RRAGD;CBX4;RING1;MTA3
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.36215299048239186,-1.5434527610587883,0.019880715705765408,0.04930872517767754,0.976,50/78,41.47%,SRSF2;TPR;FYTTD1;SRSF9;SRSF7;CDC40;FIP1L1;U2AF1;THOC2;SRSF1;SRSF11;U2AF1L4;MAGOHB;ZC3H11A;SLU7;SARNP;NUP54;NUP37;THOC1;RNPS1;ALYREF;NCBP2;U2AF2;NUP43;CPSF2;EIF4E;SEC13;NUP153;MAGOH;SRSF3;GLE1;RBM8A;THOC3;NXT1;SRSF6;SEH1L;SLBP;DHX38;NUP93;THOC7;WDR33;RANBP2;NDC1;NUP98;DDX39B;CHTOP;EIF4A3;NUP35;THOC6;NUP88
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.5030033992694185,-1.5397776693281078,0.05387931034482758,0.05052912998697344,0.978,3/18,6.17%,CALM1;HRAS;AHCYL1
gsea,RND3 GTPase Cycle R-HSA-9696264,-0.4129285224120384,-1.5394723575024318,0.03747534516765286,0.05053075877217704,0.978,8/38,9.83%,CKB;KTN1;RASAL2;KCTD13;CCDC88A;ARHGAP5;TXNL1;PICALM
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.4882894014609233,-1.538767920323023,0.04259634888438134,0.05067443816312955,0.978,5/19,13.44%,HSP90AA1;HRAS;ERBIN;NRG2;SOS1
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.4187168201369324,-1.5375061778802777,0.02574257425742574,0.05105507049858512,0.98,13/40,22.03%,DDX5;SUMO2;NPM1;PIAS1;SCMH1;ING3;TOPORS;TRIM28;CTBP1;PHC3;UBE2I;UHRF2;SUMO1
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.4643154158633344,-1.536672292100449,0.04106776180698152,0.051246731374232773,0.981,9/24,24.32%,RAN;POLR2G;POLR2K;POLR2E;POLR2F;AGO3;POLR2L;POLR2D;POLR2H
gsea,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.5156619943501362,-1.5364915657599718,0.04612159329140461,0.05122081931471275,0.981,11/17,35.01%,BTG1;CDKN1B;CAV1;GADD45A;FOXO1;FOXG1;SMAD4;SMAD3;CCNG2;RBL2;SMAD2
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.45067728019678854,-1.5308773985196538,0.03909465020576132,0.05304869890117461,0.984,7/25,13.30%,GNG3;GNB2;GNG7;KCNJ3;GNG10;KCNJ10;KCNJ4
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.5214840506055106,-1.5285791368948956,0.05010893246187364,0.05376326193125447,0.985,6/16,19.08%,YWHAB;AKT1;ZFP36L1;EXOSC9;DCP2;DCP1A
gsea,Deadenylation Of mRNA R-HSA-429947,-0.46649359779770416,-1.5274769809633604,0.028901734104046242,0.05414841022084454,0.985,9/24,19.85%,CNOT4;EIF4A2;CNOT6L;TUT4;CNOT8;EIF4A1;PABPC1;CNOT2;EIF4B
gsea,Signaling To ERKs R-HSA-187687,-0.43062992807218403,-1.526827897426722,0.03495145631067961,0.05429070088948123,0.986,9/32,19.12%,YWHAB;HRAS;RALA;BCL11B;BRAF;MAPK3;SOS1;RAP1A;MAPK1
gsea,GABA Receptor Activation R-HSA-977443,-0.40012367568090523,-1.5238692542248267,0.026915113871635612,0.055260152882018805,0.987,17/52,19.60%,GNG3;GNB2;ADCY9;GABRG2;GNG7;ARHGEF9;GABRB3;KCNJ3;GABRB2;GNG10;KCNJ10;GABRA3;KCNJ4;GNAL;GABRA5;GABRA1;GNG11
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.4572268283920263,-1.5229168703821607,0.03879310344827586,0.055526923663937515,0.987,8/23,22.11%,H2AZ1;H2AJ;H2BC4;TERF1;H2AZ2;H2AX;H2BC21;TDG
gsea,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.5051492342223632,-1.5201325605257077,0.057494866529774126,0.05648447187434145,0.988,7/16,29.86%,GNG3;GNB2;GNG7;GNG10;GNG11;BTK;GNG2
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.40342895294078696,-1.5194482459312366,0.029166666666666667,0.056586161543370934,0.988,21/44,28.07%,RAB6A;NSF;SCOC;NAA38;NAPG;M6PR;VAMP3;STX16;RHOBTB3;GCC2;RAB6B;RAB9B;COG5;TMF1;NAA30;PLIN3;RIC1;VPS53;COG2;SYS1;AKR1B10
gsea,Viral Messenger RNA Synthesis R-HSA-168325,-0.3982427240603027,-1.5184909742904624,0.024742268041237112,0.05682990430989774,0.988,29/43,43.68%,POLR2G;POLR2K;TPR;GNL3;POLR2E;GTF2F1;NUP54;POLR2F;NUP37;BLOC1S6;POLR2L;POLR2D;GTF2F2;POLR2H;NUP43;SEC13;NUP153;SEH1L;PBRM1;POLR2J;POLR2C;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.4423712205401602,-1.5161848615355147,0.036885245901639344,0.057622063939923016,0.988,8/32,13.97%,TUBA1A;TUBB2A;TUBB4B;TUBA1B;TUBB2B;TTLL8;TUBB4A;TPGS1
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.31406154662581953,-1.5143106999312452,0.004424778761061947,0.05823092182182399,0.99,49/156,30.26%,CALM1;HSP90AA1;APOE;GPHN;SDC4;CD38;COQ2;THTPA;GSTO1;APOA1;AKT1;NAXE;RFK;AASDHPPT;PNPO;RETSAT;AGRN;PTGIS;COQ3;AOX1;NAXD;PDZD11;MTHFD1;NADK2;PDXK;SLC25A16;MMAB;SDC3;PARP6;SLC19A2;RBP4;NNMT;LRP12;PTS;FLAD1;NUDT12;GPC4;LPL;PANK3;TTPA;LMBRD1;MTHFD2;C1D;AKR1B10;CD320;PARP16;MOCS3;MCCC2;LDLR
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.47739241629417595,-1.5110172427878972,0.04921259842519685,0.05953644687099976,0.991,8/18,32.33%,GNG3;GNB2;GNG7;GNG10;GNG11;CDC42;GNG2;ARHGEF6
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.43879938051601775,-1.5076052062174792,0.0420353982300885,0.06081828181873022,0.993,5/27,6.41%,CALM1;GNG3;GNB2;PLCB1;GNG7
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.47134284888705186,-1.5055595683500365,0.03982300884955752,0.06146040193172443,0.993,9/21,29.30%,HMGB1;S100B;TRAF6;IKBKG;NKIRAS2;NKIRAS1;MAVS;NFKB2;TANK
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.4450712225665705,-1.504689812788284,0.04633204633204633,0.06173514278195944,0.994,11/28,21.15%,SNRPG;PABPN1;SNRPF;CPSF6;FIP1L1;CSTF2T;PCF11;SNRPD3;PAPOLA;SNRPB;NCBP2
gsea,Mitotic Prophase R-HSA-68875,-0.3432209186904183,-1.5007737750634345,0.006198347107438017,0.06317954554810325,0.994,27/87,20.81%,H2AZ1;SET;PPP2R1A;TPR;BANF1;RAB2A;H2AJ;H2BC4;ARPP19;PPP2CA;MAPK3;RAB1B;KMT5A;NEK7;RB1;H2AZ2;RAB33B;BLZF1;GORASP2;H2AX;USO1;NUP54;NUP37;MAPK1;H2BC21;VRK1;ENSA
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.4011288105601516,-1.498502612143252,0.02494802494802495,0.06404756973699825,0.994,11/39,15.52%,NSUN6;TRMT112;LAGE3;TRMT10A;CDKAL1;TRMT44;TRMT12;TRMT6;TRMT61A;TRMT9B;TRMT13
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.4705709409883959,-1.4983144866506,0.04811715481171548,0.06400421917477767,0.994,13/21,38.04%,CANX;HSPA5;CALR;SAR1B;B2M;SEC24A;ATG14;SEC23A;SEC13;SEC24D;PIK3C3;BECN1;SEC24B
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.4716875912954539,-1.495691713492951,0.05905511811023622,0.06491888514133344,0.994,8/20,19.12%,GLI3;CBFB;YES1;MAPK3;YAP1;HEY1;RB1;MAPK1
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.4953775379035176,-1.4935792196342186,0.052525252525252523,0.06568753747059998,0.994,9/17,28.69%,DPM2;PIGW;PIGP;PIGG;PIGL;PIGF;PIGC;PIGH;PIGO
gsea,Tie2 Signaling R-HSA-210993,-0.4944374512984786,-1.4904368935561227,0.06611570247933884,0.06686912567333896,0.995,5/17,13.44%,HRAS;ANGPT2;GRB14;TEK;SOS1
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.4437627030426804,-1.490377739806408,0.05172413793103448,0.06678654534844651,0.995,8/25,17.89%,PPP2R1A;GSK3B;FZD2;FZD1;PPP2CA;FRAT1;CAV1;CTNNB1
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.4834586765757624,-1.490096179245544,0.061224489795918366,0.06678642982328471,0.995,13/19,39.18%,MYL6;RHOB;MYL12B;MYL9;ROCK2;RHOA;MYH9;MYH11;PPP1R12A;MYH14;MYH10;PPP1CB;ROCK1
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.4292489471449118,-1.4876325730261855,0.036290322580645164,0.06779937615936799,0.995,11/31,17.88%,DDX5;CHMP2A;SDC4;ISCU;CTSL;FURIN;AGRN;MAP1LC3B;RB1;ZCRB1;SDC3
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.29510894982284286,-1.4871779382072716,0.0,0.06787950611160652,0.995,88/248,31.42%,CALM1;UBB;RPS27A;NDST4;MDH2;B4GAT1;ALDOC;MDH1;TPI1;PPP2R1A;CHST9;B3GALT1;SDC4;TPR;UBC;ENO2;SLC25A11;PKM;CHORDC1;B4GALT6;UBA52;AKR1A1;PHGDH;B3GALT2;B4GALT4;PGM2L1;CSPG5;PPP2CA;UBL4A;PGP;PPP1R3C;AGRN;IDS;RPE;CHST1;PHKG1;BCAN;B3GNT2;PRKACB;CHST15;B3GNT7;PFKL;PGK1;BPGM;MAP4K5;SDC3;NUP54;ENO1;NUP37;PGAM2;GAPDHS;FUT7;CHPF;B3GALT5;CHST2;G6PC3;TKT;UST;DSEL;NUP43;GPC4;GOT2;SLC25A13;HMMR;PHKB;HYAL2;B3GAT2;GALK1;FUT2;GBE1;B4GALT5;GNPDA1;TALDO1;SEC13;B4GALT3;XYLB;NUP153;PFKFB4;SGSH;B4GALT7;PHKA1;ST3GAL6;PFKFB1;FUT9;CSPG4;RBKS;SORD;OGN
gsea,Circadian Clock R-HSA-400253,-0.36898053334808584,-1.4861294161082494,0.035196687370600416,0.06815124949183056,0.995,15/61,18.07%,UBB;RPS27A;SKP1;BHLHE41;UBC;PPP1CA;UBA52;HIF1A;PPARA;CLOCK;BHLHE40;NOCT;CUL1;CHD9;TBL1XR1
gsea,Triglyceride Metabolism R-HSA-8979227,-0.44245478619813305,-1.486076421414176,0.06451612903225806,0.06806409681295048,0.995,10/24,21.10%,FABP3;PPP1CA;GPAM;AGMO;CAV1;PRKACB;GPD2;FABP7;DGAT2;PLIN3
gsea,Hemostasis R-HSA-109582,-0.28830378937482454,-1.482346587847713,0.006289308176100629,0.0694977988930143,0.995,106/443,22.67%,CALM1;ATP1B1;TMSB4X;PPIA;TUBA4A;DGKH;YWHAZ;CAPZA2;HRAS;BSG;PFN1;RHOB;MANF;TSPAN7;PPP2R1A;CLU;HSPA5;GNG3;MAFG;ATP1B2;SDC4;GNB2;ANGPT2;F3;PRKAR1A;CAP1;KIF26B;C1QBP;GNAS;SLC7A6;SLC7A10;P2RY12;KIF22;APOA1;ATP2B1;AKT1;RAB5A;KIFAP3;TGFB3;OLA1;GNG7;TIMP3;SERPING1;VTI1B;RAB27B;ORAI2;GRB14;YES1;VCL;SELENOP;PCYOX1L;JMJD1C;PPP2CA;SOD1;TEK;MAPK3;CYRIB;CD9;ENDOD1;GNAQ;DOCK10;P2RY1;GNG10;DOCK11;SLC7A5;FAM3C;SOS1;APLP2;CAV1;EHD3;DGKI;ITGA4;PRKCE;KIF23;CAPZB;AAMP;PRKACB;DOCK1;CDC37L1;F2RL2;CD47;RAD51C;CENPE;CDK5;HDAC1;SDC3;RAP1A;CD63;RHOA;MAPK1;ABCC4;ATP1B3;GNG11;RASGRP1;PRCP;VAV3;RARRES2;KIF3A;PDE1B;KDM1A;RBSN;VEGFA;SLC7A11;CLEC3B;VEGFC;PRKAR2B
gsea,Base Excision Repair R-HSA-73884,-0.3682423212318628,-1.4814613345576961,0.03409090909090909,0.06979684677872677,0.995,18/53,25.32%,H2AZ1;PCNA;H2AJ;POLD4;H2BC4;PNKP;TERF1;POLE3;RPA3;H2AZ2;H2AX;H2BC21;FEN1;POLE4;MPG;TDG;PARG;RFC5
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.43788601058271154,-1.4799219675751583,0.03696098562628337,0.07028553384721346,0.995,7/26,22.28%,GNG3;GNB2;GNG7;GNG10;CACNB3;GNG11;CACNA2D2
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.31642147159950607,-1.4783184479723965,0.012987012987012988,0.0708974132118068,0.995,39/136,25.73%,PTGDS;SYCP2;TECR;GPX4;ACSL3;NUDT19;NDUFAB1;ACOT13;PTGES3;GPX1;PTGR2;MCEE;HSD17B8;PTGS1;DBI;ACBD6;HPGDS;HACD4;ACOX1;HACD2;PTGIS;ACOT12;PTGR1;FADS2;AMACR;ACOT1;ACSL4;PRXL2B;HSD17B12;ACBD5;CBR1;CROT;ACSL6;ACLY;PECR;MECR;ECI2;ACSBG1;ACOT11
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.45296889574504035,-1.4779340900416131,0.04819277108433735,0.07095910569113043,0.995,5/22,13.44%,HSP90AA1;HRAS;ERBIN;NRG2;SOS1
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.4220150475805012,-1.475951354059638,0.036016949152542374,0.07165495924229409,0.995,7/29,13.30%,GNG3;GNB2;GNG7;KCNJ3;GNG10;KCNJ10;KCNJ4
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.3036854239671326,-1.4746903875735535,0.007317073170731708,0.07212501822048219,0.995,50/196,22.67%,CALM1;P2RY14;PPP3CA;PPP3R1;CAMK2B;PPP2R1A;GNG3;GNB2;PRKAR1A;PLCB1;PPP1CA;GNAS;ADCY9;RGS20;P2RY12;PPP3CB;AHCYL1;CAMKK1;GNG7;SST;MTNR1A;NPY;PPP2CA;ACKR3;GNAQ;PPP1R1B;GNG10;SSTR4;SSTR2;SSTR1;GNAL;S1PR3;CXCL12;GPR37;RGS4;PRKACB;RGS14;GPR37L1;CDK5;NPY2R;MAPK1;GNG11;RXFP3;PDE1B;ADORA1;RGS10;PLCB2;OPRL1;LPAR1;PRKAR2B
gsea,RHOG GTPase Cycle R-HSA-9013408,-0.3571618027418178,-1.4702258762281817,0.026515151515151516,0.07416499849461454,0.995,17/69,15.60%,HSPE1;KTN1;NDUFA5;IQGAP2;ELMO2;LMAN1;CYFIP1;ARHGAP5;LAMTOR1;ERBIN;PKN2;VAMP3;TFRC;YKT6;CAV1;ESYT1;DOCK1
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.35048102276082677,-1.4652920336896995,0.02620967741935484,0.0766006372223033,0.995,39/71,41.47%,SUMO2;TPR;PIAS1;NSMCE4A;SCMH1;CETN2;NSMCE3;SMC1A;PHC3;UBE2I;XRCC4;NUP54;NUP37;SMC5;SUMO1;TDG;NUP43;SP100;CBX4;SEC13;RAD52;NUP153;RING1;NSMCE1;PCGF2;BLM;SMC6;SEH1L;RNF168;MDC1;WRN;NUP93;RANBP2;NDC1;NUP98;CBX8;STAG2;NUP35;NUP88
gsea,Gap Junction Trafficking R-HSA-190828,-0.4896847763448994,-1.464243241043397,0.05982905982905983,0.07701405308045674,0.995,10/17,29.05%,GJA1;AP2M1;CLTA;CLTB;GJB6;GJB2;GJA3;GJA5;GJB1;GJD2
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.3986233285320707,-1.4611906737431335,0.05040322580645161,0.07821266848679695,0.995,15/35,37.54%,UBE2N;H2BC4;XRCC6;TDP2;BABAM2;BRCC3;XRCC4;H2AX;H2BC21;UBE2V2;LRIF1;RNF168;MDC1;BABAM1;LIG4
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.33493559886622293,-1.4575535597757752,0.020202020202020204,0.07982314063063084,0.995,29/82,26.29%,NME2;UCKL1;DTYMK;ADK;NME4;NUDT5;TXN2;NT5C;RRM2B;SCO2;APRT;GUK1;NUDT16;GDA;DUT;DGUOK;AK1;GMPR2;NUDT18;GLRX;NUDT9;AK6;GMPS;AMPD2;TXNRD1;ATIC;DNPH1;PAICS;DCTPP1
gsea,Interferon Signaling R-HSA-913531,-0.31256839528140895,-1.4557196114467639,0.02097902097902098,0.0805552566447864,0.996,44/141,28.76%,UBB;RPS27A;EIF4G2;CAMK2B;TRIM35;TPR;UBC;EIF4A2;UBE2N;PIAS1;UBA52;ABCE1;GNL3;BCL11B;PDZD2;IFI30;IFNGR2;ISG15;MAPK3;TYK2;KPNA3;EIF4A1;ARIH1;KPNA1;KPNA4;B2M;NUP54;NUP37;PSMB8;IRF5;PDE12;UBE2E1;PPM1B;SUMO1;IFI35;NUP43;SOCS1;SP100;IFIT2;EIF4E;PRKCD;NEDD4;SEC13;NUP153
gsea,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.5062623271476563,-1.4550291433060747,0.07740585774058577,0.08075091138079175,0.996,11/15,39.18%,MYL6;MYL12B;YES1;MYL9;ROCK2;RHOA;MYH9;MYH11;MYH14;MYH10;ROCK1
gsea,Pyroptosis R-HSA-5620971,-0.4715750086578353,-1.4524443695262323,0.06016597510373444,0.08193274621381659,0.996,12/19,34.75%,HMGB1;CYCS;CHMP2A;GSDME;BAK1;CHMP4C;GSDMD;IL18;CHMP2B;CHMP4B;BAX;CASP3
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.44731066399329866,-1.451360663467122,0.07142857142857142,0.0824223532428797,0.996,4/28,7.42%,CALM1;NCK1;AHCYL1;ORAI2
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.33497539762213285,-1.4483517568956534,0.035634743875278395,0.08372602325039644,0.996,31/86,32.02%,DYNLL1;RPS27;DYNLL2;PPP2R1A;ITGB3BP;PPP2CA;XPO1;NUDC;NEK7;NUF2;TAOK1;CENPP;AHCTF1;BUB3;ZWINT;CENPE;RCC2;NUP37;NDEL1;MIS12;CENPF;KIF2A;NUP43;DYNC1I2;SPC25;SEC13;NEK6;CENPT;NDE1;SEH1L;PAFAH1B1
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.3401721940754697,-1.447924349828711,0.023255813953488372,0.0838238551290526,0.996,23/65,30.52%,GLP2R;GNG3;GNB2;CALCRL;GNAS;RAMP1;GNG7;FZD2;FZD1;PTRH2;GNG10;CALCB;GNG11;FZD9;CD55;CALCA;RAMP2;WNT7B;CRH;FZD8;PTCH1;GNG2;ADGRE5
gsea,G-protein Mediated Events R-HSA-112040,-0.38736199232813223,-1.447319682408749,0.04780876494023904,0.08399750051114968,0.996,18/49,27.72%,CALM1;CAMK2B;PRKAR1A;PLCB1;ADCY9;AHCYL1;CAMKK1;GNAQ;GNAL;PRKACB;MAPK1;PDE1B;PLCB2;PRKAR2B;PRKX;PLCB3;ITPR2;PRKCD
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.3977635497504417,-1.4394493026006616,0.06526315789473684,0.08779145362991721,0.996,9/36,13.63%,GNG3;GNB2;ADCY9;GNG7;KCNJ3;GNG10;KCNJ10;KCNJ4;GNAL
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.47704602994025685,-1.4380707529423802,0.07756813417190776,0.08834068164253682,0.996,6/21,14.04%,CALM1;NEFL;CAMK2B;PPM1F;PPM1E;CAMK1
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.416124270713301,-1.4360283644056966,0.07021276595744681,0.08931849705107249,0.996,12/29,33.78%,PRELID3A;BNIP3L;RABGGTB;TRIAP1;PRELID1;BBC3;APAF1;STEAP3;BCL6;RABGGTA;PPP1R13B;BAX
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.41187273754830867,-1.434744179350875,0.07051282051282051,0.0898726347312841,0.996,6/30,12.12%,UBB;RPS27A;UBC;UBA52;CNTN1;PSENEN
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.4476587032561708,-1.432690913786797,0.07068607068607069,0.09092648774102173,0.996,8/22,18.93%,MYL6;RHOB;MYL12B;RNMT;MYL9;ARHGEF12;ROCK2;RHOA
gsea,RHOF GTPase Cycle R-HSA-9035034,-0.39649517697366476,-1.4270882613200964,0.0648854961832061,0.09387717018137083,0.996,11/39,15.27%,DIAPH2;ARHGAP5;SOWAHC;VAMP3;ARHGAP12;SLC4A7;MTMR1;SYDE1;CAV1;CAPZB;ESYT1
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.4211200642557836,-1.4261838336352823,0.07,0.09423778640276,0.996,8/27,20.56%,JUN;HRAS;PKN2;MAPK3;SOS1;MAP2K7;MAPK1;VAV3
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.322354948226069,-1.4261629491333891,0.046052631578947366,0.09409215298047875,0.996,31/98,28.15%,DYNLL1;RPS27;DYNLL2;PPP2R1A;ITGB3BP;ANAPC4;PPP2CA;XPO1;NUDC;NUF2;TAOK1;CENPP;CDC26;AHCTF1;BUB3;ZWINT;ANAPC16;CENPE;RCC2;NUP37;UBE2E1;NDEL1;MIS12;CENPF;KIF2A;NUP43;DYNC1I2;ANAPC10;SPC25;ANAPC7;SEC13
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3215067202531271,-1.4215866513544324,0.04842105263157895,0.09649257632745331,0.996,25/93,24.43%,DYNLL1;RPS27;DYNLL2;PPP2R1A;ITGB3BP;PPP2CA;XPO1;PDS5B;NUDC;SMC1A;NUF2;PDS5A;TAOK1;CENPP;AHCTF1;BUB3;ZWINT;CENPE;RCC2;NUP37;NDEL1;MIS12;CENPF;KIF2A;NUP43
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.4299133455056934,-1.4202514145857255,0.07269155206286837,0.09699124315522538,0.996,5/23,13.44%,HSP90AA1;HRAS;ERBIN;NRG2;SOS1
gsea,Signaling By MET R-HSA-6806834,-0.3520259625655473,-1.4196973665280543,0.04040404040404041,0.0972040606613041,0.996,15/61,19.95%,UBB;RPS27A;HRAS;SH3GL1;UBC;UBA52;RNMT;STAM2;LAMA5;LAMA2;SOS1;RAP1A;ARF6;LAMA1;STAM
gsea,PKA Activation R-HSA-163615,-0.48958894960669774,-1.4182652813997523,0.10082304526748971,0.09787931523609472,0.996,3/15,5.44%,CALM1;PRKAR1A;ADCY9
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.4430120135952208,-1.4174648571751538,0.09233791748526522,0.09815272182372664,0.996,5/21,17.17%,HRAS;CDK5R1;TIAM1;SOS1;CDK5
gsea,PLC Beta Mediated Events R-HSA-112043,-0.38455230588347206,-1.4163755362813484,0.06627680311890838,0.09859206622496196,0.996,17/45,27.72%,CALM1;CAMK2B;PRKAR1A;PLCB1;ADCY9;AHCYL1;CAMKK1;GNAQ;PRKACB;MAPK1;PDE1B;PLCB2;PRKAR2B;PRKX;PLCB3;ITPR2;PRKCD
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.4565469758635271,-1.4148766972307472,0.07805907172995781,0.09929768053583592,0.996,5/21,12.66%,PPP2R1A;AKT1;YES1;PPP2CA;AKT3
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.39166534512524476,-1.4139613606698458,0.06666666666666667,0.09972199622333226,0.996,10/36,20.44%,H2AZ1;CEBPB;H2AJ;H2BC4;CBFB;CDK4;H2AZ2;H2AX;H2BC21;TFDP2
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3293393394387103,-1.412183346293775,0.04888888888888889,0.1006993603511426,0.996,29/82,32.02%,DYNLL1;RPS27;DYNLL2;PPP2R1A;ITGB3BP;PPP2CA;XPO1;NUDC;NUF2;TAOK1;CENPP;AHCTF1;BUB3;ZWINT;CENPE;RCC2;NUP37;NDEL1;MIS12;CENPF;KIF2A;NUP43;DYNC1I2;SPC25;SEC13;CENPT;NDE1;SEH1L;PAFAH1B1
gsea,ERK/MAPK Targets R-HSA-198753,-0.44541709029037957,-1.4116953763330886,0.07128712871287128,0.1008123487629534,0.996,8/21,19.12%,PPP2R1A;MEF2A;PPP2CA;MAPK3;VRK3;DUSP6;DUSP7;MAPK1
gsea,RHO GTPase Cycle R-HSA-9012999,-0.28231990413042746,-1.408805904288777,0.03067484662576687,0.10246176553900048,0.996,87/414,18.97%,HSP90AA1;HSP90AB1;ACTG1;WIPF3;CKB;DIAPH2;GJA1;HSPE1;RHOB;TMEM59;PTK2B;KTN1;ARHGEF4;NDUFA5;IQGAP2;RASAL2;KCTD13;BAIAP2;SLK;CCT7;CCDC88A;PARD6A;ELMO2;TUBA1B;NCK1;LMAN1;C1QBP;NCKAP1;CYFIP1;ARHGAP5;ARMCX3;ABCD3;WASF1;LAMTOR1;TXNL1;SOWAHC;FGD4;ARHGEF9;ERBIN;STAM2;TIAM1;PKN2;CDC42EP3;TRA2B;VAMP3;CCT6A;STARD8;MACO1;ABI1;WASL;CYBA;ARHGAP12;SLC4A7;CCDC115;PICALM;CCT2;ABI2;PHIP;TFRC;NUDC;PREX2;DOCK10;MTMR1;YKT6;DOCK11;SYDE1;RALGAPA1;ARHGAP44;SOS1;CDC42SE2;CAV1;ARHGEF12;CAPZB;ESYT1;DOCK1;MTX1;UACA;PRPF38B;RNF20;ROCK2;RHOU;RBM15;TMEM87A;RHOV;KIF14;RHOA;ARHGEF26
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.40883488065990514,-1.4087566996350005,0.0577319587628866,0.10232381137676544,0.996,10/27,22.67%,GNG3;GNB2;PRKAR1A;GNAS;ADCY9;GNG7;GNG10;PRKACB;GNG11;PRKAR2B
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.3924457149226961,-1.4086904364419202,0.05752212389380531,0.10221574573862471,0.996,10/32,21.02%,DPH3;ARSJ;EIF5A2;DNAJC24;EEF2;FN3KRP;FURIN;DHPS;DPH7;SUMF1
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.4484638920275358,-1.4079041247492823,0.08171206225680934,0.10248160465169684,0.996,7/20,17.60%,NPM1;CNOT4;CNOT6L;CNOT8;PLK2;RGCC;CNOT2
gsea,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.4679298933627706,-1.4076408780024752,0.06581740976645435,0.10244705712590232,0.996,4/17,14.03%,FGFR2;HRAS;SOS1;FGF1
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.49109733585820314,-1.4069637120220553,0.10865191146881288,0.10274106825059154,0.996,4/17,3.65%,GRIA2;AP2M1;TSPAN7;NSF
gsea,Signaling By PDGFR In Disease R-HSA-9671555,-0.4588678895870203,-1.4023977113540296,0.08979591836734693,0.10530638597847403,0.997,5/19,13.50%,HRAS;PDGFRA;FIP1L1;SOS1;KANK1
gsea,Gap Junction Trafficking And Regulation R-HSA-157858,-0.4546325782626699,-1.4018195226981238,0.08860759493670886,0.1054752415589354,0.997,10/19,29.05%,GJA1;AP2M1;CLTA;CLTB;GJB6;GJB2;GJA3;GJA5;GJB1;GJD2
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.4159580195920315,-1.3996990519468566,0.06212424849699399,0.10669738854680705,0.997,9/28,19.12%,JUN;PPP2R1A;MEF2A;PPP2CA;MAPK3;VRK3;DUSP6;DUSP7;MAPK1
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.37883148768159275,-1.398717250974534,0.042283298097251586,0.10713758017292195,0.997,12/38,19.60%,GNG3;GNB2;PRKAR1A;GNAS;GNG7;KCNG2;KCNS3;GNG10;PRKACB;RAP1A;AKAP5;GNG11
gsea,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.44257803996633516,-1.3973550770059593,0.07246376811594203,0.10784707852828568,0.997,11/18,39.98%,TMED2;RAB6A;FURIN;ATP2A1;SEL1L;LFNG;NOTCH1;ST3GAL6;B4GALT1;ATP2A2;NOTCH4
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.4210273711366255,-1.3969448499563315,0.08506224066390042,0.10797325625559834,0.997,9/25,19.12%,GLI3;CBFB;YES1;MAPK3;YAP1;HEY1;RB1;GLI2;MAPK1
gsea,Cardiac Conduction R-HSA-5576891,-0.3250502595817538,-1.3966542807109323,0.04054054054054054,0.10795108027521877,0.997,32/104,27.24%,CALM1;ATP1B1;ATP1A2;CAMK2B;ATP1B2;ATP2B1;AHCYL1;ORAI2;FXYD1;RANGRF;KCNJ4;SCN3B;FGF11;SCN2A;KCNK1;KCND2;TRDN;FKBP1B;FXYD2;ATP1B3;AKAP9;SCN3A;NPPA;KAT2B;CACNA2D2;SCN1B;NPR1;ATP2A1;CACNG8;SRI;KCNK2;ITPR2
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.46104841381457273,-1.3964859016777593,0.10756972111553785,0.10787392954576346,0.997,3/17,5.44%,CALM1;PRKAR1A;ADCY9
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.3197853486889041,-1.3940194396519348,0.025157232704402517,0.10917387125857059,0.997,19/95,14.03%,FGFR2;PPP2R1A;AKT1;IL1RAP;TGFA;RNMT;PDGFRA;IER3;PPP2CA;MAPK3;TRAF6;FGFR3;IRS2;PHLPP1;NRG2;AKT3;PIP5K1B;SOS1;FGF1
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.3998200668713937,-1.3891775885923185,0.07905982905982906,0.11210458181296447,0.997,5/30,7.51%,CALM1;PRKAR1A;ADCY9;AHCYL1;YES1
gsea,Nicotinamide Salvaging R-HSA-197264,-0.4514574877754455,-1.3888664925867489,0.07300884955752213,0.11211377941073628,0.997,9/17,37.35%,NAXE;PTGIS;NAXD;PARP6;NNMT;NUDT12;PARP16;PARP10;PARP14
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.4609577894710477,-1.3876957218828212,0.08649789029535865,0.11274203122337524,0.997,13/18,37.88%,MYL6;RHOB;MYL12B;CDKN1B;MYL9;KIF14;RHOA;MYH9;MYH11;PPP1R12A;MYH14;MYH10;PPP1CB
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.42066611564456985,-1.3874687885999806,0.07854406130268199,0.1127186134243945,0.997,12/27,24.88%,AKT1;CHD3;PDZD2;MAP2K6;ING3;AKT3;BRD7;HDAC1;PIP4K2A;PIP4P1;HDAC2;KAT6A
gsea,NLRP3 Inflammasome R-HSA-844456,-0.47104044033218456,-1.3865954098631064,0.10989010989010989,0.11314310754879443,0.998,7/15,36.63%,HSP90AB1;TXN2;HMOX1;PSTPIP1;NFKB2;NFKB1;SUGT1
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.32758574999047485,-1.3841332209839283,0.04618473895582329,0.11446352734459474,0.998,15/79,18.30%,UBB;RPS27A;CDK5R1;UBC;TAF11;UBA52;PDZD2;CSNK2B;TAF7L;RAD17;TAF10;RPA3;NOC2L;CDK5;TAF13
gsea,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.43424223882556107,-1.3824730362587292,0.09221311475409837,0.11531631245394292,0.998,7/21,23.28%,PRNP;CYP7B1;TPMT;FDX1;ACY1;FDX2;FDXR
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.4112424907732495,-1.3822379526230344,0.09486166007905138,0.11530060706376455,0.998,6/28,10.10%,YWHAB;HRAS;PEBP1;BRAF;VCL;MAPK3
gsea,Nicotinate Metabolism R-HSA-196807,-0.4036282000133254,-1.3818472441213625,0.06349206349206349,0.11537626350656055,0.998,13/26,37.92%,CD38;NAXE;PTGIS;NAXD;NADK2;PARP6;NNMT;NUDT12;PARP16;PARP10;NMNAT1;PARP14;NT5E
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.44561851971785815,-1.3797606882350706,0.11958762886597939,0.1165743267918636,0.998,7/19,18.93%,MYL6;RHOB;MYL12B;MYL9;ARHGEF12;ROCK2;RHOA
gsea,Defective Pyroptosis R-HSA-9710421,-0.4212387446429058,-1.3796133059719633,0.08849557522123894,0.11649991269766065,0.998,8/23,21.96%,H2AZ1;GSDME;H2AJ;H2BC4;H2AZ2;H2AX;H2BC21;EZH2
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.3164824915694378,-1.3794543674723525,0.036885245901639344,0.11642856123365868,0.998,17/88,14.03%,FGFR2;PPP2R1A;AKT1;IL1RAP;TGFA;RNMT;PDGFRA;IER3;PPP2CA;MAPK3;TRAF6;FGFR3;IRS2;NRG2;PIP5K1B;SOS1;FGF1
gsea,Interleukin-37 Signaling R-HSA-9008059,0.45437869779346196,1.3773089601041155,0.10848126232741617,1.0,1.0,4/17,3.02%,PTPN23;PTPN5;PTPN2;PTPN9
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.38123260318657126,-1.3753083890787283,0.07236842105263158,0.11903801120146758,0.999,10/33,21.22%,H2AZ1;H2AJ;H2BC4;CDKN1B;TERF1;RB1;H2AZ2;H2AX;H2BC21;CCNE2
gsea,Mismatch Repair R-HSA-5358508,-0.46359451357308923,-1.3728784723261938,0.08588957055214724,0.1204642657448129,0.999,5/15,16.49%,PCNA;POLD4;MLH1;RPA3;MSH2
gsea,RHOQ GTPase Cycle R-HSA-9013406,-0.3443434091626374,-1.372834606888727,0.07429718875502007,0.12033078633988478,0.999,12/57,14.40%,GJA1;ARHGAP5;LAMTOR1;ARHGEF9;PKN2;CDC42EP3;VAMP3;WASL;SLC4A7;TFRC;SYDE1;CAV1
gsea,DAG And IP3 Signaling R-HSA-1489509,-0.39430909799116953,-1.3721588436561,0.09090909090909091,0.12059306174016171,0.999,6/37,6.32%,CALM1;CAMK2B;PRKAR1A;ADCY9;AHCYL1;CAMKK1
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.4056489077047496,-1.3720924923114397,0.08102345415778252,0.12047952544107632,0.999,11/25,31.84%,PCNA;POLD4;POLE3;RPA3;FEN1;POLE4;PARG;RFC5;ADPRS;POLD3;LRIG1
gsea,Inflammasomes R-HSA-622312,-0.43805030431405484,-1.37136886891645,0.1301518438177874,0.12080838197921608,0.999,9/19,38.41%,HSP90AB1;TXN2;HMOX1;PSTPIP1;BCL2L1;NFKB2;NFKB1;SUGT1;AIM2
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.36138995914727795,-1.3702477842446004,0.07739307535641547,0.12135275390232732,0.999,20/45,34.89%,PREB;DNAJB9;DCTN1;SSR1;DNAJC3;EXTL2;SERP1;SRPRB;DNAJB11;TSPYL2;HDGF;GFPT1;SYVN1;GOSR2;FKBP14;EDEM1;KDELR3;MYDGF;CXXC1;TLN1
gsea,Inositol Phosphate Metabolism R-HSA-1483249,-0.359073511341464,-1.369212506694938,0.08176100628930817,0.12189832973240505,0.999,16/46,25.90%,CALM1;PLCB1;MINPP1;NUDT11;INPP1;IMPA1;NUDT10;PPIP5K2;MTMR9;PLCB2;INPPL1;NUDT3;PLCE1;ITPKB;IPPK;PLCB3
gsea,Muscle Contraction R-HSA-397014,-0.2927972793405346,-1.3685563914029537,0.03416856492027335,0.12219841988231858,0.999,45/161,27.24%,CALM1;ATP1B1;ATP1A2;MYL6;CAMK2B;TPM1;ATP1B2;MYL12B;ATP2B1;AHCYL1;ORAI2;VCL;PKN2;ACTA2;FXYD1;MYL9;TMOD2;RANGRF;KCNJ4;SCN3B;FGF11;SCN2A;KCNK1;KCND2;CACNA1H;TRDN;FKBP1B;FXYD2;ATP1B3;AKAP9;SCN3A;NPPA;KAT2B;CALD1;CACNA2D2;SCN1B;NPR1;TMOD1;ATP2A1;CACNG8;PXDN;GUCY1B1;SRI;KCNK2;ITPR2
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.442627927631279,-1.3685546361048133,0.11046511627906977,0.1220189802055457,0.999,7/19,19.83%,UBE2N;TRAF6;MAP2K6;IKBKG;UBE2V1;IRAK1;IRAK2
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.36058594791248133,-1.3600658953366616,0.05806451612903226,0.12777666753777805,0.999,15/39,22.22%,H2AZ1;H2AJ;H2BC4;TLE4;RUVBL1;PYGO2;ASH2L;H2AZ2;HDAC1;CTNNB1;H2AX;H2BC21;AXIN2;PYGO1;TLE1
gsea,Stimuli-sensing Channels R-HSA-2672351,-0.31552284414965975,-1.356717185866811,0.049145299145299144,0.13007350263954404,0.999,16/78,18.50%,CALM1;UBB;RPS27A;UBC;UBA52;CLCN2;OSTM1;CLCN4;TRPM3;WNK3;TTYH3;TTYH1;TRPC4;ANO3;TRDN;FKBP1B
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.3545608231803975,-1.3534448230676224,0.09336099585062241,0.13213788803225107,0.999,21/47,34.89%,HSPA5;PREB;DNAJB9;DCTN1;SSR1;DNAJC3;EXTL2;SERP1;SRPRB;DNAJB11;TSPYL2;HDGF;GFPT1;SYVN1;GOSR2;FKBP14;EDEM1;KDELR3;MYDGF;CXXC1;TLN1
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.29056942926272394,-1.3511924785253067,0.05443548387096774,0.1335478608754703,0.999,52/148,30.93%,DDX5;SUMO2;NPM1;TPR;PCNA;PIAS1;TOP1;NSMCE4A;SCMH1;CHD3;CETN2;NOP58;NR3C2;NSMCE3;HNRNPK;PPARA;ING3;TOPORS;SMC1A;TRIM28;IKBKG;TOP2B;NR5A2;CTBP1;THRA;PHC3;UBE2I;XRCC4;HDAC1;MITF;NUP54;NUP37;UHRF2;SMC5;SUMO1;TDG;HDAC2;NUP43;PARK7;PGR;SP100;CBX4;SEC13;RAD52;NUP153;NFKB2;RING1;VDR;NSMCE1;PCGF2;BLM;SMC6
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.35140584100655436,-1.3508494909004034,0.08027522935779817,0.13362827721671441,0.999,13/50,22.43%,HSP90AB1;UBE2N;BIRC2;TXN2;TRAF6;MAP2K6;IKBKG;AAMP;UBE2V1;IRAK1;IRAK2;HMOX1;PSTPIP1
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.39403882326717304,-1.3489764540155404,0.10763209393346379,0.1349126652099214,0.999,8/28,17.56%,LAMTOR3;LAMTOR2;RRAGA;LAMTOR1;MLST8;CAB39L;LAMTOR5;CAB39
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.2908932096517456,-1.3469036348873173,0.04100227790432802,0.13625427348059285,0.999,18/114,11.66%,CALM1;GLP2R;GNG3;GNB2;PTGER4;PRKAR1A;CALCRL;GNAS;ADCY9;AHCYL1;RAMP1;GNG7;YES1;HTR4;PTRH2;CHGA;FURIN;GNG10
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.35674170513450376,-1.3466804646095547,0.08531746031746032,0.13618931436156412,0.999,27/42,43.68%,SUMO2;TPR;SCMH1;NOP58;HNRNPK;PHC3;UBE2I;NUP54;NUP37;SUMO1;NUP43;CBX4;SEC13;NUP153;RING1;PCGF2;SEH1L;NUP93;RANBP2;NDC1;NUP98;CBX8;NUP35;NUP88;POM121;HNRNPC;NUP50
gsea,Metabolism Of Steroids R-HSA-8957322,-0.2922556251146965,-1.3460639157704228,0.04128440366972477,0.13640909172936552,0.999,30/120,24.58%,SUMO2;CYP7B1;RAN;SYCP2;STARD5;PLPP6;SAR1B;INSIG2;NFYA;CHGA;GPAM;PPARA;PTGIS;CHD9;AMACR;UBE2I;FDX1;TBL1XR1;SEC24A;MBTPS1;HSD17B12;STARD6;GGPS1;ARV1;SH3D19;FDX2;HMGCS1;FDXR;STARD3NL;INSIG1
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.33227661887717264,-1.3435195000232933,0.06157112526539278,0.13804891502139,0.999,17/56,24.32%,H2AZ1;JUN;POLR2G;POLR2K;H2AJ;POLR2E;H2BC4;ASH2L;H2AZ2;H2AX;POLR2F;H2BC21;POLR2L;KMT2C;EZH2;POLR2D;POLR2H
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.3810737278410318,-1.3424410689402082,0.10398230088495575,0.13859867886672822,0.999,10/29,22.03%,APOE;NPM1;HSPD1;TGFA;CHGA;CITED2;UBE2I;KCTD1;VEGFA;SUMO1
gsea,CaM Pathway R-HSA-111997,-0.40236264739710326,-1.3398878896627582,0.11428571428571428,0.1403708929188937,0.999,5/31,6.32%,CALM1;CAMK2B;PRKAR1A;ADCY9;CAMKK1
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.3149404508670658,-1.3395519759072012,0.07337526205450734,0.14040484395816769,0.999,34/76,35.41%,DPM2;SLC35A1;DOLK;DPM1;DPM3;PMM1;NAGK;ALG5;ALG2;ALG11;NUS1;FUOM;EGFL7;ST6GALNAC2;MPDU1;NANP;RFT1;ALG13;ST8SIA3;GNPNAT1;GMDS;GFPT1;ST8SIA4;ALG12;SLPI;ST6GAL1;ST3GAL6;CMAS;GFPT2;ALG10B;UAP1;FPGT;CTSA;ALG6
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.33982901045952696,-1.339263342882576,0.07784431137724551,0.14041949819339314,0.999,29/48,43.68%,SNRPG;SNRPF;TPR;SNRPD2;PHAX;SNRPD3;NUP54;NUP37;SNRPB;NCBP2;NUP43;SEC13;NUP153;GEMIN6;SMN1;SEH1L;GEMIN4;NUP93;DDX20;RANBP2;NDC1;SNRPE;NUP98;WDR77;GEMIN7;NUP35;NUP88;POM121;NUP50
gsea,NCAM1 Interactions R-HSA-419037,-0.3735864901603239,-1.3367216982172743,0.10975609756097561,0.14230196395860578,0.999,10/33,26.02%,PRNP;COL4A2;GFRA4;AGRN;COL6A1;CACNB3;CACNA1H;COL4A1;ST8SIA4;COL4A5
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.37371658966030263,-1.3346907319578492,0.0893970893970894,0.1436129123012124,0.999,18/34,41.57%,NDUFAB1;ACOT13;MCEE;DBI;ACBD6;ACOT12;ACOT1;MECR;ACOT11;HADHA;MMUT;ACOT2;HADH;ECI1;ACADL;THEM4;ACOT9;PCCB
gsea,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.4433161255646325,-1.3319456540168908,0.14747474747474748,0.14568203682726522,0.999,6/17,21.22%,CDK4;CDKN1B;RB1;CCND1;TFDP2;CCNE2
gsea,SUMOylation R-HSA-2990846,-0.2840692643941733,-1.3275202803625035,0.05432595573440644,0.14881696542312384,0.999,53/154,30.93%,DDX5;SUMO2;NPM1;TPR;PCNA;PIAS1;TOP1;NSMCE4A;SCMH1;CHD3;CETN2;NOP58;NR3C2;NSMCE3;HNRNPK;PPARA;ING3;TOPORS;SMC1A;TRIM28;IKBKG;TOP2B;NR5A2;CTBP1;THRA;PHC3;UBE2I;XRCC4;HDAC1;MITF;NUP54;NUP37;UHRF2;SMC5;SUMO1;TDG;HDAC2;NUP43;PARK7;SENP5;PGR;SP100;CBX4;SEC13;RAD52;NUP153;NFKB2;RING1;VDR;NSMCE1;PCGF2;BLM;SMC6
gsea,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.42756859489260596,-1.3267667064746826,0.13953488372093023,0.14918712131360667,0.999,10/21,37.92%,HSP90AB1;TXN2;HMOX1;PSTPIP1;GSDMD;NFKB2;IL18;NFKB1;SUGT1;NT5E
gsea,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.4300723049872305,-1.3263759761037701,0.1148936170212766,0.14931692681991135,0.999,9/19,36.24%,FGFR2;HRAS;SOS1;FGF1;FGF10;FGF9;PTPN11;FGF7;FGF23
gsea,FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.44405290691553445,-1.3214386659439923,0.13179916317991633,0.15298178711500565,0.999,4/16,14.03%,HRAS;FGFR3;SOS1;FGF1
gsea,Olfactory Signaling Pathway R-HSA-381753,0.4077042053046569,1.317216431596792,0.1166077738515901,1.0,1.0,10/25,16.25%,ADCY8;OR1L4;OR4K5;OR52E5;LDB2;ANO2;OR4K15;OR52K2;CNGB1;OR52B2
gsea,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.46223588050472025,1.3140200471680865,0.13709677419354838,1.0,1.0,6/15,11.99%,PI4K2B;PI4KA;VAC14;PIKFYVE;OCRL;FIG4
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.33141360019907806,-1.311440275418448,0.08669354838709678,0.1611210707134634,0.999,35/54,44.36%,CNOT4;EIF4A2;CNOT6L;LSM4;LSM7;TUT4;CNOT8;EIF4A1;EXOSC9;PABPC1;DCP2;CNOT2;DCP1A;EIF4B;SKIC3;EIF4E;LSM2;LSM3;EXOSC7;EXOSC8;EDC4;PATL1;DDX6;CNOT7;LSM5;EXOSC4;EIF4A3;LSM1;CNOT11;SKIC8;LSM6;EXOSC5;DIS3;EIF4G1;EXOSC3
gsea,Signaling By FGFR3 In Disease R-HSA-5655332,-0.4277611627677583,-1.3081993823596643,0.12896405919661733,0.16361070195273358,0.999,4/18,14.03%,HRAS;FGFR3;SOS1;FGF1
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.4319382753028194,-1.3055705927151793,0.13179916317991633,0.1656931042975446,0.999,13/19,35.70%,CYCS;GSDME;C1QBP;MAPK3;UACA;MAPK1;BAK1;APAF1;DIABLO;GSDMD;BAX;CASP3;CASP9
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.40268036847745625,-1.3052169173489974,0.13141683778234087,0.16574191102095837,0.999,4/25,3.86%,NEFL;CAMK2B;LIN7C;LIN7B
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.3816262891558234,1.3024458872332403,0.12574850299401197,1.0,1.0,9/32,10.81%,MAPT;SPTAN1;GAS2;LMNB1;PLEC;CASP7;STK24;FNTA;SATB1
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.35841440864821855,-1.3020441848945468,0.11297071129707113,0.16823061927017682,0.999,11/35,21.36%,CDK4;ANAPC4;CDKN1B;CDC26;SKP2;RB1;ANAPC16;CCND1;TFDP2;CCNE2;UBE2E1
gsea,Chromatin Modifying Enzymes R-HSA-3247509,-0.2748220864351828,-1.300394178666523,0.07276507276507277,0.1695868873679035,0.999,92/204,38.89%,MORF4L2;H2AZ1;RPS2;H2AC25;H2AJ;CHD3;H2BC4;KDM5A;KDM4C;CDK4;PRMT7;MRGBP;SETD7;RUVBL1;ING3;CLOCK;KMT5A;KAT7;MECOM;SMARCC2;PRMT6;PRDM16;KDM7A;ASH2L;SAP18;TAF10;DPY30;KANSL3;H2AZ2;ATF7IP;HDAC1;H2AX;TBL1XR1;SETD6;CCND1;ACTL6B;SMARCE1;MORF4L1;H2BC21;KAT6B;DR1;SETD3;KDM1A;KAT2B;KMT2C;EZH2;BRMS1L;HDAC2;BRD8;KAT6A;ARID4B;GPS2;PHF21A;SMARCD2;TADA1;SUV39H1;ENY2;HAT1;ACTL6A;PRMT1;MEAF6;NFKB2;KDM4D;TADA2B;ZZZ3;MTA3;SUDS3;COPRS;JADE2;TAF9;SGF29;MBIP;PBRM1;HMG20B;SUPT7L;NFKB1;MCRS1;H2BC18;KANSL2;SMARCD1;RIOX2;SAP130;KDELR2;SMARCB1;ELP2;ATXN7L3;SAP30;NSD1;RBBP5;SMARCA2;MSL3;KAT14
gsea,Signaling By Hippo R-HSA-2028269,-0.4254709912708558,-1.29872248582044,0.14545454545454545,0.17069198109266942,0.999,5/20,17.57%,YWHAE;YWHAB;AMOTL1;YAP1;WWC1
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.42931755008352473,-1.2981580704635156,0.15637860082304528,0.17093214619688432,0.999,4/16,17.29%,YWHAZ;AKT1;EXOSC9;DCP2
gsea,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.4490164200219676,-1.2979205391302189,0.15708812260536398,0.17089012989289093,0.999,5/15,11.46%,DPM2;DOLK;DPM1;DPM3;NUS1
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.3974490459510962,-1.2978262236553646,0.17063492063492064,0.17074381915382209,0.999,5/31,3.65%,GRIA2;CAMK2B;AP2M1;TSPAN7;NSF
gsea,Interleukin-20 Family Signaling R-HSA-8854691,0.4380429204385239,1.2977464054282026,0.14124293785310735,1.0,1.0,8/16,20.96%,IL20RB;STAT1;STAT2;STAT4;STAT5B;JAK3;IL10RB;JAK2
gsea,Polo-like Kinase Mediated Events R-HSA-156711,0.4440164537631515,1.295530037852275,0.14951456310679612,1.0,1.0,4/16,8.29%,EP300;MYBL2;RBBP4;CDC25A
gsea,TBC/RABGAPs R-HSA-8854214,-0.34548416609670163,-1.2929917823797312,0.13095238095238096,0.17480064136968118,0.999,12/42,21.76%,GABARAP;GABARAPL2;RAB6A;RAB5A;RAB11A;MAP1LC3B;RAB5B;RABGAP1;RAB33B;RAB6B;ARF6;TBC1D16
gsea,Regulation Of TP53 Activity R-HSA-5633007,-0.28154927338679553,-1.2911199060851668,0.06576402321083172,0.176307174112516,0.999,27/137,18.30%,UBB;RPS27A;CDK5R1;PPP2R1A;UBC;TAF11;UBA52;AKT1;CHD3;PDZD2;CSNK2B;MLST8;PPP2CA;MAP2K6;ING3;KMT5A;AKT3;BRD7;TAF7L;RAD17;TAF10;RPA3;CCNG1;NOC2L;CDK5;HDAC1;TAF13
gsea,HDACs Deacetylate Histones R-HSA-3214815,-0.3502512691162379,-1.2884372588913635,0.12139917695473251,0.17836935473866497,0.999,17/40,34.53%,H2AC25;CHD3;H2BC4;SAP18;HDAC1;TBL1XR1;H2BC21;KDM1A;BRMS1L;HDAC2;ARID4B;GPS2;PHF21A;MTA3;SUDS3;HMG20B;H2BC18
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.34251151295309096,1.2880893695227178,0.12375249500998003,1.0,1.0,7/45,4.39%,NR2F1;NR4A3;ESRRG;ESRRA;RXRA;RORA;THRB
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.35683116032332235,-1.2878318933628177,0.13871635610766045,0.17870061384582736,0.999,20/33,43.68%,NPM1;RAN;TPR;RANBP1;XPO1;NUP54;NUP37;NUP43;SEC13;NUP153;KPNB1;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Azathioprine ADME R-HSA-9748787,-0.4129635393285873,-1.2875433123177402,0.15320910973084886,0.17870394448797144,0.999,7/18,20.85%,NME2;GSTM1;TPMT;GUK1;ABCC4;VAV3;GMPS
gsea,MET Activates PTK2 Signaling R-HSA-8874081,-0.4273455599817939,-1.2863136903097163,0.1553784860557769,0.17955682425989397,0.999,8/17,28.16%,RNMT;LAMA5;LAMA2;SOS1;LAMA1;PTK2;ITGB1;LAMB1
gsea,Ca-dependent Events R-HSA-111996,-0.3828684473470462,-1.2855762752297626,0.15778688524590165,0.1799778408591748,0.999,5/33,6.32%,CALM1;CAMK2B;PRKAR1A;ADCY9;CAMKK1
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.43542281924383885,-1.2842728984737837,0.1503267973856209,0.18092453954931087,0.999,11/16,44.36%,YWHAB;EXOSC9;DCP2;DCP1A;EXOSC7;EXOSC8;ZFP36;EXOSC4;EXOSC5;DIS3;EXOSC3
gsea,Regulation Of Beta-Cell Development R-HSA-186712,-0.370872196303904,-1.2839807975699888,0.13990825688073394,0.18095120544595214,0.999,12/29,24.61%,MAML2;AKT1;MAML3;SNW1;NEUROD1;PDHX;AKT3;NR5A2;ONECUT1;KAT2B;FOXO1;FGF10
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3647740872558038,1.2833907717265225,0.14048059149722736,1.0,1.0,8/36,5.05%,HEXB;GPC6;ST3GAL3;DCN;EXT1;LUM;GPC3;SLC26A2
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.3910010817235496,-1.2827905056683186,0.1806981519507187,0.1819652179148932,0.999,3/24,7.42%,CALM1;ATP2B1;ORAI2
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.3341534469420849,-1.2750086756826544,0.11359026369168357,0.18909840141811912,0.999,13/45,21.22%,NPM1;CNOT4;PCNA;CNOT6L;CNOT8;CDKN1B;PLK2;RGCC;GADD45A;CNOT2;E2F4;TFDP2;CCNE2
gsea,NOD1/2 Signaling Pathway R-HSA-168638,-0.36903985295798547,-1.2742620575976424,0.13260869565217392,0.18955335596864034,0.999,9/32,19.83%,UBE2N;BIRC2;TRAF6;MAP2K6;IKBKG;AAMP;UBE2V1;IRAK1;IRAK2
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.3369312638394305,-1.2733199458349864,0.12215320910973085,0.19020687746855386,0.999,15/43,21.89%,H2AZ1;H2AJ;H2BC4;CBFB;MYL9;PRMT6;ASH2L;DPY30;H2AZ2;HDAC1;H2AX;AGO3;H2BC21;KAT2B;KMT2C
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.36337518920038064,-1.2728150108438043,0.12474437627811862,0.19045425388420606,0.999,8/31,14.33%,APOE;STMN1;S100B;PSENEN;YAP1;NRG2;GFAP;CXCL12
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.3518677329243725,-1.267570173957661,0.15568862275449102,0.19544153241567291,0.999,21/32,43.68%,RAN;TPR;GNL3;XPO1;NUP54;NUP37;BLOC1S6;NUP43;SEC13;NUP153;HSPA1A;SEH1L;PBRM1;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Antimicrobial Peptides R-HSA-6803157,-0.42370524675967747,-1.2671628790450749,0.1630901287553648,0.19558153948862778,0.999,5/16,15.03%,CLU;CHGA;RO60;ATOX1;PDZD11
gsea,Diseases Of Metabolism R-HSA-5668914,-0.25315867178494195,-1.2663419126893727,0.049886621315192746,0.19610553956198426,0.999,57/197,29.35%,UBB;RPS27A;PRNP;CYP7B1;SEMA5A;B4GAT1;LCT;SDC4;DPM2;UBC;UBA52;DOLK;DPM1;DPM3;ALG2;CSPG5;ALG11;PPP1R3C;TPMT;AGRN;IDS;NUS1;APRT;EGFL7;BCAN;POMGNT1;MPDU1;C1GALT1C1;ADAMTS1;RFT1;MMAB;SPON1;FDX1;SDC3;ALG13;ADAMTS6;ACY1;GFPT1;G6PC3;FDX2;FDXR;ADAMTS18;GPC4;ALG12;LMBRD1;GALK1;LFNG;GBE1;SLPI;CSF2RA;CYP1B1;TALDO1;CD320;ADAMTS17;SGSH;B4GALT7;NOTCH1
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.41891641619602005,-1.2661329931215168,0.19076305220883535,0.1960040204492871,0.999,8/18,25.24%,UBE2N;TRAF6;IKBKG;MAP2K7;UBE2V1;IRAK1;IRAK2;MAPK9
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.30229181707542774,-1.266048506188704,0.12903225806451613,0.19581411878012747,0.999,20/69,24.18%,ARF5;TMED7;TMED2;NSF;KIF26B;KIF22;KIFAP3;NAPG;ARF4;RAB1B;COPG2;KIF23;COPE;CENPE;KDELR1;ARF3;KIF3A;TMED9;COPA;KIF2A
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.3716213144293863,-1.264751493917407,0.17165668662674652,0.19675230859217394,0.999,6/26,12.66%,GSK3B;RPS6KB2;AKT1;MLST8;CDKN1B;AKT3
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.333258399137945,-1.260176839789711,0.15051546391752577,0.20102443286024524,0.999,8/42,14.03%,FGFR2;HRAS;PDE3B;FGFR3;IGF1R;IRS2;SOS1;FGF1
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.29173341528278157,-1.259301718358968,0.08893709327548807,0.20163093999983328,0.999,42/90,41.47%,HSP90AA1;HSP90AB1;TPR;UBE2N;CNBP;SAR1B;ISG15;TYK2;TRAF6;IKBKG;B2M;UBE2V1;MASP1;NUP54;IRAK1;SEC24A;NUP37;IRAK2;ATG14;G3BP2;NUP43;MAVS;SEC23A;SEC13;NUP153;SEC24D;SEH1L;PTPN11;TAB3;PIK3C3;G3BP1;NUP93;BECN1;TBK1;RANBP2;NDC1;SEC24B;NUP98;TAB2;IKBKE;NUP35;NUP88
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.38886287696435023,-1.2570321110502407,0.16071428571428573,0.20362070701826102,0.999,9/21,31.84%,PCNA;POLD4;POLE3;RPA3;FEN1;POLE4;RFC5;POLD3;LRIG1
gsea,Signaling By GPCR R-HSA-372790,-0.2381506582256711,-1.2569949910849074,0.06091370558375635,0.2033751277425806,0.999,75/470,15.97%,CALM1;PLPPR4;GLP2R;P2RY14;PPP3CA;PPP3R1;DGKH;HRAS;NTSR2;CAMK2B;GRM1;RHOB;PPP2R1A;ARHGEF4;GNG3;GNB2;PTGER4;PRKAR1A;PLCB1;PPP1CA;S1PR1;CALCRL;GNAS;ADCY9;RGS20;P2RY12;AKT1;PPP3CB;AHCYL1;CAMKK1;RAMP1;GNG7;FZD2;PDE3B;PLPPR5;FGD4;ARHGEF9;TIAM1;SST;PLPPR1;HTR4;MTNR1A;PDE7B;FZD1;NPY;PPP2CA;PTRH2;CHGA;MAPK3;PDE7A;ACKR3;GNAQ;PPP1R1B;P2RY1;GNG10;SSTR4;AKT3;SSTR2;GPNMB;SOS1;SSTR1;GNAL;S1PR3;ACKR1;CXCL12;DGKI;GPR37;ARHGEF12;PRKCE;PROK2;RGS4;PRKACB;CALCB;F2RL2;RGS14
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,-0.3044341014008561,-1.25424957312943,0.11222444889779559,0.2057347468546076,0.999,17/71,20.56%,RHOB;ARHGEF4;GNG3;GNB2;GNG7;FGD4;ARHGEF9;TIAM1;GNG10;SOS1;ARHGEF12;PRPF38B;ROCK2;RHOA;ARHGEF26;GNG11;VAV3
gsea,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.4115570633532156,-1.2521163016887096,0.16593886462882096,0.20757655271438266,0.999,4/17,17.10%,CYP7B1;SYCP2;PTGIS;AMACR
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.36963546122202146,-1.2511643708988194,0.15280898876404495,0.20832485572005344,0.999,11/25,31.42%,B4GAT1;B4GALT6;B4GALT4;CHST1;B3GNT2;B3GNT7;CHST2;B4GALT5;B4GALT3;ST3GAL6;OGN
gsea,Growth Hormone Receptor Signaling R-HSA-982772,0.3985439195510046,1.2502971216535934,0.1806083650190114,1.0,1.0,7/20,15.44%,PRLR;SOCS2;ADAM17;STAT1;GHR;PTPN1;STAT5B
gsea,Other Semaphorin Interactions R-HSA-416700,-0.41458062153377606,-1.2458699247291662,0.177319587628866,0.21336523069009886,0.999,10/19,40.06%,SEMA5A;SEMA6D;TYROBP;ITGB1;PLXNA1;SEMA4A;CD72;PLXNA2;TREM2;SEMA7A
gsea,HATs Acetylate Histones R-HSA-3214847,-0.29409651547160437,-1.2452925776914772,0.12981744421906694,0.2137409844172716,0.999,41/82,40.12%,MORF4L2;H2AC25;H2BC4;MRGBP;RUVBL1;ING3;CLOCK;KAT7;TAF10;KANSL3;MORF4L1;H2BC21;KAT6B;DR1;KAT2B;BRD8;KAT6A;TADA1;ENY2;HAT1;ACTL6A;MEAF6;TADA2B;ZZZ3;JADE2;TAF9;SGF29;MBIP;SUPT7L;MCRS1;H2BC18;KANSL2;SAP130;KDELR2;ELP2;ATXN7L3;MSL3;KAT14;KANSL1;TADA2A;TADA3
gsea,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.4176587847984321,-1.2422327325367963,0.2086021505376344,0.21658453261697508,0.999,6/15,34.11%,TLR3;IKBKG;NKIRAS2;NKIRAS1;NFKB2;NFKB1
gsea,IGF1R Signaling Cascade R-HSA-2428924,-0.32433574467342885,-1.241085575212546,0.1656441717791411,0.21717319231577273,0.999,8/43,14.03%,FGFR2;HRAS;PDE3B;FGFR3;IGF1R;IRS2;SOS1;FGF1
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.32433574467342885,-1.241085575212546,0.1656441717791411,0.21717319231577273,0.999,8/43,14.03%,FGFR2;HRAS;PDE3B;FGFR3;IGF1R;IRS2;SOS1;FGF1
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.3402549744355241,-1.2406668708085231,0.15812917594654788,0.21733712495482377,0.999,6/33,15.59%,ORC4;ORC6;MCM6;RAD17;RPA3;ORC5
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.40181352572515816,1.2381209078180342,0.1928721174004193,1.0,1.0,6/21,8.74%,PTPRD;PTPRS;LRFN1;GRIN2D;MPP3;GRIA4
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.33976810201130364,-1.2374127677631634,0.15856236786469344,0.22044934593080462,0.999,11/37,21.36%,CDK4;ANAPC4;CDKN1B;CDC26;SKP2;RB1;ANAPC16;CCND1;TFDP2;CCNE2;UBE2E1
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.3511934129759717,-1.236921928242546,0.17316017316017315,0.22067990439053514,0.999,6/30,15.59%,ORC4;ORC6;MCM6;POLE3;RPA3;ORC5
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,-0.31063158593458856,-1.2365819774308444,0.14428857715430862,0.22070597508150125,0.999,24/58,33.58%,CALM1;GRIA2;CAMK2B;FKBP5;RNMT;SST;GAD1;HDAC1;TBL1XR1;IRAK1;GAD2;AGO3;HDAC2;FOXG1;TNRC6C;GPS2;GRIN2B;NOTCH1;CRH;CAMK2A;PTPN4;AGO2;GAMT;GPRIN1
gsea,RHOB GTPase Cycle R-HSA-9013026,-0.3121030932005702,-1.2363933021019566,0.16412213740458015,0.22065308150230448,0.999,13/65,17.59%,RHOB;SLK;ARHGAP5;SOWAHC;ERBIN;PKN2;VAMP3;STARD8;TFRC;CAV1;ARHGEF12;PRPF38B;ROCK2
gsea,SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.41401789740680095,-1.2317862065541167,0.17982456140350878,0.22536582066378688,0.999,6/16,29.43%,HRAS;SOS1;FGF1;FGF10;FGFR1;FGF9
gsea,RAC2 GTPase Cycle R-HSA-9013404,-0.29272769132260235,-1.2299310410400637,0.15900383141762453,0.2271343752185753,0.999,19/84,15.73%,LMAN1;NCKAP1;CYFIP1;ARMCX3;LAMTOR1;ERBIN;TIAM1;PKN2;VAMP3;ABI1;CYBA;ABI2;TFRC;DOCK10;SYDE1;CAV1;ESYT1;DOCK1;MTX1
gsea,GPER1 Signaling R-HSA-9634597,-0.33262430641820157,-1.2299193064471825,0.1710261569416499,0.2268424741700211,0.999,6/37,6.41%,GNG3;GNB2;PRKAR1A;GNAS;ADCY9;GNG7
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.32450584114014436,-1.228287032915536,0.1592356687898089,0.22840185276633396,0.999,22/40,44.84%,SUMO2;TPR;PCNA;TOP1;TOP2B;UBE2I;NUP54;NUP37;SUMO1;NUP43;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50;AURKA
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.3455365784619863,-1.2277505885041353,0.19878296146044624,0.22869303892840334,0.999,20/31,43.68%,RAN;TPR;GNL3;XPO1;NUP54;NUP37;BLOC1S6;NUP43;SEC13;NUP153;SEH1L;PBRM1;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Signaling To RAS R-HSA-167044,-0.39151191740836044,-1.2254061052287228,0.19921875,0.23087450182999564,0.999,2/18,2.71%,HRAS;RALA
gsea,HCMV Late Events R-HSA-9610379,-0.2900717006643305,-1.223166917021181,0.13800424628450106,0.23313087923931725,0.999,38/66,43.68%,CEBPD;CHMP2A;TPR;H2AC25;H2BC4;VPS4A;TXN2;HNRNPK;VPS36;VPS28;NUP54;NUP37;H2BC21;CHMP4C;VPS37D;NUP43;TSG101;CHMP1A;SEC13;NUP153;CHMP2B;CHMP4B;SNF8;SEH1L;H2BC18;MVB12A;NUP93;MVB12B;RANBP2;NDC1;NUP98;CHMP7;NUP35;NUP88;TRMU;POM121;HSD17B4;NUP50
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3283889688970888,-1.221543502312733,0.16851441241685144,0.234638457739296,1.0,14/38,31.84%,PCNA;POLD4;PNKP;POLE3;RPA3;FEN1;POLE4;MPG;TDG;PARG;RFC5;ADPRS;POLD3;LRIG1
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.30246088026723317,-1.2203737288828431,0.1468682505399568,0.23569694393224003,1.0,16/52,28.30%,HSP90AB1;CYP7B1;VDAC2;PTGES3;AURKAIP1;PTGS1;PTGIS;MAOB;FDX1;CMBL;FDX2;FDXR;AOC2;CYP1B1;CYB5B;BPHL
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.36765771978368483,-1.2197413502177268,0.19120458891013384,0.23606198999552575,1.0,11/29,31.33%,CALM1;CAMK2B;HDAC1;TBL1XR1;AGO3;HDAC2;FOXG1;TNRC6C;GPS2;CAMK2A;AGO2
gsea,Complement Cascade R-HSA-166658,-0.3475054081156056,-1.2162174612059644,0.18244803695150116,0.23954621839220888,1.0,8/31,18.07%,CD81;CLU;PSMA7;SERPING1;VTN;CR2;MASP1;CFHR2
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.35508011436960135,-1.213365007203997,0.19665271966527198,0.24244517255449283,1.0,7/26,17.36%,SUMO2;PIAS1;NR3C2;PPARA;NR5A2;THRA;UBE2I
gsea,GPCR Downstream Signaling R-HSA-388396,-0.23197056275858108,-1.212768378179686,0.09808612440191387,0.24287497259872537,1.0,73/426,17.59%,CALM1;GLP2R;P2RY14;PPP3CA;PPP3R1;DGKH;HRAS;NTSR2;CAMK2B;GRM1;RHOB;PPP2R1A;ARHGEF4;GNG3;GNB2;PTGER4;PRKAR1A;PLCB1;PPP1CA;CALCRL;GNAS;ADCY9;RGS20;P2RY12;AKT1;PPP3CB;AHCYL1;CAMKK1;RAMP1;GNG7;PDE3B;FGD4;ARHGEF9;TIAM1;SST;HTR4;MTNR1A;PDE7B;NPY;PPP2CA;PTRH2;CHGA;MAPK3;PDE7A;ACKR3;GNAQ;PPP1R1B;P2RY1;GNG10;SSTR4;AKT3;SSTR2;GPNMB;SOS1;SSTR1;GNAL;S1PR3;CXCL12;DGKI;GPR37;ARHGEF12;PRKCE;PROK2;RGS4;PRKACB;CALCB;F2RL2;RGS14;GPR37L1;PRPF38B;CDK5;NPY2R;ROCK2
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.3932498312949007,-1.2112233627127742,0.20656370656370657,0.24423800718673944,1.0,9/18,33.58%,GRIA2;FKBP5;RNMT;HDAC1;HDAC2;GRIN2B;NOTCH1;PTPN4;GPRIN1
gsea,Visual Phototransduction R-HSA-2187338,-0.2915273142111856,-1.211046624996173,0.1570796460176991,0.2441229157211406,1.0,22/65,28.55%,CALM1;APOE;SDC4;NAPEPLD;APOA1;METAP2;NMT1;RETSAT;AGRN;RNF7;STRA6;GUCY2F;SDC3;SLC24A1;RBP4;LRP12;GPC4;LPL;RLBP1;C1D;AKR1B10;RDH5
gsea,CDC42 GTPase Cycle R-HSA-9013148,-0.2777065532400941,-1.210645300406835,0.15702479338842976,0.24428720230873655,1.0,26/140,14.69%,WIPF3;KTN1;ARHGEF4;IQGAP2;BAIAP2;PARD6A;ARHGAP5;LAMTOR1;FGD4;ARHGEF9;TIAM1;PKN2;CDC42EP3;VAMP3;STARD8;WASL;TFRC;PREX2;DOCK10;YKT6;DOCK11;SYDE1;ARHGAP44;CDC42SE2;CAV1;ARHGEF12
gsea,Platelet Homeostasis R-HSA-418346,-0.29044831783900316,-1.206539849608322,0.1670061099796334,0.24888558015516485,1.0,10/75,11.66%,CALM1;PPP2R1A;GNG3;GNB2;GNAS;ATP2B1;GNG7;ORAI2;PPP2CA;GNG10
gsea,Purine Catabolism R-HSA-74259,-0.4110617381339319,-1.206515081548014,0.19393939393939394,0.2485983668174747,1.0,7/15,25.71%,NUDT5;NT5C;NUDT16;GDA;NUDT18;NUDT9;DNPH1
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.390194090682762,-1.2063505583440655,0.21372549019607842,0.2484856433157574,1.0,12/20,37.35%,PABPN1;CPSF6;FIP1L1;CSTF2T;PCF11;PAPOLA;NCBP2;CPSF2;NUDT21;CSTF1;CSTF3;WDR33
gsea,N-Glycan Antennae Elongation R-HSA-975577,-0.4069394768810049,-1.2053973395245985,0.22444889779559118,0.24931763552370506,1.0,6/15,29.50%,B4GALT6;B4GALT4;ST8SIA3;B4GALT5;B4GALT3;ST6GAL1
gsea,Notch-HLH Transcription Pathway R-HSA-350054,-0.3525290783047668,-1.2052818227857072,0.19019607843137254,0.24912752771202293,1.0,8/28,23.69%,MAML2;HDAC11;MAML3;SNW1;HDAC1;TBL1XR1;KAT2B;HDAC2
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.38578876790018085,-1.2021966653116294,0.23170731707317074,0.2523843957532592,1.0,6/19,17.93%,ALG2;ALG11;EGFL7;MPDU1;RFT1;ALG13
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.3431577901306103,-1.200737256887985,0.22661122661122662,0.25382786546992264,1.0,10/30,25.44%,TECR;ACSL3;HSD17B8;HACD4;HACD2;ACSL4;HSD17B12;ACSL6;ACLY;ACSBG1
gsea,Costimulation By CD28 Family R-HSA-388841,-0.31248969079195466,-1.200444010188704,0.18127490039840638,0.2538151427132812,1.0,7/47,12.66%,PPP2R1A;AKT1;YES1;PKN2;MLST8;PPP2CA;AKT3
gsea,IRS-mediated Signaling R-HSA-112399,-0.3233120442465042,-1.2003663907145925,0.1738241308793456,0.25356602533722594,1.0,7/39,14.03%,FGFR2;HRAS;PDE3B;FGFR3;IRS2;SOS1;FGF1
gsea,RAC3 GTPase Cycle R-HSA-9013423,-0.287439474412888,-1.1993783804663392,0.19246031746031747,0.25437764215769165,1.0,20/88,15.27%,BAIAP2;LMAN1;NCKAP1;CYFIP1;ARHGAP5;WASF1;LAMTOR1;ERBIN;TIAM1;PKN2;VAMP3;ABI1;CYBA;ABI2;TFRC;DOCK10;YKT6;SYDE1;CAV1;ESYT1
gsea,DNA Strand Elongation R-HSA-69190,-0.3415735593302226,-1.1981149871080776,0.18120805369127516,0.2555040478152986,1.0,13/31,32.96%,PCNA;POLD4;MCM6;RPA3;FEN1;GINS4;GINS2;RFC5;GINS1;MCM7;POLD3;LRIG1;MCM4
gsea,HCMV Infection R-HSA-9609646,-0.26830584004589847,-1.1972270208835591,0.1488469601677149,0.2562718288533418,1.0,50/95,43.03%,DYNLL1;DYNLL2;CEBPD;CHMP2A;TPR;H2AC25;H2BC4;VPS4A;TXN2;HNRNPK;TRIM28;VPS36;DUT;VPS28;TBL1XR1;NUP54;NUP37;H2BC21;CHMP4C;EZH2;VPS37D;NUP43;ITGB1;DYNC1I2;GPS2;TSG101;CHMP1A;SEC13;NUP153;CHMP2B;CHMP4B;SNF8;SEH1L;NFKB1;H2BC18;MVB12A;NUP93;EGFR;MVB12B;RANBP2;NDC1;NUP98;CBX1;CHMP7;SUZ12;NUP35;NUP88;TRMU;POM121;HSD17B4
gsea,HS-GAG Biosynthesis R-HSA-2022928,0.3545404364447072,1.1969741960338307,0.22666666666666666,1.0,1.0,8/28,7.89%,GPC6;HS6ST3;HS6ST1;HS3ST2;EXT1;GPC3;NDST2;GPC1
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.291861867548734,-1.194636566804701,0.18969072164948453,0.2590687891750665,1.0,17/62,22.23%,DPM2;SLC35A1;DOLK;DPM1;DPM3;PMM1;NAGK;ALG5;NUS1;FUOM;EGFL7;ST6GALNAC2;NANP;ST8SIA3;GNPNAT1;GMDS;GFPT1
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.36162475717039305,-1.194461683857081,0.20042194092827004,0.258961345407491,1.0,5/24,12.70%,SLC6A15;SLC7A6;SLC7A10;SLC7A5;SLC16A10
gsea,RHOA GTPase Cycle R-HSA-8980692,-0.2701245285262945,-1.1943320992447604,0.16424116424116425,0.25880285645700474,1.0,28/139,20.56%,KTN1;ARHGEF4;SLK;LMAN1;C1QBP;ARHGAP5;ABCD3;SOWAHC;ERBIN;TIAM1;PKN2;VAMP3;STARD8;MACO1;CCDC115;TFRC;PREX2;YKT6;ARHGAP44;CAV1;ARHGEF12;PRPF38B;ROCK2;TMEM87A;RHOA;SCFD1;ACBD5;VAV3
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.38829855178456735,-1.1917462320790313,0.22334004024144868,0.26146135590924413,1.0,5/19,21.32%,CHST9;CSPG5;BCAN;CHST15;CHPF
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.28540634385598995,-1.1902862283212152,0.16740088105726872,0.26274556721008313,1.0,10/64,10.58%,VAMP2;PLA2G7;SPCS2;ATP6AP2;CPE;EXOC3;SPCS1;INHBA;CHGA;SPCS3
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.3697762197216302,-1.1900016203865307,0.2290836653386454,0.2627508315363839,1.0,8/21,25.44%,TECR;ACSL3;HACD4;HACD2;ACSL4;HSD17B12;ACSL6;ACSBG1
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.3508729847439449,-1.1893274110979168,0.21887550200803213,0.26325451396220045,1.0,9/29,22.48%,CALM1;CAMK2B;RANGRF;SCN3B;FGF11;SCN2A;SCN3A;CACNA2D2;SCN1B
gsea,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.3450323866275711,-1.188766018808476,0.22737306843267108,0.26353836827880367,1.0,4/26,13.21%,HMGB1;TLR3;NDUFA2;IKBKG
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,-0.3703709343271337,-1.1884180197007255,0.20582120582120583,0.2637002409892289,1.0,7/22,21.96%,H2AZ1;H2AJ;H2BC4;H2AZ2;H2AX;H2BC21;EZH2
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.39413035341247915,-1.187363052026726,0.21775898520084566,0.2646222433197122,1.0,10/18,32.60%,MAML2;ACTA2;MAML3;SNW1;HEY1;HES5;KAT2B;SMAD3;NOTCH1;MAMLD1
gsea,RHOC GTPase Cycle R-HSA-9013106,-0.29265814155765957,-1.187056494939914,0.19161676646706588,0.26466863523793555,1.0,15/69,20.36%,SLK;LMAN1;C1QBP;ARHGAP5;ABCD3;ERBIN;PKN2;VAMP3;MACO1;TFRC;CAV1;ARHGEF12;ROCK2;RHOA;ACBD5
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.371080472501988,-1.1860731818174908,0.24380165289256198,0.2655339218196334,1.0,6/21,16.30%,NOP10;RUVBL1;DKC1;TERF1;PPP6C;NHP2
gsea,Syndecan Interactions R-HSA-3000170,-0.39490438236681225,-1.185576425020263,0.2624254473161034,0.26572864251203876,1.0,10/18,38.08%,SDC4;TRAPPC4;VTN;SDC3;ITGB1;TGFB1;CASK;ACTN1;ITGAV;ITGA6
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.3739195347928651,-1.179596004562827,0.2484472049689441,0.27280301183894595,1.0,8/22,21.83%,MAML2;MAML3;SNW1;HEY1;FABP7;WWC1;HES5;KAT2B
gsea,Glycosphingolipid Metabolism R-HSA-1660662,0.3304937253416766,1.1793294613833927,0.218,1.0,1.0,11/35,10.42%,HEXB;CERK;GLB1L;B3GALNT1;NEU2;SMPD3;GLB1;ASAH1;SUMF2;ARSG;ARSK
gsea,Metabolism Of Steroid Hormones R-HSA-196071,-0.36922708572471685,-1.178402982359567,0.2532467532467532,0.2739844836584318,1.0,14/22,46.02%,CHGA;FDX1;HSD17B12;STARD6;FDX2;FDXR;STARD3NL;STARD4;HSD11B1;SRD5A2;POMC;CYP19A1;SRD5A3;HSD17B11
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.3721535381097988,-1.1760984019129204,0.25667351129363447,0.27639851808580956,1.0,7/23,17.86%,CCT7;TXNL1;TRA2B;CCT2;RNF20;ROCK2;RBM15
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.27954661033682215,-1.1756279354610562,0.19402985074626866,0.27661938722212415,1.0,11/72,10.64%,CEBPD;MED28;CEBPB;NR2F2;MED9;CDK4;MED30;MED19;MED10;MED8;PPARA
gsea,Regulation Of Complement Cascade R-HSA-977606,-0.3594104524716041,-1.175112694811531,0.2546728971962617,0.27694280317455805,1.0,7/26,18.07%,CD81;CLU;PSMA7;SERPING1;VTN;CR2;CFHR2
gsea,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.4072376089238655,-1.1709054169170756,0.2694610778443114,0.28150884937670473,1.0,3/15,4.08%,AP2M1;CLTA;CLTB
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.32496563032250414,-1.1704810073476066,0.24380165289256198,0.28170573317370307,1.0,18/31,43.68%,RAN;TPR;RANBP1;XPO1;NUP54;NUP37;NUP43;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.26738418021894417,-1.1695680609683161,0.18637274549098196,0.28235359116149816,1.0,15/89,14.03%,FGFR2;GSK3B;RPS6KB2;AKT1;TGFA;RNMT;PDGFRA;MLST8;CDKN1B;FGFR3;IRS2;NRG2;AKT3;SOS1;FGF1
gsea,Nuclear Import Of Rev Protein R-HSA-180746,-0.3285923249889571,-1.1694975174467446,0.23481781376518218,0.2820837079230931,1.0,18/30,43.68%,NPM1;RAN;TPR;NUP54;NUP37;NUP43;SEC13;NUP153;KPNB1;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.34489793280427217,-1.1691332950473643,0.248,0.28216238028623697,1.0,10/27,26.79%,NDUFAB1;PDHX;GLDC;GCSH;DBT;HOGA1;DDO;GOT2;PDHB;GRHPR
gsea,Potassium Channels R-HSA-1296071,-0.27759611056886485,-1.1690374296701507,0.20851063829787234,0.28194100505142883,1.0,19/87,19.60%,KCNA1;GNG3;KCNA2;GNB2;KCNA3;GNG7;KCNJ3;KCNF1;KCNG2;KCNS3;GNG10;KCNJ10;KCNJ4;KCNK1;KCNAB2;KCND2;KCNN3;KCNV1;GNG11
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.3369824102977095,-1.168225538116045,0.2329896907216495,0.28264238176292217,1.0,2/26,4.30%,CALM1;PLCB1
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.3047091149017065,-1.167015659124513,0.2150101419878296,0.28377405117888826,1.0,8/44,14.03%,FGFR2;HRAS;PDE3B;MAPK3;FGFR3;IRS2;SOS1;FGF1
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.3906674462197668,-1.1634214560489455,0.26899383983572894,0.2879376464742436,1.0,6/20,9.65%,PPFIA2;IL1RAPL1;IL1RAP;NTRK3;SLITRK4;SLITRK2
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.35207228866073104,-1.1624328497671197,0.24086021505376345,0.28880418813294223,1.0,4/24,14.03%,FGFR2;HRAS;SOS1;FGF1
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.3741048257299409,-1.1616530466796895,0.26141078838174275,0.2894178886861551,1.0,11/18,38.75%,PCNA;POLD4;TERF1;RPA3;FEN1;POLD3;BLM;LRIG1;WRN;TERF2IP;POLD2
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.32821659524904395,-1.161558587128417,0.24081632653061225,0.289186806569479,1.0,19/31,43.68%,SUMO2;TPR;TOPORS;UBE2I;NUP54;NUP37;SUMO1;NUP43;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.28459634224273755,-1.1595395848697663,0.22920892494929007,0.2914098169128837,1.0,13/71,18.77%,CALM1;ATP5PB;CYCS;MICOS10;MICOS13;HSPA9;SIRT3;PPARA;SSBP1;MTX1;CHD9;TBL1XR1;MTX2
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.3150691243505753,-1.1561018493830753,0.27091633466135456,0.295672546285306,1.0,22/37,43.68%,PABPN1;TPR;GNL3;ISG15;KPNA3;KPNA1;KPNA4;NUP54;NUP37;NUP43;SEC13;NUP153;KPNB1;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.2565711622405488,-1.1552992776107434,0.18502202643171806,0.2963453366408996,1.0,13/91,9.65%,GLP2R;GNG3;GNB2;PTGER4;PRKAR1A;CALCRL;GNAS;ADCY9;RAMP1;GNG7;HTR4;PTRH2;CHGA
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.3571227669283405,-1.154540329924766,0.24472573839662448,0.2969577071473902,1.0,4/21,14.03%,HRAS;FGFR3;SOS1;FGF1
gsea,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.3784062871078637,-1.1544294700835107,0.26609442060085836,0.29674928038652204,1.0,10/18,43.32%,HRAS;SOS1;FGF1;FGF10;FGFR1;FGF9;PTPN11;FGF23;FRS3;KL
gsea,Signaling By WNT In Cancer R-HSA-4791275,-0.33135433900323225,-1.154059856844587,0.2570194384449244,0.2968602381293678,1.0,10/29,30.42%,PPP2R1A;GSK3B;CTBP2;PPP2CA;CTBP1;CTNNB1;TNKS;TCF7L2;FZD8;LRP6
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.32846793516491396,-1.148366925649224,0.24688796680497926,0.3039915345952148,1.0,10/27,32.01%,SYCP2;NUDT19;ACOX1;AMACR;ACBD5;CROT;PECR;ECI2;MLYCD;ACOX2
gsea,Surfactant Metabolism R-HSA-5683826,-0.3819201431999934,-1.14708822080313,0.2585812356979405,0.30522067961211746,1.0,12/16,47.75%,CCDC59;TTF1;LMCD1;ADORA2B;CSF2RA;ADRA2A;ZDHHC2;NAPSA;ADGRF5;ADRA2C;CTSH;ADORA2A
gsea,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.36100986409919444,-1.146477535161803,0.2679738562091503,0.30573899634103074,1.0,5/21,17.41%,CALM1;METAP2;NMT1;RNF7;GUCY2F
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.29979628354184557,1.1462912506863006,0.24169741697416974,1.0,1.0,13/51,9.02%,GPC6;HS6ST3;HS6ST1;GLB1L;HS3ST2;DCN;EXT1;GPC3;HPSE;NDST2;GLB1;GPC1;HPSE2
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.38420742935404545,1.14486669213109,0.2804642166344294,1.0,1.0,9/17,24.40%,CUX1;STAT1;MYO18A;GAB2;STAT5B;LRRFIP1;PIK3CA;TRIM24;GRB2
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.3127705705433225,-1.1395879265100766,0.2818371607515658,0.3144011269794209,1.0,14/36,30.26%,APOE;SDC4;APOA1;RETSAT;AGRN;SDC3;RBP4;LRP12;GPC4;LPL;TTPA;C1D;AKR1B10;LDLR
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.34660256420476726,-1.1381530154089479,0.2925311203319502,0.3160138524375402,1.0,5/24,13.21%,RACK1;SHARPIN;BIRC2;TNFRSF1A;IKBKG
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.3543206109611349,-1.1378783998806288,0.27405857740585776,0.31603297865153945,1.0,13/23,40.81%,NPY;SIRT3;HDAC1;HDAC2;FOXO1;SMAD4;SMAD3;ATXN3;SMAD2;FBXO32;AGRP;POMC;FOXO4
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.3749069073946141,-1.136937728781299,0.2668112798264642,0.31694239154194587,1.0,8/19,28.01%,ANAPC4;CDC26;SKP2;RB1;ANAPC16;UBE2E1;ANAPC10;ANAPC7
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.32265302141199387,1.1346030564207932,0.2637571157495256,1.0,1.0,8/30,18.27%,HTR7;HRH4;ADRA1A;HTR1D;CHRM2;DRD1;ADRA1B;ADRB1
gsea,L1CAM Interactions R-HSA-373760,0.26741105248294084,1.134525246633676,0.25201612903225806,1.0,1.0,21/90,11.87%,SPTBN4;SCN8A;ANK3;DNM1;L1CAM;SPTAN1;ANK2;KCNQ2;NFASC;DCX;SPTBN5;DNM2;SCN5A;MPP3;RPS6KA2;ALCAM;KCNQ3;AP2A1;RPS6KA5;DNM3;SCN1A
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.2509321477602475,-1.1309075160284672,0.2330316742081448,0.32485677732365187,1.0,35/104,34.43%,GPHN;CD38;THTPA;GSTO1;NAXE;RFK;AASDHPPT;PNPO;PTGIS;AOX1;NAXD;PDZD11;MTHFD1;NADK2;PDXK;SLC25A16;MMAB;PARP6;SLC19A2;NNMT;FLAD1;NUDT12;PANK3;LMBRD1;MTHFD2;CD320;PARP16;MOCS3;MCCC2;ENPP1;PARP10;MOCS2;SLC46A1;MMUT;PANK2
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.3243841893317981,-1.1294732364968265,0.29958677685950413,0.3264721249406371,1.0,20/31,43.68%,TPR;GNL3;KPNA1;NUP54;NUP37;BLOC1S6;NUP43;SEC13;NUP153;KPNB1;SEH1L;PBRM1;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Signal Transduction By L1 R-HSA-445144,-0.36727947938776356,-1.1251295573367999,0.2874251497005988,0.33219704072548145,1.0,7/19,26.44%,CSNK2B;MAPK3;MAPK1;MAP2K1;ITGA9;ITGB1;FGFR1
gsea,G Alpha (S) Signaling Events R-HSA-418555,-0.24213629592050892,-1.124974719120914,0.23620309050772628,0.33202291017966035,1.0,17/113,11.66%,GLP2R;GNG3;GNB2;PTGER4;PRKAR1A;CALCRL;GNAS;ADCY9;RAMP1;GNG7;PDE3B;HTR4;PDE7B;PTRH2;CHGA;PDE7A;GNG10
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.3311324121653696,-1.1220808238754594,0.30515463917525776,0.3358002276069638,1.0,15/26,42.73%,RAN;AHCTF1;UBE2I;NUP54;NUP37;SUMO1;NUP43;SEC13;KPNB1;SEH1L;NUP93;NDC1;NUP98;NUP35;POM121
gsea,Nucleotide Salvage R-HSA-8956321,-0.35205983306598937,-1.1218157645223017,0.2975206611570248,0.33583446893577223,1.0,6/20,16.10%,UCKL1;ADK;SCO2;APRT;DGUOK;GMPR2
gsea,Drug ADME R-HSA-9748784,-0.297731142640019,-1.121248984658878,0.2879120879120879,0.33623281013425665,1.0,11/42,20.85%,NME2;BSG;GSTM1;GSTP1;TPMT;GUK1;CNDP2;ABCC4;ACY1;VAV3;GMPS
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.29096547064386136,-1.1163481170895175,0.2740286298568507,0.34290820647077574,1.0,16/52,26.44%,PRNP;HRAS;COL4A2;GFRA4;MAPK3;AGRN;COL6A1;CACNB3;SOS1;CACNA1H;MAPK1;COL4A1;PTK2;ST8SIA4;COL4A5;FGFR1
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.3643736940630388,-1.1161502410802626,0.32040816326530613,0.3427773910120701,1.0,9/19,32.60%,MAPK3;TYK2;DUSP6;DUSP7;MAPK1;MAP2K1;IL6ST;DUSP12;PTPN11
gsea,Signaling By SCF-KIT R-HSA-1433557,0.30611154727729945,1.115071658251881,0.28542914171656686,1.0,1.0,22/38,24.98%,SH2B2;TEC;CBL;PIK3R2;STAT1;PRKCA;FES;KIT;LCK;CHEK1;GAB2;GRB7;STAT5B;FYN;MMP9;PIK3CA;SRC;JAK2;VAV1;GRB2;FER;GRAP2
gsea,Regulation Of Signaling By CBL R-HSA-912631,0.3864694199889446,1.1148862441924332,0.3360488798370672,1.0,1.0,10/18,24.40%,CRKL;CBL;PIK3R2;HCK;CRK;RAPGEF1;FYN;PIK3CA;VAV1;GRB2
gsea,RHOU GTPase Cycle R-HSA-9013420,-0.30980976048649483,-1.113565064609655,0.27533460803059273,0.34602751909391577,1.0,6/38,7.65%,PTK2B;PARD6A;NCK1;TXNL1;STAM2;PKN2
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.38926686950330064,-1.1100261664803384,0.35368421052631577,0.35077918406738945,1.0,12/15,43.33%,LSM4;LSM7;DCP2;DCP1A;LSM2;LSM3;EDC4;PATL1;DDX6;LSM5;LSM1;LSM6
gsea,Tight Junction Interactions R-HSA-420029,-0.3649813467022095,-1.1096956532002145,0.3201581027667984,0.3508570346580138,1.0,4/17,11.89%,PARD6A;CLDN10;PRKCI;CLDN5
gsea,GPCR Ligand Binding R-HSA-500792,-0.21375194614390303,-1.1096240150841485,0.19461077844311378,0.3505205067376907,1.0,39/261,16.40%,PLPPR4;GLP2R;P2RY14;NTSR2;GRM1;GNG3;GNB2;PTGER4;S1PR1;CALCRL;GNAS;P2RY12;RAMP1;GNG7;FZD2;PLPPR5;SST;PLPPR1;HTR4;MTNR1A;FZD1;NPY;PTRH2;CHGA;ACKR3;P2RY1;GNG10;SSTR4;SSTR2;GPNMB;SSTR1;S1PR3;ACKR1;CXCL12;GPR37;PROK2;CALCB;F2RL2;GPR37L1
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.31374614467543943,-1.1088027706386543,0.300796812749004,0.3511675970748205,1.0,19/34,40.51%,CBX6;SCMH1;CBFB;CSNK2B;SMARCC2;PHC3;ACTL6B;SMARCE1;YAF2;SMARCD2;CBX4;ACTL6A;RING1;PBRM1;SMARCD1;SMARCB1;SMARCA2;HIPK2;CBX8
gsea,HS-GAG Degradation R-HSA-2024096,0.3548703633082888,1.1071721136189752,0.31176470588235294,1.0,1.0,7/20,9.02%,GPC6;GLB1L;GPC3;HPSE;GLB1;GPC1;HPSE2
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.3776005134754656,1.105628170421728,0.322,1.0,1.0,3/16,4.07%,PI4K2B;VAC14;PIKFYVE
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.27992490569591344,-1.1049526540500916,0.28270042194092826,0.35623734008056507,1.0,18/53,33.76%,RAN;SAR1B;INSIG2;NFYA;GPAM;PPARA;CHD9;TBL1XR1;SEC24A;MBTPS1;GGPS1;HMGCS1;INSIG1;SEC23A;NFYB;KPNB1;SEC24D;SC5D
gsea,Platelet Sensitization By LDL R-HSA-432142,-0.37294981791632537,-1.1048240627018722,0.3379721669980119,0.35598678960688845,1.0,2/16,9.36%,PPP2R1A;PPP2CA
gsea,Blood Group Systems Biosynthesis R-HSA-9033658,-0.3693936733737832,-1.1037633005693035,0.3158995815899582,0.3570736806505665,1.0,8/15,32.28%,B3GALT1;B3GALT2;FUT7;B3GALT5;FUT2;ST3GAL6;FUT9;B4GALNT2
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.2934726923377975,-1.1033670695628424,0.29310344827586204,0.3572367251118445,1.0,9/43,19.94%,PLPP3;DEGS1;ACER3;PRKD1;ORMDL2;CERS2;VAPA;SAMD8;SGMS1
gsea,FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.3712302926035925,-1.1031547723147601,0.3248407643312102,0.3571494623939419,1.0,3/16,14.03%,HRAS;SOS1;FGF1
gsea,Retinoid Metabolism And Transport R-HSA-975634,-0.30846020412519715,-1.093323120040644,0.3090128755364807,0.3713475361090309,1.0,13/32,30.26%,APOE;SDC4;APOA1;RETSAT;AGRN;SDC3;RBP4;LRP12;GPC4;LPL;C1D;AKR1B10;LDLR
gsea,Phototransduction Cascade R-HSA-2514856,-0.3435623414463607,-1.0923602544589,0.32142857142857145,0.3723565947735035,1.0,6/22,21.08%,CALM1;METAP2;NMT1;RNF7;GUCY2F;SLC24A1
gsea,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.35722616435979226,-1.0923186325217715,0.3499005964214712,0.37197096332711144,1.0,2/16,5.25%,BPNT2;SULT4A1
gsea,Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.3741616848381309,1.0917499499434538,0.32342657342657344,1.0,1.0,7/17,16.25%,OR1L4;OR4K5;OR52E5;LDB2;OR4K15;OR52K2;OR52B2
gsea,G Alpha (Z) Signaling Events R-HSA-418597,-0.29138921127235873,-1.089220027845016,0.3240343347639485,0.3761742338017367,1.0,9/42,15.28%,GNG3;GNB2;GNAS;ADCY9;RGS20;GNG7;GNG10;PRKCE;RGS4
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.28295291733604255,-1.084106276221795,0.32224532224532226,0.3837779194902199,1.0,27/50,41.47%,SUMO2;TPR;PIAS1;SCMH1;CHD3;PHC3;UBE2I;HDAC1;NUP54;NUP37;SUMO1;HDAC2;NUP43;CBX4;SEC13;NUP153;RING1;PCGF2;SEH1L;NUP93;RANBP2;NDC1;NUP98;CBX8;SUZ12;NUP35;NUP88
gsea,Heme Signaling R-HSA-9707616,0.30086687482515784,1.081758970245651,0.33739837398373984,1.0,1.0,5/39,2.34%,NPAS2;EP300;RXRA;MEF2C;RORA
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.3140498741569854,-1.0783923382058036,0.3531827515400411,0.3919185483870234,1.0,15/26,47.06%,HRAS;SOS1;FGF1;FGF10;FGFR1;FGF9;FLRT3;PTPN11;FGF23;FRS3;PIGU;KL;FLRT1;FGF20;PIK3R1
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.3709462867846352,-1.0756431328802085,0.35699797160243407,0.3955786209278314,1.0,6/16,20.99%,AP2M1;AP1S1;ATP6V1H;B2M;AP2S1;AP2B1
gsea,SLC Transporter Disorders R-HSA-5619102,-0.2572503925341624,-1.0749225852273077,0.34415584415584416,0.3963313717869933,1.0,26/72,37.79%,SLC1A3;BSG;TPR;SLC35A1;SLC4A4;SLC24A5;SLC35A3;MAP4K5;NUP54;NUP37;SLC24A1;SLC9A9;NUP43;SLC2A9;SEC13;SLC11A2;NUP153;SLC17A8;SLC16A1;SLC5A5;SEH1L;SLC12A6;NUP93;SLC22A5;RANBP2;NDC1
gsea,Collagen Chain Trimerization R-HSA-8948216,0.30052342919989755,1.0726206407941712,0.3595706618962433,1.0,1.0,9/42,9.16%,COL13A1;COL24A1;COL8A1;COL28A1;COL26A1;COL7A1;COL6A3;COL14A1;COL3A1
gsea,RND1 GTPase Cycle R-HSA-9696273,-0.2887848014930139,-1.070432817981114,0.3416149068322981,0.40289534800416393,1.0,6/39,10.27%,TMEM59;RASAL2;CCDC88A;ARHGAP5;TXNL1;TFRC
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.3359117938527501,-1.0700062626805877,0.3360488798370672,0.4031370221994344,1.0,7/22,20.99%,AP2M1;AP1S1;PKN2;ATP6V1H;B2M;AP2S1;AP2B1
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.32657043309232714,-1.064373963967327,0.3477366255144033,0.4114290054771505,1.0,8/23,21.78%,BHLHE41;PPARA;CLOCK;BHLHE40;NOCT;CHD9;TBL1XR1;KLF15
gsea,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.354305046162233,-1.0639402022830637,0.3634408602150538,0.41160408516857266,1.0,5/16,22.48%,GRM1;SCN2A;SCN3A;PLCB2;SCN1B
gsea,Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.35960816334093004,-1.0595636657440282,0.378099173553719,0.4180924710355465,1.0,4/16,11.85%,SPOCK3;FURIN;MMP16;MMP15
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.28593987845968943,-1.059215389871134,0.37475728155339805,0.4181431241711459,1.0,17/39,38.08%,SDC4;TRAPPC4;AGRN;LAMA5;LAMA2;VTN;SDC3;LAMA1;ITGB1;TGFB1;LAMB1;PDGFA;CASK;ACTN1;DDR2;ITGAV;ITGA6
gsea,RAC1 GTPase Cycle R-HSA-9013149,-0.24028928321649348,-1.0587568412735116,0.3463917525773196,0.41846150833122214,1.0,30/166,15.60%,WIPF3;KTN1;ARHGEF4;IQGAP2;BAIAP2;PARD6A;NCKAP1;CYFIP1;ARHGAP5;WASF1;LAMTOR1;ERBIN;TIAM1;PKN2;VAMP3;ABI1;WASL;CYBA;ARHGAP12;ABI2;TFRC;PREX2;DOCK10;YKT6;DOCK11;ARHGAP44;SOS1;CAV1;ESYT1;DOCK1
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.300346257180837,-1.0582330272936178,0.37448559670781895,0.41884380235714286,1.0,20/31,46.61%,PSIP1;TPR;BANF1;KPNA1;NUP54;NUP37;NUP43;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50;NUP62;SGIP1
gsea,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.3641804699569311,-1.0547965276880236,0.39139344262295084,0.4239439306930565,1.0,8/15,33.78%,PCNA;GADD45A;E2F4;TFDP2;RBL1;PRMT1;RBL2;BAX
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.3513616997026221,-1.0535974829812902,0.37872340425531914,0.42530206126574377,1.0,10/16,41.90%,PCNA;POLD4;TERF1;RPA3;FEN1;POLD3;WRN;TERF2IP;POLD2;TINF2
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,-0.2627889520375954,-1.0514927437513755,0.3711967545638945,0.4283166168456172,1.0,25/86,20.86%,LRRTM1;GRM1;LIN7C;PPFIA2;LIN7B;SHARPIN;IL1RAPL1;IL1RAP;NTRK3;LRRTM2;SLITRK4;SLITRK2;LRRTM4;RTN3;NLGN3;APBA3;SYT7;PDLIM5;GRIA3;HOMER3;SLITRK6;LRFN4;PPFIBP1;SIPA1L1;GRIN2C
gsea,Neurexins And Neuroligins R-HSA-6794361,0.27264849226995874,1.0469964048938623,0.4148296593186373,1.0,1.0,15/55,8.59%,SHANK1;DLGAP4;APBA1;DLGAP3;STX1A;MPP2;SYT9;SYT1;NLGN1;SHANK3;GRIN2D;EPB41L2;MPP3;STXBP1;EPB41L3
gsea,Other Interleukin Signaling R-HSA-449836,-0.34632243090179915,-1.0461294692021823,0.3831417624521073,0.43646356170547584,1.0,5/18,21.24%,VAMP2;SNAP25;TYK2;PTPRZ1;IL16
gsea,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.32208342584650806,-1.042244121265176,0.3874458874458874,0.44228195909256174,1.0,3/21,6.91%,F3;C1QBP;SERPING1
gsea,RHOJ GTPase Cycle R-HSA-9013409,-0.27374239701093256,-1.0371168613822308,0.39662447257383965,0.4501524409214098,1.0,10/52,14.40%,GJA1;ARHGAP5;LAMTOR1;PKN2;VAMP3;WASL;SLC4A7;TFRC;SYDE1;CAV1
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,-0.34729520349452264,-1.0304029393659104,0.4074074074074074,0.461076247831391,1.0,3/16,13.44%,HRAS;NTRK3;SOS1
gsea,Paracetamol ADME R-HSA-9753281,-0.33721029168969163,-1.0265285185208324,0.4130879345603272,0.4673892645743522,1.0,5/16,20.24%,GSTM1;GSTP1;CNDP2;ABCC4;ACY1
gsea,RND2 GTPase Cycle R-HSA-9696270,-0.2689725524648725,-1.023416725755458,0.4369918699186992,0.4723595076683423,1.0,7/39,14.40%,KTN1;KCTD13;ARHGAP5;TXNL1;TFRC;NUDC;CAV1
gsea,RHOV GTPase Cycle R-HSA-9013424,-0.2878613531137665,-1.0190906056724665,0.4271653543307087,0.4793500661952832,1.0,6/34,9.37%,PARD6A;NCK1;TXNL1;PKN2;WASL;ARHGAP12
gsea,Sphingolipid Metabolism R-HSA-428157,-0.24136498298992717,-1.0173834606214776,0.43073593073593075,0.4817372817767463,1.0,19/78,21.02%,PLPP3;DEGS1;ACER3;ARSJ;PRKD1;SMPD4;UGCG;GM2A;EGFL7;GALC;ESYT1;ORMDL2;CERS2;VAPA;CPTP;SAMD8;SMPD2;SGMS1;SUMF1
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.307990423859705,-1.0153828962721474,0.44349680170575695,0.48462027407224467,1.0,6/23,24.16%,PPP2R1A;PPP2CA;XPO1;CCNH;MNAT1;PPME1
gsea,RORA Activates Gene Expression R-HSA-1368082,0.34564574891793065,1.0146941632007331,0.42718446601941745,1.0,1.0,5/18,13.10%,EP300;RXRA;RORA;SREBF1;NCOA6
gsea,Extension Of Telomeres R-HSA-180786,-0.25467284469294704,-1.014171622910893,0.40380549682875266,0.4861394466319832,1.0,9/47,16.30%,NOP10;PCNA;POLD4;RUVBL1;DKC1;TERF1;PPP6C;RPA3;NHP2
gsea,Sensory Perception R-HSA-9709957,0.21319807591758735,1.0108122234042132,0.41396933560477,1.0,1.0,35/170,9.80%,CDH23;PCDH15;PDE6A;GPC6;ADCY8;SPTAN1;BSN;SCNN1G;TWF2;PDE6G;STX1A;OR1L4;KCNMA1;RCVRN;GPC3;TRPM4;SYN1;RDH16;OR4K5;RIPOR2;OR52E5;MYO7A;GRK4;PRKCA;RIMBP2;CLIC5;GPC1;LDB2;EPB41L3;CHRNA9;GRM4;FNTA;ANO2;OR4K15;BCO1
gsea,Sensory Processing Of Sound R-HSA-9659379,0.2463217148970633,1.0072977383893575,0.4223968565815324,1.0,1.0,13/65,8.68%,CDH23;PCDH15;SPTAN1;BSN;TWF2;STX1A;KCNMA1;SYN1;RIPOR2;MYO7A;CLIC5;EPB41L3;CHRNA9
gsea,Signaling By BMP R-HSA-201451,-0.3103756885405969,-1.0060455785986344,0.45493562231759654,0.4998139814845461,1.0,10/24,30.62%,UBE2D3;BMPR1B;BMPR1A;ACVR2A;GREM2;BMPR2;FSTL1;SMAD4;SKI;SMAD6
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,-0.2803440543274378,-1.00528269978699,0.43775933609958506,0.5006329781566611,1.0,12/35,28.01%,CEBPB;ANAPC4;CDC26;ANAPC16;CTNNB1;CCND1;AGO3;UBE2E1;TNRC6C;ANAPC10;TCF7L2;ANAPC7
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,-0.26532024715712116,-1.0052226789738223,0.4407114624505929,0.5001763784349297,1.0,11/51,21.23%,MAGED1;ARHGEF4;FGD4;ARHGEF9;TIAM1;SOS1;ARHGEF12;PRPF38B;ARHGEF26;VAV3;BAD
gsea,PI-3K cascade:FGFR2 R-HSA-5654695,-0.32823171034520593,-1.0035033814412448,0.4346938775510204,0.5025648189374068,1.0,11/18,47.99%,FGFR2;FGF1;FGF10;FGF9;PTPN11;FGF7;FGF23;PIGU;FGF20;PIK3R1;FGF18
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.33967663182169183,-1.001382710450215,0.44490644490644493,0.5058233716807236,1.0,10/15,40.99%,NFYA;CITED2;BBC3;FOXO1;BCL6;DDIT3;NFYB;PINK1;FOXO4;STK11
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.24682422236269239,-0.9948945784762964,0.455531453362256,0.5169457078334629,1.0,16/57,31.52%,BSG;COL4A2;ICAM5;ITGA7;AGRN;VTN;ITGA4;CD47;COL4A1;ITGA11;ITGA9;ITGB1;ITGB8;COL18A1;ITGA8;COL9A2
gsea,CRMPs In Sema3A Signaling R-HSA-399956,-0.33907506345165556,-0.9912599615357996,0.47514910536779326,0.5228795516484868,1.0,2/16,4.69%,CDK5R1;GSK3B
gsea,Interferon Gamma Signaling R-HSA-877300,-0.2533034000544901,-0.9874570378167534,0.4908675799086758,0.5290827309433154,1.0,6/55,8.31%,CAMK2B;TRIM35;PIAS1;BCL11B;IFI30;IFNGR2
gsea,Processive Synthesis On Lagging Strand R-HSA-69183,-0.3413195249911032,-0.9858136497119304,0.4863731656184486,0.5315158826263972,1.0,8/15,38.75%,PCNA;POLD4;RPA3;FEN1;POLD3;LRIG1;POLA1;POLD2
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.24352884495493185,0.9841023689960359,0.48828125,1.0,1.0,12/59,8.59%,CDH23;PCDH15;SPTAN1;BSN;TWF2;STX1A;KCNMA1;SYN1;RIPOR2;MYO7A;CLIC5;EPB41L3
gsea,HCMV Early Events R-HSA-9609690,-0.23135243401646902,-0.9816545259894338,0.4605809128630705,0.5385331271006603,1.0,19/71,28.76%,DYNLL1;DYNLL2;TPR;H2AC25;H2BC4;TXN2;TRIM28;DUT;TBL1XR1;NUP54;NUP37;H2BC21;EZH2;NUP43;ITGB1;DYNC1I2;GPS2;SEC13;NUP153
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.27776468560325795,-0.9805872321792666,0.4771689497716895,0.5398982218012579,1.0,4/31,11.86%,CYP7B1;SYCP2;STARD5;PTGIS
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.30195998119194234,-0.9790236296778309,0.47657841140529533,0.5422371398105822,1.0,9/22,29.50%,B4GALT6;B4GALT4;CHGA;FUT8;ST8SIA3;FUCA1;B4GALT5;B4GALT3;ST6GAL1
gsea,Voltage Gated Potassium Channels R-HSA-1296072,-0.26832940601482724,-0.9719874351558612,0.48582995951417,0.5545561030251459,1.0,9/39,19.09%,KCNA1;KCNA2;KCNA3;KCNF1;KCNG2;KCNS3;KCNAB2;KCND2;KCNV1
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.2658638719141184,-0.9719082536040954,0.49691991786447637,0.5540872849424162,1.0,20/35,43.71%,TPR;PIAS1;UBE2I;NUP54;NUP37;SUMO1;NUP43;SEC13;NUP153;SEH1L;NUP93;TRIM27;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50;VHL
gsea,Lagging Strand Synthesis R-HSA-69186,-0.30328377685071656,-0.9692172336701492,0.48903508771929827,0.558422798956261,1.0,9/20,38.75%,PCNA;POLD4;RPA3;FEN1;RFC5;POLD3;LRIG1;POLA1;POLD2
gsea,PI Metabolism R-HSA-1483255,0.2387234069776804,0.9656851717921068,0.488659793814433,1.0,1.0,18/79,11.99%,PI4K2B;PLEKHA6;MTMR14;PI4KA;PLEKHA1;PIK3C2B;VAC14;PIKFYVE;ENPP6;PIK3R2;PNPLA6;SYNJ2;INPP5K;INPP5J;OCRL;PLEKHA4;INPP5D;FIG4
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.24961951624051926,-0.9608058748531023,0.5321285140562249,0.573471938585465,1.0,5/48,11.44%,CALM1;CYCS;SIRT3;PPARA;SSBP1
gsea,Intra-Golgi Traffic R-HSA-6811438,-0.26689230990438273,-0.9608048760272941,0.4797570850202429,0.5728239476944079,1.0,12/35,25.87%,NSF;NAPG;STX16;YKT6;MAN1A2;RAB33B;COG5;BET1L;RAB36;RIC1;GOSR2;COG2
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.28253126544679374,-0.9605649580183138,0.5033259423503326,0.5726249239483673,1.0,2/27,2.94%,CYP7B1;SYCP2
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.31184871612319925,-0.9582494986835917,0.5121951219512195,0.5765009249442078,1.0,7/19,28.01%,ANAPC4;CDC26;BUB3;ANAPC16;UBE2E1;ANAPC10;ANAPC7
gsea,Signaling By PDGF R-HSA-186797,-0.24211210630354013,-0.9532209793630162,0.5361050328227571,0.5855029061743794,1.0,16/51,33.34%,HRAS;COL4A2;NCK1;PDGFRA;FURIN;COL6A1;SOS1;COL4A1;PTPN12;COL4A5;THBS4;PDGFA;BCAR1;COL9A2;PTPN11;CXXC1
gsea,Keratinization R-HSA-6805567,-0.264333755080562,-0.9528206654821496,0.5254629629629629,0.5855969130666864,1.0,6/33,20.21%,KRT10;FURIN;PKP2;KRT25;KLK8;TCHH
gsea,RET Signaling R-HSA-8853659,0.26344518155039026,0.9524340991019822,0.5168986083499006,1.0,1.0,11/35,14.43%,RAP1GAP;DOK5;PIK3R2;SHANK3;PRKCA;SHC3;FRS2;NRTN;GAB2;GRB7;SHC1
gsea,Kinesins R-HSA-983189,0.2677621964537604,0.9497228806711736,0.5211267605633803,1.0,1.0,10/33,14.23%,KIF1A;KIF5A;KIF3C;KIF1B;KLC4;KIF13B;KIF16B;KIF21B;KIF6;KIF11
gsea,CD28 Co-Stimulation R-HSA-389356,-0.27378115996424024,-0.94654809728404,0.5430861723446894,0.5970272244474042,1.0,5/31,12.66%,AKT1;YES1;PKN2;MLST8;AKT3
gsea,tRNA Aminoacylation R-HSA-379724,-0.2848678198524728,-0.9446958949380512,0.5337301587301587,0.5998978510187664,1.0,8/26,28.43%,MARS2;AIMP1;YARS2;MARS1;EEF1E1;DTD1;FARS2;RARS2
gsea,Collagen Degradation R-HSA-1442490,-0.2691589602999561,-0.9436472228198726,0.5147058823529411,0.6011849412668487,1.0,5/30,12.02%,CTSB;CTSL;FURIN;MMP15;MMP19
gsea,Myogenesis R-HSA-525793,-0.2849551956823867,-0.9369521293187839,0.5089820359281437,0.6132446033427507,1.0,6/25,17.89%,MEF2A;TCF12;CTNNA1;MAP2K6;CDH15;CTNNB1
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.28630254142248235,-0.9328412896720296,0.5324675324675324,0.6203902585880217,1.0,12/22,44.69%,MAGED1;NDUFA2;FADD;APPL1;TRADD;TANK;CASP3;CASP9;UNC5A;LY96;DAPK1;CASP8
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.26704587277879843,-0.9316524361835753,0.5634920634920635,0.6220335071863254,1.0,10/31,26.92%,APOE;PLTP;ARL4C;RXRB;APOD;TBL1XR1;AGO3;KDM1A;TNRC6C;GPS2
gsea,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.28869570629794633,-0.9315573790063172,0.5769230769230769,0.6215498910744757,1.0,3/21,14.03%,HRAS;SOS1;FGF1
gsea,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.2992892959464336,-0.9308352159642749,0.5520169851380042,0.6221936456100554,1.0,3/19,9.10%,VPS29;SNX3;VPS35
gsea,Cell-cell Junction Organization R-HSA-421270,-0.24451761673189396,-0.9306126838188984,0.5708582834331337,0.6218828680556585,1.0,8/46,14.02%,CDH9;CADM2;PARD6A;CLDN10;CTNNA1;PRKCI;CLDN5;CDH15
gsea,ECM Proteoglycans R-HSA-3000178,-0.24241006504534435,-0.9300190160776698,0.5508849557522124,0.6224166820833945,1.0,22/50,37.47%,ITGA7;TGFB3;MATN4;AGRN;LAMA5;LAMA2;VTN;BCAN;ASPN;LAMA1;ITGA9;ITGB1;TGFB1;LAMB1;ITGA8;COL9A2;SPARC;LRP4;NCAN;DMTF1;COMP;ITGAV
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.25930971820563786,-0.9299302947898539,0.5740740740740741,0.621888193707843,1.0,19/31,46.39%,TPR;NEK7;NUP54;NUP37;NUP43;SEC13;NUP153;NEK6;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50;CCNB1;NUP62
gsea,Nuclear Envelope Breakdown R-HSA-2980766,0.24513994255107438,0.9286802805536077,0.5946969696969697,1.0,1.0,9/48,9.04%,VRK2;PRKCB;NUP188;LMNB1;PRKCA;NUP214;LPIN3;NUP107;LPIN1
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.28333979322379854,-0.9283299576116818,0.5612903225806452,0.6241175646510154,1.0,11/23,37.95%,SLC39A7;SLC39A3;SLC39A10;SLC39A6;SLC39A14;SLC30A1;SLC41A1;SLC11A2;SLC30A6;SLC30A5;SLC30A10
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.3158603795731317,-0.9280894923693982,0.5390781563126252,0.6238969042232974,1.0,7/15,30.33%,SCMH1;PHC3;UBE2I;SUMO1;CBX4;RING1;PCGF2
gsea,RHOD GTPase Cycle R-HSA-9013405,-0.24518488169020827,-0.9275749851577251,0.5607843137254902,0.6242319149437107,1.0,20/49,35.37%,DIAPH2;LMAN1;ARHGAP5;VAMP3;ARHGAP12;SLC4A7;CAV1;CAPZB;ESYT1;ANKFY1;STEAP3;TOR1AIP1;FILIP1;PGRMC2;ACTN1;PLXNA1;PLXNB1;TMPO;ARHGAP21;EMD
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.22445811081225903,-0.9275390631677534,0.5901639344262295,0.623591999905316,1.0,9/62,14.03%,FGFR2;TGFA;RNMT;PDGFRA;FGFR3;IRS2;NRG2;SOS1;FGF1
gsea,TRP Channels R-HSA-3295583,0.29179956534145207,0.9261025301376391,0.5505836575875487,1.0,1.0,4/20,8.23%,TRPM2;TRPC3;TRPM4;MCOLN1
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.18404771808748308,-0.923111422777128,0.6693121693121693,0.6312417685707031,1.0,26/185,16.40%,PLPPR4;P2RY14;NTSR2;PTGER4;S1PR1;P2RY12;PLPPR5;SST;PLPPR1;HTR4;MTNR1A;NPY;CHGA;ACKR3;P2RY1;SSTR4;SSTR2;GPNMB;SSTR1;S1PR3;ACKR1;CXCL12;GPR37;PROK2;F2RL2;GPR37L1
gsea,Signaling By NODAL R-HSA-1181150,-0.3199807756715197,-0.9216592464200787,0.558,0.6332402190938453,1.0,6/16,28.30%,MAPK3;FURIN;ACVR2A;MAPK1;SMAD4;SMAD3
gsea,Generation Of Second Messenger Molecules R-HSA-202433,-0.2963280653223877,-0.9208841535507081,0.5585585585585585,0.6340279157103381,1.0,3/18,13.51%,NCK1;PKN2;ENAH
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.26325878084210635,-0.9201194962548008,0.5579567779960707,0.6347844866146027,1.0,16/28,43.68%,TPR;MAP4K5;NUP54;NUP37;NUP43;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.2119008648930962,-0.9182852521431389,0.5798319327731093,0.6376259338128859,1.0,25/99,24.18%,CAPZA2;MAFG;PRKAR1A;KIF26B;KIF22;RAB5A;KIFAP3;JMJD1C;DOCK10;DOCK11;EHD3;KIF23;CAPZB;PRKACB;DOCK1;RAD51C;CENPE;CDK5;HDAC1;KIF3A;KDM1A;RBSN;PRKAR2B;HDAC2;KIF2A
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,-0.20941426844035274,-0.9177631423498142,0.6270022883295194,0.6379998381658618,1.0,11/86,13.42%,BSG;CTSB;SPOCK3;CTSL;FURIN;LAMA5;MMP16;HTRA1;MMP15;MMP19;BCAN
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,-0.23283716253711786,-0.9176885134082559,0.5762004175365344,0.6374250543704956,1.0,11/45,21.96%,SETD7;KMT5A;MECOM;PRDM16;ASH2L;DPY30;ATF7IP;SETD6;SETD3;KMT2C;EZH2
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,0.20700742111453121,0.9098173179727335,0.617059891107078,1.0,1.0,20/111,9.73%,HEXB;GPC6;HS6ST3;ST3GAL3;HS6ST1;GLB1L;HS3ST2;ABCC5;DCN;EXT1;LUM;GPC3;HPSE;SLC26A2;NDST2;GLB1;GPC1;HPSE2;CD44;CSGALNACT2
gsea,Laminin Interactions R-HSA-3000157,-0.28200301541047273,-0.9075370136063795,0.5995762711864406,0.6562291071485882,1.0,7/22,29.14%,ITGA7;LAMA5;LAMA2;LAMA1;ITGB1;LAMB1;COL18A1
gsea,Diseases Of Glycosylation R-HSA-3781865,0.200488427339206,0.9064572292309869,0.6524064171122995,1.0,1.0,16/121,5.05%,HEXB;GPC6;B3GLCT;ST3GAL3;THSD4;DAG1;ADAMTS10;GALE;DCN;ADAMTSL1;PMM2;EXT1;LUM;DHDDS;GPC3;SLC26A2
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.2608834399382121,0.9036331206357272,0.6046966731898239,1.0,1.0,14/38,17.17%,TEC;CRKL;CBL;PIK3R2;HCK;PRKCA;CRK;INPP5D;GAB2;SHC1;STAT5B;RAPGEF1;FYN;JAK3
gsea,Regulation Of KIT Signaling R-HSA-1433559,0.309488156502837,0.8989941631691448,0.61,1.0,1.0,5/15,12.12%,SH2B2;CBL;PRKCA;KIT;LCK
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,-0.25497117792514296,-0.8978665943098832,0.6205450733752621,0.6739793663958633,1.0,5/33,14.03%,HRAS;BAG4;CPSF6;SOS1;FGF1
gsea,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.30001976510244593,-0.8959275942572074,0.5883620689655172,0.6770022255219579,1.0,5/16,17.89%,SPCS2;SPCS1;SPCS3;SEC11C;CTNNB1
gsea,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.3013880290367499,-0.894358571853634,0.6204819277108434,0.6792851644859061,1.0,5/15,25.45%,APOA1;ABCD3;PEX19;ABCA2;ABCD2
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.2886359350393294,-0.8936163584767461,0.591182364729459,0.6799982063116216,1.0,3/18,9.36%,PPP2R1A;BANF1;PPP2CA
gsea,Cell Junction Organization R-HSA-446728,0.21939967774868419,0.8923528014303302,0.6425855513307985,1.0,1.0,18/71,13.91%,DST;CADM1;PVR;CLDN16;CADM3;LIMS2;PARD6B;CDH12;PLEC;FLNA;PATJ;CDH4;SDK1;CDH10;NECTIN3;PALS1;ANG;CDH18
gsea,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.3044308310303989,-0.8903309210012518,0.5975609756097561,0.6857838762764563,1.0,7/15,39.40%,AASDHPPT;PDZD11;SLC25A16;PANK3;ENPP1;PANK2;PPCS
gsea,Downstream Signal Transduction R-HSA-186763,-0.259048567777487,-0.888586110276374,0.6361746361746362,0.6884401643771442,1.0,4/28,13.44%,HRAS;NCK1;PDGFRA;SOS1
gsea,Signaling By KIT In Disease R-HSA-9669938,-0.28539695820468625,-0.8852159286411746,0.6123711340206186,0.6942517638583698,1.0,3/19,13.44%,HRAS;YES1;SOS1
gsea,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.3026166399994332,-0.8846468160186525,0.6127049180327869,0.694580773747421,1.0,3/15,15.55%,HRAS;PKN2;PRKACB
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.23368200016807594,0.8815024394723701,0.6149068322981367,1.0,1.0,12/50,11.89%,PI4K2B;PLEKHA6;MTMR14;PLEKHA1;PIK3C2B;PIK3R2;SYNJ2;INPP5K;INPP5J;OCRL;PLEKHA4;INPP5D
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.2797365647588007,-0.8802545268304646,0.6077235772357723,0.7021592395950386,1.0,8/19,33.22%,PCNA;HDAC1;E2F4;TFDP2;RBL1;LIN52;RBL2;MYC
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.25584936156726235,-0.8802065702729318,0.659043659043659,0.7014783094765858,1.0,2/26,1.95%,CYP7B1;VDAC2
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.2837794463095941,-0.8775754484136825,0.6252545824847251,0.705792553165178,1.0,4/19,14.74%,HRAS;NRG2;SOS1;PRKCE
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.24837734710149723,-0.8737020119515417,0.6386036960985626,0.7126225503652447,1.0,11/31,38.07%,SEM1;RAD17;RPA3;RAD51;RFC5;TOPBP1;RMI2;BLM;WRN;RAD9B;RMI1
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.1926514637987502,-0.872239446888317,0.7364864864864865,0.7145187622019646,1.0,28/113,28.36%,CDIPT;CHPT1;CSNK2B;GPCPD1;GPAM;MFSD2A;AGPAT3;DDHD2;PCYT2;CPNE6;PCYT1B;PLD3;CDS2;GPD2;SELENOI;DGAT2;PLAAT3;CHKA;PLA2G3;LPGAT1;ACP6;OSBPL8;DGAT2L6;PNPLA8;PLBD1;PLA2R1;AGK;HADHA
gsea,Recycling Pathway Of L1 R-HSA-437239,0.26393215507110757,0.8704503279494121,0.6312625250501002,1.0,1.0,7/25,11.09%,DNM1;L1CAM;DNM2;RPS6KA2;AP2A1;RPS6KA5;DNM3
gsea,MET Promotes Cell Motility R-HSA-8875878,-0.2571693406463559,-0.8678746146226423,0.6734279918864098,0.721795987086125,1.0,9/27,28.16%,RNMT;LAMA5;LAMA2;SOS1;RAP1A;LAMA1;PTK2;ITGB1;LAMB1
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.26157531954567725,-0.8651799372673293,0.6529284164859002,0.7258126587823541,1.0,6/23,29.76%,TXN2;ADO;BHMT2;ADI1;GOT2;MRI1
gsea,Endogenous Sterols R-HSA-211976,-0.27025922355282705,-0.8647771664700686,0.6612576064908722,0.7257967091072841,1.0,10/20,41.59%,CYP7B1;PTGIS;FDX1;FDX2;FDXR;CYP1B1;AHRR;MIA3;POMC;CYP19A1
gsea,HDMs Demethylate Histones R-HSA-3214842,0.2765201400839463,0.8638947365076295,0.6472945891783567,1.0,1.0,6/20,12.99%,ARID5B;KDM2A;KDM3A;KDM4A;KDM5B;JMJD6
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.24314694448415694,-0.8637516267311669,0.6615384615384615,0.7269729361473589,1.0,15/31,41.90%,PCNA;POLD4;TERF1;RPA3;FEN1;RFC5;POLD3;BLM;LRIG1;WRN;TERF2IP;POLA1;POLD2;CHTF8;TINF2
gsea,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.28198586642187806,-0.8594289626721341,0.6407982261640798,0.7341747244469724,1.0,5/18,17.89%,SPCS2;SPCS1;SPCS3;SEC11C;CTNNB1
gsea,DAP12 Interactions R-HSA-2172127,-0.2603644558021927,-0.8588032640968734,0.6587473002159827,0.7345491014478089,1.0,6/24,24.82%,HRAS;SOS1;B2M;VAV3;TYROBP;BTK
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,0.25272649450195356,0.858044343771772,0.6938369781312127,1.0,1.0,13/30,21.96%,MPL;RAPGEF4;APBB1IP;CRK;TTF2;PTPN1;GP5;SHC1;RASGRP2;PDPK1;SRC;RAP1B;ITGB3
gsea,DAP12 Signaling R-HSA-2424491,-0.2609093126013649,-0.8539763560256618,0.6864406779661016,0.7426374538881114,1.0,6/23,24.82%,HRAS;SOS1;B2M;VAV3;TYROBP;BTK
gsea,PI3K Cascade R-HSA-109704,-0.2313441783024866,-0.8474631470861719,0.7208835341365462,0.7538180406656938,1.0,5/36,14.03%,FGFR2;PDE3B;FGFR3;IRS2;FGF1
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,0.23578184640688551,0.843642048918222,0.7299651567944251,1.0,1.0,11/40,16.11%,ADAR;IRF2;RSAD2;IRF7;STAT1;IFNAR1;RNASEL;PTPN1;IRF8;STAT2;IFIT1
gsea,G Alpha (Q) Signaling Events R-HSA-416476,0.18199513959649127,0.8425552834825131,0.8139130434782609,1.0,1.0,27/154,11.94%,FFAR1;TRIO;NMUR2;TACR3;LPAR5;RGS16;TRPC3;CCKBR;GPR39;DGKZ;DGKG;CD200R1;ADRA1A;PIK3R2;KALRN;PRKCA;DGKQ;QRFPR;GNRH1;RPS6KA2;GRK5;NPSR1;OXTR;HCRTR1;DGKA;LPAR3;TTF2
gsea,Insulin Processing R-HSA-264876,0.2552793186839037,0.8402112980787229,0.6750483558994197,1.0,1.0,4/25,2.67%,KIF5A;MYRIP;STX1A;PCSK1
gsea,Signaling By ALK R-HSA-201556,0.2457815974908527,0.8346629505821161,0.7108433734939759,1.0,1.0,4/25,5.49%,EP300;ALK;PRDM1;PIK3R2
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.27610906501286914,-0.833505573581454,0.6974248927038627,0.7786507288944136,1.0,6/18,28.01%,ANAPC4;CDC26;ANAPC16;UBE2E1;ANAPC10;ANAPC7
gsea,PI-3K cascade:FGFR1 R-HSA-5654689,-0.2780468694924087,-0.8313730142580524,0.7045454545454546,0.7815854890325872,1.0,10/17,47.06%,FGF1;FGF10;FGFR1;FGF9;PTPN11;FGF23;PIGU;KL;FGF20;PIK3R1
gsea,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.2667829390602786,-0.8275959140384818,0.7236842105263158,0.7874730635410716,1.0,5/19,26.65%,PLAAT3;PLA2G3;PNPLA8;PLBD1;PLA2R1
gsea,Collagen Formation R-HSA-1474290,0.19761067351174622,0.8250071703937466,0.8003565062388592,1.0,1.0,14/83,9.80%,DST;COL13A1;COL24A1;COL8A1;PCOLCE2;PLOD3;COL28A1;COL26A1;PLEC;COL7A1;COL6A3;COL14A1;COL3A1;MMP28
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,-0.18261173573672515,-0.8244138493027431,0.8375634517766497,0.7922291723920679,1.0,26/100,29.35%,NTSR2;SST;NPY;ACKR3;SSTR4;SSTR2;GPNMB;SSTR1;ACKR1;CXCL12;GPR37;PROK2;F2RL2;GPR37L1;NPY2R;EDNRB;RXFP3;OPRL1;NTSR1;HEBP1;CCR9;PNOC;CX3CL1;NPFFR2;CORT;APLN
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,0.23059085222829756,0.823891278488194,0.7557251908396947,1.0,1.0,4/35,4.15%,B3GLCT;THSD4;ADAMTS10;ADAMTSL1
gsea,Interleukin-7 Signaling R-HSA-1266695,0.26447203403760466,0.8203558071093358,0.7131782945736435,1.0,1.0,6/20,17.35%,SOCS2;PIK3R2;SMARCA4;STAT5B;JAK3;BRWD1
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.22491410173640114,-0.8198589152352271,0.7748478701825557,0.7991069103431689,1.0,10/36,26.92%,APOE;PLTP;ARL4C;RXRB;APOD;TBL1XR1;AGO3;KDM1A;TNRC6C;GPS2
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.2283271270612714,-0.8170808122904205,0.7364185110663984,0.8029229265825983,1.0,19/32,43.68%,TPR;NUP54;NUP37;ALYREF;NCBP2;NUP43;EIF4E;SEC13;NUP153;SEH1L;SLBP;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.23613266186236326,0.8163744077470851,0.696113074204947,1.0,1.0,5/30,7.63%,HEXB;ST3GAL3;GLB1L;LUM;GLB1
gsea,G0 And Early G1 R-HSA-1538133,-0.23497351068294417,-0.8150143975176707,0.7690677966101694,0.8056398302215905,1.0,10/26,33.22%,PCNA;HDAC1;E2F4;TFDP2;CCNE2;RBL1;LIN52;CCNA2;RBL2;MYC
gsea,Phosphorylation Of APC/C R-HSA-176412,-0.27023827860768834,-0.8150072451962159,0.7415254237288136,0.8047917802284812,1.0,6/18,28.01%,ANAPC4;CDC26;ANAPC16;UBE2E1;ANAPC10;ANAPC7
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.22263390374498948,-0.8116885082237492,0.7755102040816326,0.8095265184876501,1.0,12/36,38.07%,SEM1;RAD17;RPA3;RAD51C;RAD51;RFC5;TOPBP1;RMI2;BLM;WRN;RAD9B;RMI1
gsea,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.27498707213933893,-0.8083298667084133,0.734,0.8144109068644453,1.0,7/15,32.53%,HDAC1;E2F4;TFDP2;RBL1;LIN52;CCNA2;RBL2
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.20515616598928302,0.8071942784367049,0.7959927140255009,1.0,1.0,10/65,6.96%,COL13A1;COL24A1;COL8A1;PCOLCE2;PLOD3;COL28A1;COL26A1;COL7A1;COL6A3;COL14A1
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.21168529853815912,0.80293746145188,0.7985989492119089,1.0,1.0,19/51,23.63%,DST;COL24A1;COL8A1;PLEC;COL7A1;COL6A3;COL3A1;MMP28;COL6A6;COL6A5;LOXL3;COL8A2;BMP1;MMP9;LAMA4;COL5A2;COL6A2;COL11A1;LOXL2
gsea,Cholesterol Biosynthesis R-HSA-191273,-0.24897527373146866,-0.8026323760120595,0.7422037422037422,0.8229539717077266,1.0,5/23,22.70%,PLPP6;GGPS1;ARV1;SH3D19;HMGCS1
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.2398957346380426,-0.8019812993283276,0.75049115913556,0.8231622904910019,1.0,9/26,32.02%,LAMA2;POU3F1;YAP1;SOX10;HDAC2;NAB2;GJB1;LAMB1;WWTR1
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.21758732272036088,-0.800591282296698,0.7975460122699386,0.8244159575168912,1.0,12/37,38.07%,SEM1;RAD17;RPA3;RAD51C;RAD51;RFC5;TOPBP1;RMI2;BLM;WRN;RAD9B;RMI1
gsea,PI-3K cascade:FGFR3 R-HSA-5654710,-0.27498839471621583,-0.7974766235580141,0.7484787018255578,0.828547407129849,1.0,9/15,47.99%,FGFR3;FGF1;FGF9;PTPN11;FGF23;PIGU;FGF20;PIK3R1;FGF18
gsea,O-linked Glycosylation R-HSA-5173105,0.18674059169436888,0.7955610257904047,0.8544776119402985,1.0,1.0,9/83,4.47%,B3GLCT;GALNT9;ST3GAL3;THSD4;DAG1;ADAMTS10;GALNT14;ADAMTSL1;GALNT11
gsea,Nucleotide Catabolism R-HSA-8956319,-0.22586044847190523,-0.7930666141585169,0.7919191919191919,0.8346386707164589,1.0,14/29,39.02%,NUDT5;NT5C;SCO2;NUDT16;GDA;NUDT18;NUDT9;DNPH1;DPYS;SAMHD1;ADPRM;NT5E;ENTPD2;NT5M
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.21400606530972094,-0.7925890201643009,0.8378995433789954,0.8345244686753762,1.0,6/41,15.76%,CD81;ICAM5;NPDC1;PIANP;ITGA4;B2M
gsea,Adherens Junctions Interactions R-HSA-418990,0.24452841144247367,0.7917449116634517,0.7819253438113949,1.0,1.0,9/27,13.91%,CADM1;PVR;CADM3;CDH12;CDH4;CDH10;NECTIN3;ANG;CDH18
gsea,Extracellular Matrix Organization R-HSA-1474244,0.16372398971392485,0.7914793920737735,0.9329805996472663,1.0,1.0,39/245,10.75%,PTPRS;DST;KLKB1;ITGA3;COL13A1;ADAM15;COL24A1;ADAM19;DAG1;COL8A1;TNN;ADAM17;DCN;CAPN1;LUM;JAM3;PCOLCE2;PLOD3;COL28A1;COL26A1;CTSK;PLEC;COL7A1;COL6A3;COL14A1;PRKCA;CAPN15;DMD;ITGAE;ADAM8;MFAP2;COL3A1;ITGB6;CD44;LTBP3;MMP28;ITGB7;LTBP4;CAPN11
gsea,Phospholipid Metabolism R-HSA-1483257,0.16848604144875923,0.7873313852933514,0.8979206049149339,1.0,1.0,32/191,11.99%,SLC44A2;MIGA2;CPNE1;PI4K2B;PLEKHA6;MTMR14;PI4KA;TMEM86B;MIGA1;PLEKHA1;PIK3C2B;VAC14;PIKFYVE;ENPP6;AGPAT4;PIK3R2;PNPLA6;LPCAT1;PCYT1A;LPIN3;SYNJ2;PLA2G4E;INPP5K;INPP5J;LPIN1;OCRL;PLD2;PLEKHA4;PEMT;INPP5D;HADHB;FIG4
gsea,Cell-Cell Communication R-HSA-1500931,-0.18278373479984164,-0.7849074631516174,0.8614457831325302,0.8455085847622392,1.0,33/101,34.12%,PTK2B;CDH9;CADM2;PARD6A;NCK1;CLDN10;CTNNA1;WASL;PRKCI;CLDN5;CDH15;CD47;CTNNB1;MAGI2;PARD6G;TYROBP;CD2AP;PTK2;ITGB1;PXDN;CDH8;TESK1;KIRREL2;CDH2;FERMT2;CASK;SPTBN1;CLDN12;ARHGEF6;ACTN1;PTPN11;CDH13;CDH24
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.20713229318677912,-0.7823471305514209,0.8049713193116634,0.8483717725577802,1.0,22/39,43.68%,TPR;FIP1L1;NUP54;NUP37;ALYREF;NCBP2;NUP43;CPSF2;EIF4E;SEC13;NUP153;SEH1L;SLBP;NUP93;WDR33;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,Netrin-1 Signaling R-HSA-373752,0.20378054394788753,0.7814546173675798,0.816,1.0,1.0,12/46,16.73%,TRIO;ABLIM1;TRPC3;MAPK14;UNC5D;SLIT2;SIAH2;ABLIM2;UNC5B;DCC;TRPC5;FYN
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.23611353130484064,-0.7783882800071411,0.7536534446764092,0.8534314834294849,1.0,15/25,41.91%,SDC4;CSPG5;AGRN;BCAN;SDC3;GPC4;B3GAT2;B4GALT7;CSPG4;B3GALT6;NCAN;GPC2;B3GAT1;B3GAT3;XYLT1
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.21880409742190976,-0.7770783110454923,0.7975708502024291,0.8545101661537562,1.0,18/31,43.68%,TPR;NUP54;NUP37;ALYREF;NCBP2;NUP43;EIF4E;SEC13;NUP153;SEH1L;NUP93;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.2522303226306741,-0.775235778218643,0.7880085653104925,0.856297914550322,1.0,3/20,8.76%,RAB11A;ARF4;EXOC3
gsea,Sensory Perception Of Taste R-HSA-9717189,-0.24014440505216006,-0.7733384236976911,0.8146551724137931,0.8581517795823672,1.0,10/20,40.87%,GRM1;SCN2A;SCN3A;PLCB2;SCN1B;SCN9A;KCNJ2;SCN2B;SCNN1A;SCN4B
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.2145144107511422,0.7731959076616911,0.8183556405353728,1.0,1.0,4/36,4.15%,B3GLCT;THSD4;ADAMTS10;ADAMTSL1
gsea,Synthesis Of PA R-HSA-1483166,0.22399182768787523,0.7689303202305954,0.8225190839694656,1.0,1.0,5/31,9.96%,MIGA2;MIGA1;AGPAT4;LPCAT1;PLD2
gsea,Diseases Of DNA Repair R-HSA-9675135,-0.19893916878546938,-0.7677523044126237,0.8495762711864406,0.8653096067720023,1.0,10/47,25.68%,SEM1;RAD17;MLH1;RPA3;RAD51C;MSH2;RAD51;RFC5;TOPBP1;RMI2
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.1728988733427065,0.7674324574024934,0.9172932330827067,1.0,1.0,23/108,14.36%,NPAS2;EP300;ESRRA;MED26;RXRA;NCOA3;RORA;ARNT2;PPARGC1B;NRF1;MED16;MED24;ALAS1;CDK8;SREBF1;MED13L;NR1H2;FAM120B;GLIPR1;NCOA6;SIN3B;PPARGC1A;MED13
gsea,Synthesis Of PC R-HSA-1483191,0.22972135165071608,0.7654631771536766,0.8247619047619048,1.0,1.0,6/26,11.69%,SLC44A2;LPCAT1;PCYT1A;LPIN3;LPIN1;PEMT
gsea,Apoptotic Execution Phase R-HSA-75153,0.21605468493731592,0.764124849610322,0.8259109311740891,1.0,1.0,9/40,10.81%,MAPT;SPTAN1;GAS2;LMNB1;PLEC;CASP7;STK24;FNTA;SATB1
gsea,Elastic Fibre Formation R-HSA-1566948,-0.21434178122967557,-0.7608229495359327,0.8376623376623377,0.8740160742298058,1.0,9/33,29.95%,TGFB3;FURIN;VTN;MFAP3;ITGB1;EFEMP1;TGFB1;ITGB8;ITGA8
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.2381081074406803,-0.7583949948012426,0.811529933481153,0.8765122107982146,1.0,3/23,13.44%,HRAS;IRS2;SOS1
gsea,Formation Of Cornified Envelope R-HSA-6809371,-0.2365372401364243,-0.7564811615680083,0.8220720720720721,0.8781365079254653,1.0,4/22,20.21%,FURIN;PKP2;KLK8;TCHH
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.24548020964211104,-0.7503267206186213,0.7675350701402806,0.8852476646528621,1.0,5/19,17.88%,SDC4;CSPG5;AGRN;BCAN;SDC3
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.19902633754868845,-0.7476063094751828,0.867816091954023,0.887762009063856,1.0,21/38,43.68%,TPR;FIP1L1;NUP54;NUP37;ALYREF;NCBP2;NUP43;CPSF2;EIF4E;SEC13;NUP153;SEH1L;NUP93;WDR33;RANBP2;NDC1;NUP98;NUP35;NUP88;POM121;NUP50
gsea,PPARA Activates Gene Expression R-HSA-1989781,0.1687765175487992,0.7468679191496203,0.9320754716981132,1.0,1.0,22/106,14.36%,NPAS2;EP300;ESRRA;MED26;RXRA;NCOA3;RORA;ARNT2;PPARGC1B;NRF1;MED16;MED24;ALAS1;CDK8;SREBF1;MED13L;NR1H2;FAM120B;GLIPR1;NCOA6;PPARGC1A;MED13
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.19730008029941187,-0.7456229265048151,0.8674948240165632,0.8894606953360854,1.0,22/46,39.99%,CHST9;SDC4;CSPG5;AGRN;IDS;BCAN;CHST15;SDC3;CHPF;UST;DSEL;GPC4;B3GAT2;B4GALT7;CSPG4;B3GALT6;ARSB;NCAN;GPC2;B3GAT1;HEXA;B3GAT3
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.23847217025914594,-0.7454831199359189,0.8141025641025641,0.888719168232137,1.0,7/18,35.97%,TLR3;IKBKG;NKIRAS2;NKIRAS1;NFKB2;NFKB1;TBK1
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.22691324098472537,-0.7443773013533331,0.851764705882353,0.8890509208510577,1.0,3/23,13.36%,PCNA;POLD4;TERF1
gsea,Sialic Acid Metabolism R-HSA-4085001,0.21240356486932527,0.7424753743634251,0.8711538461538462,1.0,1.0,6/32,9.32%,ST3GAL3;ST8SIA5;NEU2;ST6GAL2;GLB1;ST6GALNAC6
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.2429529094878169,-0.7420212879285647,0.8035714285714286,0.8910531179083642,1.0,5/19,17.88%,SDC4;CSPG5;AGRN;BCAN;SDC3
gsea,Cell-extracellular Matrix Interactions R-HSA-446353,0.2547174435132089,0.7363479507710642,0.837573385518591,1.0,1.0,16/16,74.55%,LIMS2;FLNA;RSU1;PARVB;FBLIM1;FLNC;VASP;PARVA;LIMS1;ILK;ACTN1;ARHGEF6;FERMT2;TESK1;PXDN;ITGB1
gsea,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.2208135746669679,-0.734587145615294,0.8394308943089431,0.8991940166837723,1.0,8/25,29.95%,TGFB3;VTN;MFAP3;ITGB1;EFEMP1;TGFB1;ITGB8;ITGA8
gsea,Metabolism Of Folate And Pterines R-HSA-196757,0.2536380674501803,0.7331273853281248,0.8419117647058824,1.0,1.0,9/15,30.79%,SLC25A32;SHMT1;MTHFD1L;SHMT2;SLC19A1;MTHFR;ALDH1L1;FOLR2;DHFR
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.23954822306581247,-0.7307989245028618,0.798804780876494,0.9027566104882754,1.0,5/19,17.88%,SDC4;CSPG5;AGRN;BCAN;SDC3
gsea,TNFs Bind Their Physiological Receptors R-HSA-5669034,0.2601622507060421,0.7301062156276824,0.8581818181818182,1.0,1.0,7/17,17.19%,TNFRSF8;TNFRSF13B;TNFRSF4;TNFRSF25;EDA2R;TNFRSF18;TNFRSF11B
gsea,Acyl Chain Remodelling Of PC R-HSA-1482788,0.23585739793475813,0.7290362580490083,0.8442776735459663,1.0,1.0,7/20,20.70%,TMEM86B;LPCAT1;PLA2G4E;LPCAT3;PLA2G4B;PLA2G4A;PLA2G4C
gsea,G1/S-Specific Transcription R-HSA-69205,-0.20818944566832287,-0.7252725094865227,0.892,0.9081136720317726,1.0,16/27,50.59%,PCNA;HDAC1;E2F4;TFDP2;RBL1;LIN52;RBL2;POLA1;CCNA1;LIN37;E2F6;LIN54;TFDP1;TYMS;CDC45;LIN9
gsea,Signaling By Retinoic Acid R-HSA-5362517,0.2085543604597178,0.7151885400719442,0.8941605839416058,1.0,1.0,10/30,19.89%,RXRA;RDH16;RDH13;PPARD;DHRS4;ALDH1A2;RARG;ALDH1A3;ALDH8A1;PDPK1
gsea,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.24685266970827202,-0.7118065300276311,0.8323232323232324,0.921625437683498,1.0,1/15,1.43%,HRAS
gsea,Interleukin-2 Family Signaling R-HSA-451927,0.20515254171628133,0.7115617997540404,0.8829981718464351,1.0,1.0,12/35,20.96%,PIK3R2;STAT1;INPP5D;LCK;LGALS9;GAB2;SHC1;STAT4;STAT5B;JAK3;PIK3CA;JAK2
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,0.1985889808524949,0.7051525043931343,0.8936170212765957,1.0,1.0,4/37,4.47%,GALNT9;ST3GAL3;GALNT14;GALNT11
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.2329478042224333,-0.7051175141505233,0.8765182186234818,0.9273921952117823,1.0,3/18,18.02%,HRAS;SOS1;GOLGB1
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.23090896043850628,0.6983304598701245,0.8630952380952381,1.0,1.0,2/17,2.29%,MOV10;TNRC6B
gsea,Ephrin Signaling R-HSA-3928664,-0.23763224545009098,-0.6965199104555867,0.8631790744466801,0.9344074025353568,1.0,6/17,33.41%,EFNB3;PKN2;SDCBP;EFNB1;EFNB2;MYL12A
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.18681688813236724,-0.6963760897947397,0.9230769230769231,0.9335539389702021,1.0,8/39,25.68%,SEM1;RAD17;RPA3;RAD51C;RAD51;RFC5;TOPBP1;RMI2
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.16672020350251665,-0.6779431082098437,0.9671361502347418,0.9484161079528035,1.0,23/63,38.46%,BSG;SLC6A15;SLC2A13;SLC39A7;SLC39A3;SLC39A10;SLC39A6;SLC14A1;SLC39A14;SLC30A1;SLC13A1;SLC41A1;SLC11A2;SLC6A13;SLC16A1;SLC16A3;SLC14A2;SLC30A6;SLC22A5;SLC30A5;SLC30A10;SLC6A11;SLC18A2
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.17245780392148582,0.676687419510136,0.9592592592592593,1.0,1.0,5/52,4.15%,B3GLCT;THSD4;DAG1;ADAMTS10;ADAMTSL1
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.2247473727816589,-0.6757438571807322,0.888015717092338,0.9491822195928596,1.0,10/18,46.31%,MARS2;YARS2;DTD1;FARS2;RARS2;AARS2;TARS2;WARS2;SARS2;DARS2
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.22445539646785645,-0.6689455474277466,0.8895705521472392,0.9533915992540763,1.0,9/15,44.36%,EXOSC9;SKIC3;EXOSC7;EXOSC8;EXOSC4;SKIC8;EXOSC5;DIS3;EXOSC3
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.20945988053884063,-0.6626225681338489,0.909853249475891,0.9568462802577851,1.0,3/21,12.66%,AKT1;MLST8;AKT3
gsea,Striated Muscle Contraction R-HSA-390522,0.20181488490137767,0.6606859189509108,0.9391143911439115,1.0,1.0,6/25,12.57%,ACTN2;MYH8;DMD;MYBPC1;TMOD3;TPM3
gsea,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.20338783345956274,-0.6566594882912196,0.9110169491525424,0.9597885617720272,1.0,8/21,34.61%,PDZD2;CYBA;MAPK3;MAPK1;NOX3;PRKCD;PIK3C3;NCF1
gsea,Metabolism Of Porphyrins R-HSA-189445,-0.20155158490296793,-0.6477199357604204,0.9308176100628931,0.964496536758527,1.0,11/21,43.93%,CPOX;HMOX1;UROS;ALAD;FECH;COX15;BLVRB;HMBS;HMOX2;FLVCR1;COX10
gsea,Integrin Signaling R-HSA-354192,0.20049767832006843,0.6460698355215937,0.9207317073170732,1.0,1.0,10/24,21.96%,RAPGEF4;APBB1IP;CRK;PTPN1;SHC1;RASGRP2;PDPK1;SRC;RAP1B;ITGB3
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.17515304199597723,-0.6453400847681463,0.9617021276595744,0.9648723640721968,1.0,7/40,22.70%,NFYA;GPAM;PPARA;CHD9;TBL1XR1;GGPS1;HMGCS1
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,-0.20026671660385442,-0.6441086125772342,0.9161676646706587,0.9646638947965159,1.0,8/27,28.75%,DGKH;DGKI;PRKCE;RASGRP1;TRPC6;ITPR2;PRKCD;DGKE
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.19817454845148785,-0.6373005171059175,0.9556962025316456,0.9675143149268391,1.0,7/23,38.07%,SEM1;RAD51C;RAD51;RMI2;BLM;WRN;RMI1
gsea,Chemokine Receptors Bind Chemokines R-HSA-380108,-0.20954934162206704,-0.6329684041120662,0.9423503325942351,0.9688739598048731,1.0,4/17,27.01%,ACKR3;CXCL12;CCR9;CX3CL1
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.18192578873372228,-0.6239047149862466,0.9704016913319239,0.9724259702454602,1.0,8/29,38.07%,SEM1;SPIDR;RAD51C;RAD51;RMI2;BLM;WRN;RMI1
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.1840864545754638,-0.6154522737220032,0.9686192468619247,0.975445782189909,1.0,7/27,29.43%,BAG4;CPSF6;FGF1;ERLIN2;CEP43;FGFR1;FGF9
gsea,Interleukin-6 Family Signaling R-HSA-6783589,-0.20337875480444026,-0.6121063929290647,0.9537815126050421,0.9760481721214133,1.0,6/18,35.25%,TYK2;CRLF1;IL6ST;PTPN11;IL31RA;CNTFR
gsea,Nephrin Family Interactions R-HSA-373753,-0.19933893899916047,-0.6108394573834129,0.9461538461538461,0.975574446300411,1.0,8/21,32.52%,NCK1;WASL;MAGI2;CD2AP;KIRREL2;CASK;SPTBN1;ACTN1
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.16783052298429904,0.6086954605723287,0.9721669980119284,1.0,1.0,8/33,18.12%,ERCC4;POLR1B;ABL1;TOP3A;DNA2;RFC2;RAD9A;ATM
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.19642756533227546,-0.6074858597116757,0.9640591966173362,0.9759611105226346,1.0,5/21,27.72%,AHCYL1;PRKCE;PLD3;ITPR2;PRKCD
gsea,Resolution Of D-Loop Structures R-HSA-5693537,-0.17519648647683544,-0.6070413057413215,0.9789915966386554,0.975119926147015,1.0,8/30,38.07%,SEM1;SPIDR;RAD51C;RAD51;RMI2;BLM;WRN;RMI1
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.18978254716460355,-0.6060932711465139,0.96579476861167,0.9745367867933566,1.0,7/21,34.56%,ALDH6A1;DBT;PPM1K;MCCC2;SLC25A44;HIBADH;HIBCH
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,0.16833296238880724,0.6036995619992728,0.9696969696969697,1.0,1.0,9/32,18.26%,RYBP;RBBP4;EHMT1;EED;MAX;CHEK1;CDC7;PCGF6;MGA
gsea,Interleukin Receptor SHC Signaling R-HSA-912526,0.19405822505085812,0.5972101605762125,0.9534883720930233,1.0,1.0,9/21,24.40%,PIK3R2;INPP5D;GAB2;SHC1;JAK3;PIK3CA;JAK2;CSF2RB;GRB2
gsea,Activation Of SMO R-HSA-5635838,0.1958737954202272,0.5731660109410428,0.9576612903225806,1.0,1.0,1/16,1.04%,IQCE
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.17682239325457144,0.5523800029498895,0.9779559118236473,1.0,1.0,20/20,82.34%,AMN;MCCC1;HLCS;CBLIF;MTR;MTRR;ACACA;ABCD4;PCCA;MMADHC;TCN2;CUBN;SP8;PCCB;MMACHC;MMUT;MCCC2;CD320;LMBRD1;MMAB
gsea,PI-3K cascade:FGFR4 R-HSA-5654720,-0.18974568093054225,-0.5494997637357313,0.9792099792099792,0.9900227156656728,1.0,8/15,47.99%,FGF1;FGF9;PTPN11;FGF23;PIGU;FGF20;PIK3R1;FGF18
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.16277047575870018,-0.540736493831127,0.9897330595482546,0.9907413946933293,1.0,7/25,38.07%,SEM1;RAD51C;RAD51;RMI2;BLM;WRN;RMI1
gsea,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.1679374087378651,0.5329178493973722,0.9903100775193798,1.0,1.0,8/22,24.45%,PALB2;TOP3A;DNA2;RAD51B;ATM;BRIP1;RBBP8;BRCA2
gsea,Interleukin-10 Signaling R-HSA-6783783,-0.1725203437291462,-0.5303190363446859,0.9872340425531915,0.9914509384944121,1.0,5/21,30.90%,TNFRSF1A;TYK2;IL1R2;IL18;CSF1
gsea,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.1767877272950058,0.5101725770166812,0.9845559845559846,1.0,1.0,16/16,82.34%,AMN;ABCC1;CBLIF;LRP2;MTR;MTRR;ABCD4;MMADHC;TCN2;CUBN;LDLRAP1;MMACHC;MMUT;CD320;LMBRD1;MMAB
gsea,GPVI-mediated Activation Cascade R-HSA-114604,0.15390793878862447,0.4962023544908203,0.9941860465116279,1.0,1.0,10/29,20.81%,PLCG2;PIK3R2;LCK;LCP2;PRKCZ;FYN;PIK3R5;PDPK1;PIK3CA;PIK3R6
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,0.15771686646924643,0.4896187983573532,0.988394584139265,0.9963587018790101,1.0,3/20,10.72%,LRRC8C;NIPA1;SLC66A1
